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AIMS OF THIS THESIS
Myopia—and high myopia in particular—is more than merely an optical aberration. It is a 
highly prevalent eye disorder caused by elongation of the eyeball (Figure 1); in severe cases, 
myopia can lead to blindness. The worldwide prevalence of myopia is rising, as is the number 
of individuals who have become blind and/or visually impaired due to this disease. In the 
Netherlands today, at least one in three individuals is myopic. In recent decades, research into the 
causes of myopia has increased considerably. Family reports and twins studies suggest a strong 
influence of genetic background, and epidemiology studies have suggested that environmental 
factors—including near work, reading, education, and outdoor exposure—contribute to the 
risk of developing myopia. Although recent scientific breakthroughs have underscored the 
notion that myopia results from a complex interplay between nature and nurture, how these 
factors are interrelated and cause disease at the molecular level has remained unclear. Thus, 
more extensive research into the causes of myopia and refractive error is clearly needed. 
 
In this thesis, we addressed the following questions: 
Chapter 1:  What is the current state of knowledge regarding the genetic epidemiology of 
myopia and refractive error? 
Chapter 2:  What are the prevalence and visual consequences of myopia and refractive 
errors among the general population?
Chapter 3:  Which genetic risk factors are associated with the development of refractive 
error and endophenotypes?
Chapter 4:  How do environmental factors influence the development of myopia, and are 
gene-environment interactions involved in this process?
Chapter 5:  Can we describe functional mechanisms that play a role in the development  
  of myopia?
11
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Figure 1. Normal eye without refractive error (emmetropia, left) and with myopia (right)

1.2
General Introduction: Why do eyes become myopic? 
Adapted from: Caroline C.W. Klaver, Jan R. Polling, Jan W.L. Tideman, Magda A. Meester-Smoor, 
Virginie J.M. Verhoeven, Cataract & Refractive Surgery Today Europe, June 2014 
The original publication can be found at: http://bmctoday.net/crstodayeurope/pdfs/1014CRSTEuro_
Fundamentals.pdf 
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REFRACTIVE ERROR AND MYOPIA
Refractive errors (myopia, hyperopia, and astigmatism) are complex heterogeneous disorders of 
the human eye. Myopia (nearsightedness) is a common eye condition predominantly caused by 
an elongation of the eye’s axial length. With myopia, collimated light entering the eye produces 
an image that is focused in front of the retina rather than on the retina. This error causes blurred 
vision in the distance and can usually be corrected with negative glasses, contact lenses, and/or 
laser refractive surgery. Unfortunately, however, this elongation of the eye can lead to structural 
changes in the retina and/or optic disc, particularly in patients with a high degree of myopia. 
The most important determinants of refractive errors are axial length and corneal curvature1-3. Axial 
length and corneal curvature are highly correlated, and minimal changes in these parameters 
lead to large changes in refractive error4,5. Axial length is the primary determinant of refractive 
error and is based on a combination of anatomical factors, including anterior chamber depth, lens 
thickness, and vitreous chamber depth (Figure 1).
Although axial length measurement is more objective, precise, and reproducible compared to 
assessment of refractive status, the latter is usually used in clinical practice to define myopia. 
Refractive error (measured in diopters; D) can be easily measured automatically using an auto-
refractor. Refractive error is usually analyzed in terms of spherical equivalent (SE), which can be 
calculated using the following formula: SE = [sphere + (½ cylinder)].
Prevalence
Refractive errors are the most common eye disorders worldwide and are the leading cause of 
visual impairment6,7. Reports have shown that the prevalence of myopia is on the rise8-10. For 
example, in the United States, the prevalence of myopia increased by 145% in the past three 
decades, and the rate of high myopia (defined as refractive error greater than ‒6 D) increased by 
820%9. In South Korea, the prevalence of myopia and high myopia increased by 334% and 891%, 
Figure 1. Anatomical fractions of axial length 
Adapted from Meng et al.2; ACD = anterior chamber depth; LT = lens thickness; VCD = vitreous 
chamber depth; AL = axial length
15
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respectively, in the same time period10. Although the same trends occurred in African and European 
populations11-13, the prevalence of myopia is currently the highest among Asian populations. For 
example, 80% to 90% of all young adults in Singapore is myopic14. These dramatic figures are 
illustrated graphically in Figure 2.
High myopia (defined as more than -6 diopters) is associated with a significant risk of developing 
visual complications, including myopic macular degeneration, glaucoma, and retinal detachment 
(Figure 3)15-17. However, data regarding the absolute risk of visual impairment among individuals 
with (high) myopia are not available. 
Burden of disease
In the next ten years, an estimated 2.5 billion people worldwide will have myopia6, more than 
10% of these people (375 million) will have high myopia, and 49 million will develop severe visual 
impairment as a result of this condition. In addition to placing a considerable burden on the quality 
of life of the affected individuals and their families, this outcome can also have major financial 
consequences18,19. Given the current lack of adequate treatment modalities, the expected increase 
in new myopic patients—including here in the Netherlands—will create a significant burden in the 
coming ten years in terms of both our public health and our economy.
Course of refractive error and the onset of myopia
Children are born hyperopic and usually become emmetropic by 6-9 years of age due to a process 
known as emmetropization20. Although the cornea generally stabilizes at around six years of age21, 
the power of the lens usually continues to change until age 12, and the eye’s axis can continue to 
elongate into adulthood (i.e., until 20-25 years of age)21,22. The severity of adult myopia is inversely 
correlated with the age of onset: the onset of high myopia usually occurs in the first decade of life, 
whereas mild myopia often develops in the teenage years or early adulthood. 
Figure 2. Increasing prevalence of myopia in Asia and Europe, with the estimated prevalence in 
Europe for the year 202014,57
16
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Current hypothesis regarding the pathogenesis of myopia
The currently accepted hypothesis regarding the pathogenesis of myopia is that excessive eye 
growth is induced by a visually evoked signaling cascade that originates in the retina, traverses 
the retinal pigment epithelium (RPE) and choroid, and terminates in the sclera, where active 
remodeling of the extracellular matrix (ECM) causes the eye to become elongated. However, the 
physical events that trigger this cascade, the cell types involved, and the biochemical drivers of 
this cascade are currently unknown.
RISK FACTORS FOR DEVELOPING MYOPIA
Genetic risk factors
Evidence for the heritability of refractive error and myopia generally stems from studies of familial 
clustering23, high heritability values in twins3,24, and high occurrence rates in offspring25-27. With 
respect to refractive error, the proportion of phenotypic variation that can be attributed to genetic 
variation is estimated at >90%24.
Myopia is a common feature of several heritable connective tissue disorders, including Marfan 
syndrome (OMIM #154700), which is caused by mutations in the fibrillin-1 gene (FBN1), and 
Stickler syndrome (OMIM #108300 and #604841), which is caused by mutations in the COL2A1 
and COL11A1 genes28. Associations between these loci and common myopia have been 
suggested only for COL2A129,30.
Figure 3. Examples of complications that can occur in patients with high myopia: 1. chorioretinal 
atrophy; 2. subretinal neovascularization; 3. macular hole; and 4. glaucoma
17
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The search for genes that underlie the heritability of myopia was initiated by linkage studies 
among families and high-risk groups, yielding several loci associated with refractive phenotypes 
(MYP 1-18)7,27,31,32. Familial linkage studies have highlighted the heterogeneous genetic etiology 
of refractive error. Searches for additional candidate genes yielded positive associations with 
several genes, including genes that encode collagens (COL2A1 and COL1A129,30), transforming 
growth factors (TGFβ1, TGFβ2, and TGIF133-35), hepatocyte growth factor and its receptor (HGF 
and CMET36-39), insulin-like growth factor (IGF140,41), matrix metalloproteinases (MMP1, MMP2, 
MMP3, and MMP942,43), and the ocular developmental gene PAX6 44.
Although these studies yielded some associations, a general lack of validation emerged across 
studies. A more powerful and successful approach is genome-wide association study (GWAS) 
analysis, which robustly investigates numerous single-nucleotide polymorphisms (SNPs) across 
the genome in large populations (Figure 4)45.
Environmental risk factors
Without doubt, myopia is caused by both nature and nurture. Environmental factors are increasingly 
viewed as triggers for onset and progression of myopia46,47. In particular, education is an important 
risk factor; the risk of developing myopia is up to four times higher in persons with a university-
level education compared to persons with only primary schooling48. Similar effects are observed 
for urban versus rural areas49. Two factors appear to contribute to these associations: (1) myopic 
children spend less time outdoors than non-myopic children, and (2) they perform more near 
work at an earlier age48. Exactly why being outdoors is so protective is unclear, but several animal 
experiments suggest that dopamine release in the retina triggered by the high light intensity 
Figure 4. The principle of a genome-wide association study
18
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outdoors slow the elongation of the eyeball50. Why near work is detrimental is unclear as well, but 
animal studies on this topic suggest that near work increases hyperopic defocus in the peripheral 
retina, and thereby forms a trigger for eye growth51.
Gene-environment interactions
In most diseases that have both genetic and environmental factors, these two categories of 
factors generally have considerable interactions31,48,52. To date, gene-gene and gene-environment 
interactions have not been studied systematically for myopia or refractive error. Because 
interrelationships between genes and the environment also determine a high proportion of the 
variance in the disease53, a shift in focus from the current approach of a purely genetic dissection 
to the identification of gene-environment interactions may be challenging, but it is essential for 
identifying the missing links in myopia. 
CURRENT THERAPEUTIC OPTIONS
The current treatment strategies for myopia are limited. Atropine, a muscarinic receptor antagonist 
that can be applied topically to the eye, has been the most effective in terms of inhibiting eye 
growth54. Unfortunately, atropine has unfavorable side effects, including photophobia and blurred 
vision while performing near work, thus reducing patient compliance55. Optical correction, 
including cornea-reshaping contact lenses, can also slow the progression of myopia; however, 
these approaches are generally less effective than atropine56. 
These currently available measures will not be sufficient to counteract the predicted increase in 
new myopes; thus, there is a clear growing need for new treatments that are both effective and 
tolerated. 
19
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ABSTRACT 
Purpose
To estimate the prevalence of refractive error in adults across Europe.
Methods
Refractive data (mean spherical equivalent) collected between 1990 and 2013 from fifteen 
population-based cohort and cross-sectional studies of the European Eye Epidemiology (E3) 
Consortium were combined in a random effects meta-analysis stratified by 5-year age intervals 
and gender. Participants were excluded if they were identified as having had cataract surgery, 
retinal detachment, refractive surgery or other factors that might influence refraction. Estimates of 
refractive error prevalence were obtained including the following classifications: myopia ≤-0.75 
diopters (D), high myopia ≤-6D, hyperopia ≥1D and astigmatism ≥1D. 
Results
Meta-analysis of refractive error was performed for 61,946 individuals from fifteen studies with 
median age ranging from 44-81 and minimal ethnic variation (98% European ancestry). The age-
standardised prevalences (using the 2010 European Standard Population, limited to those ≥25 
and <90 years old) were: myopia 30.6% (95% Confidence Interval (CI) 30.4-30.9), high myopia 
2.7% (95% CI 2.69-2.73), hyperopia 25.2% (95% CI 25.0-25.4) and astigmatism 23.9% (95% CI 
23.7-24.1). Age-specific estimates revealed a high prevalence of myopia in younger participants 
(47.2% (CI 41.8-52.5) in 25-29 years-olds). 
Conclusions
Refractive error affects just over a half of European adults. The greatest burden of refractive error 
is due to myopia, with high prevalence rates in young adults. Using the 2010 European population 
estimates, we estimate there are 227.2 million people with myopia across Europe. 
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INTRODUCTION
Refractive error occurs when there is failure of the eye to correctly focus rays of light from an object 
onto the retinal plane. The resultant image perceived by the individual is blurred and refractive 
correction is required in order to see clearly. Refractive error can be divided into myopia (‘short 
or near-sightedness’), hyperopia (‘long or far-sightedness’) and astigmatism. In myopia, light is 
focussed to a point anterior to the retina as a result of excessive refraction at the cornea or lens, or, 
more commonly, an increased length of the eye (‘axial myopia’). In hyperopia, the reverse occurs 
with an image forming posterior to the retinal plane as a result of either inadequate refraction or 
a short axial length. In astigmatism, the refractive power of the eye is uneven across different 
meridians. 
Refractive error requires detection and treatment in the form of glasses, contact lenses or, 
more recently, refractive surgery. These clinical services are readily available in most European 
countries, although they come with significant financial implications to both national health care 
systems and to individuals1. However, uncorrected refractive errors are still responsible for up 
to 42% of the cases of visual impairment worldwide2, and remain prevalent even in high income 
countries3-6. Uncorrected refractive error in both low and high-income countries has significant 
economic implications in terms of potential lost productivity7.
The magnitude of refractive error in developed countries within individuals of European descent 
has been estimated by the Eye Diseases Prevalence Research Group, ten years ago, and the 
US National Health and Nutrition Examination Survey (NHANES) data3,8. However, the estimate of 
refractive error burden in Europe was based on a single cohort9. The European Eye Epidemiology 
(E3) consortium is a collaborative initiative between thirty-three cohort studies across Europe, to 
share and meta-analyse epidemiological data on eye disease in adults. The aim of the current 
study was to provide more current and precise estimates of the prevalence of refractive error 
across Europe.
26
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MATERIAL AND METHODS
Studies and participants
To date, E3 has data from thirty-three studies with a range of ophthalmic data on approximately 
124,000 individuals from population-based and case-control studies. This study drew on the 
fifteen E3 population-based cohort and cross-sectional studies that collected refractive error data 
(n=68,350). As described in Table 1, participants included in this meta-analysis were largely from 
Northern and Western Europe, mainly of middle to late age, and refractive error measurements 
were performed between 1990 and 2013. Three studies recruited participants nationally and the 
remaining twelve recruited from a local population. Further detail on individual study design and 
sampling method is provided in Table 1; broadly, the majority of study samples were obtained 
by identification of potential participants (within defined age bands and/or regions) using local 
registries, with some studies using random sampling (n=3). All studies adhered to the tenets of the 
Declaration of Helsinki, and relevant local ethical committee approvals with specific study consent 
were obtained.
Inclusion and exclusion criteria
Studies in the E3 consortium were eligible for inclusion in this analysis if they were population-
based, and data on refraction, together with age at measurement and year of birth, were available. 
Study participants were excluded if they were identified as having had cataract surgery, retinal 
detachment, refractive surgery or other factors that might influence refraction (eg. keratoconus), 
at the discretion of each study’s analysis team. 
Demographic and outcome variables 
All included studies measured non-cycloplegic refraction (i.e. no dilating drops were used) using 
the technique of subjective refraction, autorefraction or a combination of focimetry (measuring 
an individuals glasses) or autorefraction followed by subjective refraction  (Table 1). Participant’s 
spherical equivalent (SE) was considered as the mean SE of the two eyes calculated using the 
standard formula (SE = sphere + (cylinder/2)). Refractive error was categorized using the following 
definitions: myopia ≤ -0.75 diopters (D), low myopia ≤ -0.75 to > -3 D, moderate myopia ≤ -3 D to > 
-6 D, high myopia ≤ -6 D, hyperopia ≥ 1 D, high hyperopia ≥ 3 D and astigmatism ≥ 1 D.  Definitions 
of myopia vary in the literature; the cut-off of -0.75 D was chosen as unaided visual acuity at this 
level approximates 0.3 LogMAR (Logarithm of the Minimum Angle of Resolution)10, a commonly 
used driving standard, and this has been used in recent international meta-analyses of the genetic 
epidemiology of refractive error and myopia11. 
Differences in age (in five year age bands from ≥15 years to ≥90 years), gender (male/female) 
and geographical European region were examined. Geographical variations in the prevalence of 
myopia were investigated by dividing countries in three areas (Northern, Western and Southern 
Europe) according to the United Nations Geoscheme12. Information on ethnicity, when available, 
was recorded using a modified classification system based on genetic ancestry13. 
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Statistical analysis
Study specific summary data were obtained. A random effects meta-analysis was performed for 
spherical equivalent and repeated for refractive classifications overall and stratified by age. This 
enabled calculation of pooled estimates of refractive error prevalence, with studies weighted by 
sample size and between-study variance and a summary estimate standard error calculated from 
the inverse sum of the adjusted weights. A random effects model was chosen over a fixed effects 
model, to allow for heterogeneity in study design characteristics. 
Age-standardised prevalences were calculated using the following steps: firstly, age-specific 
prevalences were estimated using random-effect meta-analyses. Secondly, an age-standardisation 
with adjustments to age-specific estimates according to the European Standard Population 2010 
was performed14. This enabled refractive error prevalence estimates that are representative for the 
European population, with appropriate weighting to the age demographic distribution of Europe. 
Subsequent random effects meta-analyses were performed with stratification by age and gender, 
and subsequently age and geographical region, with differences between groups evaluated using 
ANOVA tests. 
Statistical analysis was performed using Stata version 13.1 (StataCorp. 2013. Stata Statistical 
Software: Release 13. College Station, TX: StataCorp LP). Graphical outputs were obtained using 
either Stata or ggplot215 in R (R Core Team (2014). R: A language and environment for statistical 
computing. R Foundation for Statistical Computing, Vienna, Austria. URL http://www.R-project.
org).
RESULTS
Fifteen studies contributed a total of 61,946 individuals after exclusions  (Figure 1). The median 
age of the included populations ranged from 44 to 78 years old  (Table 1). There was a slight 
female predominance in the combined study (57.6% females). Data on ethnicity was only available 
for 50% of participants, and in these there was minimal ethnic diversity (98% European ancestry), 
so no further analysis of ethnicity was carried out. 
The distribution of refractive error displayed a leptokurtotic distribution  (Figure 2), with a median 
spherical equivalent of 0.56 D (range -25.13 to 22.19). The distribution was asymmetric with a 
greater frequency of individuals with a negative refractive error.
Given there were only 314 participants aged 15-24 years and 156 greater than 90 years of age, 
subsequent analyses are limited to those aged ≥25 and <90 years (n=61,476). The overall myopia 
prevalence in our meta-analysis was 24.2% (95% Confidence Interval (CI) CI 19.9-28.5), with a 
European age-standardised myopia prevalence of 30.6% (95% CI 30.4-30.9)  (Table 2). Myopia 
was most common in younger participants (peaking at 47.2% (95% CI 41.8-52.5) in those aged 
25-29 years), almost double the prevalence of those of middle and older age (27.5% (95% CI 
23.5-31.5) in those aged 55-59 years)  (Figure 3A). Point estimates of myopia prevalence in those 
aged 15-19 years were 27.4% (95% CI 17.0-37.8), increasing to 34.2% (95% CI 27.9-40.6) in 
those aged 20-24 years. All degrees of myopia followed a similar pattern of higher prevalence in 
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the younger cohorts, lower prevalence in the middle aged and more elderly participants, and an 
increase in the very eldest participants, albeit with wide confidence intervals, most likely related to 
cataract development. Age-standardised prevalence of high myopia across all age groups was 
2.71% (95% CI 2.69-2.73), with 3-5% of young to middle-aged individuals affected and 1-2% of 
older individuals  (Figure 3B). 
Overall prevalence of hyperopia was 34.7% (95% CI 27.9-41.6), with an age-standardised 
prevalence of 25.2% (95% CI 25.0-25.4). There was less hyperopia in young participants (6.4% 
(95% CI 3.8 - 9.0) in those aged 25-29 years), compared to those in middle to older age (31.2% 
(95% CI 27.5-34.9) in those aged 55-59 years) although hyperopia rates declined after 75 years 
of age. The prevalence of high hyperopia followed a similar pattern, affecting 1-3% of younger 
and 10-13% of older individuals  (Figure 3C). Across all ages, the prevalence of astigmatism was 
27.3% (95% CI 22.6-32.1) with an age-standardised estimate of 23.9% (95% CI 23.7-24.1). The 
prevalence of astigmatism remained fairly stable at 15-25% in young and middle-aged participants 
(17.0% (95% CI 15.1-18.8) in those aged 45 to 49 years). However, in participants over 65 years 
of age, astigmatism became more common (51.1% (95% CI 40.4-61.8) in those aged 80-84 years) 
(Figure 3D). 
Age- and gender- specific analyses for myopia, hyperopia and astigmatism are reported in Table 
3. There were no significant differences in myopia prevalence between men and women across 
age strata. However, overall there was a significantly higher prevalence of astigmatism in men 
(p=0.001), with a mean difference of 3.8% across all ages, and a significantly higher prevalence 
 
Thirty-three studies with a range of ophthalmic data (approximately n=124,000) 
Fifteen population-based studies participating in refractive error meta-analysis (n=68,350) 
Exclusions: - Cataract surgery (n=4748) - Laser refractive surgery (n=242) - Retinal detachment (n=236) - Other (n=1178) 
Total individuals with refraction and age (n=61,946) 
Total individuals with refraction, age and gender (n=61,927) 
Total individuals with refraction, age and ethnicity (n=30,650) 
Figure 1. Flow chart of refractive error meta-analysis within E3
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of hyperopia in women (p=0.04) with a mean difference of 2.5% across all ages. 
Differences in the myopia prevalence between different European regions, according to the UN 
European Geoscheme, were examined. Only one cohort contributed to the Southern European 
division (Thessaloniki Eye Study, Greece), with participants all over the age of 60 years, thus 
the majority of the studies were in Northern and Western regions. The prevalence of myopia did 
not differ between Northern and Western countries and followed a similar pattern across all age 
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Figure 2. Distribution of refractive error 
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Figure 3A. Prevalence of myopia (SE ≤ -0.75D) according to age, with 95% confidence intervals 
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2
groups. The single Southern participant cohort appeared to have a higher level of myopia in its 
older participants when compared to Northern and Western countries, however there were large 
confidence intervals for these estimates (80-84 year-old myopia prevalence in North 13.6% (95% 
CI 9.3-18.0), West 18.0% (95% CI 16.1-21.1) and South 29.1% (95% CI 19.1-39.1). Overall there 
were no significant differences across age strata between the three regions of Europe studied 
(p=0.70).
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DISCUSSION
Meta-analysed data from fifteen population-based adult cohort and cross-sectional studies across 
Europe indicated age-standardised prevalence of 30.6% for myopia, 25.2% for hyperopia and 
23.9% for astigmatism. This meta-analysis usefully incorporates data from across Europe and is 
not limited to a particular place or age group. The most significant burden of refractive error within 
Europe was from myopia. 
A clear trend of higher levels of myopia in younger individuals was identified, with a rising 
prevalence during late teens and 20s reflecting the known natural history of the condition16. The 
peak prevalence of myopia was identified in the 25-29 years age group (47.2% (95% 41.8-52.5). 
In older individuals, the prevalence of myopia was lower, for example 15.9% (95% CI 13.7-18.1) 
in those aged 65-69 years old. This may reflect the rising prevalence of myopia in younger 
generations, or the known hyperopic shift in aging17,18. In our aged 75 or over participants, there 
was an increase in myopia prevalence. While we aimed to exclude those having undergone 
cataract surgery (and participants with documented cataract in some studies), the rise in myopia 
likely reflects the development of nuclear cataract, which is known to be associated with a myopic 
shift as a result of increasing lens power19. However, this age-related change in refraction may also 
occur irrespective of visible lens opacity; in the Beaver Dam Study, a ten-year longitudinal myopic 
shift (-0.19D, 95% CI -0.32 to -0.06, p<0.001) was observed in those over 70 years old, even after 
adjusting for nuclear sclerosis grading17. We did not confirm the observation of previous studies of 
higher myopia prevalence in women20.
In comparison to previous estimates, the overall burden of myopia in our population appears 
similar but slightly greater to that of other studies. The 2004 Eye Diseases Prevalence Research 
Group estimated myopia prevalence at 26.6%, 25.4% and 16.4% for European, North American 
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and Australian sub-analyses respectively8. This study included the Beaver Dam Eye Study21, the 
Baltimore Eye Survey22, the Blue Mountains Eye Study23, the Melbourne Visual Impairment Project24 
and the Rotterdam Study I25, which was also included in this meta-analysis. In their youngest 
cohort (40-49 years), 36.8% of white men and 46.3% of white women were myopic, similar to 
our estimates of 42.0% and 39.8% in 40-44 year-olds, albeit with no gender difference. The US 
1999-2004 National Health and Nutrition Examination Survey (NHANES) examined refractive error 
variation by age in three ethnicities; the prevalence of myopia in non-Hispanic white participants 
20-39 years of age was 35.1% in men and 42.3% in women, whilst the prevalence in those ≥ 60 
years was 23.1% in men and 18.6% in women20. These prevalence rates are again very similar 
to that found in our data, although we did not find higher levels of myopia in young females. Both 
comparative estimates are based on a definition of myopia ≤ -1D, and are therefore not directly 
comparable to our study definition of myopia ≤ -0.75D, an issue often encountered in refractive 
error epidemiology where there is a lack of consensus on definitions of refractive error. The adult 
prevalence of myopia in South-east Asia is of much greater magnitude than that seen in studies 
of European ancestry26-29, with remarkably high levels of myopia seen in young individuals30,31. The 
number of participants in our meta-analysis of Asian origin was very low, precluding meaningful 
reporting of these estimates. 
High myopia prevalence was relatively low in Europe, with an age-standardised estimate of 2.7% 
(95% CI 2.69-2.73). The highest prevalence was observed in younger participants, albeit with 
wider confidence intervals due to smaller sample size (Table 2). Prevalence in older participants 
was low, potentially reflective of generational changes, or perhaps exclusion due to the earlier 
need for cataract surgery in high myopes compared to other refractive groups32. Our greatest 
high myopia prevalence of 5.9% (95% CI 1.3-10.5) in 15-19 year-olds remains much lower than 
that seen in, for example, urban China where up to 14% of 17 year-olds are highly myopic33. In 
non-Hispanic White individuals in the NHANES 1999-2004 data, high myopia appeared slightly 
more common than in our data; for example in those aged 20-29 years-old “severe” myopia was 
identified in 7.4%, compared to 2.8% and 5.3% in those aged 20-24 and 25-29 respectively in this 
European study. However the NHANES definition of severe myopia (≤ -5D) again differs slightly 
from our definition of high myopia (≤ -6D).
Using the same definition of high hyperopia (≥ 3D), our study appeared to have less hyperopia 
than the Eye Diseases Research Group8; for example in 70-74 year-olds 21.3% of white women 
and 16.9% of white men were highly hyperopic compared to just 12.8% in our European data, 
which may again reflect a generational or cohort effect. 
Astigmatism rates were fairly constant (15-25%) across cross-sectional age categories, but were 
higher after the age of 65. This finding has been observed in other studies, together with a shift 
from with-the-rule to against-the-rule astigmatism20,23,29. Across all age groups, we identified higher 
astigmatism prevalence in men, particularly evident in middle to later ages (for example 39.5% 
in women and 46.2% in men aged 70-74). This observation was similar in the older participants 
of the NHANES 1999-2004 study, where in participants over the age of 60 years the astigmatism 
prevalence in women was 46.1% and in men 54.9%20. 
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The major strength of our study is the large sample size contributing to the prevalence estimates, 
providing a unique opportunity to estimate the burden of refractive error in middle and older 
aged individuals across Europe. This is beneficial for planning of clinical services and raises 
awareness, for both clinicians and economists, of the future potential issues of rising myopia 
levels and associated visual impairment34. Refractions were all non-cycloplegic, which is common 
practice for population-based adult ophthalmic epidemiological studies, thus making this study 
comparable to previous research35,36. 
Despite age and gender stratification, significant heterogeneity between studies remained in the 
meta-analysis. There are inherent differences in the included studies in terms of study design, 
refraction technique and cohort sampling, together with between country differences in levels 
of urbanisation, economy, education and climate which may influence refractive error. We were 
unable to stratify by these factors in this meta-analysis as person-specific data was not available 
for all studies. This study was mainly comprised of middle and older aged individuals, therefore 
our estimates of refractive error prevalence carry greater confidence for these ages since they 
are based on more precise estimates with narrow 95% confidence intervals. The majority of 
the studies in this meta-analysis originate from Northern and Western European countries, and 
therefore our estimates of refractive error are more representative of these European countries. 
Although our sample includes either national or locally recruited population-based studies, like all 
epidemiological studies there may be a bias of participants volunteering for an eye examination 
being more ‘health conscious’. We suspect this would have little effect on the prevalence of 
refractive error, and if anything result a slight underestimation of the prevalence. Finally, refractions 
were performed over a twenty-year period and, therefore our estimates of prevalence may be 
subject to error given temporal trends in refractive error prevalence. However, refractions were 
performed between 2000 and 2010 in thirteen out of the fifteen studies, reducing this variability.
In conclusion, this study estimates refractive error affects just over a half of European adults. 
Myopia represented the greatest burden, with an estimated 227.2 million people across Europe 
affected (using the 2010 European population estimates)37. Based on study prevalence estimates 
of high myopia, this also suggests there are 20.1 million people across Europe who are at higher 
risk of the associated sight threatening complications, such as retinal detachment, that this degree 
of myopia infers34.
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ABSTRACT
Objective
To study the frequency and causes of visual impairment in relation to refractive error.
Design
Population-based cohort study
Participants
A total of 6,597 participants from Rotterdam Study I (baseline and 4 follow-up examinations) and 
of 2,579 participants from Rotterdam Study II (baseline and 2 follow-up examinations), all aged 
55+ years, were included.
Methods
Participants underwent an extensive ophthalmic examination including best-corrected visual 
acuity and objective refraction, fundus photography, visual field perimetry, and OCT imaging of 
macula and optic disc. We calculated cumulative risks and odds ratios of visual impairment for 
various refractive error categories, determined causes by using all screening information as well 
as medical records. Main Outcome Measures: Unilateral and bilateral low vision (WHO criteria: 
VA <0.3 and VA ≥0.05; US criteria: VA <0.5 and VA ≥0.1) and blindness (WHO criteria: VA <0.05; 
US criteria: VA<0.1). 
Results
Cumulative risks of visual impairment ranged from virtually 0 in all refractive error categories at age 
55 to 9.5% (standard error (se) 0.01) for emmetropia, 15.3% (se 0.06) for high hyperopia to 33.7% 
(se 0.08) for high myopia, at age 85. The major causes of visual impairment in highly hyperopic 
persons were age-related macular degeneration (AMD), cataract, and combined causes (each 
25% ); in highly myopic persons the major cause was myopic macular degeneration (38.9%). The 
major causes of visual impairment for the other refractive error categories were AMD and cataract. 
Compared to emmetropes, high myopes had a significantly increased risk of visual impairment; 
those with ≤-6 D & ≥-10 D had a risk of OR 3.4 (95% CI 1.4-8.2) of visual impairment; those with 
<-10 D had OR 22.0 (95% CI 9.2-52.6).
Conclusion
Of all refractive errors, high myopia has the most severe visual consequences. Irreversible macular 
pathology is the most common cause of visual impairment in this group.
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INTRODUCTION
Refractive errors - both myopia and hyperopia - are very common human eye disorders and 
leading causes of visual impairment worldwide.1-3 Myopia is characterized by an elongation of 
the eye, and is accompanied by structural changes of the retina and choroid.4 These changes 
can lead to potentially blinding complications such as myopic macular degeneration, open-angle 
glaucoma and retinal detachment.5,6 Although all myopic eyes are at risk for complications4,7,8, 
highly myopic eyes, i.e., -6 diopters (D) or worse, are particularly at risk to develop functional 
blindness at a relatively young age. Hyperopia (farsightedness), by contrast, is a condition in 
which the eye is shortened. For this refractive error category, the risks of visual impairment are 
less well studied, but it is known that persons with hyperopia have a higher risk of amblyopia, 
strabismus and closed-angle glaucoma.9 An association with age-related macular degeneration 
(AMD) has also been described.10
Although numerous studies have addressed population frequencies of low vision and blindness 
none have focused on visual loss as a function of the full spectrum of refractive errors. In addition, 
frequency of causes of blindness and low vision specified per refractive error category have not 
been described until now. Given the current rise in prevalence of this trait11-13, this information 
can be useful for clinicians, patients, and researchers, and will increase awareness of the visual 
consequences of refractive errors. 
In this study, we investigated the frequency and causes of blindness and low vision stratified for 
various refractive error categories in 2 independent cohorts of the population-based prospective 
Rotterdam Study.
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MATERIAL AND METHODS
Study population
The rationale and design of the Rotterdam Study have been described in detail elsewhere.14 In 
brief, this prospective population-based follow-up study focuses on chronic ophthalmologic, 
neurologic, cardiovascular, and locomotor diseases in middle aged and elderly participants living 
in Ommoord, a city district of Rotterdam, the Netherlands. Baseline data for the ophthalmic part 
were collected between 1991 and 2002 and follow-up examinations were performed at 2-4 years 
(Figure 1). A total of 99% of study participants were from European descent. For this analysis, 
we included 9,176 participants from two independent cohorts of the Rotterdam Study. The first is 
Rotterdam Study I (RS-I): 6,597 participants aged 55 years and older. Baseline examinations took 
place between 1990 and 1993, and four follow-up examinations were performed in 1993-1995, 
1997-1999, 2002-2004, and 2009-2011 (Figure 1). The second cohort is Rotterdam Study II (RS-II), 
which included 2,579 participants aged 55 years and older. Baseline examinations took place in 
between 2000 and 2002, and two follow-up examinations were performed in 2004-2005 and 2011-
2012 (Figure 1). Persons with bilateral pseudophakia or aphakia at baseline with no knowledge of 
prior refractive error were excluded (n = 278). From these two cohorts, 9,176 participants with data 
on refractive error and visual acuity at baseline were eligible for the current analysis. The Medical 
Ethics Committee of the Erasmus University had approved the study protocols, and participants 
had given a written informed consent in accordance with the Declaration of Helsinki. 
Figure 1. Participation and ophthalmological measurement from each examination interval of the 
Rotterdam Study 
RS, Rotterdam Study
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Ophthalmic data collection
All patients underwent an extensive ophthalmological examination. Visual acuity was measured 
using the Lighthouse Distance Visual Acuity Test, a modified Early Treatment Diabetic Retinopathy 
Study chart.15 To evaluate the best-corrected visual acuity (BCVA), refraction was initially obtained 
after objective autorefraction (Topcon RM-A2000, Topcon Optical Company, Tokyo, Japan), and 
then subjectively adjusted. Screening of visual fields was performed using a modified 76-point 
supra-threshold perimetry test (Humprey Visual Field Analyzer, Zeiss, Oberkochen, Germany); 
visual field defects were confirmed by Goldmann perimetry. After pupil dilation, optic nerve head 
and macular area imaging was performed using simultaneous stereoscopic photography (Topcon 
TRC-SS2, Topcon optical Company, Tokyo, Japan), followed by a 35° film fundus camera (Topcon 
TRV-50VT, Topcon Optical Company, Tokyo, Japan). During the last examination rounds, RSI-4, 
RSI-5 and RSII-2 respectively, a Topcon digital 35° colour fundus camera (Topcon TRC 50EX with 
a Sony DXC-950P digital camera; 0.44 megapixel) was used.
Low vision and blindness were classified according to the WHO criteria16 and US criteria:
For participants with bilateral blindness and low vision, three clinical investigators (C.C.W.K, 
V.J.M.V., and K.T.W.) reached consensus on the final determination of the cause of visual 
impairment after reviewing all screening information, fundus transparencies, and medical 
information provided by ophthalmologists. 
Statistical analysis
Mean spherical equivalent (SE) was calculated according to the standard formula (SE=spherical 
value + ½*cylinder). When data from only one eye were available, the SE of this eye was used. 
Mean SE was categorized into high myopia (≤ -6 diopters (D)), moderate myopia (>-6D & ≤-3D), 
low myopia (<-3D & ≤-0.75D), emmetropia (>-0.75D & <0.75D), low hyperopia (≥0.75D & <3D), 
medium hyperopia (≥ 3D & <6D), and high hyperopia (≥ 6D), using previously defined criteria.17 
High myopia and high hyperopia were further classified as high myopia <-10 D and ≤-6 D & ≥-10 
D and high hyperopia >10 D and ≥6 & ≤10 D. Visual acuity at last visit was categorized into normal 
vision, low vision, and blindness according to WHO and US criteria as defined above. For bilateral 
visual impairment, BCVA was used. Unilateral visual impairment was defined as visual impairment 
in only one eye. 
We calculated the number of cases with bilateral and unilateral blindness and low vision as a 
percentage of the total number of all cases with blindness and low vision at the endpoint of the 
study per refractive error category.
Cumulative risks of bilateral visual impairment were estimated per refractive error category using 
Kaplan Meier product limit analysis. We assigned the age at diagnosis of blindness or low vision 
as the mean between the examination at which this endpoint was first observed and the previous 
examination. For participants who did not develop the endpoint, we used age at last examination 
for censoring. Participants who died or were lost to follow-up were counted at the time of the last 
 Low vision: WHO: VA <0.3 and ≥0.05; US: VA <0.5 and ≥0.1
 Blindness: WHO: VA <0.05; US: VA<0.1
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examination. All participants aged 85+ years were censored at age 85 years to maintain unbiased 
estimates. Cumulative risks per refractive error category were compared with the log-rank test of 
equality (Mantel-Cox) using emmetropia as the reference group.
Causes of bilateral blindness and low vision (according to the WHO criteria) were categorized, 
and frequencies of causes were calculated per refractive error category. We calculated mean 
age at diagnosis of bilateral visual impairment per refractive error category, and calculated mean 
spherical equivalent per refractive error category, stratified by normal vision, low vision and 
blindness. Statistical differences at nominal P-value <0.05 between refractive error categories 
for age at diagnosis and between visual acuity categories for mean SE were calculated using 
Student’s T test. The risk of blindness and low vision (reference normal vision) for persons with 
various refractive error categories (reference emmetropia) was assessed using logistic regression 
analysis with blindness and low vision as a combined outcome, correcting for age and sex. We 
used SPSS version 20.0.0 (SPSS Inc.) for all analyses.
RESULTS
General characteristics of the 9,176 study participants are presented in Table 1. At baseline, we 
identified 98 prevalent cases (1.1%) with bilateral low vision and 29 cases (0.3%) with bilateral 
blindness (WHO criteria). After a mean follow-up time of 9.6±6.1 years, respectively 62 and 26 
persons developed incident bilateral low vision and blindness. Subjects in RS-I were generally 
younger (mean age at inclusion 69.0 versus 64.1 years) and were less myopic (mean SE 0.84 
vs. 0.47 D) than those in RS-II, due to a cohort effect described in our previous work.17 The 
characteristics of all cases who had received a diagnosis of bilateral low vision or blindness by 
the end of the study can be found in Table 2 (WHO criteria) and Table 3 (US criteria; available at 
http://aaojournal.org). 
The distribution of bilateral and unilateral blindness and low vision (WHO criteria) per refractive 
error category is shown in Figure 2. The high myopia group showed the highest percentage of 
bilateral blindness (9.6%) and low vision (25.0%). Persons from the high hyperopia group had the 
highest proportion of unilateral blind eyes (39.1%).
Kaplan Meier curves showing cumulative risk of visual impairment for high myopia, emmetropia 
and high hyperopia appear in Figure 3. Cumulative risks ranged from virtually 0 in all refractive error 
categories at age 55 to 9.5% (standard error (se) 0.01) for emmetropia, 15.3% (se 0.06) for high 
hyperopia to 33.7% (se 0.08) for high myopia, at age 85. Risks for high myopia started to increase 
gradually before age 60; for high hyperopia between 60 and 70 years of age, whereas emmetropia 
showed a more steady increase in risk from the age of 70. Cumulative risks for persons with low 
to moderate myopia and hyperopia were not significantly different from persons with emmetropia 
(P 0.09; P 0.78). Kaplan Meier curves for US criteria can be found in Figure 4 (available at http://
aaojournal.org). Cumulative risks ranged from virtually 0 in all refractive error categories at age 55 
to 28.9% (standard error (se) 0.03) for emmetropia, 41.5% (se 0.08) for high hyperopia to 59.2% 
(se 0.08) for high myopia, at age 85.
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Table 1. Characteristics of the study population
 Rotterdam Study I Rotterdam Study II Total
N at baseline 6597 2579 9176
Follow-up time, mean ± SD (yrs) 9.8  ± 6.0 8.9 ± 2.9 9.6  ± 6.1
Baseline age, mean ± SD (yrs) 69.0 ± 9.0 64.1 ± 7.4 67.6 ± 8.8
Sex, % men 41.0 45.0 42.0
Visual acuity at last measurement - WHO criteria
Bilaterally visually impaired subjects, % 2.2 0.5 1.7
Bilaterally blind subjects, % 0.8 0.1 0.6
Unilaterally visually impaired subjects, % 6.1 3.8 5.5
Unilaterally blind subjects, % 3.4 2.1 3.0
Visual acuity at last measurement - US criteria
Bilaterally visually impaired subjects, % 6.6 1.8 5.2
Bilaterally blind subjects, % 1.1 0.1 0.8
Unilaterally visually impaired subjects, % 12.5 4.8 10.3
Unilaterally blind subjects, % 3.4 2.2 3.1
Refractive error
Spherical equivalent, mean ± SD (D) 0.84 ± 2.54 0.47 ± 2.49 0.74 ± 2.53
High myopia ≤-6D, % 1.8 1.8 1.8
Medium myopia >-6D & ≤-3D, % 5.2 7.3 5.8
Low myopia -3D & ≤-0.75D, % 9.5 12.8 10.4
Emmetropia >-0.75D & <0.75D, % 25.4 26.9 25.8
Low hyperopia ≥0.75D & <3D, % 44.4 41.1 43.4
Medium hyperopia ≥3D & <6D, % 12.3 9.2 11.4
High hyperopia ≥6D, % 1.5 1.0 1.3
SD, standard deviation; D, diopters; WHO, World Health Organization
Table 2. Characteristics of all cases  with bilateral blindness, low vision and normal vision at the 
end point of the study (WHO criteria)
 Bilaterally blind Bilaterally visually Subjects with 
subjects impaired subjects bilateral visual acuity ≥ 0.3
 N = 55 N = 160 N = 8961
Age of onset, mean ± SD (yrs) 78.1 ± 11.3 79.7 ± 10.1 NA
Range age of onset 55.4; 96.3 56.4; 106.2 NA
Sex, % men 31.0 53.0 51.0
Spherical equivalent, mean ± SD (D) -0.05 ± 5.78 0.09 ± 4.03 0.75 ± 2.45
Range spherical equivalent -19.13; 12.25 -15.31; 8.50 -19.13; 15.13
High myopia ≤-6D, % 9.1 8.1 1.7
Moderate myopia >-6D & ≤-3D, % 5.5 7.5 5.7
Low myopia -3D & ≤-0.75D, % 10.9 10.6 10.4
Emmetropia >-0.75D & <0.75D, % 16.4 19.4 26.0
Low hyperopia ≥0.75D & <3D, % 38.2 38.1 43.6
Moderate hyperopia ≥3D & <6D, % 12.7 13.8 11.4
High hyperopia ≥6D, % 7.3 2.5 1.3
SD, standard deviation; D, diopters; WHO,World Health Organization; RS, Rotterdam Study; NA, not 
applicable
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The causes of bilateral visual impairment according to WHO criteria are provided in Figure 5. 
For persons with emmetropia, low to moderate myopia, and low to moderate hyperopia, AMD 
was the major cause of visual impairment. The most important cause of visual impairment in high 
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Low & moderate myopia >-0.75D & ≤-6D, n=173 
Emmetropia >-0.75D & <0.75D, n=195
Low & moderate hyperopia ≥0.75D & <6D, n=531 
High hyperopia ≥6D, n=46 
bilateral low vision
bilateral blindness
unilateral low vision
unilateral blindness
Figure 2. Distribution of bilateral and unilateral blindness and low vision (WHO criteria) per 
refractive error category
The number of cases with bilateral and unilateral blindness and low vision is shown as a percentage 
of the total number of prevalent and incident cases with blindness and low vision per refractive error 
category. For data of visual impairment as a percentage of the entire population,  see Table 1.
WHO, World Health Organization
Figure 3. Cumulative risk of bilateral visual impairment (WHO criteria) stratified for high myopia, 
emmetropia and high hyperopia 
The X-axis represents the age at diagnosis for all cases with blindness or low vision at the end point 
of the study and age at last examination for non-cases; the Y-axis represents the cumulative risk for 
persons with visual impairment. The number of persons at risk at each decade per refractive error 
category is presented below.
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Figure 5. Causes of bilateral low vision and blindness (WHO criteria) stratified by refractive error 
category
The X-axis represents the percentage of visual impairment explained by the different causes mentioned 
on the Y-axis stratified by subjects with high myopia (Figure 5A), low & moderate myopia (Figure 5B), 
emmetropia (Figure 5C), low & moderate hyperopia (Figure 5D) and high hyperopia (Figure 5E). 
D, diopters; NA, not applicable; WHO, World Health Organization
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myopic persons was myopic macular degeneration (38.9%), followed by combined mechanisms 
(33.3, including myopic macular degeneration, cataract, and maculopathy) and cataract 
(16.7%). In highly hyperopic persons, the major causes of visual impairment were AMD (25%), 
cataract (25.0%), and combined causes (25%, including amblyopia, corneal dystrophy, cataract, 
maculopathy, age-related macular degeneration). 
The age at diagnosis of visual impairment for persons with high myopia (75.4±13.7 yrs) and 
high hyperopia (75.4±10.0 yrs) was slightly, albeit non significantly, lower than for persons with 
emmetropia (80.3±11.0 yrs; P =0.152; and P = 0.250, respectively).
Boxplots of the SE distribution among visually impaired participants with high myopia and high 
hyperopia are provided in Figure 6. Among the high myopes, persons with bilateral blindness (SE=-
15.25 ± 5.23 D; P = 0.034) and low vision (SE=-10.91 ± 2.57 D, P = 0.0036) had a significantly lower 
SE (i.e. more myopia)than persons with normal vision (SE=-8.25 ± 2.59 D). In the other refractive 
error groups, no statistical SE differences were found between the visual acuity categories (data 
not shown). The risk of blindness or low vision for high myopes versus emmetropes was OR 3.4 
(95% CI 1.4-8.2, P<0.001) for those with SE ≤-6 D & ≥-10 D, and OR 22.0 (95% CI 9.2-52.6, P 0.01) 
for those with SE <-10 D (Figure 7).
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Figure 6. Distribution of spherical equivalent in relation to bilateral visual impairment (WHO 
criteria) in participants with high myopia (Figure 6A) and high hyperopia (Figure 6B). 
Boxplots for the distribution of spherical equivalent stratified by bilateral blindness, bilateral low vision 
and normal vision (based on WHO criteria) for all subjects with high myopia SE ≤-6D (Figure 6A) and 
high hyperopia ≥ 6 D (Figure 6B). 
D, diopters; WHO, World Health Organization; NS, not significant
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Figure 7. Risk of bilateral blindness and low vision (WHO criteria) for high myopes
Odds ratios with 95% confidence intervals for blindness and low vision (reference normal vision) for 
persons with high myopia with SE ≤-6 D & ≥-10 D or SE <-10 D (reference emmetropia) are shown. 
CI, Confidence Interval; D, Diopters; OR, Odds Ratio; R, reference; WHO, World Health Organization; *, 
statistically significant OR (P < 0.05) compared to the reference group
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DISCUSSION
In this population-based longitudinal study, we found that persons with high myopia (SE≤-6D) and 
high hyperopia (SE≥6D) are at a considerable risk of visual impairment. Blindness or low vision 
occurred in one third of high myopes, mainly caused by myopic macular degeneration. The blind 
and visually impaired persons within this group had a higher degree of myopia than the ones 
with normal vision; the risk of visual impairment was 22x increased for those with refractive errors 
of -10 D or more when compared to emmetropes, but also 6x higher than those with refractive 
errors between -6 and -10 D. The onset of visual impairment appeared to occur at a younger age; 
cumulative risks of visual impairment rose at least 10 years earlier for high myopia (before the age 
of 60) than for emmetropia (from the age of 70). For high hyperopia, we found that 15% of the 
persons were visually impaired. Causes of visual impairment for this refractive error showed more 
variation, and included cataract, AMD, and combined mechanisms. 
This is the first report on refractive error specific risks and causes of blindness and low vision. 
Strengths of this study are the investigation of the full spectrum of refractive errors, the large 
sample size, and the lengthy follow-up time. In addition, our ophthalmic examination was extensive, 
which enabled an accurate determination of the cause of visual impairment. Our study also had 
limitations. Despite the large sample size, subgroup numbers were relatively small, jeopardizing 
precision of the risk estimates. Also, we focused on causes of visual impairment in persons with 
bilateral low vision, and did not study those with unilateral visual impairment. Therefore, we may 
have missed refractive error specific causes of visual impairment that are more likely to occur 
unilaterally, such as rhegmatogenous retinal detachment18, and closed-angle glaucoma19 in (high) 
myopes and amblyopia in (high) hyperopes. Lastly, selective non-participation of disabled persons 
may have caused an underestimation of the frequencies of blindness and visual impairment. 
Our findings are in line with results from previous studies that showed a highly increased risk for 
high myopes (SE≤-6D).8,20 Except for one person with moderate myopia, all persons with myopic 
macular degeneration were highly myopic. Those with extreme refractive error values of ≥ -10 D 
had the highest risk of visual impairment. We could not confirm the previously described mildly 
increased risk of visual impairment for persons with low to moderate myopia.8,20
Myopia is a growing public health problem since the prevalence is rapidly increasing, particularly 
in East Asia.11-13 With time, this trend is predicted to occur in other regions as well, and the increase 
in myopia and high myopia prevalence will result in a higher frequency of complications. Atropine 
eyedrops can currently be used as a therapy in children to slow the progression of myopia and 
decrease the final adult value of myopic refractive error.21 Our data underscore the objective of 
this therapy, because realisation of a lower refractive error will lower the risk of visual impairment 
later in life.22
It was previously shown that clinically significant pathological changes can be noted in highly 
myopic patients who are middle-aged or even younger.23,24 Our mean age at diagnosis of visual 
impairment is likely to be overestimated, since we included persons over age 55 years with visual 
impairment at baseline; baseline age was 69 years for RS-I and 64.1 years for RS-II. We did not 
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have information on the actual age of onset of visual impairment occurring before this age. 
The frequency of visual impairment in the high hyperopia group was relatively high. The number of 
cases with blindness or low vision in this group was very small (n = 8). Also, the proportion of high 
hyperopes in our older study sample was quite large, so these data are not necessarily applicable 
to the general population. Previous research has mainly focused on high myopia rather than on high 
hyperopia, but our results at least show that high hyperopia should be subject to further studies as 
well. Cataract was an important cause of visual impairment in all refractive error categories. This 
may be an overestimation of the current situation, since the majority of the data had been collected 
in the 1990’s, and since then cataract surgery has become a more easily accessible and safer 
procedure. Several studies showed an increased incidence of nuclear cataract and subcapsular 
posterior cataract in high myopes.25 We considered whether the exclusion of pseudophakic and 
aphakic persons might have introduced a selection bias and an underestimation of the risks of 
visual impairment in high myopic persons in our study. This does not seem to be the case, since 
only 2 out of 287 excluded participants (0.7%) with pseudophakia or aphakia were blind or visually 
impaired due to myopic macular degeneration diagnosed on the fundus photograph. 
In summary, our data indicate that risks and causes of visual impairment vary with refractive error. 
The risks for high myopes are by far the highest with more than 1 in 3 persons with high myopia 
developing bilateral blindness or low vision. This large health risk requires public awareness and 
a focus to initiate strategies to reduce this burden in those at risk of myopia.
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ABSTRACT
Objective
To study the relationship between axial length and visual impairment in high myopia.
Design
Three population-based cohort studies (Rotterdam Study I, II, and III), one family-based study 
(Erasmus Rucphen Family Study, ERF), and one high-myopia case-control study (MYopia STudy, 
MYST).
Participants
A total of 6271 participants were included (RS-I: N = 662 (55+ years of age); RS-II: N = 1074 (55+ 
years); RS-III: N = 1148 (45+ years); ERF: N = 2353 (25+ years); and MYST: N = 671 cases and 
363 controls, 25+ years)).
Methods
Participants received an extensive ophthalmic examination, including best-corrected visual acuity 
(VA), auto-refraction (spherical equivalent; SE), and measurements of axial length (AL) and corneal 
curvature (CC). Analyses were based on data from right eyes. The frequency of visual impairment 
was calculated as a function of AL (in mm), stratified by age. Cumulative risk of visual impairment 
(VI) per AL category (reference AL: 23-24 mm) was assessed using Kaplan-Meier product-limit 
analysis, . 
Main Outcome Measures
Definition of high myopia: SE ≤ -6 diopters. Definition of low vision , according to the WHO criteria, 
VA <0.3 and VA ≥0.05; blindness VA <0.05. 
Results
Mean AL in RS-I, RS-II, RS-III and ERF combined was 23.38 mm (SD: 1.15); in MYST, mean AL 
was 27.36 mm (SD: 1.62) in cases and 23.49 mm (SD: 0.76) in controls. The correlation of AL 
between right and left eyes was high (population-based R2 = 0.906; case control R2 = 0.932) . The 
frequency of VI in our total study population was 1.5%. In subjects with high myopia the frequency 
of VI was 5.1%, which increased with age (P trend <0.0001). The risk of VI was low (1.8%) in all 
high myopes at age 40, irrespective of AL; by age 80, however, the cumulative risk of VI was 7% 
for AL 23-24 mm, 30.5% for AL 26-28 mm, 44.7% for AL 28-30 mm, and 90.5% for AL ≥30 mm. 
Mean age of onset of visual impairment was strongly related with AL, and varied from 45 years in 
AL >28 mm to 58 years in AL 26-28 mm. 
Conclusions
The risk of VI in high myopes is highly correlated with AL, and reaches extremely high figures in AL 
≥30 mm. In high myopes, each incremental increase in AL worsens the long-term visual prognosis.
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INTRODUCTION
Myopia is an extremely common form of refractive error and the major cause of visual impairment 
worldwide1,2. Myopia results from excessive growth in axial length (AL). AL is the primary 
determinant of refractive error and is based on a combination of anatomical factors, including 
anterior chamber depth, lens thickness, and vitreous chamber depth3-5. Although AL measurement 
is more objective, precise, and reproducible compared to assessments of refractive error, the 
latter is routinely measured in clinical practice and most commonly used to define myopia. 
High myopia) is defined as a refractive error of -6 diopters (D) or worse. The AL in high myopia 
mostly exceeds 26 mm. High myopia occurs in 3-20% of the general population, and is currently 
one of the leading causes of legal blindness in developed countries due to myopic macular 
degeneration, retinal detachment, or glaucoma1,6,7. Strikingly, evidence suggests that the global 
prevalence of myopia and high myopia is increasing rapidly8,9. This alarming increase, combined 
with the sight-threatening complications, represents a significant medical and socio-economic 
burden10.
The relationship between myopia and pathology has been addressed in several studies. These 
studies found that only few eyes with mild-to-moderate myopia have pathological ocular signs, 
whereas many eyes with high myopia develop pathologic complications11-15. A higher AL increases 
the risk of retinal lesions and myopic retinopathy, but how it relates to visual outcome is unknown. 
Indeed, to the best of our knowledge, no study has examined the relationship between AL and 
visual impairment. For the current analysis, we combined data obtained from the population-
based Rotterdam I, II, and III studies, the Erasmus Rucphen Family Study, with data from the high 
myopia case-control study (MYST) to study cumulative risk of visual impairment as a function of 
axial length.
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PATIENTS AND METHODS 
Study population 
This study included data from a total of 6271 subjects from the population-based Rotterdam Study 
I-III (RS-I, RS-II, and RS-III), the family-based Erasmus Rucphen Family Study (ERF), and the high-
myopia case-control MYopia Study (MYST), all of which were conducted in the Netherlands. All 
subjects with available data on best-corrected visual acuity (BCVA), axial length, and refractive 
error were included in our analysis.
The Rotterdam Study is a prospective population-based cohort study of middle-aged and elderly 
subjects (45+ years of age) living in Ommoord, a suburb of Rotterdam, the Netherlands. The 
rationale and study design of this study have been described elsewhere16. In brief, the Rotterdam 
Study consists of three independent cohorts (RS-I (55+ years of age), RS-II (55+ years of age), 
and RS-III (45+ years of age)); this study examined cardiovascular, endocrine, neurological, 
respiratory, and ophthalmic outcomes. Baseline examinations—including BCVA and refractive 
error measurements—were performed from 1990 to 1993 (RS-I), 2000 to 2002 (RS-II), and 2006 
to 2008 (RS-III). Axial length was measured in a subset of RS-III at baseline and in a subset of the 
studies during follow-up examinations (RS-I: 2009-2011, RS-II: 2011-2012, RS-III: 2011-2012). In 
total, 2284 subjects were eligible for our analysis (RS-I, N = 662; RS-II, N = 1074, RS-III, N = 1148). 
The Erasmus Rucphen Family (ERF) study is a family-based study of a genetically isolated 
population living in the south-west of the Netherlands. This study included more than 3000 living 
descendants of 20 couples who lived in the region of Rucphen (the participants were 18-86 years 
of age at the time of the study). The subjects were examined from 2002 through 2005. The rationale 
and design of this study have been described elsewhere17,18. Only subjects ≥25 years of age were 
included in our study sample. In total, 2353 subjects were eligible for the analysis. 
The MYopia STudy (MYST) is a high-myopia case-control study. High-myopic cases and 
emmetropic controls were recruited by eye care providers, opticians, and optometrists; by 
ophthalmologists from university hospitals (primarily from the Erasmus Medical Center, Leiden 
University Medical Center, and Nijmegen University Medical Center) and community hospitals 
(primarily from the Eye Hospital Rotterdam, the Focus Clinic Rotterdam, and the Amphia Hospital 
Breda); by public media outlets (www.myopiestudie.nl); and by door-to-door flyer distribution. 
High-myopic cases were defined as having refractive error ≤‒6 D, and emmetropic controls were 
defined as having refractive error ≥-1.5 D and ≤1.5 D. All participants were ≥25 years of age. The 
subjects were examined from 2010 through 2012. In total, 1057 participants (690 cases and 367 
controls) were included in this study. Of these participants, 1034 (671 cases and 363 controls) 
were eligible for our analysis.
Measurements in all studies were collected after receiving approval from the medical ethics 
committee of the Erasmus University Medical Center, and all participants provided written informed 
consent in accordance with the Declaration of Helsinki. 
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Ophthalmic examination 
Participants in the RS and ERF studies received an extensive ophthalmological examination as 
described previously16. This examination included a non-cycloplegic measurement of refractive 
error using a Topcon RM-A2000 auto-refractor (Topcon Optical Company, Tokyo, Japan). After 
additional subjective refraction, BCVA was measured using the Lighthouse Distance Visual Acuity 
Test, a modified version of Early Treatment Diabetic Retinopathy Study (ETDRS) chart19. AL was 
measured using a Lenstar LS900 (Laméris Ootech, Haag-Streit, UK; in the RS-I, RS-II, and RS-III 
cohorts) or an A-scan ultrasound device (Pacscan, Sonomed Escalon, Germany; in the ERF and 
RS-III cohorts). Measurements of AL were introduced after the initiation phase of the RS studies; 
measurements of AL were available in only 25%. 
The MYST study protocol included a complete ophthalmological examination, a questionnaire, 
and peripheral blood sampling for genotyping. A non-cycloplegic measurement of refractive error 
and keratometry was performed for both eyes using a Topcon RM-A2000 autorefractor (Topcon 
Optical Company). BCVA with objective refraction was measured using standardized ETDRS 
protocols19. Intraocular pressure was measured using Goldmann applanation tonometry. AL, 
corneal thickness, anterior chamber depth, and lens thickness were measured using a Lenstar 
LS900 (Laméris Ootech). For subjects with AL >30 mm, we used an A-scan ultrasound device 
(Pacscan, Sonomed Escalon) to measure AL, anterior chamber depth, and lens thickness. After 
dilating the pupils with tropicamide/phenylephrine 0.5/5%, we performed indirect ophthalmoscopy 
to quantify myopic degeneration of the retina (including the peripheral retina)20. Stereoscopic digital 
colour photographs (35°) were taken of the lens, the optic nerve head, and the macular area using 
a Topcon digital fundus camera (Topcon TRC 50EX; 0.44 megapixel, Topcon Optical Company) 
or a Sony DXC-950P digital camera (Sony Corporation, Minato, Japan). We also performed 
fundus autofluorescence, infrared, and red-free measurements of the macular area of each eye 
(Heidelberg HRA-2, Heidelberg Engineering, Heidelberg, Germany). Optic discs were imaged 
using confocal laser scanning tomography (Heidelberg Retina Tomograph HRT II, Heidelberg 
Engineering). Optical coherence tomography was performed using Topcon 1000, 2000 (SD) and 
Topcon-DRI (SS) (Topcon Optical Company), and scans were made of both the optic nerve and 
the macula. The questionnaire included questions regarding the subject’s complete ocular and 
medical history, family history of myopia, education level, and near-work and outside activities 
during young childhood, adolescence, and adulthood. 
In all studies, visual impairment was defined as either low vision (VA <0.3 and VA ≥0.05) or 
blindness (VA <0.05) according to the WHO criteria21.
Statistical analysis
All analyses were performed on the subjects’ right eyes. Spherical equivalent (SE) was calculated 
using the following standard formula: SE = sphere + (½ cylinder). For our analysis of SE and AL, we 
excluded subjects with a history of cataract surgery or refractive surgery with no prior knowledge 
of refractive error. For participants with both A-scan ultrasound as well as Lenstar measurements 
of AL, the Lenstar measurement was used. AL (per mm), VA (>0.8, 0.5-0.8, 0.3-0.5, 0.05-0.3, and 
<0.05), and age (<45, 45-60, and ≥60 years) were categorized. he distribution of AL was assessed 
in the population-based versus case-control study samples. Pearson correlation coefficients (R2) 
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were used to evaluate correlations between AL in right and left eyes, between AL and SE and 
between the AL/CC ratio and SE. The frequency of visual impairment was calculated per millimeter 
category of AL, stratified by age. We considered linear age trends on visual impairment using 
logistic regression, adjusting for gender. Cumulative risk of visual impairment (i.e., VA <0.3) was 
estimated per AL category using Kaplan-Meier product limit analysis. We assigned the age at 
diagnosis of blindness or impaired vision as the mean age between the examination in which this 
endpoint was observed and the previous examination. For participants who did not reach this 
endpoint, we used their age at the last examination for censoring. Participants who died or were 
otherwise lost to follow-up were analyzed using the last examination. All participants ≥85 years of 
age were censored at 80 years of age in order to ensure unbiased estimates. Statistical analyses 
were performed using the SPSS software package version 20.0 (IBM, Armonk, NY).
RESULTS
The general characteristics of our study populations are summarized in Table 1. We observed an 
increasing prevalence of myopia in our population-based Rotterdam studies due to a cohort effect 
described in our previous work14,22. The distributions of AL in the population-based studies and the 
MYST study are shown in Figure 1. The population-based studies (RS-I, RS-II, RS-III, and ERF) and 
the case-control study MYST included 131 and 684 right eyes with an AL ≥26 mm, respectively. 
The mean AL of all right eyes in the population-based studies was 23.38 mm (SD: 1.15); in the 
MYST study, the mean AL of the cases and controls was 27.36 mm (SD: 1.62) and 23.49 mm (SD: 
0.76), respectively. High correlation was found in AL between right and left eyes (population-
based R2 = 0.906; case control R2 = 0.932).
Figure 2 shows the correlation between AL and SE, and between the AL/CC ratio and SE. We found 
good correlation between AL and SE (population-based R2 = 0.695; case-control R2 = 0.906); and 
high correlation between SE and the AL/CC ratio (population-based R2 = 0.798; case-control R2 = 
0.943), with the highest correlation at the more extreme ends of SE. 
The relationship between AL and visual acuity in the three different age categories in the combined 
dataset is shown in Figure 3. Individual study data are presented in the Supplementary Information. 
We did not observe large differences in frequencies of visual impairment between the population-
based studies and the case control study. The overall frequency of VI (i.e., VA <0.3) in our total 
study population was 1.5%. In subjects with high myopia the frequency of VI was 5.1%, which 
increased with age (P trend <0.0001). Among eyes from participants <45 years, 45-60 years, and 
≥60 years of age, the frequency of VI was 2.6%, 5.3%, and 15% at AL ≥26 mm compared to 0%, 
0.8%, and 0.8% at mean AL 23-24 mm, respectively.
Next, we examined the cumulative risk of VI in relation to AL; these data are shown in Figure 4. Our 
analysis revealed that the risk of VI was low (1.8%) in all AL categories at age 40; by age 80, the 
cumulative risk of VI was 7% (standard error of the mean (SEM): 0.029) for AL 23-24 mm, 30.5% 
(SEM 0.125) for AL 26-28, 44.7% (SEM: 0.171) for AL 28-30 mm, and 90.5% (SEM: 0.082) for AL 
≥30 mm. The risk of VI for eyes with AL 26-28 mm increased gradually from 60-70 years, whereas 
eyes with AL >28 mm were visually impaired beginning at approximately 45 year of age.
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Table 1. General characteristics of the study participants
  RS-I RS-II RS-III ERF MYST
cases controls
N 662 1074 1148 2353 671 363
Gender (%) men 48.9 47.3 44.2 44.9 35.2 46.7
Age, years ± SD 60.5 ± 4.3 61.3 ± 4.6 59.6 ± 7.8 50.2 ± 12.7 46.0 ± 12.5 48.9 ± 12.5
Age, range 55.0 - 76.3 49.1 - 87.0 47.4 - 89.3 25.1 - 86.5 25.0 - 79.6 25.0 - 78.6
Age (years)
< 45 0 0 0 872 278 116
45-60 342 488 647 913 275 169
≥60 320 586 501 568 118 78
Mean spherical 
equivalent, D (± SD)
0.50 ± 2.12 0.47 ± 2.49 -0.13 ± 2.45 0.12 ± 2.05 -10.4 ± 3.4 0.02 ± 0.28
Mean corneal 
curvature, radius 
(± SD)
7.73 ± 0.26 7.70 ± 0.24 7.75 ± 0.26 7.73 ± 0.27 7.74 ± 0.36 7.80 ± 0.25
Axial length (mm)
Mean ( ± SD) 23.54 ± 1.07 23.50 ± 1.14 23.48 ± 1.32 23.25 ± 1.07 27.36 ± 1.62 23.50 ± 0.76
Range 20.8 - 27.65
19.79 - 
29.17
16.33 - 
30.12
19.66 - 
29.70
23.41 - 
33.46
21.17 - 
25.82
< 22 mm (%) 5.9 8.1 9.6 10.3 0.1 2.2
22 - 23 mm (%) 24.5 23.8 26.8 31.2 0.0 24.8
23 - 24 mm (%) 38.5 39.2 33.7 37.7 0.4 43.3
24 - 25 mm (%) 22.1 20.2 18.2 15.5 3.7 26.4
25 - 26 mm (%) 6.9 5.7 7.9 3.6 14.9 2.8
26 - 27 mm (%) 1.8 2.4 3.0 1.4 28.3 0.3
27 - 28 mm (%) 0.3 0.5 0.3 0.3 22.4 0.3
28 - 29 mm (%) 0.0 0.0 0.1 0.0 13.7 0.0
29 - 30 mm (%) 0.0 0.1 0.3 0.0 5.8 0.0
30 - 31 mm (%) 0.0 0.0 0.1 0.0 4.9 0.0
31 - 32 mm (%) 0.0 0.0 0.0 0.0 3.6 0.0
32 - 33 mm (%) 0.0 0.0 0.0 0.0 1.2 0.0
≥ 33 mm (%) 0.0 0.0 0.0 0.0 0.9 0.0
Visual acuity
Median visual 
acuity 1.00 1.00 0.64 1.00 1.00 1.25
> 0.8 (%) 96.5 93.9 NA 93.7 67.1 93.7
0.5 - 0.8 (%) 2.1 3.7 97.6 3.7 19.8 5.5
0.3 - 0.5 (%) 0.8 0.7 1.4 1.2 7.2 0.6
0.05 - 0.3 (%) 0.6 0.8 0.8 1.0 3.3 0.0
  < 0.05 (%) 0.0 0.8 0.2 0.3 2.7 0.3
NA = not applicable
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DISCUSSION
In this study, we found a strong relationship between axial length and visual impairment in a large 
dataset which included a high number of high myopes. Strikingly, the cumulative risk of VI was 
30% in eyes with AL 26-28 mm and 45% in eyes with AL 28-30 mm; in eyes with an AL>30 mm, this 
frequency increased to >90%. Eyes with AL 26-28 mm gradually developed VI from 60-70 years, 
whereas eyes with >28 mm began to develop VI as early as 45 years of age. 
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A strength of this study is that we combined our Rotterdam cohorts with a high myopia case-
control study, to warrant a sufficiently high proportion of subjects at the extreme ends of AL. On 
the other hand, this combination was also a potential source of limitations. For example, selective 
non-participation of disabled persons in population-based studies may lead to underestimation of 
risks, while selective participation of functionally disabled in case control studies may overestimate 
this risk. The effect of these biases appeared to be small in our study, as risk estimates did not 
show statistical differences between the studies of different design.
Our findings are in line with previous studies which showed a higher prevalence of pathologic signs 
at greater axial lengths11,23,24.Neither of these studies directly assessed the relationship between 
axial length and VA. We recently reported that one third of all high myopes eventually becomes 
bilaterally blind and/or visually impaired14. Although the number of high myopes in our previous 
study was relatively small, we already calculated a much higher risk of VI among individuals with 
a refractive error of -10 D compared to individuals with a refractive error between -6 and -10 D. 
Our current study describes in an even more detailed manner the exponential rise of risk of VI at 
extreme eye lengths.
Our study suggests that age modifies the effect of AL on visual impairment. There appeared 
to be a lag between the onset of myopia, usually during childhood and adolescence, and the 
manifestation of  visual impairment, which occurred predominantly in middle-aged and elderly 
adults. Other studies have also reported an age effect in relation to the occurrence of retinal 
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Figure 4. Cumulative risk of visual impairment (WHO criteria) as a function of axial length
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lesions and myopic retinopathy25-28. Experimental animal studies on the long term effects of myopia 
suggest that although the sclera thins rapidly during earlydevelopment, shifts in the collagen fibril 
diameter are not apparent until later in myopia development29. In experimental myopic chick 
eyes, neither staphyloma formation nor development of chorioretinal atrophy occurred soon after 
visual deprivation30. This suggests that, in mechanical stretching, age-related changes induce the 
development of myopic fundus changes. High myopic eyes with their thinned ocular tissue at the 
posterior pole may be particularly vulnerable for anatomical alterations that occur with aging, such 
as thickening of Bruch’s membrane, vascular changes of the choroid, and scleral calcification31.
Currently, few strategies are available for treating myopia. Atropine, a muscarinic receptor 
antagonist that can be applied topically to the eye, and orthokeratology lenses can be effective in 
inhibition of eye growth32. Our data underscore the value of these therapies even in high myopes, 
as achieving a lower final AL would significantly decrease the patient’s risk of developing VI later 
in life. Likewise, preventative measures such as increasing outdoor exposure in progressive high 
myopes is warranted. Indeed, each incremental decrease in final AL increases the chance of 
lifelong preservation of visual acuity.
In summary, we examined the risk of VI in several categories of AL using data combined from 
population-based and case-control studies. The risk of VI in high myopes was highly correlated 
with AL and reached extreme values in AL ≥30 mm. Our data emphasize the morbidity of high 
myopia, and strengthen current strategies to develop treatment options.
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ABSTRACT
Refractive errors are the most common ocular disorders worldwide, and may lead to blindness. 
Although this trait is highly heritable, identification of susceptibility genes has been challenging. 
We conducted a genome-wide association study testing single nucleotide polymorphisms for 
association with refractive error in 5,328 unrelated individuals of a Dutch population-based study, 
and replicated findings in four independent cohorts (10,280 persons). We identified a significant 
association at chromosome 15q14 with P=2.21x10-14 for rs634990. The odds ratio of myopia versus 
hyperopia for the minor allele (MAF 0.47) was 1.41 (95% CI 1.16-1.70) for heterozygous, and 1.83 
(95% CI 1.42-2.36) for homozygous subjects. The associated region lies in the vicinity of genes 
which are expressed in the retina, GJD2 and ACTC1, and appears to harbor regulatory elements 
which may influence transcription of these genes. Our data suggest that common variants at 
15q14 influence susceptibility for refractive errors in the general population.
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INTRODUCTION & RESULTS
Refractive errors are by far the most common cause of visual impairment in humans1-5. They result 
from aberrant coordinated effects of the ocular biometric components, most notably of axial length. 
Elongation of the eye axis leads to myopia (nearsightedness), while a shortened axis causes 
hyperopia (farsightedness). Refractive errors often cause alterations in the anatomical structure 
of the eye, increasing the risk of complications6. Myopia may lead to ocular morbidity such as 
glaucoma and retinal detachment, and high myopia in particular can cause posterior staphyloma 
and macular degeneration7-11. Treatment options for myopia are limited; it is the fifth most common 
cause of impaired vision, and the seventh most common cause of legal blindness worldwide10,11.
The etiology of refractive errors and myopia is complex and largely unknown. The current notion 
is that eye growth is triggered by a visually evoked signaling cascade, which begins in the retina, 
traverses the choroid, and subsequently mediates scleral remodeling. Established risk factors are 
education, reading, outdoor exposure, and familial predisposition11-14. Familial aggregation studies 
quantified a strong genetic basis; the estimated sibling recurrence risk (λs) varied between 1.5-
3.0 for low myopia- and between 4.9-19.8 for high myopia, and heritability estimates (h2) ranged 
from 0.60-0.9015. Segregation analyses suggested the involvement of multiple genes rather than 
a single major gene effect11,13,15. In an attempt to identify causal genes, previous mapping studies 
mainly focussed on highly myopic probands with multiple affected relatives, and thereby identified 
at least 20 putative genetic loci11. Replication of these results has been limited, and proposed loci 
were shown to have little to no effect in unselected populations. Genome-wide mapping has not 
been conducted in refractive error studies of the general population. Hence, the genetic basis of 
common refractive errors and myopia remains to be elucidated. 
We performed a genome-wide association study (GWAS) in the population-based Rotterdam 
Study (RS-I, n=5328), and investigated refractive error as a quantitative trait. Study design and 
baseline characteristics are provided in the Methods and Supplementary Table 1. The mean 
spherical equivalent in this older population of European descent was +0.86 (standard deviation 
(SD) 2.45) dioptres. Refractive errors occurred in 52% (n=2790) of the participants, ranging from 
-19 to +10 diopters (D). 
We genotyped the entire sample using the Illumina HumanHap 550k and 610Q arrays (Methods). 
Genotypes for more than 2.5 million autosomal single nucleotide polymorphisms (SNPs) were 
imputed with reference to the HapMap Phase II CEU build 36. Comparison of the observed 
and expected distributions (QQ plot, Supplementary Figure 1) showed modest inflation of the 
test statistics (λGC=1.054 for RS-I). Using an additive model, we identified a novel genome-wide 
significant (P=1.76x10-8) locus on chromosome 15q14 (Table 1, Figure 1). Subsequently, we 
investigated 31 SNPs spread across four loci on chromosome 15q14, 14q24, 1q41, and 10p12.3 
reaching P<10-6 (Supplementary Table 2) for further investigation in four independent replication 
cohorts, i.e., RS-II (n=2008; λGC=1.012), RS-III (n=1970; λGC=1.012), Erasmus Rucphen Family 
Study (ERF, n=2032; λGC=1.037) from the Netherlands; and a twin study from the United Kingdom 
(TwinsUK; n=4270; λGC=1.04. The designs of RS-II and RS-III were population-based; those of ERF 
and TwinsUK family-based. Cohorts were not selected on a disease phenotype. All studies 
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consisted predominantly of individuals of European ancestry, and all used similar protocols to 
evaluate refractive error (Methods, Supplementary Table 2). 
At validation, meta-analysis confirmed a significant association between refractive errors and 
locus 15q14 (Table 1). Frequencies of the risk alleles at this region were similar across the studies. 
The P-values were nominally significant for the 14 top SNPs in RS-II, RS-III, and TwinsUK, and 
the direction of the effect (regression coefficient beta) of the minor alleles was consistent. The 
strongest signal in the meta-analysis was observed for rs634990 (P=2.21x10-14; Table 1), and this 
SNP accounted for 0.5% of the variance in spherical equivalent.
To determine the impact of this locus on the risk of clinically relevant outcomes, we compared 
subjects with myopia to those with hyperopia in a logistic regression analysis. We found strong 
evidence that the C allele of rs634990 carried a higher risk of myopia (Figure 2). The odds ratio 
(OR) of mild or severe myopia versus mild or severe hyperopia was 1.41 (95% Confidence Interval 
(CI) 1.16-1.70) for heterozygous individuals, and 1.83 (95% CI 1.42-2.36) for homozygous persons.
The 15q14 region of highly significant SNPs (Figure 3) lies in an intergenic region in the vicinity of 
the genes GJD2 (39 kb from rs634990 at 3’ end), ACTC1 (74 kb at 3’end), and GOLGA8B (180 
kb at 5’end). We investigated a potential function for these genes in eye growth development 
by examining gene expression levels in the retina of postmortem human eyes (Supplementary 
Table 3), and observed a moderate to high expression for GJD2 and ACTC1, and a much lower 
expression for GOLGA8B. GOLGA8B (Golgi autoantigen golgin-67) encodes a 67 kDa protein, 
Figure 1. Genome-wide signal intensity (Manhattan) plot of discovery cohort Rotterdam Study I 
The statistical significance values across the 22 autosomes of each SNP association with refractive error 
(measured as spherical equivalent) are plotted as –log10 P-values. SNPs with minor allele frequency 
>=0.01 were included. The blue horizontal line indicates P-value of 10-5; the red line P value of 5x10-8. 
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belongs to a family of Golgi auto-antigens, and is localized at the cytoplasmic surface of the Golgi 
complex16. A specific function of this gene in the retina has not been reported. ACTC1 (cardiac 
muscle alpha actin 1) encodes a 42 kDa smooth muscle actin. The functional role of ACTC1 in 
the eye is currently unclear, but actins which are similar, such as α-SMA, have been shown to be 
increased in developing myopic eyes17. α-SMA influences the number of contractile myofibroblasts 
in the sclera, and contributes to extracellular matrix remodeling. As these are key factors occurring 
in eye enlargement, it is intriguing to know whether ACTC1 has these characteristics as well. 
The functional properties of GJD2 make this gene an interesting candidate to explain our findings. 
GJD2 (gap junction protein delta 2) encodes the 36 kDa connexin36 (CX36), which is a neuron-
specific protein belonging to a multi-gene family of integral membrane proteins18. CX36 forms gap 
junction channels between adjacent membranes of neuronal cells, is present in photoreceptors, 
amacrine, and bipolar cells, and plays a critical role in the transmission process of the retinal electric 
circuitry by enabling intercellular transport of small molecules and ions18-21. Further exploration of 
Spherical equivalent rs634990 TC
Odds ratio
0.5 1.0 1.5 2.5 3.5 5.0
RS−I TC(OR=1.342;95% CI=0.980−1.839)
RS−II TC(OR=1.694;95% CI=1.052−0.527)
RS−III TC(OR=1.145;95% CI=0.691−1.899)
ERF TC (OR=1.959;95% CI=0.999−3.841)
TwinsUK TC(OR=1.36;95% CI=1.03−1.78)
Summary 1.41 (1.16−1.70)
Spherical equivalent rs634990 CC
Odds ratio
0.5 1.0 1.5 2.5 3.5 5.0
RS−I CC(OR=1.68;95% CI=1.159−2.444)
RS−II CC(OR=2.579;95% CI=1.418−4.688)
RS−III CC(OR=1.995;95% CI=1.042−3.822)
ERF CC (OR=1.673;95% CI=0.646−4.332)
TwinsUK CC(OR=1.47;95% CI=0.92−2.34)
Summary 1.83 (1.42−2.36) 
Figure 2. Forest plot of associations for myopia (SE<= -3D) versus hyperopia (SE >= +3D)
Forest plot of the estimated per-genotype odds ratio for topSNP rs634990 for the 5 studies separately, 
and for the meta-analysis of all studies. RS-I, Rotterdam Study I; RS-II, Rotterdam Study II; RS-III, 
Rotterdam Study III; ERF, Erasmus Rucphen Family Study; TwinsUK, the Twin Cohort recruited in the 
UK; OR, odds ratio; 95%CI, 95% Confidence Interval.
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GJD2 using Ingenuity analysis (Methods, Supplementary Figure 2) alluded to a role in eye growth 
regulation as well as lens fiber maturation in knock-out animals22,23. To identify possible causal 
variants in this gene, we performed direct sequencing of all exons and intron-exon boundaries 
of GJD2 in 47 subjects with either high myopia, high hypermetropia, or emmetropia. We found 
neither new mutations nor frequency differences of variants between groups (Supplementary 
Table 4), and conclude that linkage disequilibrium with common functional variants in GJD2 is 
unlikely to explain the observed association. 
The next step was to assess whether the intergenic region itself can have functional consequences. 
We evaluated the expression of SNPs of our associated region in lymphoblastoid cell lines. At least 
two of our most associated SNPs significantly altered expression, providing evidence that elements 
of our locus are transcribed and may alter cell function (Supplementary Table 5). Subsequently, 
we searched for regulatory elements24,25 in the entire 53 kb locus of highly significantly correlated 
SNPs using UCSC Genome Browser, and found the predicted presence of seven DNase I 
hypersensitive sites, six enhancers based on experimentally validated H3 chromatin signatures 
in Hela and K562 cells24,25, 20 peaks of sequence conservation in alignments of multiple species 
of placental mammals, and one insulator site (Supplementary Figure 3)25. Enhancers are known 
to facilitate transcription of distal genes, and its range of activity is confined by insulators25. 
Remarkably, the greatest peak of our association coincided with an insulator site. Precedents of 
genomic alterations of insulators causing hereditary disease have been reported26,27. We speculate 
that variants or mutations in regulatory elements at 15q14 may lead to illegitimate transcription of 
genes in the area, e.g., of ACTC1 and GJD2.
Figure 3. Regional plot at chromosome 15q14
Log10 P-values from the discovery cohort Rotterdam Study I as a function of genomic position (HapMap 
release 22 build 36). The P-value for the top SNP is denoted by the large diamond; P-values for other 
genotyped and imputed SNPs are shown as smaller diamonds. P-values for SNPs of unknown type are 
presented as squares. Superimposed on the plot are gene locations (green) and recombination rates 
(blue).
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In GWA studies, sources of heterogeneity may cause spurious findings. To address this issue 
and minimize potential biases, we applied genomic control to the cohort-level test statistics in the 
population cohorts, and correction using the identity by descent structure for the family-based 
cohorts. Three studies significantly replicated our initial findings. The fourth study, ERF, showed 
the same direction of association, albeit non-significant, and revealed similar risks of myopia for 
carriers of the risk allele (Figure 2). Thus, the observed effects of the genetic variants at 15q14 are 
relatively homogeneous among the 5 studies, enhancing credibility of the findings.
In the same issue of this journal, Hysi et al. report the results of a GWAS for refractive errors in 
the TwinsUK study28. The authors find genome-wide significance (best combined P=1.85x10-9 for 
rs939658 and P=2.07x10-9 for rs8027411) for a locus on chromosome 15q25, explaining 0.81% of 
the variance in spherical equivalent. The locus includes the promoter of the RASGRF1 gene. This 
gene is known to be functionally involved in eye development29, and, similar to GJD2, is involved 
in synaptic transmission of photoreceptor responses30. TwinsUK and RS-I are two of the largest 
existing refractive error cohorts with GWAS data. Our studies identified different genome-wide 
significant tophits in terms of P-values, and we both estimated the variation in refractive error 
explained by these SNPs to be small. Therefore, it is likely that common variants with a substantial 
disease risk do not play a role in the pathogenesis of this trait. The findings of our studies suggest 
that the genetic variance of refractive error is mostly determined by multiple variants with a low to 
moderate penetrance, resembling traits such as height31. 
Nevertheless, the mutual validation of the direction and beta of the effect of variants at 15q14 
and 15q25 suggests that alterations at these genomic loci lead to refractive error and myopia. 
To unravel the mechanism, next steps should include comprehensive resequencing of the entire 
associated regions and flanking genes, validation in cohorts of other ethnicities, functional assays, 
and study of risk modulation by environmental factors. This may help to launch new pathogenic 
pathways for refractive errors, and may eventually lead to novel strategies to reduce the sight-
threatening consequences of myopia.
MATERIAL & METHODS
Discovery cohort
The Rotterdam Study (RS-I) is a prospective population-based cohort study of 7,983 residents 
aged 55 years and older living in Ommoord, a suburb of Rotterdam, the Netherlands32. The 
baseline examination for the ophthalmic part took place between 1991 and 1993, and included 
6,775 persons. Subjects were excluded if they had undergone bilateral cataract surgery, laser 
refractive procedures, or other intra-ocular procedures which might alter refraction. Complete data 
on refractive error and genome-wide SNPs were available on 5,328 persons, of whom 99% were 
of European ancestry. 
Replication cohorts
The first three replication studies originated from the Netherlands. The first cohort was RS-II, an 
independent cohort which included 2,157 new participants aged 55+ years living in Ommoord 
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since 200032, who had good quality genotyping data. Baseline examinations took place between 
2000 and 2002; follow-up examination from 2004 to 2005. The second replication cohort was RS-
III, a study which included 2,082 new participants aged 45 and older living in Ommoord since 
2006, who had good quality genotyping data. Baseline examination took place between 2006 and 
2009. The third replication study was the Erasmus Rucphen Family (ERF) Study, a family-based 
study in a genetically isolated population in the southwest of the Netherlands. This study included 
2,032 living descendants aged 18 years and older originating from 22 families who had at least six 
children baptized in the community church between 1880 and 1900, and who had good quality 
genotyping data. The fourth replication cohort was derived from the United Kingdom (TwinsUK). 
This study is an adult twin registry of over 10,000 healthy volunteer twins based at St Thomas’ 
Hospital in London. Participants were recruited and phenotyped between 1998 and 2008. A total 
of 4,270 Caucasian participants had complete data on ocular phenotype and genotype33. 
As in the discovery cohort, participants in the four replication cohorts had been excluded if they 
had undergone bilateral surgery which inhibited evaluation of the original refractive error.
Measurements of refractive error
All studies used a similar protocol for phenotyping. Participants underwent an ophthalmologic 
examination which included non-dilated automated measurement of refractive error (RS I –III, ERF: 
Topcon RM-A2000 autorefractor; TwinsUK cohort: Humphrey-670 (Humphrey Instruments, San 
Leandro, CA) from 1998 to 2002; and then ARM-10 (Takagi Seiko, Japan), best-corrected visual 
acuity, and keratometry. Spherical equivalent (SE) was calculated from the standard formula: 
spherical equivalent = sphere + (cylinder/2). In addition to investigating SE as a quantitative trait, 
we stratified SE into categories of refractive error to evaluate findings from a clinical viewpoint. 
Myopia was categorized into low (SE –1.5 to –3 diopters (D)), moderate (SE –3 to –6D), and 
high (SE –6 D or lower). For hyperopia, these categories were mild (SE +1.5 to +3D), moderate 
(SE +3 to +6D), and high (SE +6D or higher), respectively. We considered SE -1.5 to +1.5D as 
emmetropia. 
Ethics
All measurements in RS-I-III and ERF were conducted after the Medical Ethics Committee of the 
Erasmus University had approved the study protocols, and all participants had given a written 
informed consent in accordance with the Declaration of Helsinki. In the TwinsUK study, all twins 
gave fully informed consent under a protocol reviewed by the St Thomas’ Hospital Local Research 
Ethics Committee.
Genotyping
Discovery cohort
All persons attending the baseline examination in 1990-1993 consented to genotyping, and had 
DNA extracted from blood leucocytes. Genotyping of autosomal SNPs was performed in persons 
with high-quality extracted DNA (n=6,449) using the Illumina Infinium II HumanHap550chip v3.0® 
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array according to the manufacturer’s protocols. Samples with low call rate (<97.5%, n=209), with 
excess autosomal heterozygosity (>0.336, n=21), and with sex-mismatch (n=36) were excluded, 
as were outliers identified by the identity-by-state (IBS) clustering analysis (>3 standard deviations 
from population mean, n=102 or IBS probabilities >97%, n=129). The total sample of individuals 
with good quality genotyping data was 5,974.
Replication cohorts
In RS-II, the majority of the 2,516 DNA samples were genotyped using the HumanHap 550 Duo 
Arrays; 133 (5%) were genotyped using the Human 610 Quad Arrays (Illumina). In the RS-III 
cohort, all DNA samples were genotyped using the Illumina Infinium II HumanHap550chip v3.0® 
array. In ERF, DNA was genotyped on four different platforms (Illumina 6k, Illumina 318K, Illumina 
370K and Affymetrix 250K). Genotyping for the TwinsUK cohort took place in stages; in the first 
stage 1,810 individuals were genotyped using Illumina’s HumanHap 300k duo chip, at a later 
stage 2,578 persons were genotyped using Illumina’s HumanHap610 Quad.
Imputation
The set of genotyped input SNPs used for imputation in each study was selected based on highest 
quality GWA data. The callrate was set at >98% in Rotterdam Study I-III; the minor allele frequency 
at >0.01; and the Hardy-Weinberg P >10-6. We used the Markov Chain Haplotyping (MaCH) 
package version 1.0.15 software (Rotterdam; imputed to plus strand of NCBI build 36, HapMap 
release #22) for the analyses. For each imputed SNP, a reliability of imputation was estimated (as 
the ratio of the empirically observed dosage variance to the expected binomial dosage variance: 
O/E ratio). 
Statistical analysis
Discovery cohort
Refractive error measured at baseline as a continuous variable was used as outcome in the 
analysis. We calculated the mean SE for those with measurements on both eyes, and included the 
SE of only one eye if data from the other eye were missing. Linear regression models with 1-degree 
of freedom trend test were used to examine the associations between SNPs and SE, adjusted for 
age and gender. Using these linear regression models, we calculated regression coefficients with 
corresponding 95% confidence intervals (CIs). Odds ratios (ORs) of myopia and hyperopia were 
calculated with logistic regression analysis, adjusting for age and gender.  GWAS analyses were 
performed using GRIMP34.
We used genomic control to obtain optimal and unbiased results, and applied the inverse variance 
method of each effect size estimated for both autosomal SNPs that were genotyped and imputed 
in both cohorts. A P-value <5x10-8 was considered genome-wide significant. 
Replication analyses
The topSNPs with P-value <1 x 10-6 from the discovery analysis were examined in the replication 
cohorts RS-II, RS-III, ERF and TwinsUK cohorts using SPSS version 15.0.0 for Windows (SPSS inc., 
Chicago, IL, USA; 2006), and R statistical package version 2.8.1 for Linux. A meta-analysis was 
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performed on all 5 studies using Metal for Linux. 
GRIMP34 was used for the analysis of the population-based replication cohorts. To adjust for family 
relationships, the GenABEL package35 was used in the ERF study, and Merlin in the TwinsUK 
Study36. SNPs which deviated significantly from Hardy-Weinberg equilibrium (P<10-6), or which 
had minor allele frequency <0.01 were excluded. 
Gene expression data in human eye tissue
Human gene expression data were obtained essentially as described37. In short, postmortem eye 
bulbs (RPE: 6 donor eyes, choroid: 3 donor eyes, photoreceptors: 3 donor eyes), provided by the 
Corneabank Amsterdam, were rapidly frozen using liquid N2. Donors were between 63 and 78 
years old and had no known history of eye pathology.
Cryosections were cut from the macula, and histology confirmed a normal histological appearance. 
RPE, photoreceptor and choroidal cells were isolated from macular sections using a Laser 
Microdissection System (PALM, Bernried, Germany). Total RNA was isolated and the mRNA 
component was amplified, labelled, and hybridized to a 44k microarray (Agilent Technologies, 
Amstelveen, The Netherlands)38. At least 3-6 microarrays were performed per tissue. Sample 
isolation, procedures, and expression microarray analysis were carried out according to obligatory 
MIAMI guidelines and the relevant expression data are deposited in the GEO database (2010) with 
accession number GSE20191. As a measure of the level of expression we sorted all the genes 
represented on the 44k microarray by increasing expression and calculated the corresponding 
percentiles (Supplementary Table 3). 
Ingenuity database search
We explored the Ingenuity knowledge database using the keyword ‘eye development’ for all genes 
involved in ‘function or diseases’. This search provided approximately 100 genes, which formed 
a new network for eye development. We subsequently added the GJD2 gene to the network, and 
used the Path Explorer tool to search for possible functional relationships between GDJ2 and 
these eye development genes in human, mouse, rat, and in vitro models (Supplementary Figure 
2A). We continued the search using the keyword ‘eye growth’ for all genes involved in ‘function 
or diseases’, and investigated functional links between molecules using the connect tool and 
upstream-downstream analysis (Supplementary Figure 2B).
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ABSTRACT
Myopia is a complex genetic disorder and a common cause of visual impairment among 
working age adults. Genome-wide association studies have identified susceptibility loci on 
chromosomes 15q14 and 15q25 in Caucasian populations of European ancestry. Here, we 
present a confirmation and meta-analysis study in which we assessed whether these two loci 
are also associated with myopia in other populations. The study population comprised 31 
cohorts from the Consortium of Refractive Error and Myopia (CREAM) representing 4 different 
continents with 55,177 individuals; 42,845 Caucasians and 12,332 Asians. We performed a 
meta-analysis of 14 single nucleotide polymorphisms (SNPs) on 15q14 and 5 SNPs on 15q25 
using linear regression analysis with spherical equivalent as a quantitative outcome, adjusted for 
age and sex. We calculated the odds ratio (OR) of myopia versus hyperopia for carriers of the 
top-SNP alleles using a fixed effects meta-analysis. At locus 15q14, all SNPs were significantly 
replicated, with the lowest P-value 3.87 x 10-12 for SNP rs634990 in Caucasians, and 9.65 x 10-4 
for rs8032019 in Asians. The overall meta-analysis provided P-value 9.20 x 10-23 for the top SNP 
rs634990. The risk of myopia versus hyperopia was OR 1.88 (95% CI 1.64, 2.16, P < 0.001) 
for homozygous carriers of the risk allele at the top SNP rs634990, and OR 1.33 (95% CI 1.19, 
1.49, P < 0.001) for heterozygous carriers. SNPs at locus 15q25 did not replicate significantly 
(P-value 5.81 x 10-2  for top SNP rs939661).  We conclude that common variants at chromosome 
15q14 influence susceptibility for myopia in Caucasian and Asian populations world-wide. 
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INTRODUCTION
Refractive errors are common optical defects of the visual system. An important refractive error 
is myopia (nearsightedness), which occurs when the eye elongates beyond the focal plane. The 
prevalence of myopia is high, affecting about one third of the world’s population, and reaching 
over 70% in certain Asian ethnic groups1-5. High degrees of myopia are associated with pathologic 
ocular changes, such as myopic macular degeneration, retinal detachment, and glaucoma6-10. 
Due to the limited treatment options, myopia is a common cause of visual impairment10,11. 
Refractive errors, and myopia in particular, are complex genetic traits with a largely unknown 
etiology. Established environmental factors are education, early reading, and reduced outdoor 
exposure11-17. Although heritability estimates are high (50-90%18), the search for myopia genes 
is still ongoing.  Previous linkage and association studies have led to the identification of at least 
18 myopia (MYP) loci, 10 additional chromosomal regions, and several candidate genes11,19. 
Replication of these associations has been inconsistent, and their application to the general 
population is limited19. 
Recent genome-wide association studies (GWAS) reported several susceptibility loci for refractive 
error and myopia20-25. Solouki et al.25 and Hysi et al.20  were the first to perform a GWAS in a 
general Caucasian population, and identified susceptibility loci on chromosomes 15q14 and 
15q25, respectively. In both studies, carriers of single nucleotide polymorphism (SNP) rs634990 at 
15q14 (OR 1.83, 95% CI 1.42-2.36) and of SNP rs8027411 at 15q25 (OR 1.16, 95% CI 1.02–1.28) 
had a higher risk of myopia. Confirmation of these findings was obtained in various replication 
studies20,25,26. However, these replication cohorts were relatively limited in size, increasing the 
chance of a type 1 error.
To address potential inaccuracies and to investigate generalizability, we investigated the 
associations between refractive error and the 15q14 and 15q25 susceptibility loci in a large 
international replication and meta-analysis study (Consortium of Refractive Error and Myopia, 
CREAM) including 31 cohorts with various ethnicities from 4 different continents.
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RESULTS
Meta-analysis of allelic effects on spherical equivalent (SE)
Complete data on refractive error and genome-wide SNPs were available in all 29 population-
based studies comprising 49,364 subjects: 42,224 Caucasians and 7,140 Asians (Table 1, Figure 
1, Supplementary Table 1). This includes the previously reported discovery set consisting of 
15,60825 and 17,608 subjects20, respectively. 
Table 1. Descriptives of all study cohorts
Study n mean age (SD) age range % men mean SE (SD)
1958 British Birth Cohort 1658 42 (0.0) 40-50 54.2% -0.96 (2.00)
AGES Reykjavik 2986 76.3 (5.4) 60-80+ 35.3% 1.22 (2.05)
ALSPAC 3804 15.4 (0.3) 14.25-17.08 47.2% -0.38 (1.28)
AREDS 1 816 79.5 (5.1) 60-80+ 43.5% 0.68 (1.94)
AREDS 2 1506 68.0 (4.7) 55-81 41.1% 0.54 (2.25)
Australian Twins 1819 22.2 (12.7) 5-90 44.0% -0.22 (1.28)
BMES 1574 64 (7.9) 50-80+ 43.4% 0.59 (1.96)
Croatia Split 366 49.8 (14.4) 18-85 46.0% -1.83 (1.83)
Croatia Vis Island 544 55.8 (14.0) 18-83 40.0% -0.16 (1.93)
Croatia Korcula Island 836 56.0 (13.8) 18-98 35.0% -0.25 (1.92)
ERF 2032 48.5 (14.3) 18+ 43.1% 0.07 (2.13)
EGCUT 338 34.8 (15.2) 18-85 36.9% -2.60 (2.00)
Finnish Twin Study on Aging 127 68.2 (3.8) 63-76 0.0% 1.68 (1.54)
Framingham Eye Study 1500 55.5 (9.0) 20-80 42.5% -0.17 (2.40)
Gutenberg Health Study I 2745 55.7 (11) 35-74 51.5% -0.38 (2.44)
Gutenberg Health Study II 1142 55.0 (10.9) 35-74 49.8% -0.41 (2.58)
KORA 1867 55.6 (11.7) 35-84 49.6% -0.29 (2.27)
MESA 1462 62 (9.4) 46-86 49.5% -0.28 (2.62)
ORCADES 505 54.8 (13.7) 22-88.5 43.0% 0.01 (2.14)
Rotterdam Study I 5328 68.5 (8.6) 55+ 41.3% 0.86 (2.45)
Rotterdam Study II 2009 64.2 (7.4) 55+ 45.9% 0.48 (2.51)
Rotterdam Study III 1970 56.0 (5.5) 45+ 43.9% -0.35 (2.62)
OGP Talana 623 44.5 (21.1) 5-89 51.8% -0.15 (1.78)
SCORM 929 10.8 (0.8) 10-15 48.0% -2.02 (2.26)
SiMES 2226 57.7 (10.8) 40-80 49.3% -0.08 (1.98)
SINDI 2055 55.7 (8.7) 40-80+ 51.2% 0.01 (2.13)
SP2 1930 47.5 (10.9) 20-80 45.4% -1.67 (2.89)
TwinsUK 4270 55.0 (12.0) 20-82 7.4% -0.39 (2.73)
Young Finns 397 37.6 (5.2) 25-50 45.0% -1.20 (2.29)
Kyoto Study 5192 NA NA NA NA
     cases 1143 58.4 (14.3) 20-91 33.3% -10.50 (6.44)
     controls 1 3120 58.5 (13.6) 20-90 61.7% NA
     controls 2 929 38.8 (11.8) 0-74 41.3% NA
SORBS 621 NA NA NA NA
     cases 100 45.4 (6.6) 18-40 36.4% NA
     controls 521 28.3 (15.16) 18-80 45.0% NA
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Table 2 shows the results of the meta-analysis of the 14 SNPs20,25 at locus 15q14 and 5 SNPs at 
locus 15q25. The frequency of the effect allele C for top SNP rs634990 at locus 15q14 ranged from 
0.38 to 0.64, while frequency of the effect allele A for top SNP rs939661 at 15q25 showed a larger 
variation, ranging from 0.28 to 0.63 (Supplementary Figure 1). The sample size of each SNP per 
study is provided in Supplementary Table 1.  For locus 15q14, the magnitude and direction of the 
effects were consistent in all cohorts except Croatia Vis and SIMES. For locus 15q25, there was 
less consistency; for top SNP rs939661 8 cohorts - both Caucasian and Asian (Australian Twins, 
Croatia Split, Croatia Vis, EGCUT, FITSA, GHS II, ORCADES, and SIMES) - had a regression beta 
coefficient in the opposite direction to that of the other studies. 
For locus 15q14, the replication set, consisting of all studies except the ones previously used  in 
the discovery analysis, showed a statistically significant association between SE and all SNPs 
with a best P-value 4.53 x 10-14 for top SNP rs634990. Confirmation was achieved in 23 out of 25 
Caucasian studies (overall P 3.87 x 10-12  for SNP rs634990), and in 3 out of 4 Asian studies (overall 
P 2.21 x 10-3 for SNP rs634990). Meta-analysis of the discovery and replication cohorts together 
provided P-value 9.20 x 10-23 for SNP rs634990. 
For locus 15q25, neither Caucasian nor Asian validation studies replicated the original association. 
Meta-analysis of the combined set of the 5 SNPs yielded a lowest P 1.22 x 10-4 for SNP rs939661. 
As a subsequent analysis, we investigated locus 15q25 in more detail, and tested another 26 
SNPs in 26 out of 29 cohorts (no data available in ALSPAC, AREDS 1, and EGCUT). This set of 
SNPs was not replicated either, however, meta-analysis including the discovery cohort was still 
Figure 1. Mean age and distribution of spherical equivalent in all study cohorts
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significant (best P 2.07 x 10-4  for SNP rs1915726; Supplementary Table 3). 
Meta-analysis of risk of myopia for top SNP
Genotype distributions for rs634990 at locus 15q14 were available for 28 out of 31 studies (all but 
FITSA, Australian Twins, and SORBS). There was no evidence of heterogeneity in the analyses 
of homozygote carriers (chi-squared 21.35 (d.f. 26),  P 0.724,  I2 0.0%) or heterozygote carriers 
(chi-squared 24.22 (d.f. 26), P 0.564, I2 0.0%). Therefore, only results from fixed effects meta-
analysis were used. Figure 2 shows the forest plots for the risk of myopia for homozygous and 
heterozygous carriers of the top SNP rs634990. The OR of moderate to high myopia (SE ≤ -3 
D) versus moderate to high hyperopia (SE ≥ +3 D) was 1.88 (95% CI 1.64, 2.16, P < 0.001) for 
homozygous carriers of the risk allele at the top SNP rs634990, and 1.33 (95% CI 1.19, 1.49, P < 
0.001) for heterozygous carriers.
DISCUSSION
Chromosome 15q was first implicated in refractive error and myopia by genome-wide analysis of 
two large studies located in Northern Europe20,25. Here, in an international meta-analysis consisting 
of 31 independent studies from the CREAM consortium, we provide further support that the 
association with locus 15q14 is robust and present in both Caucasians and Asians. We combined 
the results with those of the initial study into a powerful meta-analysis of highly associated SNPs 
with a total study population of 55,177 participants. The combined results showed that all tested 
SNPs for locus 15q14 were associated with refractive errors, and that homozygous carriers of the 
top SNP rs634990 had approximately twice the risk of myopia. SNPs at the other locus, 15q25, 
could not be convincingly replicated. 
This study has strengths and limitations. Major strengths of the study include the sample size 
and the inclusion of different ethnicities. The CREAM consortium represents the largest study on 
refractive error known to date. Previous replication studies have not been large scaled and focused 
on populations of the same ancestry27-29. Another advantage of our study is the incorporation 
of clinical relevant endpoints such as high myopia and high hyperopia. Among the limitations 
are differences in designs and methods of the studies. (1) Population-based as well as case 
control studies were incorporated. However, the latter were only two (Kyoto Study and SORBS) 
and both had results within the same range as the population-based studies. (2) Different types 
of equipment and measurement methods were used to detect refractive error. These differences 
are generally subtle, and are not likely to cause false findings. (3) Various methods of genotyping 
and imputation were used, and genotyping was not complete in all studies. All SNPs at 15q14 had 
similar effect; thus, we do not think this has influenced these associations. SNPs at 15q25 showed 
larger variation, and the incomplete genotyping may have underpowered this analysis. 
Earlier replication of the 15q14 locus was reported by Hayashi et al.26 in a Japanese sample of 
high myopic probands and controls.  In a comparison of 1125 high myopes (axial length >26.1 
mm) versus 1295 controls, the risk of high myopia was increased for the carriers of the initial top 
SNP rs634990 (OR 1.84 in homozygotes (95% CI 1.44-2.36)). Taken together with the current 
findings, this suggests that 15q14 plays a role in both common and high myopia.
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The 15q14 associated region contains two interesting genes that are both well expressed in the 
retina, GJD2 and ACTC1. GJD2 encodes the Connexin36 protein, which plays a crucial role in the 
transmission and processing of visual signals in the retina by enabling intercellular transport of 
small molecules and ions in photoreceptors, amacrine and bipolar cells30-33. We speculated that 
the protein encoded by the other candidate gene, ACTC1, could play a role in scleral remodeling, 
given the fact that similar actin proteins have been shown to be increased in developing myopic 
tree shrew eyes34. Previous GJD2 25 and ACTC1 (unpublished data) direct sequencing experiments 
did not reveal a functional variant, but the 15q14 locus appeared to harbor regulatory elements 
which may influence transcription of these genes25.
The 15q25 region contains the interesting candidate gene RASGRF1, which is highly expressed in 
the retina and has previously been implicated in photoreception and visual sensory processes35,36. 
The association with this locus and gene is not robust, since none of the initial SNPs replicated 
significantly, and determination of more SNPs did not increase significance. A type 1 error may 
explain the initial finding.  Another potential cause for the non-replication is a large variation in 
Figure 2. Forest plots of odds ratios of myopia (spherical equivalent ≤ −3 diopters) versus 
hyperopia (spherical equivalent ≥ +3 diopters) for top SNP rs634990.  
Figure 2A. Homozygotes carriers of alleles TT vs CC for SNP rs634990. Figure 2B. Heterozygotes carriers 
of alleles TT vs TC for SNP rs634990.  For studies without subjects with high or moderate hyperopia , 
emmetropia was used as a reference group.
A
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allele frequencies. The range of allele frequencies at 15q25 (0.28 to 0.63) was only slightly larger 
than at 15q14 (0.38 to 0.64) in our consortium, making this an unlikely explanation (Supplementary 
Figure 1). Finally, population stratification within cohorts did not appear to play a major role, since 
only two cohorts had significant principal components, which were addressed in the analyses.  
Other GWAS loci were only found for high myopia in Asian case control studies, and they were 
located on chromosomes 11q24.123, 5p1521,  4q2522, and 13q12.1224. The locus on chromosome 
5p15 harbors the excellent candidate gene CTNND2 which is involved in retinal morphogenesis, 
adhesion, retinal cell architecture integrity37,38, and was replicated in subjects of the same 
ethnicity28. Replication studies for the 4q2527 and 11q24.129 loci were only successful in case of 
the 4q25 locus; these loci did not have prominent candidate genes. 
What should be the next steps? For 15q14, comprehensive resequencing of the entire associated 
region and the flanking genes can reveal the responsible gene defects which determine the 
association. Novel techniques such as next-generation sequencing are promising in this regard. 
Functional studies in knockout animals will shed light on potential protein effects. Lastly, evaluation 
of gene-environment interactions may explain phenotypic variation and help identify high risk 
groups. For myopia genetics in general, performance of a genome-wide meta-analysis is a logical 
next step. The current CREAM collaboration is an excellent platform for this project.
B
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In summary, we have convincingly demonstrated that common variants at chromosome 15q14 
influence susceptibility for myopia in both Caucasian and Asian populations around the world. 
Identification of functional variants and responsible genes that explain this association will provide 
more insight in the complex etiology of myopia.
MATERIALS AND METHODS
Subjects and phenotyping
A total of 31 study cohorts from the Consortium of Refractive Error and Myopia (CREAM) participated 
in this meta-analysis. 29 Population-based  as well as 2 case-control studies were included. 
General methods, descriptives and phenotyping and genotyping methods of the study cohorts 
can be found in Table 1, the Supplementary Material and Supplementary Table 1, respectively. 
In short, 22 cohorts consisted of Caucasian, and 5 of Asian study subjects.  All studies were 
performed with the approval of their local Medical Ethics Committee, and written informed consent 
was obtained from all participants in accordance with the Declaration of Helsinki.
All studies used a similar protocol for phenotyping. Exclusion criteria were age ≤10 years, and 
bilateral cataract surgery, laser refractive procedures or other intra-ocular procedures which might 
alter refraction. Eligible participants underwent a complete ophthalmologic examination including 
a non-dilated measurement of refractive error (Table 1) of both eyes. Spherical equivalent was 
calculated according to the standard formula (SE=sphere + ½ cylinder), and the mean of two eyes 
was used for analysis. When data from only one eye were available, the SE of this eye was used. 
SE was categorized into low (SE from −1.5 to −3 D), moderate (SE from −3 to −6 D) and high (SE 
of −6 D or lower) myopia; and also into low (SE from +1.5 to +3 D), moderate (SE from +3 to +6 
D) and high (SE of +6 D or higher) hyperopia. Emmetropia was defined as SE equal to or between 
−1.5 to +1.5 D. 
Genotyping & imputation
DNA was extracted according to standard procedures, and genotyping and imputation of SNPs 
across the entire genome was performed using various methods (Table 1). Samples with a low 
call rate, with excess autosomal heterozygosity, with sex-mismatch, or outliers identified by the 
identity-by-state clustering analysis were excluded. 
Statistical analysis
Meta-analysis of allelic effects on spherical equivalent 
We selected 19 SNPs within loci 15q14 (14 SNPs) and 15q25 (5 SNPs) with a P-value of < 10-6  from 
two previous GWAS20,25. Linear regression models with a 1 degree of freedom trend test were used 
to examine associations with SE as a quantitative trait outcome, adjusting for age and gender and 
significant principal components if applicable. From all population-based cohorts, we obtained 
effect allele, non effect allele, regression coefficient beta, standard error, P value, minor allele 
and minor allele frequency for each of these SNPs. METAL for Linux was used to perform a meta-
analysis on betas and standard errors for all SNPs. First, discovery cohorts20,25 and replication 
studies were analyzed separately, followed by a combined meta-analysis.  As a second analysis, 
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26 additional SNPs within the same linkage disequilibrium (LD) block were selected and tested 
for association using the procedures mentioned above. For these analyses, Bonferroni corrected 
P-values (0.05 / number of tested SNPs) of 3.57 x 10-3 for 15q14, and 1.0 x 10-2 (5 SNPs, Table 2) 
or 1.92 x 10-3 (26 SNPs, Table 3 Supplementary Material) for 15q25 were considered statistically 
significant. 
Meta-analysis of risk of myopia for top SNP
From all population-based and case control studies, we obtained genotype distributions of the 
replicated top SNPs. We calculated heterogeneity (chi-square, I2 calculated and corresponding 
P-values) between studies, crude OR with corresponding 95% CI and P-value of moderate and 
high myopia versus moderate and high hyperopia with a random as well as fixed effects meta-
analysis using Stata 11. When these analyses provided similar outcomes, data from fixed effect 
analysis were used. For studies without subjects with high or moderate hyperopia, emmetropia was 
used as a reference group. A standard P-value of <0.05 was considered statistically significant. 
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ABSTRACT 
Refractive error is the most common eye disorder worldwide, and a prominent cause of blindness. 
Myopia affects over 30% of Western populations, and up to 80% of Asians. The CREAM consortium 
conducted genome-wide meta-analyses including 37,382 individuals from 27 studies of European 
ancestry, and 8,376 from 5 Asian cohorts. We identified 16 new loci for refractive error in subjects of 
European ancestry, of which 8 were shared with Asians. Combined analysis revealed 8 additional 
loci. The new loci include genes with functions in neurotransmission (GRIA4), ion channels (KCNQ5), 
retinoic acid metabolism (RDH5), extracellular matrix remodeling (LAMA2, BMP2), and eye 
development (SIX6, PRSS56). We also confirmed previously reported associations with GJD2 and 
RASGRF1. Risk score analysis using associated SNPs showed a tenfold increased risk of myopia for 
subjects with the highest genetic load. Our results, accumulated across independent multi-ethnic 
studies, considerably advance understanding of mechanisms involved in refractive error and myopia. 
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INTRODUCTION & RESULTS
Refractive error is the most important cause of visual impairment in the world1. Myopia, or 
nearsightedness, in particular is associated with structural changes of the eye, increasing the risk 
of severe complications such as macular degeneration, retinal detachment, and glaucoma. The 
prevalence of myopia has been rising dramatically over the past few decades2, and it is estimated 
that 2.5 billion people will be affected by myopia within a decade3. Although several genetic loci 
influencing refractive error have been identified4-10, their contribution to phenotypic variance is 
small, and many more loci are expected to explain its genetic architecture. 
Here the Consortium for Refractive Error and Myopia (CREAM) presents results from the largest 
international genome-wide meta-analysis on refractive error with data from 32 studies from Europe, 
the United States, Australia, and Asia. The meta-analysis was performed in three stages: as a 
first step, we investigated genome-wide association study (GWAS) results of 37,382 individuals 
from 27 populations of European ancestry (Supplementary Note, Supplementary Table 1) using 
spherical equivalent as a continuous outcome; as a second step, we aimed to test cross-ethnic 
transferability of the statistical significant associations from the first stage in 8,376 individuals from 
5 Asian cohorts (Supplementary Note, Supplementary Table 1). As a third step, we performed a 
GWAS meta-analysis on the combined populations (total n = 45,758). Subsequently, we examined 
the influence of associated alleles on the risk of myopia in a genetic risk score analysis, and lastly, 
we evaluated gene expression in ocular tissues and explored potential mechanisms by which 
newly found loci may exert their effect on refractive development. 
At step 1, we analyzed ~2.5 million autosomal single nucleotide polymorphisms (SNPs) which were 
obtained through whole-genome imputation of genotypes to HapMap 2. The inflation factors (λGC) of 
the test statistics in individual studies contributing to the meta-analysis ranged between 0.992 and 
1.050, indicating excellent within-study control of population substructure (Supplementary Table 
2). The overall lambda was 1.09, consistent with a polygenic inheritance model for refractive error 
(QQ plot, Supplementary Figure S1). We did not perform a lambda correction as Yang et al. have 
shown that in this situation substantial genomic inflation can be expected, even in the absence 
of population structure and technical artifacts11. We identified 309 SNPs that exceeding the 
conventional genome-wide significance threshold of P=5.0x10-8 in the European ancestry sample. 
These SNPs were clustered in 18 distinct genomic regions across 14 chromosomes (Figure 1, 
Table 1). At step 2, we investigated the 18 best associated SNPs in the Asian population: ten 
showed evidence of association (Table 1). The most significant association in both ancestry groups 
was at a previously identified locus on chromosome 15q14 in the proximity of the GJD2 gene (SNP 
rs524952; Pcombined=1.44x10-15)4,12. The locus near the RASGRF1 gene was also replicated in the 
meta-analysis (SNP rs4778879; Pcombined=4.25x10-11)9, the remaining 16 genome-wide significantly 
associated loci had not previously been reported in association with refractive error. Those loci 
that were not significant in the smaller sized Asian population mostly had a similar effect size 
and direction of effect as in the European ancestry sample. At step 3, we identified 8 additional 
loci which exceeded genome-wide significance in the combined analysis (Table 2). Regional and 
forest plots of the associated loci are provided in Supplementary Figures 2 and 3.
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Genotype distributions of the risk alleles were evaluated in Rotterdam Studies I-III (n=9,307). The 
clinical utility for the prediction of risk of myopia was evaluated by a weighted genetic risk score 
analysis based on the aggregate of effects (regression coefficients betas) of individual SNPs derived 
from the meta-analysis, using the middle risk category as a reference. Risk scores ranged from a 
mean risk score of 1.88 (95% CI 1.86 - 1.89) in the lowest risk score category to 3.63 (95% CI 3.61-
3.65) in the highest risk score category. Having the lowest or the highest genetic risk score was 
associated with an odds ratio of 0.38 (95% CI 0.18-0.77), and an odds ratio of 10.97 (95% CI 3.727-
31.251) of myopia, respectively (Figure 2). The predictive value (area under receiver operating 
characteristic curve, AUC) of myopia versus hyperopia was 0.67 (95% CI 0.65-0.69), a relatively high 
value for genetic factors in a complex trait13,14. The genetic variants explain 3.4% of the phenotypic 
variation in refractive error in the Rotterdam Study. 
We examined the expression of genes harboring a genetic association signal by measuring levels 
of RNA in various eye tissues, and found most of these genes expressed in the eye (Supplementary 
Table 3). The genes PRSS56, LOC100506035, and SHISA6 were not available in the expression data 
set; all other genes were expressed in the retina. Subsequently, we assessed the areas where our 
SNP hits reside for H3K27ac modification marks15, and HaploReg16 annotations for marks of active 
regulatory elements (Supplementary Table 4, Supplementary Figure 4). We found that many hits 
contain these elements, and alteration of regulatory function is therefore a suggestive mechanism.
The widely-accepted model for myopia development is that eye growth is triggered by a visually-
evoked signaling cascade, which originates from the sensory retina, traverses the retinal pigment 
epithelium and choroid, and terminates in the sclera, where active extracellular matrix (ECM) 
remodeling results in a relative elongation of the eye17. Many of the genes in or near the identified 
loci can be linked to biological processes that drive this cascade. Neurotransmission in the retina 
is a necessary mechanism for eye growth regulation; the most significantly associated gene GJD2 
plays a role herein. This gene forms a gap junction between neuronal cells in the retina, enabling 
Figure 1. Manhattan plot of the GWAS meta-analysis for refractive error in the combined analysis (n = 45,758) 
The plot shows −log10-transformed P values for all SNPs; the upper horizontal line represents the genome-wide 
significance threshold of P < 5.0 × 10−8; the lower line indicates P value of 10-6. Previously reported genes are 
depicted in grey. The A2BP1 gene is also known as RBFOX1.
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intracellular exchange of small molecules and ions. The other previously-reported gene RASGRF1 
is a nuclear exchange factor that promotes GDP/GTP exchange on Ras-family GTPases, and 
is involved in synaptic transmission of photoreceptor responses18,19. Both GJD2 and RASGRF1 
knockout mice show retinal photoreception defects18,20. One of the newly identified genes, GRIA4 
(SNP rs11601239; Pcombined=5.92x10-9) also has a potential function in this pathway. This gene is 
a glutamate-gated ion channel that mediates fast synaptic excitatory neurotransmission21, is 
present in various retinal cells22, has been shown to be critical for light signaling in the retina23 
and emmetropization24. Another gene involved in synaptic transmission is A2BP1 (also known 
as RBFOX1; SNP rs17648524; Pcombined=5.64x10-10), an RNA-binding splicing regulator which 
modulates membrane excitability25.
We identified for the first time a number of genes involved in ion transport, channel activity and 
maintenance of membrane potential. KCNQ5, a potassium channel regulator (SNP rs7744813; 
Pcombined=4.18x10-9), participates in the transport of K+ from the retina to the choroid, and may 
contribute to voltage-gated K+ channels in photoreceptors and retinal neurons associated with 
myopia26,27. CD55 (SNP rs1652333; Pcombined=3.05x10-12) is known to elevate cytosolic calcium ion 
concentration. Other ion channel genes include CACNA1D, a voltage-sensitive calcium channel 
regulator; KCNJ2 , a regulator of potassium ion transport; CHRNG, a nicotinic cholinergic receptor; 
and MYO1D, a putative binder of calmodulin, which mediates Ca+ sensitivity to KCNQ5 ion channels.
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Figure 2. Genetic risk score for myopia
Distribution of subjects from Rotterdam Study I-III (n= 9,307) with myopia (SE ≤ -3 D), emmetropia (SE ≥ -1.5 D & ≤ 
1.5 D) and hyperopia (SE ≥ 3 D) as a function of genetic risk score. This score is based on the regression coefficients 
and allele dosages of the associated SNPs for all 26 loci identified in the meta-analysis. The mean OR of myopia 
was calculated per risk category, using the middle risk score category (risk score 2.50; 2.75) as a reference. 
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Retinoic acid is synthesized in the retina and highly expressed in the choroid and has been implicated 
in eye growth in experimental myopia models28-30. Retinol dehydrogenase 5 (RDH5), a novel refractive 
error susceptibility gene (SNP rs3138144; Pcombined=4.44x10-12), is involved in the recycling of 11-cis-
retinal in the visual cycle31. Mutations in RDH5 cause congenital stationary night blindness (OMIM 
#136880), a disease associated with myopia. Other genes involved in retinoic acid metabolism are 
RORB (RAR-related orphan receptor), and CYP26A1, genes that were significant in the European 
ancestry studies. Notably, retinoic acid contributes to ECM remodeling by regulating cell differentiation.
ECM remodeling of the sclera is the pathological hallmark in myopia development. LAMA2 (laminin 
α2, SNP rs12205363; Pcombined=1.79x10-12) is the most prominent gene in this respect. LAMA2 forms 
a subunit of the heterotrimer laminins which are essential components of basement membranes, 
stabilizing cellular structures and facilitating cell migration32. The two bone morphogenic genes (BMP2, 
SNP rs235770; Pcombined=1.57x10-8; BMP3) can also be placed within the ECM architecture. They are 
members of the transforming growth factor-β (TGFβ) super-family, regulate growth and differentiation 
of mesenchymal cells, and may orchestrate the organization of other connective tissues than bone 
such as sclera. Remarkably, BMP2 shows bidirectional expression in retinal pigment epithelium in 
myopia animal models33.
Genes involved in eye development appeared as a separate entity among the gene functions. 
SIX6 (SNP rs1254319; Pcombined=1.00x10-8) has been linked to anophthalmia and glaucoma34,35, 
PRSS56 (protease serine 56, SNP rs1656404; Pcombined=7.86x10-11) to microphthalmia36-38, CHD7 to 
CHARGE syndrome, a congenital condition with severe eye structural defects, and ZIC2 to brain 
development including visual perception. For the remaining novel gene associations, a mechanism 
in the pathogenesis of myopia is not immediately clear. Results from Ingenuity and the Protein Link 
Evaluator39 (Supplementary Figure 5) visualize the subcellular location of all associated genes, and 
illustrates their interrelationships. Direct connections between genes were surprisingly infrequent, 
suggesting molecular disease heterogeneity or functional redundancy in the pathobiological events 
involved in development of refractive error and myopia.
In summary, we identified 24 new chromosomal loci associated with refractive error through a large-
scale meta-analysis of GWAS from international multi-ethnic studies. The significant overlap in genetic 
loci for refractive error between subjects of European ancestry and Asians provides evidence for 
shared genetic risk factors between the populations. The tenfold increased risk of myopia for those 
carrying the highest number of risk alleles depicts the clinical significance of our findings. Further 
elucidation of the mechanisms by which these loci affect eye growth carries the potential to improve 
the visual outcome of this common trait.
METHODS
Study design
We performed a meta-analysis on directly genotyped and imputed SNPs from individuals of European 
ancestry in 27 studies, with a total of 37,382 individuals. Subsequently, we evaluated significant SNPs 
in 8,376 subjects of Asian origin from 5 different studies, and performed a meta-analysis on all studies 
combined .
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Subjects and phenotyping
All studies participating in this meta-analysis are part of the Consortium for Refractive Error and 
Myopia (CREAM). All studies had a population-based design and had a similar protocol for 
phenotyping (Supplementary Table 1). Eligible participants underwent a complete ophthalmologic 
examination including a non-dilated measurement of refractive error of both eyes. Exclusion criteria 
were all conditions that could alter refraction, such as cataract surgery, laser refractive procedures, 
retinal detachment surgery, keratoconus, or ocular or systemic syndromes. Inclusion criteria were 
persons aged 25 years and over who had data on refractive error and genotype. 
The meta-analysis of step 1 was based on 27 studies of European ancestry: 1958 British Birth 
Cohort, ALSPAC, ANZRAG, AREDS1a1b, AREDS1c, CROATIA-Korcula, CROATIA-Split, CROATIA-
Vis, EGCUT, FECD, TEST/BATS, FITSA, Framingham, GHS 1, GHS 2, KORA, ORCADES, TwinsUK, 
WESDR, YFS, ERF, DCCT, BMES, RS-I, RS-II, RS-III, and OGP Talana. The second step was formed 
by 5 Asian studies: Beijing Eye Study, SCES, SIMES, SINDI, and SP2. 
General methods, demographics and phenotyping and genotyping methods of the study cohorts 
can be found in the Supplementary Note and Supplementary Table 1. All studies were performed 
with the approval of their local Medical Ethics Committee, and written informed consent was obtained 
from all participants in accordance with the Declaration of Helsinki.
Genotyping and imputation
Particulars of genotyping in each cohort, particular platforms used to generate genotyping and 
methods of imputation can be found in more detail in the Supplementary Table 5. To produce 
consistent datasets and enable meta-analysis of studies across different genotyping platforms, the 
cohorts performed genomic imputation on the HapMap Phase 2 available genotypes with MACH40 or 
IMPUTE41, using the appropriate ancestry as templates. 
Each cohort applied stringent quality control procedures prior to the imputation, including minor 
allele frequency cutoffs, Hardy-Weinberg equilibrium (P > 10-7), genotypic success rate (>95%), 
Mendelian inconsistencies, exclusion of individuals with more than 5% shared ancestry (exception 
made for family-based cohorts in which due adjustment for family relationship was made) and 
removal of all individuals whose ancestry as determined through genetic analysis did not match the 
prevailing ancestry group of the own cohort. SNPs with low imputation quality were filtered using 
metrics specific to the imputation method and thresholds used in their previous GWAS analyses. 
Hence, imputation quality criteria varied slightly among studies, and low-confidence imputed SNPs 
were omitted in the meta-analysis for individual studies.
Statistical analysis
Spherical equivalent was calculated according to the standard formula (SE=sphere + ½ cylinder), 
and the mean of two eyes was used for analysis. When data from only one eye was available, the SE 
of this eye was used.
Each cohort performed association analyses in which the spherical equivalent (determined as 
described above) was the dependent variable and genotypes (number of alleles in each of the 
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HapMap2 loci) as the independent variables. Analyses in all cases also adjusted for sex and age at 
the time of phenotype measurement. In family-based cohorts score-test based association test was 
used to adjust for within-family relatedness (see Supplementary Note)42,43. Study-specific lambda 
estimates are shown in Supplementary Table 2. 
All study effect estimates were corrected using genomic control and were oriented to the positive 
strand of the NCBI build 36 reference sequence of the human genome, which was the genomic build 
on which most available genotyping platforms were based. The coordinates and further annotations 
of the SNPs were further converted into build 37, the most recent of the available builds at the time 
of writing. 
Meta-analyses used effect size estimations (beta regression coefficients) and standard errors from 
individual cohorts’ summary statistics. Random-effects were assumed for all the meta-analyses which 
were performed using GWAMA44. We tested for heterogeneous effects between the two ancestries 
using METAL45 for Linux. For the purpose of these analyses, we defined significance as equal to or 
better than the conventional multiple testing genome-wide thresholds of association (P<5.0 x 10-8) 
for stage 1 and nominally significant probabilities (P<0.05) for stage 2. Manhattan, regional plots and 
forest plots were made using R and Locuszoom46.
For the Rotterdam Study I-III, a weighted genetic risk score per individual was calculated using 
the regression coefficients from the GWAS meta-analysis model for the association of SNPs within 
the associated 26 loci (Table 1, Table 2; per locus only one SNP was included in the analysis) and 
the individual allele dosages per genotype to evaluate the relationships between myopia (SE ≤ - 3 
D), emmetropia (-1.5 D ≤ SE ≤ 1.5 D) and hyperopia (SE ≥ +3 SD). The weighted risk scores were 
categorized and mean odds ratios per risk score category were calculated for subjects with myopia 
versus hyperopia, using the middle risk score category as a reference. Subsequently, the area 
under the receiver curve (AUC) was calculated for myopia versus emmetropia and myopia versus 
hyperopia. Lastly, the proportion of variance of spherical equivalent explained by the identified SNPs 
was calculated. For these analyses, we used SPSS version 20.0.0 (SPSS Inc.). 
Gene expression data in human eye tissue
Independently designed, collected, and reported human ocular tissue array data from two different 
sources, as well as literature reviews were used to verify evidence of expression of the candidate 
genes. 
RPE, photoreceptors and choroid
Human gene expression data of RPE, photoreceptors and choroid were obtained essentially as 
described47 and the dataset has been deposited in NCBI’s Gene Expression Omnibus48 (GEO series 
accession number GSE20191). In short, postmortem eye bulbs (retinal pigment epithelium was 
obtained from six donor eyes, choroid was obtained from three donor eyes and photoreceptors 
were obtained from three donor eyes), provided by the Corneabank Amsterdam, were rapidly 
frozen using liquid nitrogen. Donors were between 63 and 78 years old and had no known history 
of eye pathology. Cryosections were cut from the macula, and histology was used to confirm a 
normal histological appearance. Retinal pigment epithelium, photoreceptor and choroidal cells 
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were isolated from macular sections using a Laser Microdissection System (PALM). Total RNA was 
isolated and the mRNA component was amplified, labeled and hybridized to a 44K microarray 
(Agilent Technologies)49. At least three to six microarrays were performed per tissue. Sample isolation, 
procedures and expression microarray analysis were carried out according to MIAMI guidelines. As 
a measure of the level of expression, we sorted all the genes represented on the 44K microarray by 
increasing their expression, and we calculated the corresponding percentiles (Supplementary Table 
3a).
Sclera, cornea and optic nerve
We assessed expression of the associated genes in sclera, cornea and optic nerve tissue in an 
additional dataset (unpublished data). Adult eyes were obtained from the North Carolina Eye Bank 
(Winston-Salem, North Carolina). All whole globes were immersed in RNALater (Quiagen, Hilden, 
Germany) within 6.5 hours of collection, shipped overnight on ice, and dissected on the day of arrival. 
The retina, choroid and scleral tissues were isolated at the posterior pole using a circular, double 
embedded technique using round 7 mm and 5 mm biopsy punches. To reduce contamination of 
retina to the other ocular tissues samples, the second biopsy punch of 5 mm was used in the center 
of the 7 mm punch after retinal removal. RNA samples (quality control of RNA concentration and 
260/280 nm ratios using Nanodrop®) (Invitrogen, Carlsbad, California, USA) were hybridized to 
whole genome microaray Illumina® HumanHT-12 v4 Expression BeadChips (over 25,000 genes and 
48,000 probes) in two batches. The first batch was hybridized to adult RPE, choroid, and sclera RNA 
samples (n=6). The second batch of newer chips with additional probes was hybridized to adult optic 
nerve and cornea samples (n=6). The data were exported from Illumina® GenomeStudio and log2 
transformed. Sample outliers were determined by principle component analyses using the Hoteling’s 
T2 test50 (at 95% confidence interval) and removed from further analyses. The data intensity was 
normalized by Quantile normalization followed by Multichip Averaging51 to reduce chip effects. For 
each tissue type, the probes with signal intensities below background levels and those with the lowest 
(5%) signal intensities (detection P<0.10) were excluded. Evidence of expression in the remaining 
probes was defined by detection P<0.05. Probes with detection P values < 0.10 and > 0.05 required 
additional tissue expression support from EyeSAGE or literature reports (Supplementary Table 3b).
Search for regulatory elements
We used the ‘Integrated Regulation from ENCODE’ track in the UCSC genome browser to look 
at H3K27ac modificiation marks as a mark of active regulatory elements. Numbers of H3K27ac 
modification marks were counted between the associated topSNP from a locus and the nearest gene 
and within (the nearest) gene itself. We also used HaploReg16 annotations to look for other signs of 
regulatory activity at the site of the associated SNP itself, such as enhancer histone marks, DNAse 
hypersensitivity sites, binding proteins and motifs changed.
Pathway analyses
We used two different programs for pathway analysis; Ingenuity, version August 2012, application 
build 172788, content version 14197757) and the Disease Association Protein-Protein Link Evaluator 
(DAPPLE)39. 
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Subcellular localization assignment and functional annotation of myopia associated disease 
genes as well as molecular pathway analysis was carried out using the Ingenuity knowledge 
database. The candidate myopia disease genes discovered in this study were entered into the 
Ingenuity knowledge database (IPA). We used the “IPA toggle subcellular layout” function to 
show the subcellular location (extracellular, plasma membrane, cytoplasm, nucleus, unknown) of 
the proteins corresponding to these genes, which yield a first glance which signaling molecules 
and pathways are involved in myopia. Subsequently, we used the IPA “connect” function to 
discover potential direct or indirect functional relationships or molecular pathways in between 
these entries. This yielded surprisingly little hits, which suggest molecular disease heterogeneity 
and/or functional redundancy in the pathobiological events leading to myopia. Next, we used the 
IPA “overlay” function to annotate the myopia candidate disease genes with (their involvement 
in) “functions and diseases”, “canonical pathways” and a range of custom made gene lists 
from previous studies, including photoreceptor, RPE, and choroidal specific transcripts (partly 
published52). Lastly, we used the Disease Association Protein-Protein Link Evaluator (DAPPLE)39 to 
look for physical connections between proteins encoded from disease-genes associated regions. 
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ABSTRACT
Refractive error (RE) is a complex, multifactorial disorder characterized by a mismatch between the 
optical power of the eye and its axial length that causes object images to be focused off the retina. 
The two major subtypes of RE are myopia (nearsightedness) and hyperopia (farsightedness), 
which represent opposite ends of the distribution of the quantitative measure of spherical refraction. 
We performed a fixed effects meta-analysis of genome-wide association results of myopia and 
hyperopia from 9 studies of European-derived populations: AREDS, KORA, FES, OGP-Talana, 
MESA, RSI, RSII, RSIII and ERF. One genome-wide significant region was observed for myopia, 
corresponding to a previously identified myopia locus on 8q12 (p=1.25x10-8), which has been 
reported by Kiefer et al as significantly associated with myopia age at onset and Verhoeven et 
al as significantly associated to mean spherical-equivalent (MSE) refractive error. We observed 
two genome-wide significant associations with hyperopia. These regions overlapped with loci on 
15q14 (minimum p value=9.11x10-11) and 8q12 (minimum p value 1.82x10-11) previously reported 
for MSE and myopia age at onset. We also used an intermarker linkage- disequilibrium-based 
method for calculating the effective number of tests in targeted regional replication analyses. We 
analyzed myopia (which represents the closest phenotype in our data to the one used by Kiefer 
et al) and showed replication of 10 additional loci associated with myopia previously reported 
by Kiefer et al. This is the first replication of these loci using myopia as the trait under analysis. 
“Replication-level” association was also seen between hyperopia and 12 of Kiefer et al’s published 
loci. For the loci that show evidence of association to both myopia and hyperopia, the estimated 
effect of the risk alleles were in opposite directions for the two traits. This suggests that these loci 
are important contributors to variation of refractive error across the distribution.
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INTRODUCTION
Refractive errors (RE) are etiologically complex, multifactorial disorders characterized by a 
mismatch between the optical focal length of the eye and its axial length. This optical mismatch 
causes images to be focused away from the retina. The two major subtypes of spherical RE are 
myopia (nearsightedness) and hyperopia (farsightedness). Clinically significant myopia affects at 
least 25% of individuals over age 40 in the United States and western Europe, while hyperopia 
affects about 10% of individuals in this same age group1. Recent reports show that the prevalence 
of myopia has increased significantly in the United States over the last 3 decades; myopia of 2 (D) 
diopters or more was estimated to afflict 41.6% of Americans aged 12 to 54 years in 1999-2004, 
compared to only 25% in 1971-19722. The myopia epidemic is most acute in East Asia, where 
prevalence estimates of myopia (of at least 0.5 D) routinely surpass 70% among late teenagers 
and young adults3-5 A recent study of 19 year-old male military conscripts from Seoul, Korea, found 
that a staggering 96.5% were myopic6.
The causes of RE are complex and are a combination of environmental and genetic factors7. Twin 
studies have reported a heritability greater than 0.50 for RE8. Several studies have calculated the 
heritability to be as high as 0.98 for myopia and 0.75 for hyperopia9-12. The search for environmental 
factors influencing RE have mostly focused on myopia. These include near work and time spent 
outdoors during childhood and teenage years13-16. Genome-wide association studies have become 
an essential tool in the study of traits such as RE, and to date there have been 67 published loci for 
refraction phenotypes17. In particular, Kiefer et al18 performed a genome-wide association study of 
myopia using self-reported age at onset in 45,771 participants and found 22 significant genome-
wide associations. Verhoeven et al performed a genome wide association of the quantitative trait 
mean spherical equivalent (MSE) and found 24 significant genome-wide associations (2 of which 
were replications of previously published loci)19. Thirteen loci were genome-wide significant in 
both the Kiefer et al and Verhoeven et al studies20. 
Here we present the results of a genome-wide association meta-analysis of 2 dichotomous RE 
traits, myopia and hyperopia (adjusted for age, sex and years of education), in 9 populations: 
the Age-Related Eye Disease Study (AREDS), the Cooperative Health Research in the Region 
of Augsburg (KORA) the Framingham Eye Study (FES), Ogliastra Genetic Park-Talana (OGP-
Talana) Study, the Multi-ethnic Study of Atherosclerosis (MESA), the Rotterdam Eye Studies I, 
II and III (RSI, RSII, RSIII) and the Erasmus Rucphen Family Study (ERF). These are termed the 
discovery meta-analyses of myopia and hyperopia hereafter. Eight of the discovery samples were 
previously included in the meta-analysis of refractive error by Verhoeven et al19. One sample, 
the MESA study, was not included in either Kiefer et al18 or Verhoeven et al’s studies19,21. We 
attempted replication of significant and suggestive associations from the discovery meta-analyses 
through meta-analysis of association studies using these same trait definitions to these selected 
regions in 8 additional studies: the 1958 British Birth Cohort, the Blue Mountains Eye Study 
(BMES), the CROATIA-Vis Island Study, the CROATIA-Korcula Study, the Diabetes Control and 
Complications Trial (DCCT), the Orkney Complex Disease Study (ORCADES), the TwinsUK Study, 
and the Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR). All of these studies 
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were previously included in the meta-analysis of refractive error by Verhoeven et al19. Finally, we 
examined the results of our discovery meta-analyses of myopia and hyperopia in the regions 
found to be associated with myopia age at onset by Kiefer et al18. In genetic association studies, 
the term replication is generally used to mean detection of statistical association of the same 
trait to the same associated genetic locus in an independent set of data. Here, we also use the 
term replication when discussing the results of our myopia trait (adjusted for age at examination, 
sex and years of education) since it is expected to be quite similar to the age at onset of myopia 
trait used by Kiefer et al. in their study18. We show independent replication of 11 of Kiefer et al’s 
loci for myopia age at onset18, and while our myopia trait is not exactly the same as that of Kiefer 
et al18, it is the closest phenotype available in our data. We also examined these same regions 
for association to hyperopia. The association to hyperopia would not constitute a “replication” of 
Kiefer et al’s myopia findings, but association with this related trait may help to clarify the complex 
genetic underpinnings of refractive error.
MATERIAL AND METHODS
Populations
The nine GWASs meta-analyzed in the discovery GWAS portion of this study included subjects 
aged 35-84 years from the Cooperative Health Research in the Region of Augsburg Study (KORA 
F3, Southern Germany), subjects aged 55-80 from the Age-related Eye Study (AREDS), unrelated 
subjects aged 28-84 from the Framingham Eye Study (FES), subjects aged 46-86 from the Multi-
Ethnic Study of Atherosclerosis (MESA) study, and subjects aged 18-88 from the Ogliastra Genetic 
Park-Talana (OGP-Talana) study in Sardinia, subjects aged 55 and older from the Rotterdam Eye 
Study I, subjects aged 55 and older from the Rotterdam Eye Study II, subjects aged 45 and older 
from the Rotterdam Eye Study III, and subjects aged 18-86 from the ERF study, resulting in a total 
sample size of 16,830 individuals for the myopia analyses and 14,981 for the hyperopia analyses. 
All individuals were of European ancestry. This study involved meta-analysis of aggregate statistics 
from multiple studies. Approval was obtained by the local ethics committees for all studies, all 
studies were conducted according to the principles expressed in the Declaration of Helsinki and 
informed consent was obtained from the study participants at all study sites.
Study design
GWAS analyses of genotype data imputed to HapMap-II were performed for the traits myopia 
and hyperopia (adjusted for age at examination, sex and years of education) in 9 studies: the 
Age-Related Eye Disease Study (AREDS), the “Kooperative Gesundheitsforschung in der Region 
Augsburg” (KORA, “Cooperative Health Research in the Region of Augsburg”), the Framingham 
Eye Study (FES), the Ogliastra Genetic Park – Talana (OGP-Talana) study, the Multiethnic Study of 
Atherosclerosis (MESA) and the Rotterdam Eye Studies RSI, RSII, RSIII and the Erasmus Rucphen 
Family Study (ERF). The results from these analyses were then combined into a discovery meta-
analysis GWAS of each trait. Fixed effects meta-analyses were performed with METAL22 using p 
values and the effective sample size for each population. METAL calculates a genomic control 
value23 for each population and then adjusts each population’s results using the corresponding λ 
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value. The discovery meta-analysis genome-wide significance threshold was taken to be 5x10-8.
In an attempt to replicate our discovery meta-analysis results and to increase the power of the 
analyses using our discovery dataset, we obtained association results from 8 other studies, the 
Blue Mountains Eye Study (BMES), CROATIA-Split, CROATIA-Vis Island, CROATIA-Korcula 
studies, the Diabetes Control and Complications Trial (DCCT), and the Orkney Complex Disease 
Study (ORCADES) (Supplemental Methods), just for 30 genomic regions that contained SNPs with 
association p-values less than 1x10-5 to either myopia (11 regions) or hyperopia (14 regions) or 
both (5 regions) in our discovery meta-analysis (the previously well-replicated association region 
on chromosome 15q14 was excluded). These studies all performed association of SNPs in these 
regions with myopia and hyperopia (adjusted for age at examination, sex, years of education when 
available and up to three principal components when there was significant evidence of population 
stratification in the data). A replication meta-analysis was performed using the same methods 
as above on association results in the novel genome-wide significant region for the hyperopia 
trait in these 8 additional datasets. An additional meta-analysis was then performed in these 30 
regions combining results from the discovery datasets and these 8 additional studies. All 8 of 
these additional datasets were part of the Verhoeven et al. study of mean spherical equivalent. 
This additional analysis and these datasets are described in Supplemental Materials. 
Quality control of discovery datasets
AREDS and KORA: Quality control measures are described elsewhere24 but in brief: Individuals 
with chromosome abnormalities and sex discrepancies were removed. Cryptic relatedness was 
estimated by calculating pairwise identical by descent (IBD) coefficients. For each pair with a 
kinship coefficient of 0.125 or greater, one member of the pair was dropped based on genotyping 
rate and trait phenotype, preferring to retain the person with higher genotyping rates and more 
extreme phenotypes. Population stratification was assessed using principal components. Batch 
effects and patterns of missingness were eliminated by testing each batch against the others using 
Fisher’s Exact test. As AREDS was a multi-center study, we also tested for differences between 
collection sites. Samples were dropped for poor performance on the array or a genotyping rate 
of < 98%. SNPs were also removed from a population if its call rate was below 99%, its minor 
allele frequency was below 0.01, or if its distribution departed significantly from Hardy-Weinberg 
expectations (p<1x10-4) in a single population. We additionally dropped SNPs in both populations 
where HWE p < 1x10-4 in 1 population and HWE p < 1x10-3 in the other. SNPs were also excluded 
if they showed more than one genotype inconsistency between HapMap control samples and the 
consensus genotype in the HapMap database or investigator-provided duplicate samples.
Framingham Eye Study: Quality control measures are described elsewhere24 but in brief: Samples 
were chosen based on pedigree information and genotyping quality. Samples with a genotypic 
call rate below 95% were not chosen for analysis. The mean call rate for analyzed samples was 
99.2% (SD=0.4%). The final marker list contained 436,494 high-quality SNPs with a minor-allele 
frequency >= 0.01, a Mendelian error rate below 2% across all pedigrees, a genotype call rate 
above 95%, and whose distribution was consistent with Hardy-Weinberg expectations (P>1x10-4). 
MESA: For the MESA dataset, SNPs with MAF less than 0.02 or HWE p value less than 0.001 were 
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removed from the analysis. Genotyping was performed using the Affymetrix Genome-Wide Human 
SNP Array 6.0. IMPUTE version 2.1.0 was used to perform imputation for the MESA Caucasian 
participants (chromosomes 1-22) using HapMap Phase I and II - CEU as the reference panel 
(release #24 - NCBI Build 36 (dbSNP b126)). SNPs with genotype call rate less than 0.95, MAF less 
than 0.02, HWE p value less than 0.001, or oevar less than 0.3 were removed from the analysis. 
Association tests were performed by SNPTEST v2 (Marchini et al, 2007).
OGP-Talana: Quality control of the SNP data was performed using the GenABEL software package 
in R. Samples with overall SNP call rate < 93%, with minor allele frequency < 0.01, with Hardy-
Weinberg P value >10−6, showing excess heterozygosity, or being classified as outliers by allelic 
identity-by-state (IBS) clustering analysis, were excluded.
Rotterdam Eye Studies I,II and III: Subjects with cataracts and history of cataract or refractive surgery 
were excluded from the study. DNA was extracted from blood leucocytes according to standard 
procedures. Genotyping of SNPs was performed using the Illumina Infinium II HumanHap550 chip 
v3.0 array (RS-I); the HumanHap550 Duo Arrays and the Illumina Human610-Quad Arrays (RS-
II), and the Illumina Human 610 Quad Arrays (RS-III). Samples with low call rate (<97.5%), with 
excess autosomal heterozygosity (>0.336), or with sex-mismatch were excluded, as were outliers 
identified by the identity-by-state clustering analysis (outliers were defined as being >3 s.d. from 
population mean or having identity-by-state probabilities >97%). GWAS analyses were performed 
using GRIMP. 
Erasmus Rucphen Family Study: Subjects with cataracts and history of cataract or refractive surgery 
were excluded from the study. DNA was genotyped on one of four different platforms (Illumina 6k, 
Illumina 318K, Illumina 370K and Affymetrix 250K). Samples with low call rate (<97.5%), with 
excess autosomal heterozygosity (>0.336), or with sex-mismatch were excluded, as were outliers 
identified by the identity-by-state clustering analysis (outliers were defined as being >3 s.d. from 
population mean or having identity-by-state probabilities >97%). GWAS analyses were performed 
using the ProbABEL package from the ABEL set. A lambda correction was performed to adjust 
for cryptic relationship.
Genotype imputation of data
To produce a consensus set of genotypes for imputing to the HapMap-II, AREDS and KORA 
high quality SNPs were filtered to those present on HapMap-II. Imputation to the HapMap-II 
reference panel (CEU population release 22, NCBI build 36) was performed in MACH22,25 in 2 
stages. Stage one was the model parameter estimation stage which used a random sample of 
300 individuals from each population, using the greedy option which only uses the reference 
haplotypes (supplied here from the HapMap) and 100 Markov Chain iterations. Stage two is the 
actual imputation stage and uses the model parameters estimated in stage one to speed up the 
imputation of the genotypes. After imputation, the remaining high quality genotyped SNPs were 
merged back in with the SNPs from the imputation procedure for the AREDS and KORA data. For 
the FES data, genotype imputation to the HapMap-II reference panel (CEU population release 22, 
NCBI build 36) was carried out in a two-step process using the Markov Chain Haplotyping (MACH 
version 1.0.16.a) software. First, crossover and error-rate maps were built using 400 unrelated 
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individuals (200 male and 200 female) sampled from FHS subjects. Second, genotype imputations 
of approximately 2.5 million autosomal HapMap-II SNPs were carried out on the entire FHS dataset 
using parameters estimated from step 1. For MESA, IMPUTE version 2.1.0 was used to perform 
imputation for the Caucasian participants (chromosomes 1-22) using HapMap Phase I and II - CEU 
as the reference panel (release #24 - NCBI Build 36 (dbSNP b126)). For OGP-Talana, using the 
phase II CEU HapMap individuals (release 22, NCBI build 36) as reference panel for imputation, 
genotypes were imputed for nearly 2.5 million SNPs using MACH. SNPs imputed with Rsq <0.3 
were excluded. For RSI,II and III and ERF, a set of genotyped input SNPs with call rate >98%, with 
minor allele frequency >0.01, and with Hardy-Weinberg P value >10−6 was used for imputation. 
We used the Markov Chain Haplotyping (MACH) package version 1.0.15 software (Rotterdam, The 
Netherlands; imputed to plus strand of NCBI build 36, HapMap release #22) for the analyses. For 
each imputed SNP, a reliability of imputation was estimated as the ratio of the empirically observed 
dosage variance to the expected binomial dosage variance (O/E ratio).
Data analysis
Genetic association was estimated by fitting a logistic regression model separately to the traits 
myopia and hyperopia. To create the dichotomous traits, we calculated mean spherical equivalent 
(MSE) as the average of spherical equivalent (SE) of refraction between the two eyes, or the single 
SE value for persons with only a single SE measurement. For myopia, cases were defined as MSE 
< -1D, controls > 0D and individuals between 0D and -1D coded as unknown. For hyperopia, 
cases were defined as MSE >+1D, controls < 0D and individuals between 0D and +1D coded 
as unknown. A general additive genetic model was used to code the SNP effect (i.e. SNPs were 
coded according to the number of minor alleles [0,1,2] for each person); covariates included 
age; sex; and years of education. For AREDS, KORA and FES, this was accomplished using 
the PLINK (version 1.07) statistical software (http://pngu.mgh.harvard.edu/~purcell/plink)26. For 
AREDS analyses, the first three principal components (eigenvectors) of the EIGENSTRAT analysis 
were also included along with the covariates listed above. For MESA, these association tests 
were performed by SNPTEST v2.52. For OGP-Talana, all regression models were run using the 
ProbABEL package from the ABEL set of programs which adjusts jointly for cryptic relationship and 
population stratification. For RSI, II and III and ERF, we used genomic control23 to obtain optimal 
and unbiased results and applied the inverse variance method of each effect size estimated for 
both autosomal SNPs that were genotyped and imputed in both cohorts. 
Association analyses were performed for both traits and a genome-wide meta-analysis was 
performed on the 9 populations and 8 replication data sets (Blue Mountains Eye Study, Croatia Vis 
Island Study, Croatia Korcula Study, Diabetes Control and Complications Trial, Orkney Complex 
Disease Study, UK Twins Study, 1958 British Birth Cohort, Wisconsin Epidemiologic Study of 
Diabetic Retinopathy). Details of the genome-wide analyses of the individual discovery datasets 
and the replication analyses are shown in the supplemental methods and results including 
QQ-plots and Manhattan plots for each of the discovery cohorts in Supplementary Figures 1-9. 
Supplementary Figure 10 is a flowchart showing the workflow of the entire study.
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SNP selection for replication 
Thirty genomic regions that contained SNPs with association p-values less than 1x10-5 to either 
myopia (11) or hyperopia (14) or both (5) in our discovery meta-analysis (excluding the 15q14 
region) were chosen for replication or further study in the 8 additional datasets. We analyzed 
all SNPs within a 500 kb window centered on the most significant SNP in each region from the 
discovery meta-analysis.
For the comparison of our discovery meta-analysis results with the myopia age at onset loci from 
the Kiefer et al18 study, a list of strongly associated variants that were genome-wide significant 
(p ≤ 5x10-8) or suggestive (p < 1x10-6) in Kiefer et al18 was selected. We analyzed all SNPs within 
a 500 kb window centered on these replication SNPs in our data. 
Calculation of effective number of tests and replication significance thresholds
It has become increasingly clear that only attempting to replicate the exact SNPs found to be 
genome-wide significant in a discovery GWAS can produce a failure to replicate due to underlying 
differences in linkage disequilibrium (LD) and allele frequencies27,28, even in populations self-
identified as having the same ethnicity. Ioannidis et al.29 have shown that restricting replication 
efforts to only a few of the most significant SNPs from an associated region leads to less robust 
information for those loci. The resulting failure to replicate may be because those selected 
SNP(s) are not necessarily more informative or closer to the causal variant than other SNPs in the 
region. Several approaches to this problem have been proposed, including incorporating linkage 
information30, pathway-based association31 and other methods which use multiple SNPs in the 
analysis32-39. A linkage disequilibrium (LD) based binning strategy, proposed by Christoferou39 
may prove to be the most useful. However, the issues of handling SNPs which map to more than 
one gene due to overlapping reading frames and the correlations between genes and derivative 
gene scores still need to be resolved. Until that problem has a solution, it may be more powerful 
to study a dense panel of SNPs from each associated region, and utilize imputation to the latest 
version of 1000 Genomes data to provide additional genotypes to harmonize available SNPs 
across studies even when genotyped on different platforms. Here we selected all SNPs that were 
within a specified window of the original SNP and used the method of Ramos et al40 to model the 
LD structure in one of the replication populations to calculate the effective number of independent 
tests being performed across all of our replication regions. Traditional methods of correcting for 
multiple comparisons, such as the widely used Bonferroni correction considering all SNPs tested, 
are notoriously conservative because they do not take intermarker correlation fully into account but 
treat all the tests as independent. By using the effective number of independent tests in a Bonferroni 
correction, Type I error is still controlled and power is improved. Various approaches to calculating 
the effective number of independent tests when using such a regional replication strategy have 
been proposed since many of the SNPs in such a region are in LD with each other and do not 
represent independent tests41-45, although many of these approaches are still overly conservative. 
The Ramos et al.40 approach properly accounts for SNP interdependence, allows computation of 
the effective number of independent tests for very large numbers of highly correlated SNPs and is 
less computationally intensive than permutation-based methods. We used the method of Ramos 
et al40 to calculate the number of effective tests (Neff) in all the replication regions and divided a 
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by this effective number of tests to calculate the significance threshold separately in the AREDS, 
KORA and Framingham datasets. The Ramos method calculates (Neff) by first estimating the KxK 
covariance matrix for the K SNPs in the replication regions using the genotype data. Then the 
covariance matrix is spectrally decomposed to calculate the eigenvalues. The effective number of 
tests is then estimated using the relationship
in which λk is the kth eigenvalue of the K×K covariance matrix for the K SNPs
46. The Bonferroni-
corrected significance threshold is then calculated as α / Neff
The markers in each region are very densely spaced, with high levels of LD between markers 
in each block. The calculations from the AREDS data gave the largest effective number of tests 
and thus the most conservative Bonferroni-corrected significance threshold; thus this was chosen 
as our significance threshold for our replication studies. However, the Bonferroni-corrected 
thresholds derived by applying this method to the KORA and Framingham data were only slightly 
less conservative than the threshold derived from the AREDS data.
RESULTS
After all quality control measures and appropriate association analyses, genome-wide association 
results from Caucasian participants in the AREDS, KORA, FES, OGP-Talana, MESA, RSI, RSII, 
RSIII and ERF studies were combined in a genome-wide discovery meta-analysis totaling 16,830 
individuals for myopia and 14,981 individuals for hyperopia. Table 1 describes the characteristics 
of the populations after classifying participants into myopia, hyperopia, control or unknown 
categories.
Testing for population stratification using EIGENSOFT and principal components analysis found 
no evidence of population stratification in KORA, but some evidence of substructure was detected 
in the AREDS, FES and MESA studies. These were adjusted for in the genome-wide association 
analyses by including the first three principal components from the PCA as covariates in our 
regression models. The OGP-Talana data were also adjusted for cryptic relatedness using the 
ProbABEL R package. For ERF and RS I-III, the population was assumed to be homogeneous 
and outliers excluded. Genomic control23 values (λ) calculated by METAL47 for each population 
prior to meta-analysis for each trait are given in Table 1. These values were used by METAL to 
adjust each population’s results before including in the fixed effects meta-analysis. The QQ plots 
of the meta-analysis p values (Figure 1A and Figure 2A) showed some deviation from the null. 
However, the genomic control method23 was used to further control for population stratification and 
inter-population differences in the final meta-analysis. The variance inflation factors calculated by 
METAL47 for the final meta-analysis across the nine cohorts for myopia and hyperopia were 1.038 
and 1.046 respectively. Lambda values ranging from approximately 0.95 to 1.1 are considered 
desirable.
Neff = λk
k=1
K
∑
⎛
⎝
⎜⎜
⎞
⎠
⎟⎟
2
/ λk
2
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K
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Results of the genome-wide meta-analyses are shown in Figure 1B and Figure 2B and results 
for each sample separately are given in Supplemental Figure 1 (AREDS), Supplemental Figure 
2 (KORA), Supplemental Figure 3 (FES), Supplemental Figure 4 (MESA), Supplemental Figure 
5 (OGPT), Supplemental Figure 6 (RS-I), Supplemental Figure 7 (RS-II), Supplemental Figure 8 
(RS-III), Supplemental Figure 9 (ERF). Eight additional studies (1958 British Birth Cohort, BMES, 
CROATIA-Vis, CROATIA-Korcula, DCCT, ORCADES, TwinsUK and WESDR) were used for 
replication and baseline characteristics of these studies can be found in Supplemental Table 
S3. Results of further meta-analyses of genomic regions that exhibited suggestive evidence of 
association with myopia or hyperopia using regional results from the 8 additional studies listed 
above are given in Supplemental Tables S6 and S7. Meta-analyses combining the replication 
region association results from the 9 discovery datasets and the 8 replication datasets did not 
result in genome-wide significant results, except for the 8q12 locus (results not shown) that was 
already genome-wide significant in the discovery dataset.
Figure 1. QQ and Manhattan plots for the myopia analysis of all cohorts. A. QQ plot for association 
between all SNPs analyzed and myopia in the meta‐analysis. Each dot represents an observed 
statistic (defined as -log10 P) versus the corresponding expected statistic. The red line corresponds 
to the null distribution. B. Manhattan plot for association between all SNPs analyzed and myopia in 
the meta‐analysis. Each dot represents an observed statistic (defined as -log10 P). The darker gray 
line corresponds to the genome-wide significance threshold and the lighter gray line represents the 
suggestive threshold.
B
A
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To determine if our discovery meta-analyses showed evidence of association in any of 35 loci 
(Supplemental Table S1) reported to exhibit genome-wide significant or suggestive (p < 1x10-
6) association with myopia age at onset by Kiefer et al18, a total of 33,591 SNPs overlapping all 
associated loci were selected (Supplemental Table S2). These included the most significant 
discovery SNP plus all available genotyped and imputed SNPs within 500kb of the most significant 
discovery SNP (Supplemental Table S2). Accounting for all the LD in each region reduced the 
effective number of tests, Neff, to 475.71. The replication significance threshold, calculated while 
taking into account this LD structure in replication regions40, was
0.05 0.0001
475.71effN
a
= = .
Myopia 
Results of the discovery meta-analysis (Figure 1, Supplemental Table S4) shows one genome-
wide significant marker corresponding to a previously identified myopia age at onset18 and 
refractive error19 locus on 8q12 (rs10113215, p=1.25x10-8). We also observed association 
to the well-replicated locus on 15q14 (near GJD2) that was close to genome-wide significant 
(rs1370156, p=2.29x10-7). No attempt was made to replicate the chromosome 15q14 region since 
it has been well replicated. SNPs in the 8q12 replication region did not reach the replication 
threshold (for rs10113215, replication p=0.02; top replication p-value in the region was p=0.0022 
for rs6995115). For the discovery meta-analysis suggestive regions, one of the selected SNPs 
achieved the replication threshold for myopia (rs4326350 on 8p23, p=6.1x10-5). However, it 
should be remembered that this region did not exhibit genome-wide significant association in the 
discovery meta-analysis (replication p-values in Supplementary Table S6).
In addition to the 8q12 locus, 10 other myopia age at onset regions from the Kiefer et al study18 
showed significant evidence of replication in our discovery meta-analysis (Table 2). Eight of these 
loci have also been reported as associated with MSE by Verhoeven et al 19. However, two of 
the regions we replicated were not reported significantly associated with MSE by Verhoeven et 
al19. On chromosome 3p26, rs2587916 reached the replication threshold in our discovery meta-
analysis (p=2.79x10-5). This SNP is 256bp away from the SNP reported in this region by Kiefer 
et al18, rs1843303 (which had p=6.32x10-4 in our data, Table 2). These two SNPs exhibit strong 
linkage disequilibrium with an R2 of 0.963 and a D′ of 1 in our data. The most significant SNP at 
the second locus on chromosome 6 is the same SNP as reported by Kiefer et al18, rs7744813 
(p=6.07x10-6, Table 2). 
Due to the high genomic control values for OGP-Talana and ERF (Table 1), we examined QQ plots 
of only the common SNPs (MAF > 0.2) to see if this made an improvement, since all the associated 
SNPs reported here have high MAFs. In OGP-Talana this improved the QQ plots (Supplementary 
Figure 9) but it made no difference for ERF. Therefore, we dropped ERF from the analysis and 
re-examined the results (Figure 3). For most loci this made minimal difference to the p values. 
However, for 3 loci there was a considerable difference. The genome-wide significant result for 
myopia on chromosome 8 was no longer genome-wide significant (p=8.8x10-7), although it still 
remained well below our replication significance threshold. The loci on 2q37 and 3p26 were no 
longer below our replication threshold.
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Table 2. Results of the replication of regions significantly associated with myopia age at onset by 
Kiefer et al18 showing meta-analysis association results for each chosen SNP with myopia in our 
data
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rs6702767 1 200844547 1.12E-01 rs4471299 391129 1.92E-04 No
rs11681122 2 146786063 NA rs10928276 661 4.61E-04 No
rs17428076 2 172851936 7.13E-02 rs3821093 157350 7.50E-03 No
rs1898585 2 178660450 NA rs1405645 192929 1.47E-03 No
rs1550094 2 233385396 NA rs1656404 5456 3.72E-05 PRSS56 Yes
rs1843303 3 4185124 6.32E-04 rs2587916 256 2.79E-05 SUMF1/
SETMAR
No
rs7624084 3 141093285 2.93E-02 rs1007118 247701 3.53E-03 No
rs1031004 4 80516849 NA rs1440853 10203 4.09E-04 No
rs5022942 4 81959966 NA rs1353387 12783 6.16E-05 BMP3 Yes
rs7744813 6 73643289 6.07E-06 KCNQ5 No
rs12193446 6 129820038 8.74E-06 LAMA2 Yes
rs9365619 6 164251746 5.26E-01 rs6900149 211224 2.34E-02 No
rs2137277 8 40734662 2.84E-05 rs4736884 5031 1.78E-05 ZMAT4 Yes
chr8:60178580 8 60178580 NA rs10113215 46386 1.25E-08 TOX Yes
rs10963578 9 18338649 NA rs10115405 17893 8.99E-04 No
rs11145746 9 71834380 1.12E-02 rs3002374 35408 2.88E-04 No
rs4245599 10 60365755 5.75E-05 rs12264028 87616 2.57E-05 BICC1 Yes
rs6480859 10 79081948 5.36E-02 rs16933964 457642 1.00E-03 No
rs745480 10 85986554 6.88E-03 rs4244950 34147 2.12E-04 No
rs4367880 10 114795256 NA rs7071843 316234 1.11E-03 No
rs11602008 11 40149305 NA rs7924805 61948 1.02E-03 No
chr11:65348347 11 65348347 NA rs610037 198510 5.94E-03 No
rs10736767 11 84637065 6.61E-02 rs1940124 18791 6.49E-04 No
rs6487748 12 9435768 NA rs12822596 125774 1.83E-03 No
rs3138142 12 56115585 6.68E-02 rs2291615 219566 3.18E-03 No
rs4291789 13 100672921 NA rs8000506 3929 2.98E-05 ZIC2/
ZIC5
Yes
rs61988414 14 42313443 NA rs12878452 2013 1.61E-03 No
chr14:54413001 14 54413001 NA rs12147340 493078 1.43E-03 No
rs524952 15 35005886 8.74E-05 rs1370156 21004 2.29E-07 GJD2 Yes
rs4778882 15 79382019 NA rs925114 323501 6.84E-04 No
rs17648524 16 7459683 3.03E-06 rs4581716 1549 1.65E-06 RBFOX1 Yes
rs2908972 17 11407259 4.10E-03 rs4792105 295899 1.79E-03 No
rs10512441 17 31239645 2.47E-03 rs17780981 120609 5.52E-04 No
rs9902755 17 47220726 1.51E-01 rs7222737 31323 2.16E-03 No
chr17:79585492 17 79585492 NA rs11651296 232337 8.53E-03 No
1. SNPs which are either genome-wide significant or meet our replication threshold are highlighted in bold text. 
Allele frequencies for these SNPs in each of our discovery populations can be found in Supplemental Table S8. 
2. For each SNP reported by Kiefer et al, Replication P value is the P value of that SNP in our analysis. If that SNP 
was not genotyped or imputed in our data, it is indicated with NA.
3. For regions where the most significant SNP in our analysis is not the original reported SNP, that SNP is reported 
as Best SNP. 
4. Offset is the absolute distance in base pairs to the original SNP and the P value associated with Best SNP.
5. Z scores and direction of effect for all SNPs are in Supplemental Table S2.
6. This column left blank where the original SNP is the most significant SNP in the region. 
7. Nearest Gene(s) indicates the closest gene by physical position for these SNPs.
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Hyperopia
Meta-analysis results showed two genome-wide significant associations with hyperopia (Figure 2, 
Supplemental Table 5). These regions overlapped with loci on 15q14 (rs11073060, p=9.11x10-11) 
and 8q12 (rs10089517,p=1.82x10-11) previously reported for MSE in Verhoeven et al19 and for 
myopia age at onset in Kiefer et al18. No attempt was made to replicate the 15q14 locus since 
it has been well replicated for MSE. None of the SNPs selected to attempt replication of the 
discovery meta-analysis genome-wide significant association with hyperopia on chromosome 
8q12 achieved the replication threshold (rs10089517, p=0.08; top replication p-value in the region 
was 0.014 at rs11778476) (Supplementary Table S7). In addition, for the discovery meta-analysis 
suggestive regions, one SNP achieved the replication threshold for hyperopia (rs12660628 on 
6q21, p=7.7x10-5). However, it should be remembered that this region did not exhibit genome-
wide significant association in the discovery meta-analysis (replication p-values in Supplementary 
Table S7).
Figure 2. QQ and Manhattan plots for the hyperopia analysis of all cohorts. A. QQ plot for association 
between all SNPs analyzed and hyperopia in the meta‐analysis. Each dot represents an observed 
statistic (defined as -log10 P) versus the corresponding expected statistic. The red line corresponds 
to the null distribution. B. Manhattan plot for association between all SNPs analyzed and hyperopia in 
the meta‐analysis. Each dot represents an observed statistic (defined as -log10 P). The darker gray 
line corresponds to the genome-wide significance threshold and the lighter gray line represents the 
suggestive threshold.
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In addition to the 15q14 and 8q12 loci, 10 other regions (Table 3) that were genome-wide 
significant in the Kiefer et al18 analysis of myopia age at onset exhibited p values for association 
with hyperopia that met our “replication” threshold for these regions. Given this is a different but 
related trait, this finding is interesting. Five of these regions have been replicated using myopia 
as the trait in our data here (three of which were also found to be significantly associated with 
MSE by Verhoeven et al19 also found that 1 more of these 10 regions (Table 3) showed significant 
association with MSE. Of the remaining 4 regions from Table 3 the most significant of these 4 SNPs 
was rs1371993 (p=1.13x10-5), a SNP on chromosome 4, 35Kb from the SNP reported by Kiefer et 
al18 for myopia age at onset (rs1031004, not available in our data). 
Due to the high genomic control values for OGP-Talana and ERF (Table 1), we examined QQ 
Figure 3. QQ and Manhattan plots for the myopia analysis excluding the ERF cohort. A. QQ plot for 
association between all SNPs analyzed and myopia in the meta‐analysis excluding the ERF cohort. Each 
dot represents an observed statistic (defined as -log10 P) versus the corresponding expected statistic. 
The red line corresponds to the null distribution. B. Manhattan plot for association between all SNPs 
analyzed and myopia in the meta‐analysis excluding the ERF cohort. Each dot represents an observed 
statistic (defined as -log10 P). The darker gray line corresponds to the genome-wide significance 
threshold and the lighter gray line represents the suggestive threshold.
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Table 3. Results of the hyperopia analyses in the regions that were significantly associated with 
myopia age at onset by Kiefer et al18 showing meta-analysis association results for each chosen 
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rs6702767 1 200844547 1.60E-01 rs6703834 264384 4.58E-03 No
rs11681122 2 146786063 NA rs17412774 12116 1.50E-04 No
rs17428076 2 172851936 6.43E-03 rs3821093 157350 2.44E-04 No
rs1898585 2 178660450 NA rs6718702 84399 1.47E-05 PDE11A No
rs1550094 2 233385396 NA rs1881494 12631 4.63E-05 PRSS56 Yes
rs1843303 3 4185124 1.98E-05 rs795294 826 1.18E-05 SUMF1/
SETMAR
No
rs7624084 3 141093285 NA rs9821337 2901 1.88E-04 No
rs1031004 4 80516849 NA rs1371993 35034 1.13E-05 GK2 (OMIM
#137028)
No
rs5022942 4 81959966 NA rs2201544 30290 4.94E-03 Yes
rs7744813 6 73643289 7.00E-08 KCNQ5 No
rs12193446 6 129820038 1.84E-07 LAMA2 Yes
rs9365619 6 164251746 2.67E-01 rs2759387 412079 9.50E-03 No
rs2137277 8 40734662 2.72E-02 rs6474290 94596 2.42E-03 Yes
chr8:60178580 8 60178580 NA rs10089517 141 1.82E-11 TOX Yes
rs10963578 9 18338649 NA rs10115405 17893 2.54E-04 No
rs11145746 9 71834380 8.33E-03 rs10481782 22378 2.71E-04 No
rs4245599 10 60365755 1.16E-03 rs1866168 4194 8.11E-04 Yes
rs6480859 10 79081948 1.45E-02 rs16933964 457642 4.35E-04 No
rs745480 10 85986554 3.26E-01 rs17103281 25190 1.06E-04 No
rs4367880 10 114795256 NA rs7914029 215000 3.40E-04 No
rs11602008 11 40149305 NA rs10837366 75045 7.61E-05 LRRC4C 
(OMIM 
#608817)
No
chr11:65348347 11 65348347 NA rs11820062 81589 7.56E-03 No
rs10736767 11 84637065 1.99E-01 rs10898278 303825 3.05E-03 No
rs6487748 12 9435768 NA rs7305636 157088 9.29E-04 No
rs3138142 12 56115585 4.32E-02 rs12828230 230568 5.87E-04 No
rs4291789 13 100672921 NA rs1347190 24823 6.65E-06 ZIC2/ZIC5 Yes
rs61988414 14 42313443 NA rs10149831 125528 1.35E-03 No
chr14:54413001 14 54413001 NA rs17127526 444960 1.26E-03 No
rs524952 15 35005886 3.07E-08 rs11073060 16036 9.11E-11 GJD2 Yes
rs4778882 15 79382019 NA rs1443658 4348 2.88E-03 No
rs17648524 16 7459683 4.86E-07 RBFOX1 Yes
rs2908972 17 11407259 1.39E-04 rs12602611 166838 1.26E-05 SHISA6 No
rs10512441 17 31239645 4.78E-03 rs17183113 210521 2.40E-03 No
rs9902755 17 47220726 2.81E-01 rs8064938 439898 1.73E-03 No
chr17:79585492 17 79585492 NA rs6565596 60374 1.13E-02 No
1. SNPs which are either genome-wide significant or meet our replication threshold are highlighted in bold text. Allele 
frequencies for these SNPs in each of our discovery populations can be found in Supplemental Table S8. 
2. For each SNP reported by Kiefer et al, Replication P value is the P value of that SNP in our analysis. If that SNP was 
not genotyped or imputed in our data, it is indicated with NA.
3. For regions where the most significant SNP in our analysis is not the original reported SNP, that SNP is reported 
as Best SNP. 
4. Offset is the absolute distance in base pairs to the original SNP and the P value associated with Best SNP.
5. Z scores and direction of effect for all SNPs are in Supplemental Table S2.
6. This column left blank where the original SNP is the most significant SNP in the region. 
7. Nearest Gene(s) indicates the closest gene by physical position for these SNPs.
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plots of only the common SNPs (MAF > 0.2) to see if this made an improvement, since all the 
SNPs reported here have high MAFs. In OGP-Talana this improved the QQ plots (Supplementary 
Figure 9) but it made no difference for ERF. Therefore, we dropped ERF from the analysis and re-
examined the results (Figure 4). For all loci this made minimal difference to the p values and did 
not change the conclusions.
DISCUSSION
We conducted a meta-analysis of 9 myopia and hyperopia genome-wide association studies. We 
detected the known loci on chromosomes 8q12 and 15q14. The locus on chromosome 8q12 has 
been reported associated with mean spherical equivalent in an analysis which included many 
Figure 4. QQ and Manhattan plots for the hyperopia analysis excluding the ERF cohort A. QQ plot 
for association between all SNPs analyzed and hyperopia in the meta‐analysis excluding the ERF cohort. 
Each dot represents an observed statistic (defined as -log10 P) versus the corresponding expected 
statistic. The red line corresponds to the null distribution. B. Manhattan plot for association between 
all SNPs analyzed and hyperopia in the meta‐analysis excluding the ERF cohort. Each dot represents 
an observed statistic (defined as -log10 P). The darker gray line corresponds to the genome-wide 
significance threshold and the lighter gray line represents the suggestive threshold.
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of the cohorts in this study19, and myopia age at onset in an independent study18. The locus 
on chromosome 15q14 was discovered in some of the cohorts included in this analysis48 and 
has been well replicated in studies of both MSE19 and myopia age at onset18. These findings 
were therefore expected. However, the signal for 15q14 is only genome-wide significant in the 
hyperopia analysis here. In addition, although the 8q12 locus was genome-wide significant in 
the myopia analysis, it was more significant in the hyperopia analysis. Nonetheless, the direction 
of effect of these SNPs is exactly opposite in the myopia and hyperopia analyses – suggesting 
that the causal mechanisms being tagged by these SNPs are operating across the spectrum of 
refractive error.
We also examined the results of our discovery meta-analyses of myopia (which were adjusted 
for age at examination and years of education) to attempt targeted “replication” of 35 GWAS-
identified loci that have previously been reported by Kiefer et al to be associated with age at onset 
of myopia. Since age at onset was not available in all our study samples, it was not possible to 
perform an exact replication of the Kiefer et al18 trait on which they performed survival analysis of 
myopia age at onset. Our analyses, where we included age at exam and years of education, is the 
closest phenotype we had available. We also examined evidence for association with hyperopia 
in these same regions of the genome, since myopia and hyperopia represent opposite ends of the 
distribution of refractive error. It is reasonable that loci that affect the variability of MSE as a whole 
may therefore affect risk of both myopia and hyperopia. 
Our analysis provides evidence for replication of a number of loci identified by Kiefer et al18. 
Those which were replicated using the myopia trait (Table 2) represent the closest phenotype 
available from all of our samples to the one used in their analysis. In particular, this study presents 
the first report of replication of 11 regions associated with myopia. Of note, nine of these regions 
also showed genome-wide significant evidence of association to MSE by Verhoeven et al19: 
chromosome 2 near PRSS56 (OMIM #609995), chromosome 4 near BMP3 (OMIM #112263), 
chromosome 6 near LAMA2 (OMIM #156225), chromosome 8 near ZMAT4 (40734662 bp), 
chromosome 8 near TOX (OMIM #606863, 60178580 bp), chromosome 10 near BICC1 (OMIM 
#612717), chromosome 13 near ZIC2 (OMIM #603073)/ZIC5, chromosome 15 near GJD2 (OMIM 
#607058) and chromosome 16 near RBFOX1 (OMIM #605104). The candidate genes in these 
9 regions have been discussed by both Kiefer et al18 and Verhoeven et al19. The two remaining 
Kiefer et al. loci that were not reported as significantly associated with MSE in Verhoeven et al19 
were on 3p26.1 and 6q13. The SNP reported by Kiefer et al18 in the 3p26.1 region did not meet 
our replication threshold but another SNP, only 256bp away and in strong linkage disequilibrium 
with this SNP, did meet our threshold. Kiefer et al18 proposed the nearby gene SETMAR (OMIM 
#609834), a histone methylation and DNA repair gene as a candidate to explain their observed 
association with myopia. However, both the SNP detected in our study and the SNP reported 
by Kiefer et al18 are intronic to one transcript of SUMF1 (OMIM #607939), which codes for an 
enzyme that catalyzes the hydrolysis of sulfate esters. Mutations in this gene are known to cause 
the lysosomal storage disorder multiple sulfatase deficiency. This multisystem syndrome has 
been reported to have ocular phenotypes, in the form of retinal degeneration and nystagmus49. 
However, this signal on 3p26.1 was no longer a significant replication when the ERF study results 
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were removed from the analysis. While the QQ plot of the ERF study results shows some deviation 
from expected, it does not appear to exhibit overall inflation of the false positive rate for this sample. 
Thus the replication of this 3p26 locus using all 9 studies may be valid but additional evidence 
from a larger study will be useful in determining the importance of this locus to risk of myopia. In 
the 6q13 region, our study replicated the exact same SNP that was reported to have the strongest 
association with myopia age at onset in the Kiefer et al18 study and this result did not change with 
the removal of the ERF study results from our meta-analysis. This associated SNP is in an intron 
of the KCNQ5 gene (potassium voltage-gated channel, KQT-like subfamily, member 5, OMIM 
#607357), which is a member of the KCNQ potassium channel gene family. KCNQ5 has been 
shown to be differentially expressed in subregions of the brain and in skeletal muscle50. Voltage-
dependent potassium channels are important regulators of the resting membrane potential and 
affect the excitability of electrically active cells (OMIM #607357). KCNQ5 is also expressed in the 
retinal pigment epithelium (RPE) and neural retina. These potassium channels are believed to 
affect ion flow across the RPE51 and the function of cone and rod photoreceptors51,52.
Other regions that were found to be significantly associated with myopia by Kiefer et al18 showed 
some evidence of association with hyperopia but not with myopia in our data. The significance 
levels of these associations reached our “replication” threshold. This intriguing result suggests 
that these loci may not be myopia specific. However, much larger sample sizes will be required to 
further investigate this issue. 
One of the Kiefer et al18 loci that did not replicate in the analysis of myopia and was not previously 
reported as significantly associated with MSE was a locus on 2q31.2. This locus showed evidence 
of association with hyperopia in our data that reached our “replication” threshold. Kiefer et al 
suggested that this association might be due to variants in the phosphodiesterase 11A gene 
(PDE11A, OMIM #604961), which as a known cell signaling molecule is a good candidate gene 
for development of refractive errors, given the importance of neural signaling in the control of 
eye growth. However, the signal in our hyperopia analysis stretches across 3 genes: PDE11A; 
tetratricopeptide repeat domain 30A (TTC30A) protein; and alkylglycerone phosphate synthase 
(AGPS, OMIM #603051). Mutations in AGPS are associated with rhizomelic chondrodysplasia 
punctata, type 3, a multisystem developmental disorder in which patients frequently develop 
cataracts53.
For the locus on chromosome 4 that showed some evidence of association with hyperopia in our 
data, Kiefer et al18 suggested that ANTXR2 (OMIM #106490), a gene involved in extracellular 
matrix adhesion was the best candidate, but other good candidates exist in this region such as 
BMP2 inducible kinase (BMP2K) and annexin A3 (ANXA3, OMIM #106490) a gene involved in 
regulation of cell growth and signal transduction pathways. Two other bone morphogenic proteins 
whose genes are located elsewhere in the genome have been identified as candidate genes by 
Kiefer et al18 and Verhoeven et al19 and have also been observed in animal models of myopia54,55. 
The role of this group of genes in growth regulation is well known56. 
Given that hyperopia and myopia are the extreme ends of the refractive error distribution, it is 
tempting to assume that the same risk factors must affect the risk of developing both traits equally. 
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However, it is not yet clear whether those environmental and genetic factors which increase the 
risk of developing myopia necessarily affect the risk of hyperopia. The results presented here 
provide some tantalizing evidence that some genetic factors may be important in both traits 
whereas others may be more important in driving myopization than hyperopization or vice versa. It 
has now been shown that 9 regions (2q37, 4q21, 6q22, 8p11, 8q12, 10q21, 13q32, 15q14, 16p13) 
show association to age at onset of myopia18, myopia adjusted for age at exam, sex and years 
of education (results presented here) and mean spherical equivalent19. However, we observed 
replication-level association with myopia for an additional 2 loci (6q13 and 8p11) which were not 
genome-wide significant for mean spherical equivalent19 but were genome-wide significant for 
myopia age at onset18. An additional four regions that were genome-wide significant in the Kiefer 
et al analysis of age at onset of myopia18 have only been “replicated” in our hyperopia analyses. 
These results indicate that the genetic underpinnings of refractive errors are quite complex and 
that analyses of both the qualitative and quantitative phenotypes may add to our understanding 
of refractive error causation. The study participants whose data were analyzed here were not 
selected for extreme or “high” myopia (typically defined as SE < -6D) and there were very few 
individuals with high myopia in any of these datasets. Future studies to examine whether any of the 
loci that show association to myopia, hyperopia and mean spherical equivalent in the population-
based studies also show evidence of association to high myopia would be interesting and should 
be pursued. 
Some of the other loci that showed significant association with myopia in the Kiefer et al18 study 
did not replicate in our current study. Dichotomizing the trait from spherical equivalent to myopia 
or hyperopia in each population did reduce sample size for each population compared to the 
number of individuals with measurements of spherical equivalent. This consequent reduction in 
power was the reason we added additional populations to our discovery meta-analysis compared 
to our refractive error meta-analysis17, to offset the lower sample size. This current study is still, 
however, smaller than the Kiefer et al18 study we were attempting to replicate and so some of the 
other loci may yet replicate in a larger study. 
In summary, we have provided evidence in favor of replication of 11 loci involved in causation of 
myopia. Twelve loci that have been shown to be associated with myopia age at onset18 showed 
“replication-level” association with hyperopia here (7 of these loci also showed replication-level 
association with the myopia trait; 5 loci only showed this level of association with hyperopia). 
Further research is required to determine whether any of the candidate genes identified near these 
associated SNPs are truly causing the development of refractive errors, or whether the actual 
causal variant is located in another nearby gene or other functional locus in high LD with the SNPs 
associated with the trait. Evidence for expression of many of these genes have indicated that they 
are active in the eye19 and investigation of the ENCODE data suggests many loci have regulatory 
functions, which is consistent with the current hypothesis of regulation of eye growth through a 
visually-evoked signaling cascade. However, more research using in vitro and in vivo models is 
necessary to elucidate the underlying mechanisms of normal emmetropization and how it can be 
disrupted to produce refractive errors.
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ABSTRACT
Refractive errors are common eye disorders of public health importance worldwide. Ocular axial 
length (AL) is the major determinant of refraction and thus of myopia and hyperopia. We conducted 
a meta-analysis of genome-wide association studies for AL, combining 12,531 Europeans and 
8,216 Asians. We identified eight genome-wide significant loci for AL, including RSPO1, C3orf26, 
LAMA2, GJD2, ZNRF3, CD55, MIP and ALPPL2, and confirmed one previously reported AL locus, 
ZC3H11B. Of the nine loci, five, LAMA2, GJD2, CD55, ALPPL2 and ZC3H11B, were associated 
with refraction in 18 independent cohorts (n = 23,591). Differential gene expression was observed 
for these loci in minus-lens induced myopia mouse experiments and human ocular tissues. Two of 
the AL genes, RSPO1 and ZNRF3, are involved in Wnt signaling, a pathway playing a major role 
in the regulation of eyeball size. This study provides evidence of shared genes between AL and 
refraction, but importantly, also suggests that these traits may have unique pathways. 
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INTRODUCTION
Myopia (nearsightedness), the most common form of refractive errors, is an ocular disorder of 
major public health importance worldwide, particularly in Asia. About 40% of adults and 80–90% of 
children completing high school are myopic in urban areas in East Asian countries, and 10–20% of 
them have high myopia.1,2 Uncorrected myopia and refractive errors are leading causes of visual 
impairment.3-6 Furthermore, adults with high myopia are at a substantially higher risk of potentially 
blinding pathologies, including glaucoma, retinal detachment and myopic maculopathy.7 The 
correction of myopia and refractive errors in general by spectacles, contact lenses or refractive 
surgery can entail substantial socioeconomic costs8,9 and does not treat the underlying mechanism 
of disease. 
Myopia develops primarily from an eye that is excessively elongated axially and thus ocular axial 
length (AL) is an attractive endophenotype to investigate for several reasons. First, AL alone 
accounts for more than 40% of variation in refractive errors.10-12 Magnetic resonance imaging 
studies of the orbit have also demonstrated that extremely high myopic eyes are generally prolate 
in shape with unusually long ALs, leading to associated visually disabling complications such as 
posterior staphylomas.13,14 Second, the heritability of AL (67% to 94%) is consistently higher than 
that for refraction.15-18 Furthermore, the measurement of AL (in mm) is more objective, precise and 
reproducible compared to assessments of refractive status. 
While more than 30 myopia loci have been implicated in previous linkage and genome-wide 
association studies (GWAS), there have been few reports of AL-specific loci. A recent GWAS 
identified an association at ZC3H11B for both AL and high myopia in Asians.19 To identify additional 
genetic variants that modulate AL, we conducted the largest international GWAS meta-analysis of 
AL to date in cohorts participating in the Consortium for Refractive Error and Myopia (CREAM).20,21
MATERIAL AND METHODS
We used a three-stage approach.21 First, we performed a GWAS meta-analysis in 12,531 European 
ancestry individuals (stage 1). Second, we tested the cross-ethnic transferability of the associations 
from this first stage in 8,216 Asian ancestry individuals (stage 2). Lastly, we conducted a meta-
analysis combining individuals of European and Asian ancestry, totaling 20,747 individuals (stage 
3). We subsequently examined the effect of the associated AL loci on spherical equivalent (SE) in 
23,591 individuals from 18 other independent cohorts.
Study populations in CREAM
All studies participating in this meta-analysis are part of the CREAM.20,21 The discovery cohorts 
included 12,531 European ancestry individuals from 18 studies (Table 1), including ALSPAC 
Children,22 BATS/TEST,23 BMES,24,25 Croatia-Korcula, Croatia -Split, Croatia-Vis,26 ERF,27,28 RS-I, 
RS-II, RS-III,29 ORCADES,30 and RAINE.31-33 In addition, 8,216 Asian ancestry individuals from six 
cohorts (Table 1), including BES,34 SCES,35 SCORM,36 SiMES,37 SINDI,35 and STARS Parents,38 
were included in the replication stage. General methods, demographics and phenotyping of the 
study cohorts have previously been described extensively and are provided briefly in Table 1. All 
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studies were performed with the approval of their local Medical Ethics Committee, and written 
informed consent was obtained from all participants in accordance with the Declaration of Helsinki.
Independent populations in CREAM
To examine whether the loci affecting AL contributed to SE, we studies associations with SE in 
an additional 18 studies (Table S1), including the 1958 British Birth Cohort,39 ALSPAC Mothers,40 
ANZRAG,41 AREDS 1a1b, AREDS 1c,15,16 DCCT,42 EGCUT,43 FECD,44 FES,45 FITSA,46 GHS 1, GHS 
2, KORA,47-50 OGP Talana,51 SP2,52 TwinsUK,53 WESDR,54 and Young Finns Study.55 Only SE but 
not AL measures were available in these additional 18 CREAM studies. Detailed study design and 
methodology of these studies have been published elsewhere. Descriptive data on demographics 
and phenotypes of these cohorts are briefly shown in Table S1. 
Phenotype measurements
All studies used a similar protocol for ocular phenotype measurements. Eligible participants 
underwent an ophthalmologic examination including measurements of AL and refraction of both 
eyes. AL was measured using either optical laser interferometry or A-scan ultrasound biometry 
(Table 1). Refraction was measured by autorefractor and/or subjective refraction (Table S1). SE 
was calculated according to the standard formula (SE = sphere+1⁄2 cylinder).  
Genotyping and imputation
The study samples were genotyped on either the Illumina (San Diego, CA, USA) or Affymetrix 
(Santa Clara, CA, USA) platforms. Each study performed single nucleotide polymorphism (SNP) 
imputation using the genotype data, together with the HapMap Phase II ethnically matched 
reference panels (CEU, JPT+CHB, or the 4 HapMap populations) on the basis of build 36 databases 
(release 22 or 24). The Markov Chain Haplotyping software, IMPUTE56,57 or MACH,58 were adopted 
for imputation. A detailed description regarding genotyping platforms and imputation procedures 
for each study is provided on Tables S2 and S3. 
Stringent quality control of genotype data was applied in each cohort. Samples with low call rates 
(<95%) or with gender discrepancies were excluded. Cryptically related samples and outliers in 
population structure from principal component analyses were also excluded. SNPs flagged with 
missingness >5%, gross departure from Hardy Weinberg Equilibrium (P value <10-6, except in the 
ALSPAC study where a threshold of <10-7 was used) and minor allele frequency (MAF) <1% were 
removed from further analyses.  
Statistical Analysis
For each study, an allele-dosage regression model at each genotyped or imputed SNP was 
conducted to determine its association with AL as a quantitative trait as well as its association 
with SE. Individuals with prior refractive or cataract surgery, or other intra-ocular procedures that 
could alter refraction, were excluded. The mean of the right and left eyes was taken. When data 
from only one eye were available, the AL or SE of this eye was used. Sample outliers with AL value 
exceeding 4 standard deviations from the mean were excluded at the study level. We assumed 
an additive genetic model where the dosage of each SNP is a continuous variable ranging from 
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0 to 2 for minor alleles carried. Primary analysis for AL was adjusted for age, sex and height (as 
height was consistently correlated with AL59,60) and in the case of SE for age and sex. Additional 
adjustment for principal components was carried out according to the population substructure in 
each individual study.  
The per-SNP meta-analyses were performed using METAL software with weighted inverse-variance 
approach, assuming fixed effects, as for initial discovery purposes, the fixed-effects model is 
preferred for increased statistical power.61 A Cochran’s Q test was used to assess heterogeneity 
across studies.62 Imputation quality scores were reviewed for the top SNPs reported to ensure 
good imputation quality (proper-info of IMPUTE or R2 of MACH >0.3). 
Gene-based testing was conducted using VEGAS software63 on the European ancestry and Asian 
ancestry meta-analysis results separately. VEGAS incorporates information from the full set of 
markers within a gene and thus can be more powerful than tests of individual SNPs if there are 
multiple risk variants within a gene. VEGAS corrects for LD and gene size by conducting simulations 
based on the LD structure in the population of interest (here, European or Asian ancestry). VEGAS 
was hence run separately on all the European and Asian GWAS data, with results for each gene 
combined at the end using meta-analysis on the two sets of gene-based P-values using Fisher’s 
methods. For samples of European descent, we used the HapMap 2 CEU population as the 
reference to estimate patterns of LD. For Asian ancestry groups, we used the combined HapMap 
2 JPT and CHB populations as the reference population to approximate linkage disequilibrium 
(LD) patterns. To include gene regulatory regions, SNPs were included if they fell within 50 kb of a 
gene.  
VEGAS-Pathway analysis63,64 was carried out using prespecified pathways from Gene Ontology. 
Pathways of with 10 to 1,000 components were selected, yielding 4,628 pathways. Pathway 
analysis was based on combining gene-based test results from VEGAS. Pathway P-values were 
computed by summing χ2 test statistics derived from VEGAS P-values. Empirical VEGAS-Pathway 
P values for each pathway were computed by comparing the summed χ2 test statistics from real 
data with those generated in 500,000 simulations where the relevant number (according to the size 
of the pathway) of randomly drawn χ2 test statistics was summed. To ensure that clusters of genes 
did not adversely affect results, within each pathway, gene sets were pruned such that each gene 
was >500 kb away from all other genes in the pathway. Where required, all but one of the clustered 
genes was dropped at random when genes were clustered. We performed meta-analysis on the 
two sets of pathway P-values using Fisher’s method.
Differential gene expression in a mouse model of myopia
Animal study approval was obtained from the SingHealth Institutional Animal Care and Use 
Committee (AAALAC accredited). All procedures performed in this study complied with the 
Association of Research in Vision and Ophthalmology Statement for the Use of Animals in 
Ophthalmology and Vision Research. Experimental myopia was induced in B6 wild-type (WT) mice 
(n = 36) by applying a -15.0 diopter spectacle lens on the right eye (experimental eye) for 6 weeks 
from post-natal day 10. The left uncovered eye served as the contra-lateral control eye. Age-
matched naive mice eyes were also used as independent control eyes (n = 36).65,66 Eye biometry, 
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refraction, tissue collection, RNA extraction, real-time polymerase chain reaction (PCR) qRT-PCR 
methods and analysis were followed as described previously.19 qRT-PCR primers (Table S4) were 
designed using ProbeFinder 2.45 (Roche Applied Science, Indianapolis, IN) and performed using 
a Lightcycler 480 Probe Master (Roche Applied Science, Indianapolis, IN). The experiments were 
repeated in triplicate. Gene expression of all identified genes in the control and experimental 
groups was quantified using the 2-ΔΔCt method.67 Student’s t-test was performed to determine the 
significance of the relative fold difference of mRNA between the myopic eyes of the experimental 
mice and the age-matched controls.
Gene expression in human tissues
Adult ocular samples were obtained from normal eyes of an 82-year-old European ancestry female 
from the North Carolina Eye Bank, Winston-Salem, North Carolina, USA. All adult ocular samples 
were stored in Qiagen’s RNAlater within 6.5 hours of collection and shipped on dry ice overnight 
to the lab. Isolated tissues were snap-frozen and stored at -280 oC until RNA extraction. RNA was 
extracted from each tissue sample independently using the Ambion mirVana total RNA extraction 
kit. The tissue samples were homogenized in Ambion lysis buffer using an Omni Bead Ruptor 
Tissue Homogenizer per protocol. Reverse transcription reactions were performed with Invitrogen 
SuperScript III First- Strand Synthesis kit. The expression of the identified genes was assessed by 
running 10 μl reactions with Qiagen’s PCR products consisting of 1.26 μl H2O, 1.0 μl 10X buffer, 
1.0 μl dNTPs, 0.3 μl MgCl, 2.0 μl Q-Solution, 0.06 μl taq polymerase, 1.0 μl forward primer, 1.0 
μl reverse primer and 1.5.0 μl cDNA. The reactions were run on a Eppendorf Mastercycler Pro 
S thermocycler with touchdown PCR ramping down 1oC per cycle from 72 oC to 55 oC followed 
by 50 cycles of 94 oC for 30 seconds, 55 oC for 30 seconds and 72 oC for 30 seconds with a final 
elongation of 7 minutes at 72 oC. All primer sets were designed using Primer3.68 Products were 
run on a 2% agarose gel at 70 volts for 35 minutes. Primer sets were run on a custom tissue panel 
including Clontech’s Human MTC Panel I, Fetal MTC Panel I and an ocular tissue panel.
RESULTS
We analyzed 2.5 million genotyped and imputed SNPs (Table S2). The genomic control inflation 
factor (λ) for individual studies (Table S2) as well as for the meta-analysis (λGC = 1.06) and quantile-
quantile plots (Figure S1) showed little evidence for inflation. 
Per-SNP meta-analysis
In the first stage, a total of 177 SNPs, representing 24 physically distinct loci, were associated with 
P <1 x 10-5 in the European ancestry discovery cohort (Table S5). Of them, we identified one locus 
at chromosome 15q14 in the proximity of GJD2 ([OMIM #607058] rs11073058, P = 2.0 x 10-8) 
exceeding genome-wide significance level (P <5 x 10-8; Table 2), which was previously reported 
to be associated with refractive errors.69 We took the 177 SNPs forward for replication in the Asian 
cohorts (stage 2). Five regions showed significant evidence of replication (1.12 x 10-9 ≤ P ≤1.18 
x 10-2, Table 2), including RSPO1 (OMIM #609595), C3orf26 and LAMA2 (OMIM #156225), and 
regions close to ZC3H11B and GJD2. In the combined meta-analysis of all 18 European and Asian 
cohorts (stage 3, n = 20,747), all five loci surpassed genome-wide significance level (3.97 x 10-13 
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 x 10-8; Table 2 and Figure 1). Furthermore, in stage 3 we detected an additional genome-wide 
significant locus at ZNRF3 (OMIM #612062, P = 4.08 x 10-8, Table 2).
Overall, the significant regions included six loci for AL, including RSPO1, C3orf26, LAMA2, GJD2, 
ZNRF3, and one previously identified locus for AL at 1q41 close to ZC3H11B.19 A common SNP 
in RSPO1 displayed the strongest evidence for association (rs4074961, β = 0.07 mm per copy 
of risk allele, P = 3.97 x 10-13), with no evidence of heterogeneity (I2 = 0%, P = 0.78) across the 
18 AL cohorts (Table S6), while the strongest effect was observed for the rarer intronic variant 
in LAMA2 (rs12193446, β = 0.12 mm, P = 1.24 x 10-8). Figure 2 shows the regional association 
plots for the six loci significant in single SNP tests. Forest plots showing the effect sizes across 
cohorts are provided in Figure S2. We constructed a multi-locus genetic risk score to evaluate the 
combined effects of the AL SNPs in the Blue Mountains Eye Study24,25 and the Singapore Chinese 
Eye Study,35 both of which were part of the 18 AL discovery cohorts. Figure S3 shows that the odd 
ratios for longer AL (Tertile 3 vs. Tertile 1) were higher with increasing genetic risk scores. 
Gene-based meta-analysis
In addition to per-SNP meta-analysis, we applied gene-based tests using VEGAS,25 with genome-
wide significance declared if Pgene-based <0.05/17872 = 2.8 x 10-6 (17,872 genes tested). Over 
and above the loci found in per-SNP tests, three additional genomic regions were genome-wide 
significantly associated with AL using gene-based tests (Table 3): CD55 (OMIM #125240), ALPPL2 
(OMIM #171810) and TIMELESS/MIP/SPRYD4/GLS2 (OMIM #603887 for TIMELESS). Figure S4 
shows the regional association for the three loci significant in gene-based tests. 
Figure 1. Summary of meta-analysis results for genome-wide association to ocular axial length. 
Data of both directly genotyped and imputed SNPs are presented in the Manhattan plot. The y axis 
represents –log10 P values for association with axial length, and the x axis represents chromosomes and 
base-pair positions based on human genome build 36. The horizontal red line indicates the genome-wide 
significance level of P <5.0 x 10-8. The horizontal blue line indicates the suggestive significance level of P 
<1.0 x 10-5. The previously described locus for axial length is labeled in black. Other loci reaching genome-
wide significance identified from the per-SNP meta-analysis are labeled in red. The genes identified in 
gene-based tests are labeled in blue.
RSPO1
CD55
ZC3H11B
C3orf26
LAMA2
GJD2
ZNRF3
15
ALPPL2
TIMELESS/MIP/
SPRYD4/GLS2
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Association with refraction 
We subsequently assessed the association of these AL SNPs and genes with SE in 23,591 
individuals from 18 independent studies in CREAM that had SE but no AL measures (Tables S1 
and S3). We found associations (P <0.05) with SE for three of the six AL SNPs (Table 4 and 
A B 
C D 
E F 
	  
Figure 2. Regional association plots and recombination rates of the loci associated with ocular 
axial length. 
Data are shown for association at chromosome A. 1p34.3 (RSPO1), B. 1q41 (ZC3H11B), C. 3q12.1 
(C3orf26), D. 6q22.33 (LAMA2), E. 15q14 (GJD2), and F. 22q12.1 (ZNRF3) in the combined meta-
analysis. Data of both directly genotyped and imputed SNPs are presented. In each panel, the genotyped 
SNP with the most significant association is denoted with a purple diamond. The color coding of all 
other SNPs indicates LD with the lead SNP, estimated by CEU r2 from phase II HapMap: red, r2 ≥ 0.8; 
yellow, 0.6 ≤ r2 <0.8; green, 0.4 ≤ r2 < 0.6; cyan, 0.2 ≤ r2 < 0.4; blue, r2 < 0.2; and gray, r2 unknown. The 
left y axis represents –log10 P values for association with axial length, the right y axis represents the 
recombination rate, estimated from the International HapMap Project, and the x axis represents base-pair 
positions along the chromosome based on human genome build 36. Gene annotations are taken from the 
University of California Santa Cruz (UCSC) genome browser. The plots were created using LocusZoom.
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Table 3. Loci associated with ocular axial length in gene-based tests
Pgene-based value
Gene OMIM # Chr Start positiona
End 
positiona
European 
ancestry 
cohorts Asian cohorts Combinedb
CD55 125240 1 205561439 205600934 1.3 x 10-5 9.6 x 10-4 2.3 x 10-7
ALPPL2 171810 2 232979795 232983669 6.4 x 10-5 1.7 x 10-3 1.8 x 10-6
TIMELESS/MIP/
SPRYD4/GLS2c 603887 12 55097173 55168448 2.0 x 10-7 7.3 x 10-2 2.8 x 10-7
aPosition is based on NCBI human genome build 36. Note this is the start and stop position of the gene. 
For gene-based tests, 50kb was added to either side to account for possible regulatory variants which 
fall outside the gene boundaries.
bGene-based genome-wide significance was defined as P <2.80x10-6. Only loci that were genome-wide 
significant in gene-based testing but not genome-wide significant in per SNP testing are shown.
cTIMELESS was the most significant gene in the region. Due to the +/- 50kb added to the definition for 
each gene and the close proximity of the genes, MIP, SPRYD4, GLS2 and TIMELESS all had similar 
gene-based P-values (ranged from 1.4 x 10-6 to 2.8 x 10-7 for the combined analysis), and thus only 
P-value and OMIM # for TIMELESS is presented.
Chr, chromosome.
Table 4. Association with spherical equivalent of the SNPs most strongly associated with axial 
length in each genomic locus in independent cohorts
Lead SNP Nearest gene Effect allele Betaa SEM P value
rs4074961 RSPO1 (OMIM #609595) T 0.004 0.023 0.84
rs994767 ZC3H11B A 0.054 0.022 1.3 x 10-2
rs9811920 C3orf26 A -0.022 0.022 0.31
rs12193446 LAMA2 (OMIM #156225) A -0.242 0.039 3.6 x 10-10
rs11073058 GJD2 (OMIM #607058) T -0.121 0.022 1.7 x 10-8
rs12321 ZNRF3 (OMIM #612062) C -0.004 0.021 0.86
aEffect sizes on spherical equivalent are in diopters.
SNP, single nucleotide polymorphism; SEM, standard error of the mean.
 
Table 5. Association of the axial length genes identified in gene-based tests with spherical 
equivalent in independent cohorts
Gene OMIM # Chr Pgene-based valuea
CD55 125240 1 4.5 x 10-6
ALPPL2 171810 2 8.3 x 10-3
TIMELESS/MIP/SPRYD4/GLS2 603887 12 0.14
aThe association with spherical equivalent was assessed in 17 European ancestry cohorts of the 18 
independent cohorts, using the HapMap 2 CEU population as the reference to estimate patterns of LD.
cDue to the +/- 50kb added to the definition for each gene and the close proximity of the genes, MIP, 
SPRYD4, GLS2 and TIMELESS all had similar gene-based P-values (ranged from 0.14 to 0.20 for the 
combined analysis), and thus only P-value and OMIM # for TIMELESS is presented.
Chr, chromosome.
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Figure S5), including rs994767 (ZC3H11B, P = 0.013), rs11073058 (GJD2, P =1.66 x 10-8), and 
rs12193446 (LAMA2, P = 3.58 x 10-10), with directions of the SE association being consistent with 
AL. For example, the risk allele T of rs11073058 in GJD2 was associated with both longer AL and 
more myopia (more negative SE). In gene-based tests, only CD55 (P = 4.5 x 10-6) and ALPPL2 (P 
= 8.3 x 10-3) were associated with SE (Table 5). 
SNPs close to CD55 had reached genome-wide significant association with SE in the meta-
analysis of all CREAM cohorts (i.e. with and without AL measures).21 There was an association with 
SE at CHRNG, along with a less significant independent hit near ALPPL2 (125kb away).21 Our AL 
gene-based results showed a genome-wide significant signal at ALPPL2 but not at CHRNG. There 
was also an association with SE at RDH5,21 on the same chromosomal band as the AL signal at 
MIP (OMIM #154050), but RDH5 and MIP are 727kb apart without LD between them, suggesting 
that they are independent signals. 
Pathway analysis
We conducted pathway analysis using VEGAS-Pathway63,64 by combining the gene-based 
P-values for 4,628 pre-specified pathways. The most significant pathway was the “Wnt receptor 
signaling” pathway (P = 2.9 x 10-5). The Bonferroni corrected P value was 0.13 (for the total number 
of 4,628 pathways tested). However, Bonferroni correction is an over correction, as many of the 
pathways have overlapping genes. The identification of the Wnt signaling pathway, even if only 
nominally associated, is of interest as the pathway involves two genes identified from the per-SNP 
tests. Also among the top 10 pathways were “lens development in camera-type eye” (P = 2.4 x 
10-4) and “collagen” pathways (P = 5.1 x 10-4, Table S7). The collagen pathway was implicated in 
a recent meta-analysis of corneal thickness.64
Gene expression
Differential expression of the nearest genes in the six implicated loci from per-SNP meta-analysis 
(Table S4) was assessed by measuring mRNA levels in minus-lens induced myopia mouse 
models.65,66 The mRNA levels of all six genes had a two-fold difference in the induced myopic eyes 
as compared to the control eyes in most of the tissues tested: sclera, retinal pigment epithelium 
(RPE) and neural retina (Figure S6). 
In human ocular tissue, we have previously shown that ZC3H11B is expressed in neural retina, 
RPE and sclera,19 LAMA2 is expressed in sclera and optic nerve, and CD55 is expressed in retina, 
choroid and cornea, whereas GJD2 is less abundant in sclera and other ocular tissues.21 In this 
study, we measured the mRNA expression levels of the other genes in adult ocular tissues using 
reverse-transcriptase PCR. We found that C3orf26, ZNRF3 and TIMELESS were expressed in most 
ocular tissues while the expression of RSPO1, ALPPL2 and MIP was less strong and/or more 
restricted (Table S8).
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DISCUSSION
We identified five AL loci (RSPO1, C3orf26, LAMA2, GJD2 and ZNRF3) and confirmed the 
previously described locus (ZC3H11B) using per-SNP tests. In addition, three loci (CD55, ALPPL2 
and TIMELESS/MIP/SPRYD4/GLS2) were identified using gene-based tests. Therefore, a total of 
nine AL loci were identified in this meta-analysis. Seven of the nine AL loci are located within the 
genomic region of protein-coding genes (Tables 2 and 3). Of note, two of them (RSPO1 and ZNRF3) 
encode proteins that are directly involved in the Wnt signaling pathway. RSPO1 is a member of 
a family of secreted proteins that act as stem-cell growth factors by enhancing the Wnt signaling 
pathway.70 On the other hand, ZNRF3 is a membrane-bound protein that acts as a negative 
regulator of the Wnt signaling pathway by mediating degradation of the Wnt receptor complex 
components Frizzled and LRP6.71 The two proteins have recently been shown to interact, RSPO1 
enhancing Wnt signaling through inhibition of ZNRF3.71 The Wnt signaling was the most significant 
pathway in our analysis, further supporting its prominent role in vertebrate eye development.72 
Indeed, overexpression of a dominant negative variant of human ZNRF3 in zebrafish embryos 
induces small eye or loss of eyes.71
Remodeling of extracellular matrix in sclera plays an important role in changes of eye size 
during myopia development. LAMA2 encodes the alpha 2 chain of laminin, a major extracellular 
protein of the basement membrane. We used HaploReg73 to search for evidence of a functional 
role for variants at the LAMA2 locus, as it has the largest per-allele effect on AL. The intronic 
lead SNP rs12193446 lies within the promoter and enhancer histone marks as well as DNase 
hypersensitive sites. Analysis with RegulomeDB274 suggested that rs12193446 occurs in a region 
that binds EP300, TCF4, STAT3, GATA2 and RFX4. Four of these interactions (EP300, TCF4, 
STAT3 and GATA2) were predicted by HaploReg73 to be affected by the genotype at rs12193446. 
Mutations in the cognate gene for TCF4 cause Pitt-Hopkins syndrome (PTHS [OMIM #610954]), 
the predominant ocular feature of which is high-grade myopia.75 Interestingly, common genetic 
variants in TCF4 (OMIM #602272) have also been associated with Fuchs corneal dystrophy, 
suggesting the pleiotropic effects of TCF4 on ocular diseases.76
Gene-based testing implicated the TIMELESS/MIP/SPRYD4/GLS2 region although determining 
which of these genes are functionally relevant is difficult as there are multiple association signals 
in the region. MIP is an interesting candidate gene as it is expressed in the ocular lens and is 
required for correct lens function.77 CD55, implicated here in AL and previously in SE,21 is known 
to elevate cytosolic calcium ion concentration.
For all six of the genes identified in our per-SNP meta-analysis, we found evidence for differential 
expression in a mouse model of myopia. Differential expression was observed in the mouse sclera 
and retina as well as RPE cells, suggesting a role for these genes in myopia. Further strengthening 
our results, the expression data showed all but one of these genes expressed in the adult human 
eye. These data potentially provide insights into the complexity of AL elongation and myopia 
at the biological level. Some genes, namely ZC3H11A, GJD2 and LAMA2, showed changes in 
expression that are consistently in the same direction across the different eye sections analyzed, 
whereas others, namely RSPO1, C3orf26 and ZNRF3, showed variable directions of differential 
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expression. These results, together with the pathway analysis results, suggest that the genetic 
mechanisms of myopia are complex, involving more than one eye component.
We have previously shown that up to 50% of the variation in SE is due to shared genetic factors 
with AL.78 Thus, we undertook further analyses and found that five of the nine AL loci are also 
associated with SE. Furthermore, we looked up the association of AL with the SNPs discovered 
from the recent CREAM GWAS meta-analysis on SE in 32 cohorts21 and observed that 23 of the 
29 SNPs identified with SE have significant effects on AL (P < 0.05, Table S9). This has important 
implications. First, it confirms the previous findings in twins78 that there are common genetic 
determinants of the two traits, such as variants in GJD2, LAMA2, CD55 and ALPPL2. Second, 
it indicates that some genetic variants for AL do not influence SE, suggesting they regulate 
the co-ordinated scaling of eye size.79 For example, the SNP in RSPO1 showed the strongest 
evidence of association with AL, yet it had no association with refractive error. In eyes without 
refractive error, AL and corneal curvature are carefully scaled relative to one another, and have 
a high phenotypic correlation between them.80 Therefore, genes like RSPO1, might mediate a 
compensatory mechanism through changes in corneal curvature or optical power thus balancing 
their effects on SE. 
Shorter axial length is a major risk factor for angle closure glaucoma. A recent GWAS on primary 
angle closure glaucoma identified three genome-wide significant loci located at PLEKHA7 (OMIM 
#612686), COL11A1 (OMIM #120280) and PCMTD1-ST18.81 However, none of the common 
variants in the three loci were significantly associated with AL in our meta-analysis (Table S10). 
This suggests that susceptibility genes do not overlap between primary angle closure glaucoma 
and eyes with shorter axial length. 
In summary, we identified nine loci associated with AL. They fall into two groups, one also 
influencing common refractive error variation, the other, which includes two genes in the Wnt 
signaling pathway, uniquely determining eye size with little effect on natural refractive status. 
Further elucidation and characterization of the causal variants underlying the growth of ocular 
component dimensions and the development of myopia may enable new pathway and target 
identification, leading to potential prevention and treatment development. 
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ABSTRACT
To identify genetic variants associated with refractive astigmatism in the general population, meta-
analyses of genome-wide association studies were performed for: White Europeans aged at least 
25 years (20 cohorts, n=31,968); Asian subjects aged at least 25 years (7 cohorts, n=9,295); 
White Europeans aged <25 years (4 cohorts, n=5,640); and all independent individuals from the 
above three samples combined with a sample of Chinese subjects aged <25 years (n=45,931). 
Participants were classified as cases with refractive astigmatism if the average cylinder power 
in their two eyes was at least 1.00 diopter and as controls otherwise. Genome-wide association 
analysis was carried out for each cohort separately using logistic regression. Meta-analysis was 
conducted using a fixed effects model. In the older European group the most strongly associated 
marker was downstream of the neurexin-1 (NRXN1) gene (rs1401327, P=3.92E-8). No other region 
reached genome-wide significance, and association signals were lower for the younger European 
group and Asian group. In the meta-analysis of all cohorts, no marker reached genome-wide 
significance: The most strongly associated regions were, NRXN1 (rs1401327, P=2.93E-07), TOX 
(rs7823467, P=3.47E-07) and LINC00340 (rs12212674, P=1.49E-06). For 34 markers identified 
in prior GWAS for spherical equivalent refractive error, the beta coefficients for genotype versus 
spherical equivalent, and genotype versus refractive astigmatism, were highly correlated (r=-0.59, 
P=2.10E-04). This work revealed no consistent or strong genetic signals for refractive astigmatism, 
however the TOX gene region previously identified in GWAS for spherical equivalent refractive 
error was the second most strongly associated region. Analysis of additional markers provided 
evidence supporting widespread genetic co-susceptibility for spherical and astigmatic refractive 
errors. 
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INTRODUCTION
Refractive astigmatism results from the optical summation of the eye’s corneal astigmatism and 
astigmatism from internal eye components (e.g., lens). In most individuals, these two sources of 
astigmatism tend to compensate for each other, such that overall refractive astigmatism is typically 
low in magnitude1. High levels of refractive astigmatism are usually the result of high corneal 
astigmatism rather than high internal astigmatism2,3. Astigmatism in infancy is a risk factor for 
amblyopia4. In later life, astigmatism commonly accompanies myopia and hyperopia5-7, reducing 
visual acuity unless corrected by spectacles, contact lenses or refractive surgery8. 
The results of twin9-12, family13,14 and molecular genetic studies15-17 suggest that astigmatism is highly 
heritable, as does its high prevalence in specific ethnic groups such as Native Americans18-20. For 
refractive astigmatism, the heritability has been estimated at 0.33 to 0.63 from twin studies10,21,22. 
Using a case-control genome-wide association study (GWAS) meta-analysis of 8,513 individuals 
of Asian ethnicity, Fan et al.15 identified the PDGFRA gene on chromosome 4q12 as a susceptibility 
locus for corneal astigmatism. Cases were defined as subjects with corneal astigmatism 
(averaged between the two eyes) of at least 0.75 dioptres (D) and controls as those with corneal 
astigmatism less than 0.75 D. Three single nucleotide polymorphisms (SNPs) attained genome-
wide significance (P <5.0E-08); rs7677751, rs2307049 and rs7660560. SNPs in the same region of 
PDGFRA have since been found to be associated with both corneal curvature and axial length23-25, 
but not with spherical refractive error24. A second GWAS meta-analysis in 22,100 individuals of 
European descent by Lopes et al.16 reported suggestive evidence that SNPs in the VAX2 gene on 
chromosome 2p13 also confer susceptibility to refractive astigmatism (most strongly associated 
SNP, rs3771395; P = 2.0E-07). These authors modelled astigmatism as a continuous trait, by using 
an inverse normal transformation of the refractive astigmatism averaged between the two eyes. 
The GWAS meta-analyses of Fan et al.15 and Lopes et al.16 both assessed large numbers of 
individuals derived from cohorts that were largely population-based. It is therefore unlikely that 
common autosomal genetic variants, i.e. those with a minor allele frequency (MAF) > 5%, with 
profound effects on the risk of developing astigmatism (e.g. OR >2) exist, as both studies would 
have had high power to detect them. Instead, the results of the two studies imply that most of 
the additive genetic risk for astigmatism arises from the combined action of a large number of 
individual risk variants, each with a small effect. This scenario, which also holds for spherical 
refractive error26-29, suggests that substantially increasing the sample size of GWAS meta-analyses 
will be an effective method of discovering new variants, albeit with increasingly diminishing 
returns30. Here, we describe the largest GWAS for refractive astigmatism yet undertaken involving 
almost 46,000 persons. 
MATERIAL AND METHODS
Selection of studies for inclusion in the meta-analysis
The CREAM consortium comprises researchers from more than 30 research groups who share 
a common interest in the genetics of refractive error. From March to July 2012, all Principal 
Investigators (PI’s) of studies known to CREAM members who had collected refractive error 
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phenotype information and genome-wide genotyping information on a study sample were invited 
to join CREAM. An analysis plan detailing the protocol for the astigmatism GWAS meta-analysis 
was circulated, inviting all PI’s to perform the requested analyses and to submit GWAS results 
for their study sample. There were no restrictions on which studies were eligible to join the meta-
analysis. 
Study cohorts and meta-analysis overview
GWAS results were meta-analyzed for a total of 32 cohorts. The subject demographics of the 
cohorts are summarized in Table 1: Further details can be found in the Supplement and in previous 
publications31-58. The mean age of the participants in each cohort varied from 15 to 74 years and 
37,608 of them were of White European ancestry while 10,212 were of Asian ancestry. Because the 
magnitude and axis of astigmatism is known to vary with age59,60, and to limit the effects of differing 
SNP-causal variant relationships across ethnicities, meta-analyses were carried out separately 
for (a) White Europeans aged < 25 years, (b) White Europeans aged ≥ 25 years, and (c) Asians 
aged ≥ 25 years. This age classification scheme follows that adopted previously by the CREAM 
consortium28,61, and was agreed to by the CREAM Executive Committee prior to commencement of 
the meta-analyses. A final meta-analysis was performed combining all independent samples from 
these three groups with the SCORM study of Asians aged <25 years. Each participating study 
defined the astigmatism trait in the same manner and performed association analyses specifically 
for this study using equivalent logistic regression models (described below and in the supplement).
Phenotypic assessment
Subjects underwent an ophthalmic examination that included either subjective refraction, 
cycloplegic autorefraction or non-cycloplegic autorefraction (Supplemental Methods and 
Supplemental Table S1a). Astigmatism was defined in the same way during association analysis 
in all cohorts participating in this meta-analysis study. Participants with conditions that could alter 
refraction, such as cataract surgery, laser refractive procedures, retinal detachment surgery, 
keratoconus or ocular or systemic syndromes were excluded. Additional exclusion criteria were, 
firstly, a cylinder power ≥ 5.00 D in either eye (to exclude subjects with undiagnosed keratoconus 
or potential measurement errors), and secondly, a difference in cylinder power between the two 
eyes beyond four standard deviations from the mean (except for subjects with data for only one 
eye). Subjects were classified as astigmatic cases if the average cylinder power in the two eyes 
was ≥ 1.00 D and as controls otherwise (note that cylinder axis was ignored). The threshold value 
of 1.00 D was chosen due to its common usage in prior work8,62. The average of the two eyes was 
taken in order to maximise statistical power63. 
Genotyping and genotype imputation
Genotyping and imputation were carried out as described previously28. Briefly, participants in 
each cohort were genotyped using a whole genome SNP platform. The genotypes of subjects 
that passed a series of quality control (QC) filters, including call rate at least >95% and ancestry 
matching that of the reference population, were imputed to a common set of markers (HapMap
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Table 1. Cohort demographics
Study Ethnicity N Age Astigmatism Astigmatism Astigmatism %Female
(Cases/controls) (mean ± SD) Mean ± SD Median (IQR) Range
years D D D
European adult cohorts
1958 British Birth Cohort White European 1645 42 ± 0 0.47 ± 0.53 0.38 0.00 – 4.50 45.8%
(182/1463) (0.13 – 0.63)
ALSPAC Mothers White European 1889 44 ± 2 0.63 ± 0.53 0.50 0.00 – 4.62 100.0%
(343/1546) (0.25 – 0.75)
AREDS White European 1864 68 _ 5 0.77 ± 0.67 0.75 0.00 – 4.50 59.2%
(567/1297) (0.25 – 1.00)
BATSplusTEST White European 204 40 ± 14 0.63 ± 0.57 0.38 0.00 – 2.75 62.7%
(49/155) (0.25 – 0.89)
CROATIA-Korcula White European 826 56 ± 13 0.63 ± 0.52 0.50 0.00 – 4.00 64.7%
(135/691) (0.25 – 0.75)
CROATIA-Split White European 343 51 ± 13 0.55 ± 0.41 0.44 0.00 – 3.00 56.3%
(35/308) (0.25 – 0.63)
CROATIA-Vis White European 529 56 ± 13 0.68 ± 0.57 0.51 0.00 – 4.68 59.7%
(104/425) (0.21 – 0.81)
ERF4 White European 2485 49 ± 14 0.58 ± 0.54 0.50 0.00 – 4.13 43.4%
(472/2013) (0.25 – 0.75)
FITSA White European 87 68 ± 3 0.75 ± 0.52 0.63 0.00 – 3.50 100.0%
(18/69) (0.38 – 0.88)
Framingham White European 1532 60 ± 12 0.78 ± 0.56 0.63 0.00 – 4.38 56.1%
(745/787) (0.38 – 1.00)
GUTENBERG White European 3954 56 ± 11 0.55 ± 0.54 0.44 0.00 – 4.63 49.2%
(640/3314) (0.13 – 0.75)
KORA White European 1852 56 ± 12 0.72 ± 0.64 0.50 0.00 – 4.75 50.6%
(448/1404) (0.25 – 1.00)
OGLIASTRA White European 472 52 ± 16 0.31 ± 0.52 0.00 0.00 – 3.00 69.0%
(49/423) (0.00 – 0.50)
ORCADES White European 502 58 ± 14 0.70 ± 0.65 0.56 0.00 – 4.69 56.8%
(113/389) (0.22 – 0.90) 
ROTTERDAM 1 White European 5422 69 ± 9 0.95 ± 0.66 0.75 0.00 – 4.75 58.6%
(2193/3229) (0.38 – 1.13)
ROTTERDAM 2 White European 1973 64 ± 7 0.89 ± 0.59 0.75 0.00 – 4.50 54.3%
(725/1248) (0.44 – 1.07)
ROTTERDAM 3 White European 1971 56 ± 6 0.81 ± 0.57 0.63 0.00 – 4.00 56.5%
(580/1391) (0.31 – 0.94)
TwinsUK White European 2658 55 ± 13 0.80 ± 0.65 0.63 0.00 – 4.88 91.1%
(751/1907) (0.38 – 1.00)
WESDR adults White European 280 35 ± 8 0.71 ± 0.65 0.50 0.00 – 4.50 75.4%
(69/211) (0.19 – 0.81)
YFS White European 1480 42 ± 5 0.64 ± 0.52 0.50 0.00 – 4.13 55.3%
(269/1211) (0.25 – 0.75) 
Asian adult cohorts
BES Chinese 585 62 ± 9 0.66 ± 0.59 0.50 0.00 – 3.50 65.8%
(154/431) (0.25 – 1.00)
HK-MGS adults Chinese 120 34 ± 7 1.29 ± 1.05 0.97 0.00 – 5.31 61.7%
(59/61) (0.50 – 1.84)
SCES Chinese 1662 57 ± 9 0.99 ± 0.63 0.85 0.00 – 4.30 48.8%
(670/992) (0.48 – 1.23)
SIMES Malay 2165 57 ± 11 0.90 ± 0.66 0.73 0.00 – 4.85 50.8%
(706/1459) (0.39 – 1.06)
SINDI Indian 1998 56 ± 9 0.96 ± 0.62 0.83 0.00 – 4.53 48.7%
(739/1259) (0.47 – 1.18)
SP2 Chinese 1954 48 ± 11 0.81 ± 0.56 0.68 0.00 – 4.18 54.2%
(543/1411) (0.36 – 0.0.99)
STARS Chinese 811 39 ± 5 0.72 ± 0.67 0.60 0.00 – 4.32 48.0%
(205/606) (0.21 – 0.94)
European youngsters cohorts
ALSPAC children White European 3828 15 ± 0.3 0.65 ± 0.42 0.63 0.00 – 4.25 48.8%
(580/3248) (0.38 – 0.75)
BATSplusTEST children White European 561 18 ± 4 0.40 ± 0.48 0.25 0.00 – 4 54.0%
(60/501) (0.13 – 0.5)
RAINE White European 1007 20 ± 0  0.74± 0.40 0.69 0.08 – 3.11 49.3%
(215/792) (0.45-0.93)
WESDR children White European 244 18 ± 4 0.64 ± 0.57 0.50 0.00 – 3.38) 50.8%
(52/192) (0.25 – 0.75)
Asian youngsters cohort
SCORM Chinese 917 11 ± 1 0.77 ± 0.66 0.57 0.00 – 4.32 48.0%
(247/670) (0.21 – 0.94)
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Phase 2) with either MACH64 or IMPUTE65. SNPs that passed cohort-specific QC metrics were used 
as a framework for imputation, and reference haplotypes were chosen from the best available 
HapMap Phase 2 ancestry group28. See Supplemental Methods and Table S1b for more details.
Statistical analysis
A GWAS was carried out separately for each participant cohort. SNPs were tested individually 
for association with astigmatism in a logistic regression model, with case/control status as the 
dependent variable. SNP imputed dosage was modelled as a linear covariate (on a continuous 
scale from 0 – 2) where one allele was assigned as the reference allele and the other allele the 
risk allele. Age and sex were included as additional covariates when appropriate. If significant 
population stratification was detected in a cohort, then either the first two principal components 
(PCs) were included in the logistic regression or an analysis method was used that jointly adjusted 
for population stratification and cryptic relatedness as part of the analysis. This approach is 
commonly used in GWAS meta-analysis66-68. Details of the GWAS analyses performed in each 
cohort are given in Supplemental Methods. SNPs were carried forward for meta-analysis if they 
met the following criteria of a MAF >1%, and an OR (odds ratio) between 0.2 and 5.0 (the latter 
step being included to remove SNPs with an OR of approximately zero or infinity, which occurred 
for a few SNPs in the smaller cohorts due to low minor allele counts). Effect estimates were 
reported with reference to the positive strand of the NCBI Build 36 reference sequence of the 
human genome. Meta-analysis was carried out using a fixed-effects model with METAL 69. For 
the meta-analysis of all cohorts, the adult ALSPAC sample was excluded because, given the 
inclusion of the ALSPAC young persons sample (biological relatives of the adults), this could have 
led to falsely-inflated estimates of association. The number of subjects contributing information to 
the meta-analysis summary statistic varied, as shown in Tables 2 and 3. This occurred primarily 
through markers being monomorphic (uninformative) in certain samples, and to a small extent 
through missing data for certain markers in specific individuals. A P-value <5.0E-08 was used to 
declare genome-wide significance70,71.
RESULTS
Meta-analyses of refractive astigmatism GWAS results were carried out for 3 subject groups: White 
Europeans aged ≥25 years, White European subjects aged <25 years, and Asians aged ≥25 
years. There was little evidence of population stratification in any of the meta-analysis results 
datasets (Genomic Control lambda, lGC=1.014, 1.011, 1.018 and 1.022 for White Europeans aged 
≥25 years, White European subjects aged <25 years, Asians aged ≥25 years, and all samples 
combined, respectively).
Meta-analysis of White Europeans aged at least 25 years 
For the meta-analysis of older White European individuals (n= 31,968) there were 6 regions 
containing markers with P-values <5.0E-06, suggestive of association (Table 2; Figures. 1 & 2). 
However, only a single region contained markers that met the P-value conventionally accepted 
to declare genome-wide significance (P <5.0E-08). This was at 2p16.3, downstream of the 
gene encoding neurexin-1 (NRXN1; Figure 2A) with the most strongly associated marker being 
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rs1401327. Each copy of the A allele of rs1401327 increased the odds of astigmatism with an OR= 
1.16 (95% CI: 1.10 to 1.22; P=3.92E-08). The next most strongly associated regions were at 3q23, 
4p15, 6p22.3, and 18q12.1 (Table 2). There was little evidence of heterogeneity of effect across 
cohorts at any of the above loci (I2 <14; Table 2).
Meta-analysis of White Europeans aged less than 25 years 
The meta-analysis of younger White European cohorts identified 4 regions with P-values below 
5.0E-06 (Table 2). However, the much smaller sample size (n=5,640) meant that this meta-analysis 
had limited statistical power to detect true-positive associations. The most strongly associated 
SNP was rs1366200 (OR=1.31, 95% CI=1.17 to 1.46; P=1.04E-06) within the AQPEP gene on 
chromosome 5q23.1.
Meta-analysis of Asians aged at least 25 years 
In the meta-analysis of Asian cohorts (n=9,295) the most strongly associated marker was rs7534824 
(OR=2.30, 95%CI=1.65 to 3.22; P=9.00E-07) within a gene of unknown function, LOC101928334, 
on chromosome 1. This marker had a low allele frequency (MAF=0.03). Two other regions also 
contained SNPs with P-values <5.0E-06 (Table 2). However, this meta-analysis also had limited 
statistical power to detect true-positive associations.
Meta-analysis of all cohorts 
In order to search for evidence to corroborate the initial findings, we carried out a meta-analysis 
of all independent individuals from the above 3 cohort groups combined with Asians <25 years of 
age from the SCORM study (n= 45,931). As shown in Table 3, this revealed little evidence across 
cohort groups to substantiate the initial findings. The three most strongly associated regions were 
the NRXN1 locus, the TOX gene locus on chromosome 8q12.1, and the LINC00340 gene locus 
at 6p22.3, all of which were amongst the most highly-associated regions identified in the meta-
analysis of older White European subjects. Association at the NRXN1 gene locus (rs1401327, 
Figure 1. Results of the meta-analysis of White European subjects aged ≥ 25 years old. 
Panel A: Manhattan plot of log P-values against genomic position. The red horizontal line is the threshold 
commonly used to for declaring genome-wide significance (P=5.0E-08). The blue line indicates 
P=1.0E-05. Genes adjacent to the association signal are indicated. Panel B: Quantile-quantile (QQ) plot 
of observed versus expected distribution of log P-values. The red line shows the distribution expected 
by chance.
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Figure 2. Regions showing the strongest evidence for association with refractive astigmatism in 
the meta-analysis of White Europeans aged ≥ 25 years
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OR=1.139, 95% CI: 1.084-1.198, P=2.93E-07) was driven solely by the European cohorts, 
since the associated SNPs were monomorphic in Asians, and thus uninformative. The most 
strongly-associated marker at the TOX gene locus was rs7823467 (OR=1.09, 95% CI: 1.05-1.12; 
P=3.47E-07) while that at the LINC00340 gene locus was rs12212674 (OR=1.09, 95% CI: 1.05-
1.12; P=1.49E-06).
Interestingly, the TOX region is one of the loci identified in the CREAM consortium GWAS for 
spherical equivalent refractive error28 and the age-of-onset of myopia GWAS carried out by 
23andMe29. Therefore to investigate whether spherical refraction and astigmatism share common 
genetic determinants more widely, we examined the association with refractive astigmatism of 
34 genome-wide significant SNPs (Table S1) reported in the CREAM28 and 23andMe29 spherical 
equivalent GWAS meta-analyses (4 additional SNPs associated with spherical equivalent could 
not be included since they were not analysed in the current study). For each SNP, the effect size 
(beta coefficient describing the magnitude of association) with spherical equivalent was plotted 
against the effect size for association with refractive astigmatism (Figure 3). The betas were found 
Figure 3. Common genetic determinants for spherical equivalent refractive error are shared with 
refractive astigmatism. 
GWAS meta-analysis beta coefficients (which quantify the effect size of SNPs) were compared between 
studies of spherical equivalent and refractive astigmatism. The SNP beta coefficients for spherical 
equivalent were obtained from the CREAM consortium GWAS for spherical equivalent28, while those 
for refractive astigmatism were from the current study. The 34 SNPs analysed were chosen based on 
prior genome-wide significant evidence of association with spherical equivalent in the CREAM28 and 
23andMe29 GWAS meta analyses. The solid line is the best linear fit to the data.
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to be highly correlated (r=-0.59, P=2.10E-04). Excluding the SNP in the TOX gene region had 
minimal influence on the correlation of the betas for the remaining 33 SNPs (r=-0.60, P=2.29E-04).
DISCUSSION
This GWAS meta-analysis of nearly 46,000 individuals identified several novel, suggestive 
candidate genes/regions for refractive astigmatism, including NRXN1, TOX and LINC00340. One 
of these regions, near the NRXN1 gene region, reached genome-wide significance in the White 
European adult group. Two thirds of the ~46,000 subjects included in the full meta-analysis were 
White European adults and so the results are likely to have been driven mainly by this group. 
Therefore, until the opportunity arises for replication in independent samples, especially in large 
numbers of comparable White European adults, caution is needed in interpreting these results. 
These results should not be considered to be relevant to other populations until replicated in 
younger White European samples or in other ethnic groups.
Novel candidate genes underlying the observed associations
Neurexin-1, one of the largest genes in the human genome, is thought to function in cell adhesion, 
as well as synapse development and maintenance72,73. Structural genomic deletions that delete 
or disrupt NXRN1 are strongly implicated in causing psychiatric and cognitive phenotypes 
including schizophrenia, autism and mental retardation74. To our knowledge these conditions 
are not known to be associated with refractive astigmatism although refractive errors, in general, 
are more prevalent in individuals with learning difficulties75. A recent survey of 25 patients with 
exonic deletions involving the gene for neurexin-174 unfortunately did not describe these patients’ 
ocular features. While the strength of association reached genome-wide significance in the adult 
European sample (n=31,968, P=3.92E-08), this weakened when the younger European subjects 
were included (n=35,719, P=2.93E-07) while having little impact on the estimated effect size 
(OR=1.16 and OR=1.14, respectively). The associated SNPs in this region were monomorphic in 
Asian subjects, suggesting they arose relatively recently in human evolution.
The associated variants at 8q12.1 lie upstream of the TOX promoter and thus would be well-placed 
to influence its transcription level. However it is not clear whether TOX or a nearby gene mediates 
this locus’ impact on spherical equivalent refractive error – and potentially astigmatism. The known 
roles of TOX relate to immune function, which argues against a role in refractive development and 
instead suggests that another gene such as SDCBP (syndecan binding protein) also known as 
syntenin, which lies 600 kb from the most-strongly associated marker may be involved. Syntenin 
acts as a link between the proteoglycan/matrix receptor syndecan-1 and the cytoskeleton, and its 
proposed functions include cell adhesion. Furthermore, syntenin-null mice show wound healing 
defects that are particularly marked in the cornea76,77. 
The 6p22.3 locus containing the long intergenic non-coding RNA gene LINC00340 (also known 
as FLJ22536 and CASC15) is gene-poor (Figure 2D) yet has previously shown association with 
aggressive neuroblastoma in GWAS studies78. The mechanisms through which non-coding RNAs 
act are poorly understood79,80 but in the case of lincRNAs the mechanism may involve epigenetic 
regulation81. No obvious candidate astigmatism susceptibility gene is present in this genomic 
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location. As with NRXN1, the association with LINC00340 was almost wholly driven by the adult 
European cohorts (P=1.45E-06 versus P=1.49E-06 in all cohorts combined). 
As well as NRXN1 and SDCBP, additional genes in the most strongly associated regions have 
putative roles in cell adhesion and/or synapse function. The gene nearest to the lead SNP at 
3q23 in European adults (rs12638075, P=4.69E-06) is TRIM42 (tripartite motif containing-42). 
Because members of the TRIM gene family function mostly in immune signalling82, the adjacent 
gene CLSTN2 (calsyntenin-2; also known as cadherin-related family member-13) is potentially of 
greater interest given its proposed role in cell adhesion and synapse function83. Furthermore, the 
association described above for markers in the vicinity of the SDCBP gene, encoding syntenin, 
lends support to the putative involvement of CLSTN2. One of the two regions on chromosome 
4p15 (lead SNP rs2871434; Figure. 2E) contains the PCDH7 (protocadherin-7) gene, which given 
its role in cell adhesion is a plausible candidate gene for astigmatism. In mice homozygous for 
a null allele of the EGR1 gene, which develop a transient axial myopia postnatally, a member of 
the protocadherin gene family, Pcdhb9, was the most highly differentially expressed retinal gene 
when compared to wild type mice84. The second associated region at 4p15 (lead SNP rs2309717; 
Figure. 2B) contains no known genes - the closest being MIR4275, which lies 600 kb away. 
However, amongst the more than 6000 predicted targets of miR-4275 is the nearby PCDH7.
Genetic co-determination of spherical equivalent and refractive astigmatism
One of the most exciting findings from this study was the evidence for overlap in genetic 
susceptibility between spherical and astigmatic refractive errors (Figure 3). It is well-known that 
spherical and astigmatic refractive errors tend to co-occur8,85. However, to our knowledge this is 
the first study to provide evidence supporting shared genetic susceptibility for the two traits. Kee 
and co-workers6,86 have shown in monkeys and chickens that visual experience can alter spherical 
equivalent and astigmatic refractive errors concurrently. Hence, in line with the view that genetic 
factors might alter refractive development by regulating how the eye responds to visual cues87,88, 
it is feasible that causal variants tagged by the SNPs examined here impact on both spherical 
equivalent and astigmatism via visual feedback.
The suggestive findings here that genes related to cell adhesion and synapse function may 
be involved in susceptibility to astigmatism is also consistent with the concept of genetic co-
determination of spherical equivalent and refractive astigmatism, as several candidate genes 
identified in GWAS for spherical equivalent refractive error have putative roles in synapse function 
or plasticity, for example RASGRF1, GRIA4, RBFOX1, LRRC4C, DLG227-29,89 as well as in cell 
adhesion, for example TJP2, CTNND2, ANTXR2, and LRFN528,29,90.
Comparison with previous work and limitations of the current study
Results from the meta-analysis of all cohorts for SNPs previously associated with astigmatism are 
shown in Table 4. Because the cohorts studied here overlap substantially with those examined 
previously15,16, low P-values were expected – but not found. Thus the P-values in Table 4 provide 
little evidence for replication of the previously associated markers. This is especially surprising for 
the corneal astigmatism-associated SNP at the PDGFRA locus15, since this has already 
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been replicated in a cohort of differing ethnicity24. Instead, the lack of replication may reflect 
the different traits examined (corneal versus refractive astigmatism). The other SNPs previously 
associated with astigmatism did not reach genome-wide significance in the original study, and 
were associated with astigmatism when analyzed as a quantitative trait, which may explain the 
lack of independent replication. 
Genetic studies of astigmatism are hampered by the variation in its magnitude and orientation with 
age, and its non-Gaussian frequency distribution, all of which complicate the choice of analysis 
model. In younger individuals, astigmatism is typically “with the rule” (WTR; axis of minus power 
cylindrical correcting lens close to horizontal) while in later life it usually switches to “against the 
rule” (ATR; correcting negative cylinder axis close to vertical)5,85. Amongst the theories explaining 
this transition, a loosening of eyelid tension is the most widely supported8. If it is the case that 
ATR and WTR astigmatism have different etiologies, then GWAS investigations should attain 
maximum statistical power by modelling younger and older subjects separately, modelling ATR 
and WTR astigmatism separately, or in modelling astigmatism as a vector quantity. However, the 
age-dependent shift in WTR to ATR largely concerns low-level astigmatism whereas higher levels 
may be more stable over the life course91,92. Thus, the present study adopted a dichotomous 
case/control classification scheme, and analyzed younger and older subjects separately, in an 
attempt to mitigate the effects of axis changes with age. The dichotomization scheme also allayed 
concerns regarding the non-normality of the trait, although this would have been at the expense 
of statistical power.
The use of a dichotomous phenotype definition for our GWAS meta-analysis of astigmatism 
contrasts with the quantitative trait approach used in previous GWAS meta-analyses by the 
CREAM consortium for refractive error and axial eye length28,93. It has been shown that binary trait 
GWAS meta-analysis results are sensitive to unequal numbers of cases and controls in individual 
cohorts, especially when the sample size is small69. However, we found very similar results when 
overcoming this potential source of bias by using an “effective sample size” rather than actual 
sample size during meta-analysis69. In addition to the problem of unequal case/control sample 
sizes, we also observed highly inflated type-I errors during initial meta-analysis trials due to 
extreme OR estimates for a small number of low MAF markers in certain cohorts, e.g. if the minor 
allele was present in controls but absent in cases. To circumvent this, we pre-screened each 
GWAS results file, excluding markers with unfeasibly high OR estimates (OR < 0.2 or OR >5.0). 
Out of 7 Asian adult cohorts (total n=9,295), 5 were Chinese cohorts (n=5,132, about 55% of 
the total Asian adult sample). Therefore, we cannot generalize our results from the Asian adult 
group with ease. Importantly, the SNP (rs7534824, in the gene LOC101928334) which showed the 
strongest suggestive association in the Asian group was only polymorphic in the Chinese cohorts 
(monomorphic in the Indian and Malay cohorts). For the other 3 SNPs reported in Table 2, although 
they are polymorphic in all three ethnic groups, the association signal was mainly driven by the 
observed association in the 5 Chinese cohorts.
In summary, this large-scale meta-analysis of GWAS studies for refractive astigmatism identified 
only a single locus that reached genome-wide significance (2p16.3, near NRXN1, in European 
175
3
GWAS on astigmatism in CREAMChapter 3.6
adults) and there was no evidence for replication of this region in younger European individuals 
or in non-Europeans. Several putative candidate genes with functions relating to cell adhesion 
and/or synapse function were present in the next most strongly associated regions. Consistent 
with earlier work, all of the most strongly associated genetic variants identified had small effects, 
supporting the polygenic nature of genetic susceptibility to refractive astigmatism in the general 
population. Fewer candidate risk variants were discovered for refractive astigmatism than were 
found previously by the CREAM consortium for spherical equivalent refractive error28, despite 
studying similar subject cohorts. Nevertheless, there was compelling evidence for shared genetic 
susceptibility for spherical and astigmatic refractive errors, implying that the co-occurrence of 
these traits is, at least in part, genetically determined.
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ABSTRACT
Objective
To investigate whether myopia is becoming more common across Europe and explore if rising 
education levels, an important environmental risk factor for myopia, might explain any temporal 
trend. 
Design
Meta-analysis of population-based, cross-sectional studies from the European Eye Epidemiology 
Consortium (E3).
Participants
The E3 Consortium is a collaborative network of epidemiological studies of common eye diseases 
in adults across Europe. Refractive data were available on 61,946 participants from fifteen 
population-based studies performed between 1990-2013 with a median age range of 44-78 years.
Methods
Non-cycloplegic refraction, year of birth and highest educational level achieved were obtained 
for all participants. Myopia was defined as mean spherical equivalent ≤-0.75 diopters. A random 
effects meta-analysis of age-specific myopia prevalence was performed, with sequential analyses 
stratified by year of birth and highest level of educational attainment.
Main outcome measure
Variation in age-specific myopia prevalence for differing years of birth and educational level.
Results
There was a significant cohort effect for rising myopia prevalence across more recent birth 
decades; age-standardized myopia prevalence increased from 17.8% (95% Confidence Interval 
(CI) 17.6-18.1) to 23.5% (95% CI 23.2-23.7) in those born between 1910-39 compared to 1940-
79 (p=0.03). Education was significantly associated with myopia; for those completing primary, 
secondary and higher education the age-standardized prevalences were 25.4% (CI 25.0-25.8), 
29.1% (CI 28.8-29.5) and 36.6% (CI 36.1-37.2) respectively. While more recent birth cohorts were 
more educated, this did not fully explain the cohort effect. Compared to the reference risk of 
participants born in the 1920s with only primary education, either higher education or being born 
in the 1960’s doubled the myopia prevalence ratio (2.43 (CI 1.26-4.17) and 2.62 (CI 1.31-5.00) 
respectively), whilst individuals born in the 1960s completing higher education had almost four 
times the reference risk, prevalence ratio of 3.76 (CI 2.21-6.57). 
Conclusions
Myopia is becoming more common in Europe; while education levels have risen and are associated 
with myopia, higher education appears to be an additive rather than explanatory factor. Rising 
levels of myopia carry significant clinical and economic implications, with more people at risk of 
the sight threatening complications associated with high myopia.
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INTRODUCTION
Myopia (near-sightedness) occurs when a distant object’s image is formed anterior to the retinal 
plane, most commonly as result of an increased axial length. This results in blurred distant vision 
and, unlike hyperopia, requires refractive correction at all ages and severity for clear focus. Myopia 
is already the most common eye condition worldwide but the prevalence is significantly increasing, 
especially in Southeast Asia1-3. In Europe, Australia and the United States the prevalence of myopia 
appears to be lower4,5, however there is evidence of a rising prevalence in the United States and 
elsewhere6-8, particularly in young adults9. This is of concern as myopia, even when appropriately 
corrected, is associated with an increased risk of sight threatening diseases such as myopic 
maculopathy, retinal detachment, glaucoma and cataract10. Myopic maculopathy is currently 
untreatable and already contributes to visual impairment in working age adults11. Rising myopia 
levels in Europe would carry implications for public health policy both in the provision of clinical 
services and economic sequelae from the resulting visual impairment in the working population. 
Myopia is a highly heritable trait12,13 and to date a number of genetic polymorphisms have 
been associated with refractive error, albeit explaining a small proportion of this heritability14,15. 
Environmental factors play a key role in myopia development and must explain the recent changes 
in prevalence16. Myopia has been associated with education, near work, urbanisation, pre-natal 
factors, socio-economic status, cognitive ability, season of birth, light and time spent outdoors2,16-25. 
One of the strongest and most replicated risk factors is educational attainment16,26, and there 
is some evidence of interaction between genetic factors and education to influence the risk of 
myopia27. The increased levels of higher education over the 20th Century28 might be a causative 
factor, or marker of a causative factor, for rising myopia prevalence. 
The aims of this study are to identify whether myopia is becoming more common across Europe 
and to examine whether rising levels of education explain any temporal trend, using data from over 
60,000 participants from the European Eye Epidemiology (E3) Consortium.
MATERIAL AND METHODS 
Study population
The European Eye Epidemiology (E3) consortium is a collaborative initiative to share and meta-
analyse epidemiological data on common eye diseases across Europe. Thirty-three studies are 
currently part of the consortium and a range of ophthalmic data is available on approximately 
124,000 individuals, from population-based and case-control cohorts. All studies adhere to the 
tenets of the Declaration of Helsinki, and relevant local ethical committee approvals with specific 
study consent were obtained. 
Refractive error measurements were included from 68,350 adults within the fifteen E3 population-
based studies who had data on refractive error. These included population-based cross-sectional 
or cohort studies, with two studies recruiting participants nationally and thirteen recruited from a 
local population. Further detail on each study is provided in Table 1. Exclusion criteria included 
subjects who had cataract or refractive surgery, retinal detachment, or other conditions, such as 
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keratoconus, which might influence refraction (n=6404). Data on age at refraction and birth year 
was available for 61,946 individuals, with information on education level in 60,125 subjects. 
Participants were mainly middle to late age, 98% European descent (where ethnicity was known), 
predominantly from Northern and Western Europe, and refractive examinations were performed 
from 1990 to 2013 (Table 1). 
Study variables
Non-cycloplegic refractions were performed on all individuals using subjective refraction, 
autorefraction or a combination of focimetry with subjective refraction. Spherical equivalent (SE) 
was calculated using the standard formula (SE = sphere + (cylinder/2)). Myopia was defined as ≤ 
-0.75 diopters (D). Myopia prevalence by age was calculated, using five and ten year age bands 
from ≥15 years to ≥90 years. To study the impact of education on myopia, given the variation 
in educational systems across Europe, we established a simplified three-tier level of education 
across all cohorts. Primary education was defined as those leaving school before 16 years of 
age, secondary education in those leaving education up to the age of 19 years of age and higher 
education in those leaving education at or after the age of 20. Those under the age of 20 at the 
time of refraction (and therefore unable to have reached the highest education tier) were excluded 
from this analysis to avoid misclassification bias. 
We investigated the evidence for a cohort effect for rising myopia prevalence by observing 
variations in myopia prevalence within defined age bands. These analyses are focused on the age 
range constituting the majority of our cohort (40-80 years of age, birth year 1910-1979, n=56,088), 
meaning the youngest and oldest participants, for whom we had no comparative birth cohort, 
were not considered. Prevalence was examined between different birth cohorts, initially using 
decade bins (1910 to 1970) and subsequently in two birth cohort groups divided by the median 
birth decade (1940-49). Finally we examined the influence of education by examining the myopia 
prevalence between birth cohorts with the additional stratification of educational status. 
Statistical analysis
Study-specific summary data for myopia prevalence were obtained and combined in a random 
effect meta-analysis stratified by age. A random effects model was chosen over a fixed effects 
model, to allow for expected heterogeneity between studies as a result of varying study design. 
Age-standardization was performed with demographic distribution adjustments to age-specific 
estimates according to the European Standard Population 201029. Evidence for the presence of a 
cohort effect was investigated using random effect meta-analyses of myopia prevalence stratified 
by age and birth year, and subsequently age, birth year and educational level. Differences 
between estimates of myopia prevalence were evaluated using the ANOVA test, proportion z tests 
and prevalence ratios (relative difference in prevalence against a defined baseline). Differences 
were considered significant at p<0.05.
Statistical analysis was performed using Stata version 13.1 (StataCorp. 2013. Stata Statistical 
Software: Release 13. College Station, TX: StataCorp LP). Graphical outputs were obtained using 
either Stata, Origin v9.0 (OriginLab Corporation 2013, Northampton, MA) or ggplot230 in R (R Core 
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Team (2014). R: A language and environment for statistical computing. R Foundation for Statistical 
Computing, Vienna, Austria (URL http://www.R-project.org)). 
RESULTS 
In this meta-analysis of 61,946 adults the overall myopia prevalence was 24.3% (95% Confidence 
Interval (CI) 20.1 - 28.5), with an age-standardised prevalence in Europe of 30.6% (95% CI 30.3-
30.8). Age stratified analyses revealed a high prevalence in young adults (47.2% (95% CI 41.8-
52.5) in those aged 25-29 years), which was almost double the prevalence in those of middle 
to older age (27.5% (95% CI 23.5-31.5) in those aged 55-59 years). There were no significant 
differences in the myopia prevalence by gender. 
Cohort effect for rising myopia prevalence
There was a trend of higher myopia prevalence with more recent birth decade across all age 
groups (Figure 1), although sample sizes for some point estimates were low, resulting in wide 
confidence intervals (Table 2). 
We examined the prevalence of myopia in two birth cohort groups (divided by the median 
birth decade): those born between 1910-1939 (n=22,660) and those born between 1940-1989 
(n=33,428) (Figure 2). Myopia prevalence in a variance model was significantly higher in the more 
recent birth cohort group (p=0.03). Age-standardized myopia prevalence over a comparable age 
range of 50-79 years, increased from 17.8 % (95% CI 17.6-18.1) in those born 1910-1939 to 23.5% 
(95% CI 23.2-23.7) in those born 1940-1979. In age-specific analyses the prevalence of myopia 
in 50-59 year-olds was 22.5% (95% CI 20.2-24.9) in those born before 1940, compared to 29.2% 
(95% CI 25.3-33.0) in those born after 1940 (p=0.004). A similar significant rise of 15.3% (95% CI 
13.4-17.3) to 21.2% (95% CI 18.6-23.8) was observed in those aged 60-69 years old (p<0.001).
Figure 1. Prevalence of myopia (spherical equivalent ≤ -0.75 diopters) against age stratified by 
decade of birth. Individuals aged 40 to 79 included.
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The influence of education on myopia risk & the cohort effect
The association between education and myopia was investigated in the thirteen studies for which 
these data were available (n=60,125 participants). Educational level was significantly associated 
with myopia prevalence across all age strata (p<0.0001). Overall the age-standardized myopia 
prevalence for those completing primary, secondary and higher education were 25.4% (95% CI 
25.0-25.8), 29.1% (95% CI 28.8-29.5) and 36.6% (95% CI 36.1-37.2) respectively. There was 
an approximate two-fold increase in age-specific myopia prevalence between participants with 
primary compared to those with higher education in those aged 35-84 (the majority of study 
subjects) (Figure 3). For example, in subjects aged 45-49 when tested, the myopia prevalence 
Figure 2. Prevalence of myopia (spherical equivalent ≤ -0.75 diopters) as a function of age for two 
birth cohorts (1910 to 1939, 1940 to 1979) with 95% confidence interval
Figure 3. Prevalence of myopia (spherical equivalent ≤ -0.75 diopters) with 95% confidence 
intervals stratified by highest educational level achieved. Primary education - leaving education at 
<16 years old, secondary education - leaving school at ≤19 year of age, higher education - leaving school 
≥20 years of age
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was 26.3% (95% CI 20.1-32.5) with primary education compared to 51.4% (95% CI 46.7-56.0) 
with higher education, and in those aged 60-64 myopia prevalence was 14.0% (95% CI 12.3-
15.8) compared to 28.7% (95% CI 25.4-32.0) for primary and higher education respectively. The 
trends observed are less clear in younger subjects (<35) in Figure 3, most likely due to small 
sample sizes (n=216 aged 20-25 years, n=336 aged 25-30 years), which are further stratified by 
education level with corresponding wide confidence intervals. 
Levels of education throughout Europe have increased in the last 90 years (Figure 4). The 
proportion of individuals progressing to higher education rose from 4% in those born in the 1900s, 
to 16% in the 1920s, 20% in the 1940s, 33% in the 1960s and to approximately 61% in those born 
in the 1980s. 
However, although those born more recently were more likely to have achieved a higher 
educational level, this alone did not explain the cohort effect of rising myopia. As shown in Figure 
5, for individuals aged 45-65 years (age range selected for minimal age-related myopia variance 
and large available sample size), the increase in myopia prevalence with a more recent birth 
decade was observed across all educational groups. This was most pronounced for participants 
only achieving a primary education, where myopia prevalence increased from 10.7% (95% CI 7.6-
13.8) to 28.1% (95% CI 18.1-38.0) between birth decades 1920-29 and 1960-69 (p=0.001). The 
corresponding increase in myopia in those with higher education was from 26.0% (95% CI 17.4-
34.6) to 40.2% (95% CI 30.5-50.0) (p=0.03). Compared to the reference risk of participants with 
primary education and born in the 1920s, the myopia prevalence ratio for those achieving a higher 
education was 2.43 (95% CI 1.26-4.17) and 2.62 (95% CI 1.31-5.00) for those born in the 1960s. 
Individuals both born in the 1960s and completing higher education had almost four times the 
baseline risk, with a prevalence ratio of 3.76 (95% CI 2.21-6.57). Thus, the individual associations 
of educational level and birth cohort had an additive effect on myopia prevalence.
Figure 4. Distribution of highest educational level achieved, stratified by year of birth (1900-1989)
Primary education - leaving education at <16 years old, secondary education - leaving school at ≤19 
year of age, higher education - leaving school ≥20 years of age
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DISCUSSION 
Our study provides the first evidence that myopia is becoming more common across Western 
and Northern Europe, with a clear trend of higher myopia prevalence in participants with a more 
recent birth year (Figure 1). This is similar to the increase reported in North America and, albeit to 
a lesser extent, Southeast Asian populations6,7,31,32. Evidence of rising myopia prevalence carries 
clinical and economic implications. The increased requirement for detection and treatment of 
myopia, entailing glasses, contact lenses or more recently laser refractive surgery, has significant 
implications for clinical optometric and ophthalmic service provision, and the health care system. 
Additional ophthalmic services will be needed for treatable sight threatening complications such 
as retinal detachment, glaucoma and cataract10,33. The rising prevalence of myopia also implies 
that untreatable complications, such as myopic maculopathy, most commonly seen in high 
myopia, will become more common. This will result in more visual impairment in middle to late 
aged individuals, including a proportion of the working age population, with consequent economic 
implications.
Myopia has been strongly associated with education2,21,24,34 and we explored this using a simple 
three-tier classification of educational level. Increasing educational level had a strong effect, with 
myopia twice as common in those achieving a higher education compared to participants leaving 
Figure 5. Myopia prevalence (spherical equivalent ≤ -0.75 diopters) by birth cohort and educational 
level in individuals aged 45-65 years old
Primary education - leaving education at <16 years old, secondary education - leaving school at ≤19 year 
of age, higher education - leaving school ≥20 years of age
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school before 16. There was a clear trend of increasing prevalence of myopia across the tiers 
of education level, suggesting a potential additive effect of years of education. This interesting 
association may reflect a number of factors; greater near work activities with more education and 
less time in outdoor light, shared genetic factors underlying myopia and intelligence, or factors 
related to educational opportunity such as socioeconomic status or maternal nutrition. These 
associations have been explored in younger cohorts18,20,21,35-37, although causal pathways are yet 
to be fully understood. 
Reasons for the observed cohort effect are clearly multifactorial, and education is an obvious 
possible explanation; in our data only 12% of participants born in the 1920s went on to higher 
education, compared to 33% born in the 1960s. This educational expansion has been observed 
across Europe in both men and women, with a sharp trajectory towards mass higher education 
after World War II28,38. In addition to disruption of education and economic consequences of World 
War II, adverse health outcomes have been reported in young people growing up at that time, 
notably diabetes, depression and heart disease39. Whilst there is no known direct link between 
these health issues and myopia, the deprivation may have affected eye growth and resulting 
refraction. Certainly there was a rise in myopia in subjects born after 1950, but it is difficult to be 
certain what aspect of the seismic changes in Europe after the war might be responsible.
However, although the younger generations were more educated, we found a clear increase in 
the prevalence of myopia across the birth cohorts within each educational stratum as well as the 
additive effect of educational status. Therefore increasing levels of myopia were not explained 
by education alone and a more recent birth year and higher educational level had an additive 
effect on myopia risk. Our simple three-tier education stratification may be subject to residual 
confounding from variation in educational practices and it may be these, rather than changes 
in education level, that are contributing to the observed cohort effect. In the latter half of the last 
century, there have been increasing use of computers, increasing length of the educational day 
with increased after-school tuition, and less outdoor play as a result of reduced recess time40. 
The E3 consortium has provided a large dataset to meta-analyse temporal trends and educational 
associations for myopia prevalence across Europe. Limitations to this consortium meta-analysis 
include heterogeneity between studies. Contributing studies inherently differed in study design 
and cohort sampling. Acknowledging this heterogeneity we have performed a random rather 
than a fixed meta-analysis, assuming no fixed effect between studies. There are also differences 
between European countries in terms of urbanization, economy, social class, education and 
lifestyle, which are known to influence myopia. Data on these variables at an individual or study-
specific level was not uniformly available, and data collection was often performed in middle aged 
and older participants, so retrospective collection of potential contributing factors such as outdoor 
exposure, amount of reading and area of residence during the critical first 20 years of refractive 
error development would be impossible. Additionally, potential multicollinearity of these likely 
highly correlated factors (eg. reading and education) would make assessment of separate effects 
difficult. In attempt to reduce heterogeneity arising from these associated factors we performed a 
random effects meta-analysis stratified by age and educational level (both significantly associated 
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with myopia). Applicability of our findings is greatest for middle to older aged individuals and to 
those from Northern and Western European countries, given the sampled ages and the location 
of the E3 studies (Table 1).
Further limitations include the crude nature in which education was classed, which as previously 
acknowledged may result in residual confounding. In addition, education status was collected 
retrospectively and therefore prone to recall error, possibly heightened in older participants. 
Refractions were all non-cycloplegic, although this is reasonable given the age of participants41,42. 
Finally, these data are not longitudinal, so we have not examined reasons for the lower prevalence 
with age within birth decades, although the cohort effect we have identified may be part of this 
explanation. Other reasons include the well-known hyperopic shift with age, and could include 
other factors such as censoring with age if myopic subjects have earlier cataract surgery.
We can conclude, for the first time, that the prevalence of myopia is increasing in Europe; a finding 
that is not fully explained by rising education levels despite higher educational achievement being 
associated with myopia and becoming more widespread in Europe. The changes in prevalence 
are similar to that observed in North America although remain far less than that identified in 
Southeast Asia, possibly due to differing intensity of education from an early age1,6,40. High levels 
of myopia were detected in the younger adults with a more recent birth year, of whom nearly half 
were affected. This has significant implications for the future; increasing myopia prevalence, and 
specifically high levels in younger individuals, will potentially result in an increasing burden of 
associated visual impairment in the future.
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ABSTRACT
Myopia is a complex inherited ocular trait resulting from an interplay of genes and environmental 
factors, most of which are currently unknown. In two independent population-based cohorts 
consisting of 5256 and 3938 individuals from European descent, we tested for biological interaction 
between genetic predisposition and level of education on the risk of myopia. A genetic risk 
score was calculated based on 26 myopia-associated single nucleotide polymorphisms recently 
discovered by the Consortium for Refractive Error and Myopia. Educational level was obtained by 
questionnaire and categorized into primary, intermediate, and higher education. Refractive error 
was measured during a standardized ophthalmological examination. Biological interaction was 
assessed by calculation of the synergy index. Individuals at high genetic risk in combination with 
university-level education had a remarkably high risk of myopia (OR = 51.3; 95% CI 18.5-142.6), 
while those at high genetic risk with only primary schooling were at a much lower increased risk of 
myopia (OR = 7.2, 95% CI 3.1-17.0). The combined effect of genetic predisposition and education 
on the risk of myopia was far higher than the sum of these two effects (synergy index 4.2, 95% CI 
1.9-9.5). This epidemiological study provides evidence of a gene-environment interaction in which 
an individual’s genetic risk of myopia is significantly affected by his or her educational level. 
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INTRODUCTION
Myopia (nearsightedness) is the most common refractive error and one of the leading causes of 
blindness1,2. Myopia currently affects more than one in four people in the United States and Western 
Europe3, and has a prevalence higher than 70% in urban areas in Asian countries4,5. The global 
incidence of myopia is growing6,7, increasing the frequency of sight-threatening complications 
such as myopic macular degeneration, glaucoma, and retinal detachment8-10.
Myopia is highly heritable; the risk of developing myopia is increased at least three-fold among 
children with two myopic parents compared to children with no myopic parents11,12, and heritability 
estimates for refractive error range from 0.60 to 0.9013. The Consortium for Refractive Error and 
Myopia (CREAM) and 23andMe independently conducted large genome-wide association studies, 
and identified more than 20 genetic loci for this trait14-16. Individuals with many risk variants at these 
loci have a tenfold increased risk of myopia14.
Education is the most important environmental risk factor for myopia identified to date17.The 
risk of developing myopia is up to four times higher in persons with a university-level education 
compared to persons with only primary schooling17. Achieving a higher level of education requires 
many hours of intensive near work (up-close work)—particularly reading—and this may contribute 
to the increased relative risk of developing myopia. Indeed, an increase in the average population-
wide educational level may have contributed to the recent rise in the prevalence of myopia6,7,18. 
There are hints that education may influence the effect of myopia genes, e.g., a study of an Amish 
population found that the refractive errors of well-educated carriers of the MMP1 and MMP10 
risk variants tended to be more myopic than those of individuals with lower levels of education19. 
Whether this gene-education interaction plays a role in the entire spectrum of genetic variants is 
unknown. 
We assessed the combined effect of genetic predisposition and educational level on the risk 
of myopia in two independent population-based cohorts from Rotterdam, the Netherlands. We 
computed a genetic risk score based on 26 established loci for refractive error, calculated mean 
refractive error as a function of genetic risk score for levels of education, estimated risk of myopia 
in combined strata of genetic risk and educational level, and examined biological interaction 
according to the synergy index developed by Rothman20.
MATERIAL AND METHODS
Study population
The study population consisted of participants from the Rotterdam Study cohorts who had baseline 
data on refractive error, educational level and genotype. All measurements were conducted after 
the Medical Ethics Committee of the Erasmus University had approved the study protocols and all 
participants had given a written informed consent in accordance with the Declaration of Helsinki. 
All participants were from European descent.
Rotterdam Study I (RS-I) was used as discovery cohort (Table 1). This prospective population-
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Table 1. Characteristics of the study population from all cohorts
 
Discovery 
cohort
Replication cohort Combined 
 RS-I RS-II RS-III
RS-I, RS-II, 
RS-III
N 5256 1984 1954 9194
Sex, % men (±SD) 42 46 44 43
Age, yrs  (±SD) 68.4±8.5 64.2±7.5 59.1±5.5 64.9±9.2
Baseline examinations 1991-1993 2000-2002 2006-2009 1991-2009
     
Refractive error     
Mean refractive error, D (±SD) 0.85±2.45 0.47±2.51 -0.34±2.61 0.52±2.54
High myopia ≤-6D , % 91 (1.7) 35 (1.8) 61 (3.1) 187 (2.0)
Medium myopia >-6D & ≤-3D , % 268 (5.1) 145 (7.3) 240 (12.3) 653 (7.1)
Low myopia -3D & ≤-0.75D , % 500 (9.5) 258 (13.0) 358 (18.3) 1116 (12.1)
Emmetropia >-0.75D & <0.75D , % 1355 (25.8) 528 (26.6) 625 (32.0) 2508 (27.3)
Low hyperopia ≥0.75D & <3D , % 2309 (43.9) 813 (41.0) 549 (28.1) 3671 (39.9)
Medium hyperopia ≥3D & <6D , % 661 (12.6) 187 (9.4) 104 (5.3) 952 (10.4)
High hyperopia ≥6D , % 72 (1.4) 18 (0.9) 17 (0.9) 107 (1.2)
     
Educational level     
Primary education , % 2798 (53.2) 651 (32.8) 522 (26.7) 3871 (43.2)
Intermediate education , % 1850 (35.2) 912 (46.0) 807 (41.3) 3569 (38.8)
Higher education, % 608 (11.6) 421 (21.2) 625 (32.0) 1654 (18.0)
     
Genetic risk     
Mean genetic risk score (±SD) 2.7±0.4 2.7±0.4 2.7±0.4 2.7±0.34
Low genetic risk score (1.40-2.25), % 463 (8.8) 173 (8.7) 164 (8.4) 800 (8.7)
          Mean N carried risk alleles (±SD) 17.7±1.4 17.6±1.4 17.6 (1.5) 17.7±1.4
Medium genetic risk score (2.25-3.00), % 3582 (68.2) 1364 (68.8) 1334 (68.3) 6280 (68.3)
          Mean N risk alleles (±SD) 22.7±1.9 22.8±2.0 22.7 (1.9) 22.8±1.9
High genetic risk (3.00-4.00) , % 1211 (23.0) 447 (22.5) 456 (23.3) 2114 (23.0)
          Mean N risk alleles (±SD) 27.7±1.7 27.7±1.7 27.7±1.7 27.7±1.7
Values are means ± standard deviation. 
SD, standard deviation; RS, Rotterdam Study; D; diopters.
based cohort study included a total of 5256 participants aged 55 years and older living in Ommoord, 
a suburb of Rotterdam, the Netherlands21. Baseline examinations took place between 1991 and 
1993. Two independent Rotterdam Study cohorts were combined into a replication cohort (Table 
1). The first cohort was Rotterdam Study II (RS-II), an independent cohort which included n = 1984 
participants aged 55+ years living in Ommoord since 200021. Baseline examinations took place 
between 2000 and 2002. The second cohort was Rotterdam Study III (RS-III), which included 
n = 1954 participants aged 45+ years and older living in Ommoord since 200621 .Baseline 
examinations took place between 2006 and 2009. 
Assessment of refractive error
All participants underwent a complete ophthalmological examination including a non-dilated 
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measurement of refractive error of both eyes using a Topcon RM-A2000 autorefractor. Refractive 
error was analyzed as spherical equivalent, calculated according to the standard formula ‘SE 
= sphere + ½ cylinder’. Mean refractive error was calculated; when data from one eye was 
unavailable, the SE of the other eye was used. Exclusion criteria were (bilateral) cataract surgery 
and laser refractive procedures without knowledge of prior refraction, other refraction influencing 
intra-ocular procedures, keratoconus, and syndromes. Refractive error was categorized into 
high myopia (≤ -6 diopters (D)), moderate myopia (>-6D & ≤-3D), low myopia (<-3D & ≤-0.75D), 
emmetropia (> -0.75D & <0.75D), low hyperopia (≥0.75D & <3D), medium hyperopia (≥ 3D & <6D), 
and high hyperopia (≥ 6D), using criteria defined by the CREAM consortium (CREAM consortium 
meeting, 2012, Sardinia, Italy). 
Assessment of educational level
Information on educational level was obtained during a home interview. Level of education was 
classified into: primary education (primary school or lower vocational education); intermediate 
education (lower secondary education or intermediate vocational education); and higher education 
(higher secondary education, vocational education, or university). 
Genotyping 
We selected all 26 genome-wide significant single nucleotide polymorphisms (SNPs) associated 
with refractive error and myopia derived from a meta-analysis from the CREAM consortium 
involving a total of 45,758 study subjects14. SNP genotyping and imputation have been described 
in detail elsewhere22. Genotyping was performed using the Illumina Infinium II HumanHap550 chip 
v3.0 array (RS-I); the HumanHap550 Duo Arrays and the Illumina Human610-Quad Arrays (RS-
II), and the Human 610 Quad Arrays Illumina (RS-III). For imputation, we used the Markov Chain 
Haplotyping (MACH) package version 1.0.15 software (imputed to plus strand of NCBI build 36, 
HapMap release #22, CEU panel). Most of the SNPs were genotyped or had a high imputation 
quality score (r2 ≥ 0.8). 
Genetic risk score
The genetic risk score was calculated based on all 26 SNPs using a previously reported weighting 
method14. Each SNP was weighted according to its relative effect size (β regression coefficient 
from CREAM meta-analysis, Supplementary Table 2). Genetic risk scores ranged from 1.4 to 4.0, 
with higher scores indicating a greater genetic predisposition to myopia. The genetic risk score 
was categorized into a low (1.4-2.25), medium (2.25-3.00) or high genetic load (3.00-4.00) based 
on the association with myopia (Supplementary Figure 1). We also calculated the number of risk 
alleles carried per individual (homozygote for the risk allele = 2 risk alleles, heterozygote = 1 risk 
allele, homozygote for the other allele = 0 risk alleles).
Statistical analysis
Separate analyses were performed for the discovery cohort (RS-I), the replication cohort (RS-II 
and RS-III combined), and for the cohorts combined (RS-I, RS-II, and RS-III). First, we assessed 
independent associations between education and refractive error and myopia, and genetic risk 
score and refractive error and myopia using linear and logistic regression. Second, we examined 
202
Education influences the role of genetics in myopiaChapter 4.2
the continuous relation between genetic risk score, level of education and refractive error by 
calculating mean refractive error and the regression coefficients β per genetic risk score category, 
stratified by level of education, and tested for significant differences between groups with a one 
way ANOVA F-test. Third, we assessed the risk of moderate to high myopia (refractive error ≤ -3.0 
D) versus moderate to high hyperopia (refractive error ≥ 3.0 D) for combined strata of genetic 
risk score and educational level with logistic regression analyses, using low genetic risk score 
and primary education as the reference, adjusting for age and sex. These analyses were also 
performed using moderate to high myopia (refractive error ≤ -3.0 D) versus emmetropia (refractive 
error > -0.75D & <0.75D) as the outcome.
We tested for biological interaction between genetic predisposition and education by calculating 
the age and sex adjusted synergy index (SI) according to Rothman20. This measures deviation 
from additivity of 2 factors, and is based on the ratio of the combined effect to the sum of the 
separate effects. A synergy index of more than 1.0 suggests that the effect of both factors together 
is greater than the sum of the effect of the separate factors. 
All reported P values are nominal and two-sided. We used SPSS version 20.0.0 (SPSS Inc.) for all 
analyses.
RESULTS
Demographics of the study participants in the discovery (RS-I) and in the replication (RS-II and 
RS-III combined) cohorts can be found in Table 1. In all cohorts, the majority of subjects were low 
hyperopic or emmetropic; the mean refractive error was 0.52 D (SD 2.54). Primary or intermediate 
educational level was most common, although its relative proportion was highest in the discovery 
cohort (RS-I) (Table 1). The genetic risk score ranged from 1.4 to 4.0 with a mean of 2.7 (SD 0.4), 
corresponding to a range of 12 to 35 carried risk alleles, and a mean of 23.4 (SD 3.3) risk alleles 
per subject. The genetic risk score had identical distributions across all cohorts (Table 1). Both 
educational level and the genetic risk score were significantly associated with refractive error and 
myopia (P<0.0001, Table 2). 
The continuous relation between genetic risk score and refractive error stratified by level of 
education for the combined cohorts is shown in Figure 1. Subjects who received a university 
or higher vocational education had a lower mean refractive error with increasing genetic risk 
than subjects with intermediate-level or primary education. These differences were statistically 
significant (βhigh education = -0.78; βintermediate = -0.53; βprimary = -0.47; P<0.0001 for both the discovery and 
replication cohorts). Among individuals with the highest genetic risk, the refractive error averaged 
-2 diopters for high educational level, -0.8 diopters for intermediate education, and 0 diopters or 
emmetropia for primary schooling. 
We then estimated the risk of myopia for the combined strata of genetic risk and educational 
level (Table 3, Figure 2). In both the discovery and replication cohorts, the risk of myopia among 
subjects with a high genetic risk score and high educational level was highly increased (ORcombined 
= 51.3; 95% CI: 18.5-142.6), and far higher than the sum of the risks among individuals with only 
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Table 2. Association with refractive error and risk of myopia for genetic risk score and level of 
education
 Refractive error Myopia
 n β se P-value n OR 95% CI P-value
Education         
    Discovery cohort (RS-I) 5256 -0.48 0.05 <0.0001 1092 2.3 1.9-2.8 <0.0001
    Replication cohort (RS-II & RS-III) 3938 -0.58 0.06 <0.0001 807 2.2 1.7-2.7 <0.0001
    Combined (RS-I, RS-II, RS-III) 9194 -0.55 0.04 <0.0001 1899 2.3 12.0-2.6 <0.0001
Genetic risk score         
    Discovery cohort (RS-I) 5256 -0.67 0.06 <0.0001 1092 2.4 1.9-3.1 <0.0001
    Replication cohort (RS-II & RS-III) 3938 -0.72 0.07 <0.0001 807 3.1 2.3-4.2 <0.0001
    Combined (RS-I, RS-II, RS-III) 9194 -0.69 0.05 <0.0001 1899 2.7 2.2-3.2 <0.0001
Beta regression coefficients of the association with refractive error were calculated using 
linear regression analyses. The risk of myopia (defined as refractive error ≤-3 diopters) were 
calculated using logistic regression analyses with hyperopia (defined as a refractive error ≥3 
diopters) as a reference. Analyses for education were corrected for age, sex, and genetic 
risk score. Analyses for the genetic risk score were corrected for age, sex, and education. 
β, beta regression coefficient in diopter; se, beta standard error; OR, odds ratio; 95% CI, 95% confidence 
interval; RS, Rotterdam Study.
one of these two factors (ORcombined for primary education = 6.1, 95% CI: 2.1-17.6.; ORcombined for 
high genetic risk = 7.2, 95% CI: 3.1-17.0). 
The synergy index according to Rothman20 was statistically significant in both the discovery cohort 
and the replication cohort (SIcombined = 4.2; 95% CI: 1.9-9.5), indicating a biological interaction 
(Table 3). 
Figure 1. Refractive error as a function of genetic risk score stratified by level of education
Mean refractive error was calculated for each genetic risk score category and presented according to 
educational level. Regression lines were plotted, and the regression coefficient (β) is indicated for each 
line. The data are shown for the combined cohort (including RS-I, RS-II, and RS-III). The differences 
between educational level groups were statistically significant (P<0.0001) for the discovery, replication 
and combined cohorts.
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The risks in the combined strata using myopia versus emmetropia as the outcome showed similar 
trends, however, ORs were lower in all strata and the synergy index did not reach statistical 
significance (Supplementary Table 1, Supplementary Figure 2). 
DISCUSSION
In two independent cohorts from the population-based Rotterdam Study, we found a significant 
biological interaction between education and genetic risk of myopia as represented by 26 
associated SNPs14. Subjects with high genetic risk in combination with high levels of education 
had a far higher risk of myopia than subjects with only one of these two factors. We observed this 
effect in both quantitative analyses with refractive error in diopters as a continuous outcome, as 
well as in qualitative analyses comparing the extreme ends of the physiological spectrum. The 
interaction effect of genetic predisposition and education on myopia risk was more than 4 times 
higher than the sum of the separate effects. 
Our study has specific strengths. First, the size of the combined study population and the 
frequency of exposures and outcomes were sufficiently high to detect a biological interaction. 
In addition, the interaction and the risk estimates were significant in the discovery cohort and 
were confirmed in the replication cohort, suggesting high reliability of these results. On the other 
hand, our study was limited by the rough approximations of the two risk factors (genetic risk and 
education level). Our genetic risk score was based on 26 myopia risk SNPs which were identified 
by the CREAM consortium, and of which 14 were also found by 23andMe15. The effect sizes of the 
Figure 2. Risk of myopia for educational level and genetic risk score
The age- and sex-adjusted odds ratio for myopia (defined as a refractive error ≤-3 diopters) versus 
hyperopia (defined as a refractive error ≥3 diopters) for educational level and genetic risk score are 
plotted for the combined cohort (including RS-I, RS-II, and RS-III). The group with low genetic risk and 
primary education served as the reference.
*, significant OR compared to the reference group; SI, synergy index; 95% CI, 95% confidence interval; 
OR , odds ratio; R, reference (i.e., OR = 1.0).
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remaining 8 23andMe top hits were very small (betas between 0.03 to 0.08), and incorporation of 
these SNPs did not change our findings. Nevertheless, more in-depth knowledge regarding the 
genetic background of myopia in the future will improve precision of the effect sizes. In addition, 
education may be an even stronger effect modifier when absolute years of education can be 
incorporated. Finally, we observed a cohort effect that merits mention. Subjects from the RS-I 
study (which covered the period 1991 through 1993 and included subjects age 55 years and 
older) generally had a lower educational level than subjects from the RS-III study (which covered 
the period from 2006 through 2009 and included subjects age 45+ years). However, because 
the interaction effect of education and genetic risk was detected independently in each of these 
cohorts, this cohort effect did not likely affect our findings. 
What mechanisms might underlie this strong interaction between education and genetic risk? 
Achieving higher levels of education requires more intensive near work. Several studies have 
reported that near work is directly related to the development of myopia by causing retinal 
defocus and degradation of retinal image contrast, which can subsequently trigger eye growth as 
a compensatory mechanism23-27. However, others point out that persons with a higher educational 
level are at risk of myopia because they spend less time outside28. Education may reflect a 
complex combination of these factors, ultimately leading to up-regulation of risk genes, excessive 
eye growth and development of myopia.
The 26 recently discovered SNPs are present in genes involved in various processes, including 
neurotransmission, ion channel function, extracellular matrix formation and stabilization, retinoic 
acid metabolism, and ocular development. As with gene-environment interactions described for 
other disorders29, it is unlikely that all of these genes contribute to the gene-education interaction 
in myopia. We hypothesize that neurotransmission-related genes that are expressed in the outer 
retina may be particularly vulnerable to the effect of retinal defocus, in contrast to developmental 
eye genes and genes involved in the extracellular matrix. A genome-wide analysis of SNP-
education interaction in a large study population might reveal the modifying effects of individual 
SNPs. 
Interestingly, a combined effect between near work and outdoor activity —a known protective 
factor against myopia—has also been reported28. In addition, several studies have reported that 
outdoor activity can counteract the increased risk from near work28,30,31. Whether this type of work 
can also reduce the risk of near work among individuals at high genetic risk is an interesting 
question that merits investigation.
Genetic research regarding myopia has traditionally been guided by the assumption that genes 
exert a direct effect on the trait. Our finding of a robust gene-environment interaction casts new 
light on the current evolutionary model and offers new opportunities to identify additional myopia 
genes. Working many hours at near work tasks appears to be the requisite trigger for eliciting 
strong gene effects, and once this condition is satisfied, the genes become highly penetrant. We 
recommend that the search for new myopia genes should focus on study participants who are 
selected based on exposure (i.e., subjects with a high level of education and/or intensive near 
work work). This approach can also be readily extended to the study of other complex disorders. 
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If environmental exposures show considerable variation within the study sample, genes might 
account for only a small percentage of the phenotypic variation. However, if these exposures have 
low variability among the study cohort, a disease that had previously been believed to arise from 
many small genetic effects might actually be caused by only a few genes, each of which exerts a 
relatively large effect.
Traditionally, analyzing gene-environment interactions has been extremely challenging, and this is 
primarily because the low relative frequencies of the exposures and/or trait have limited the study’s 
statistical power32. However, given that our analysis has overcome these limitations, this approach 
may serve as a textbook example of biological interactions between genes and the environment.
This epidemiological study provides evidence of gene-by-environment (GxE) interaction, in which 
an individual’s genetic risk of myopia is affected by his or her educational level. Subjects with 
many variants in myopia genes and a higher educational level (e.g. university) are much more 
susceptible to develop myopia than those with only one of these two factors. Education may reflect 
a complex combination of higher level of reading exposure and corresponding lower levels of 
outdoor physical activity, ultimately leading to up-regulation of risk genes, excessive eye growth 
and the development of myopia.
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ABSTRACT
Myopia is the most common human eye disorder with complex genetic and environmental 
causes. The recent rapid rise in myopia prevalence globally poses a major public health challenge. 
We hypothesized that integrating educational information and its potential interaction with genetic 
variants may facilitate the detection of susceptibility genes for myopia, thus accounting for a 
greater proportion of its heritability. We surveyed common genetic variants across the genome 
in 40,036 adults from 25 studies of European ancestry and 10,315 adults from 9 studies of Asian 
ancestry and performed a joint meta-analysis to test main and SNP × education interaction effects 
on refractive error. In European ancestry individuals and combined cohorts, six novel genetic 
loci (FAM150B, LINC00340, FBN1, DIS3L-MAP2K1, ARID2 and SLC14A2) associated with 
refractive error were identified (P < 5.0 x 10-8). In Asian populations, three genome-wide significant 
genetic variants highlighted genes AREG, GABRR1 and PDE10A (P < 5.0 x 10-8), all of which 
showed strong interactions with education (P < 8.5 x 10-5). In support of a role for GABRR1, its 
expression was found to be upregulated in sclera and retina in a mouse myopia model, implicating 
neurotransmitter GABA signaling in myopia development. The discovery of these novel loci 
represents an important advance in the understanding how gene and environment interactions 
contribute to the heterogeneity of myopia. 
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INTRODUCTION
Myopia, or nearsightedness, has rapidly emerged as a global health concern in the last three 
decades1. It is one of the leading causes of visual impairment, and it is associated with potentially 
blinding ocular complications including retinal detachment, myopic maculopathy, glaucoma and 
cataract2. Evidence from family and twin studies strongly supports the heritability of myopia3. 
Estimates for the heritability of the quantitative trait refractive error have been reported to be 
as high as 90%4. On the other hand, the rapid upsurge of myopia in the last few decades in 
many parts of the world is likely to be a consequence of lifestyle changes, such as the increasing 
educational intensity, particularly in urban East Asia5,6. 
Major attempts undertaken in genome-wide association studies (GWAS) to elucidate the genetic 
determination of myopia and refractive error have recently led to the discovery of more than 
30 distinct susceptibility loci7,8. Nevertheless, collectively these genetic variants explain only 5% 
of phenotypic variance8. As myopia is a result of the combination of genetic and environmental 
factors, interplay between genes and environment may account for a substantial proportion of 
the phenotypic variance9. Recently, we showed biological interactions between education and 
genetic risk score of myopia derived from 26 known GWAS SNPs in the Rotterdam Study10; the 
combined effect of genetic predisposition and education on the risk of myopia was substantially 
greater than anticipated from a simple sum of these two factors. At a gene level, a few genes, such 
as DNAH9 which modulates neurotransmission between retinal cells, have been shown to interact 
with education level and exhibit strong genetic effects for myopia among Asians of at least higher 
secondary education11. In the current study, we hypothesized that genes implicated in myopia 
development may be uncovered by taking into account the potential interaction between genetic 
variants and education level. 
In the context of the etiology of refractive errors, education level has largely been considered 
a surrogate measure for accumulated near work activity1. When viewing near objects, the eye 
generates extra optical power through the process of accommodation to focus the image on the 
on the retinal plane to maintain clear vision12. The retina has a central role in the mechanism 
linking such visual input with eye growth and refractive development13. Several neurotransmitters 
or moleculars have long been implicated in this process from animal studies including dopamine, 
acetylcholine, vasoactive intestinal peptide (VIP), gamma-aminobutyric acid (GABA) and 
glucagon14,15. However, an organized framework for the retinal signaling mechanisms underlying 
refractive error development under various environmental conditions remains to be elucidated.
Accounting for differences in environmental exposures may enhance power for the detection of 
genes, especially in circumstances where a genetic locus has a differential effect conditional on 
specific environment exposures16,17. Gene-environment-wide interaction studies (GEWIS) using a 
joint meta-analysis approach on SNP effects and SNP x environment interactions have recently 
been described18,19. This approach has proven successful in identifying six novel loci associated 
with fasting insulin and glucose accounting for interactions with body mass index19. It also led to 
the identification of two novel loci for pulmonary function that did not emerge from analyses based 
on the genetic main effects alone20. The well-documented effects of educational attainment on 
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myopia and refractive error make the proposed interaction an excellent analytical candidate for 
the GEWIS.
Availability of large-scale GWAS datasets on spherical equivalent from the Consortium for 
Refractive Errors And Myopia (CREAM) makes gene and environment (G × E) interaction analyses 
feasible. To identify additional genetic variants for refractive error, we performed GEWIS approach 
comprising 40,036 adults from 25 studies of European ancestry and 10,315 adults from 9 studies 
of Asian ancestry in the CREAM. Furthermore, we validated the relative over-expression of gamma-
aminobutyric acid (GABA) receptor GABRR1 in the retina and scleral tissues in myopic eyes in a 
mouse model.
MATERIAL AND METHODS
Study populations
From the Consortium of Refractive Error and Myopia (CREAM), A total of 34 studies comprising 
40,036 individuals of European ancestry from 25 studies and 10,315 individuals of Asian ancestry 
from 9 studies were included for this analysis (Table 1; Supplementary Table 1-2). Individuals 
aged less than 20 years were excluded, as well as those who had undergone cataract surgery, 
laser or other intra-ocular procedures that could alter refraction. Many of these studies were also 
included in the previous CREAM GWAS on spherical equivalent8. All studies adhered to the tenets 
of the Declaration of Helsinki and were approved by their local research ethics committees. All 
participants provided a signed, informed consent before the start of the study.
Phenotyping and education levels
Participants in the included studies underwent an ophthalmological examination (Supplementary 
Table 1). Non-dilated refraction was measured by auto-refraction and/or subjective refraction. 
Spherical equivalent was calculated as the sphere power plus half of the cylinder power for each 
eye. The mean spherical equivalent of the right and left eyes was used as a quantitative outcome. 
When data from only one eye was available, the spherical equivalent of that eye was used. For 
education, subjects reported the highest level of education achieved, or the years of schooling 
through a self-reported questionnaire or in an interview. 
We dichotomized education for all participants. The higher education group consisted of those who 
had completed at least higher secondary education, gained a polytechnical school certification, 
or with ≥ 12 years spent in formal education.  The lower education group included individuals who 
had only completed lower secondary education or less, or with < 12 years of formal education. 
For four cohorts of relatively young European participants (BATS, DCCT, RAINE and WESDR; total 
sample size of 2,349), almost all of them had completed 12 or more years of schooling. We thus 
chose to categorize individuals with tertiary or university education as the higher education group 
in these studies. Sensitivity analysis excluding these four cohorts did not appreciably change our 
meta-analysis results (data not shown). 
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Genotyping and imputation
Detailed information on the genotyping platforms and data cleaning procedures for each study is 
provided in Supplementary Table 2. Each study applied stringent quality control filters for GWAS. 
In general, individuals reflecting duplicates, low call rate (< 95%), gender mismatch, or population 
outliers were excluded. SNPs were excluded if low genotyping call rate (> 5% missingness), 
monomorphic SNPs, with MAF < 1%, or in Hardy-Weinberg disequilibrium (p-value < 10-6). After 
quality control (QC) filtering, the array genotypes of each study were imputed using the 1000 
Genomes Project data21 as reference panels (build 37, phase 1 release, March 2012) with the 
software Minimac22 or IMPUTE23 (Supplementary Table 2). SNPs which passed imputation quality 
thresholds (MACH: r2 > 0.5 or IMPUTE info score > 0.5) and with minor allele frequency ≥ 5% were 
eligible for the meta-analysis. 
Statistical models
For each study, a linear regression model at each genotyped or imputed SNP was constructed 
with the mean spherical equivalent as the outcome. We assumed an additive genetic model where 
the number of risk alleles is an ordinal variable (0, 1 and 2) for directly genotyped SNPs, or a 
continuous variable of allele dosage probability ranging from 0 to 2 for imputed SNPs. The primary 
analytic model included SNP, education, a SNP × education interaction term, as well as age and 
sex as covariates. Additional adjustments for the top principal components of genomic marker 
variations were performed in individual studies when applicable (i.e., when there was evidence of 
population stratification). 
We used the following additive genetic model to test for a joint effect of SNP (βSNP) and SNP x 
education interaction (βSNP × education) on mean spherical equivalent: Y = β0 + βSNP × SNP + βeducation × 
Education + βSNP × education × SNP × Education + βC × Cov + ε (Model 1), where Y is the mean spherical 
equivalent, education is a dichotomous variable (0 = lower education group and 1 = higher 
education group); cov is a set of covariates such as age, sex and first top five principal components 
when applicable. For family-based studies, the kinship matrix was estimated empirically from the 
SNP data and included as a random effect in the generalized mixed model24. To test an effect of 
SNP x education interaction, we assessed βSNP × education from Model 1. 
The linear regression analyses in each study were conducted with Quickest (http://toby.freeshell.
org/software/quicktest.shtml) or ProbABEL25 for the unrelated samples, and MixABEL24 for family-
based data. The command ‘robust’ was used in the above software to calculate the robust 
(‘sandwich’, Huber-White) standard errors of βSNP and βSNP × education , and error covariance of βs, to 
correct the potential inflation of false positive rate for the interaction p-value26. 
In addition, each study also tested the main effect of education on spherical equivalent by adjusting 
for age and gender using the linear regression model: Y = β0 + βeducation × education + βC × Cov + ε 
(Model 2), where the definition of variable is the same as in Model 1.
GEWIS join meta-analyses
We adopted the joint meta-analysis (JMA) approach18,27 to simultaneously test both main SNP 
effects and SNP × education interactions for spherical equivalent with a fixed-effect model, using 
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SNP and SNP × education regression coefficients and a betas’ covariance matrix from each study. 
A Wald statistic, following a chi-square distribution with two degrees of freedom, was used to 
test the joint significance of the SNP and SNP × education regression coefficients. The JMA was 
performed with METAL28, using a script patch provided by Manning et al27. A Cochran’s Q test was 
used to assess heterogeneity of the beta coefficients across studies for the SNP and interaction 
effects. To test for interaction between the SNP and education, we conducted a secondary 
meta-analysis of the SNP × education interaction effects for spherical equivalent (one degree of 
freedom) with a fixed-effects model using inverse-variance weighting in METAL; this is a traditional 
meta-analysis to investigate SNP × education interactions per se. Effects and standard error of the 
SNP (βSNP) on spherical equivalent in the lower education group and higher education (βSNP + βSNP × 
education) were derived from the JMA output27.
We performed a meta-regression to explore sources of heterogeneity in our meta-analysis for three 
loci showing G x E interactions (R package ‘metafor’). Meta-regression included the following 
study-specific variables as covariates: study sample size, proportion of individuals in the higher 
education group, average spherical equivalent, education main effects, ethnicity, study design, 
study year, and average age.  Meta-regression was also conducted to test the fold-changes of the 
interaction beta coefficients in Asians versus Europeans for the 39 known myopia loci.    
The study-specific genomic control inflation factors lgc for the joint test for SNP and interaction 
term ranged from 1.009 to 1.125 with an average of 1.019 (Supplementary Table 2), calculated by 
the ratio of the observed median chi-square divided the expected median of the 2df chi-square 
distribution (1.382). Genomic control (GC) correction was applied to chi-square statistics in each 
individual study29. For three studies of small sample sizes (N < 500) and lgc greater than 1, we 
further, prior to starting the meta-analysis, excluded SNPs showing significant joint P value < 
1 x 10-5 but neither the main effects nor the interaction effects supporting such an association. 
Quantile-quantile (QQ) plots of the p-values showed only modest inflation of the test statistics in 
the JMA test (Europeans: lgc = 1.081; Asians: l gc = 1.053; Combined: lgc = 1.092; Supplementary 
Figure 1), similar to previous GEWIS studies with comparable sample sizes19,20. We excluded a 
small number of markers in the meta-analysis with PHET < 0.0001. The lgc for the SNP x education 
interaction term in the individual studies ranged from 1.01 to 1.08, indicating little evidence of test 
statistic inflation for each study. 
Annotation of genetic variants
The coordinates and variant identifiers are reported on the NCBI B37 (hg19) genome build, and 
annotated using UCSC Genome Browser30. We identified variants within each of the linkage 
disequilibrium (LD) blocks (r2 ≥  0.8) in European and Asian populations of the 1000 Genomes 
Project (100 Kb flanking the top SNP; hg19) to apply functional annotations with experimental 
evidence of transcription regulation using HaploReg31 and Encyclopedia of DNA Elements 
(ENCODE)32 data. 
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Animal procedures
Differential gene expression
We further evaluated gene expression of GABRR1 using a mouse model of myopia. Experimental 
myopia was induced in B6 wild-type (WT) mice (n = 36) by applying a -15.00 D spectacle lens 
to the right eye (experimental eye) for 6 weeks from post-natal day 1033,28. The left eyes were 
uncovered and served as contra-lateral controls. Age-matched naive mice eyes were used as 
independent control eyes (n = 18). Each eye was refracted weekly using an automated infrared 
photo refractor as described previously29. Animal study approval was obtained from the SingHealth 
Institutional Animal Care and Use Committee (AAALAC accredited). All procedures performed in 
this study complied with the Association of Research in Vision and Ophthalmology Statement for 
the Use of Animals in Ophthalmology and Vision Research.
Eyes were enucleated after six weeks of myopia induction and retina was carefully dissected 
out. RNA extraction, real-time polymerase chain reaction (qRT-PCR) methods, and analysis were 
followed as described previously28. qRT-PCR primers were designed with ProbeFinder 2.45 
(Roche Applied Science) and performed with a Lightcycler 480 Probe Master (Roche Applied 
Science). The primer sequences were as follows: GABRR1 Forward: tgcctgctagagtcccctta and 
Reverse: ccgtgatgatggtggacat. The experiments were repeated in triplicate. Mean values from 
the triplicates were used in the statistical analysis. Student’s t-test was performed to determine the 
significance of the relative fold difference of mRNA between the myopic eyes of the experimental 
mice and the age-matched controls. 
Immunohistochemistry and Western blot
Protein expression and localization were assessed by immunohistochemistry and Western blot. 
Whole mouse eyes (n = 6) were enucleated and embedded in Optimal Cutting Temperature 
compound at -20 o C for 1 hour. Six-micron sections were cut with a cryostat (HYRAX C 50, Carl 
Zeiss Microimaging GmbH, Germany) and collected on POLYSINETM microscope glass slides 
(Gerhard Menzel, Thermo Fisher Scientific, Newington, CT). Sections were air dried at room 
temperature for 1 hour. The procedure for immunofluorescence staining has been described 
previously28. Immunofluorescent staining using specific antibodies for GABRR1 (Ab85667; Abcam 
[Cambridge, MA, USA]) was carried out in the mouse myopic retina, choroid and scleral tissues to 
study the localization of these proteins. Sections incubated with 4% BSA without primary antibody 
were utilized as negative controls. A fluorescence microscope (Axioplan 2; Carl Zeiss Meditec 
GmbH, Oberkochen, Germany) was used to examine the slides to capture image. Experiments 
were repeated in duplicate from two batches (3 eyes per batch). We performed a western blot on 
retinal samples to quantify the protein expression in myopic eyes and naive control eyes. Protein 
extraction and quantification was carried-out as described previously28. 
Gene expression in human tissues GWAS Meta-analyses and SNP functional annotation
To assess gene expression in human tissues, we examined the Ocular Tissue Database and the 
EyeSAGE database34,35. The estimated gene and exome level abundances are available online 
(https://genome.uiowa.edu/otdb). Normalization of gene expression used the Probe Logarithmic 
Intensity Error (PLIER) method with GC-background correction34.
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RESULTS
Educational level and its main effects on spherical equivalent 
Baseline characteristics of 50,351 participants from 34 studies in our meta-analysis are shown in 
Table 1. A total of 40,036 of subjects were of European ancestry and 10,315 were of Asian ancestry; 
the age of the participants ranged from 20 to 99 years. Among Europeans, the proportions of 
participants who completed higher secondary education ranged from 16.0% (FITSA and OGP 
Talana) to 94.4% (AREDS) with an average of 50.7% (Supplementary Table 1). In Asians, the 
proportions of individuals who completed higher secondary education ranged from 6.7% (SiMES) 
to 75.9% (Nagahama) with an average of 30.0%. Across all studies, individuals in the higher 
education group had a spherical equivalent refractive error that was on average 0.59 diopters 
(D) more myopic, or less hyperopic, compared to those in the lower education group (β = -0.59; 
95% CI: -0.64, -0.55). High education level was associated with a two-fold more myopic spherical 
equivalent in individuals of Asian as compared to European ancestry (Asians: β = -1.09, 95% CI: 
-1.20, -0.98; Europeans: β = -0.49, 95% CI: -0.54, -0.44; Figure 1).  
GEWIS in Europeans 
The genome-wide joint meta-analysis (JMA) for SNP main effect and SNP × education interaction 
in 40,036 European Ancestry individuals showed association with spherical equivalent at 12 
previously implicated loci (Figure 2A  & Supplementary Table 3). We also identified 4 previously 
unreported loci associated with spherical equivalent achieving genome-wide significance (PJMA 
< 5.0 × 10-8; Phet ≥ 0.086; Table 2): FAM150B, LINC00340, FBN1, and DIS3L-MAP2K1. Two of 
them (FAM150B and DIS3L-MAP2K1) were replicated in Asians (PJMA < 0.05; refer to the following 
section). The significant association for JMA test at these loci in Europeans was primarily driven 
by SNP effects in both lower and higher education strata (4.40 × 10-8 ≤ P ≤ 1.35 × 10-6, 7.61 × 10-11 
≤ P ≤ 1.75 × 10-6, respectively). SNP x education interaction was not significant (Pint ≥ 0.208). The 
estimated effect sizes of SNP effects on spherical equivalent were highly similar across education 
strata. 
GEWIS in Asians 
The JMA for spherical equivalent in 10,315 individuals from the Asians cohorts identified genome-
wide significant association for three genes: AREG, GABRR1 and PDE10A (PJMA < 5.0 × 10-8; Table 
3 & Figure 2B). SNP x education interaction effects associated with spherical equivalent were 
observed at all three loci, with genetic effects significantly larger within subjects who had a higher 
level of education compared with those with a lower education level: AREG (rs12511037, βint = 
-0.89 ± 0.14 D; Pint = 6.87 x 10-11), GABRR1 (rs13215566, βint = -0.56 ± 0.14 D; Pint = 8.48 x 10-5) 
and PDE10A (rs12206610, βint = -0.72 ± 0.13 D; Pint = 2.32 x 10-8). The genotype and phenotype 
associations were highly significant in the higher education stratum (main genetic effects 1.97 × 
10-10 ≤ P ≤ 8.16 × 10-8) but were considerably weaker in the lower education stratum (0.008 ≤ P ≤ 
0.243). There was no evidence of inter-study heterogeneity at index SNPs within AREG, GABRR1 
or PDE10A (Q test: Phet ≥ 0.122). 
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Table 1. Characteristics of study participants
Study N Study year Age (SD)  Age range Male (%) Spherical 
Equivalent
Europeans (n=40,036)
ALIENOR 509 2006 - 2008 79.2 (4.1) 73 - 93 43.2 0.98 (1.98)
ALSPAC 1865 1999 - 2000 45.9 (4.5) 32 - 59 0 -0.76 (2.16)
AREDS 1842 1992 68.1 (4.7) 55 - 81 41.0 0.54 (2.15)
BATS 383 1992 - 2013 24.8 (7.8) 20 - 67 41.3 -0.67 (1.58)
BMES 1896 1992 - 2009 66.8 (8.9) 49 - 94 43.8 0.58 (1.94)
CROATIA-Korcula 807 2007 - 2008 56.2 (13.3) 25 - 94 34.9 -0.13 (1.59)
CROATIA-Split 787 2008 - 2009 51.9 (13.0) 25 - 80 38.6 -1.27 (1.59)
DCCT 1057 1982 - 1993 35.4 (5.8) 25 - 49 54.1 -1.47 (1.80)
EGCUT 904 2002 - 2013 56 (17.0) 25 - 99 38.8 0.33 (3.36)
EPIC 1083 2004 - 2011 68.8 (7.5) 50 - 88 43.8 0.34 (2.27)
ERF 2604 2002 - 2005 48.9 (14.4) 25 - 87 45.0 0.12 (2.03)
FES 2479 1973 - 1975 
/1989 - 1991
54.8 (9.3) 28 - 84 55.3 0.27 (2.37)
FITSA 188 2000 - 2001 68.5 (3.3) 63 - 76 0.0 1.44 (2.08)
GHS1 3178 2007 - 2008 55.3 (10.9) 35 - 74 50.4 -0.38 (2.47)
GHS2 1354 2008 54.6 (10.8) 36 - 74 49.6 -0.39 (2.51)
KORA 2326 2004 - 2006 55.1 (11.8) 35 - 84 49.4 -0.26 (2.18)
OGP Talana 456 2002 52.6 (16.3) 25 - 89 57.3 -0.20 (0.24)
ORCADES 1124 2009 56.5 (13.2) 29 - 92 39.1 0.10 (2.07)
RAINE 348 2010 - 2012 20.4 (0.34) 20 - 22 49.1 0.03 (1.29)
RS-I 5702 1991 - 1993 68.7 (8.7) 55 - 99 41.0 0.83 (2.55)
RS-II 2021 2000 - 2002 64.3 (7.9) 55 - 95 46.0 0.48 (2.51)
RS-III 2918 2006 - 2009 56.9 (6.6) 45 - 86 44.0 -0.28 (2.60)
TwinsUK 2154 1998 - 2010 53.8 (11.4) 25 - 84 8.4 -0.96 (2.78)
WESDR 561 1979 - 2007 31.7 (7.0) 25 - 65 50.3 -1.65 (2.07)
YFS 1490 2011 41.9 (5.0) 34 - 49 44.6 -1.09 (2.16)
Asians (n=10,315)
BES 589 2006 - 2011 62.1 (8.5) 50 - 90 34.0 -0.06 (1.86)
Nagahama 723 2008 - 2010 49.2 (15.2) 30 - 74 33.6 -1.93 (2.46)
SCES I 1710 2009 - 2011 57.5 (7.0) 44 - 84 51.6 -0.72 (2.69)
SCES II 543 2011 - 2012 59.3 (8.9) 46 - 83 51.2 -0.89 (2.74)
SiMES 2256 2004 - 2006 46.8 (10.2) 40 - 80 49.1 -0.03 (1.81)
SINDI 2088 2007 - 2009 55.8 (8.8) 43 - 84 51.5 0.04 (2.07)
SP2-1M 811 1992 - 1998 46.8 (10.2) 25 - 80 62.3 -1.80 (2.84)
SP2-610 854 1992 - 1998 48.4(11.3) 25 - 82 19.6 -1.44 (2.89)
STARS 741 2007 - 2009 38.5 (5.2) 26 - 58 52.4 -2.80 (2.85)
ALIENOR, Antioxydants, Lipids Essentiels, Nutrition et maladies OculaiRes; ALSPAC, Avon Longitudinal Study of 
Parents and Children; AREDS, Age-Related Eye Disease Study; BATS, Brisbane Adolescent Twins Study; BMES, Blue 
Mountains Eye Study;  DCCT, Diabetes Control and Complications Trial; EGCUT, Estonian Genome Center, University 
of Tartu; EPIC, EPIC-Norfolk Eye Study; ERF, Erasmus Rucphen Family Study; FES, Framingham Eye Study; FITSA, 
Finnish Twin Study on Aging; GHS, Gutenberg Health Study; KORA, Cooperative Health Research in the Region of 
Augsburg;  OGP Talana, Ogliastra Genetic Park, Talana study; ORCADES, Orkney Complex Disease Study;  RAINE, 
RAINE Eye Health Study; RS, Rotterdam Study; TwinsUK, Twins UK study; WESDR, Wisconsin Epidemiologic Study 
of Diabetic Retinopathy; YFS, Young Finns Study; BES, Beijing Eye Study; SCES, Singapore Chinese Eye Study 
Singapore; SiMES, Singapore Malay Eye Study; SINDI, Singapore Indian Eye Study; SP2, Singapore Prospective Study 
Program; STARS, Strabismus, Amblyopia, and Refractive Error Study of Preschool Children; SD, standard deviation.; 
Age is in years; SD, standard deviation.
220
GEWIS on spherical equivalent in CREAMChapter 4.3
GABRR1 and PDE10A index SNPs were not associated with spherical equivalent in European 
samples, for either the JMA test, SNP effect, or SNP  education interaction (Table 3). AREG SNP 
rs12511037 was excluded in the meta-analysis of European studies after quality control filtering 
(due to MAF < 0.05), hence a proxy SNP, rs1246413, in LD with rs12511037 (r2 = 0.67, D’ = 
1) was tested, whereas insignificant association (PJMA = 0.527; P for interaction = 0.176). The 
meta-regression including study-level characteristics as covariates in the model confirmed 
the heterogeneity between populations of European and Asian ancestry (GABRR1: P = 0.006; 
PDE10A: P = 0.0419; Supplementary Table 4). For PDE10A, besides ethnicity, average spherical 
equivalent of each study also explained the inter-study heterogeneity for the interaction effects (P 
= 0.025). 
We examined whether the underlying assumption of G x E independence held at these three G x E 
interaction loci. We performed a meta-analysis of logistic regression analysis for education level on 
AREG SNP rs12511037, GABRR1 SNP rs13215566 and PDE10A SNP rs12296610, adjusting for 
age, gender and population stratification in the Singapore cohorts (n = 9,004). Our analysis did not 
reveal any significant associations between these loci and education level (P ≥ 0.200, Phet ≥ 0.118; 
Supplementary Table 5). Furthermore, the three loci were also not associated with educational 
attainment in a large meta-analysis of GWAS recently conducted in European cohorts36. Thus, our 
G x E results are unlikely to be biased due to dependence between gene and education37.
Figure 1. Forest plot of the main effect of education on spherical equivalent across studies
The beta coefficient represents the differences of diopters in refractive error comparing individuals in 
higher education group versus lower education group. The studies are sorted by effect size of education 
on spherical equivalent within Europeans and Asians studies
                                          β  [95% CI] 
All:                         -0.59 [-0.64, -0.55] 
Europeans:          -0.49 [-0.54, -0.44] 
Asians:                  -1.09 [-1.20, -0.98] 
Europeans 
Asians 
Beta coefficient (β) 
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We also evaluated the association for spherical equivalent in Asian cohorts for four loci identified 
from European populations. Two of them were replicated (FAM150B: PJMA = 0.013; DIS3L-
MAP2K1: PJMA = 0.0042; Table 2). DIS3L-MAP2K1 also showed suggestive SNP × education 
interaction in Asians (Pint = 7.95 x 10-4), while this was not significant in Europeans (Pint = 0.208).  
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LINC00340 
KCNQ5 
LAMA2 
TOX 
TJP2 RDH5 
SIX6 
GJD2 
ARID2 
FBN1 
DIS3L-MAP2K1 
A2BP1 
DNAH9 
KCNJ2 
SLC14A2 
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Figure 2. Manhattan plots of –log10(P) for the Joint meta-analysis on SNP and SNP x education 
effects on spherical equivalent in A. Europeans and B. Asians
Manhattan plots of –log10(P) for the Joint meta-analysis on SNP and SNP x education effects on spherical 
equivalent in A. European Ancestry populations and B. Asian population. The horizontal red line indicates 
the genome-wide significance level of p < 5 x 10-8. The horizontal blue line indicates the suggestive 
significance level of p < 1 x 10-5. Novel loci reaching genome-wide significance are labeled in red, and 
known loci are in grey.
A. Europeans
B. Asians
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GEWIS of all cohorts
We subsequently conducted a combined meta-analysis, including both the European and Asian 
subjects of all 34 studies. This analysis revealed two additional SNPs: ARID2 (PJMA = 4.38 × 10-
8) and SLC14A2 (PJMA = 2.54 × 10-8). Both loci showed suggestive association with spherical 
equivalent in European cohorts, while the association was attenuated in Asian cohorts (Table 2). 
We also detected genome-wide significant associations with spherical equivalent for 17 known 
loci8 identified in our previous CREAM GWAS (Supplementary Table 3). The regional plots of the 
identified novel loci are presented in Supplementary Figure 2. 
Gene and education interactions for GWAS known loci
For the previously reported genetic association with spherical equivalent at 39 loci identified from 
recent two large GWAS7,8, we evaluated their interactions with education. Two SNP x education 
interactions were nominally significant (Supplementary Table 6): TJP2 in Europeans (rs11145488; 
Pint = 6.91 x 10-3) and SHISA6-DNAH9 in Asians (rs2969180; Pint = 4.02 x 10-3). In general, the index 
SNPs tested at 39 loci had larger SNP x education interaction effect on spherical equivalent in 
Asians versus Europeans (meta-regression P for fold changes < 0.001; Supplementary Figure 3). 
For 20 SNPs with the same direction of the interaction effect, the magnitudes of interaction effects 
were 4-fold larger on average in Asians than in Europeans (P = 0.003). 
Gene and near work interactions for three identified loci
High-level education may reflect an estimator for the greater accumulative effect of near work38,39. 
We thus examined whether there was evidence for SNP x near work interactions associated with 
spherical equivalent at the three newly-identified loci (AREG, GABRR1 and PDE10A) in pediatric 
cohorts (SCORM, Guangzhou Twins, and ALSPAC; combined n = 5,835; Supplementary Table 7). 
Tentative support for a SNP x near work interaction was observed for PDE10A (rs12206610; Pint = 
0.032; Phet = 0.927), with the stronger genetic effect in children spending more hours on reading, 
writing or compute use. Weaker support for an interaction was noted at GABRR1 (rs13215566; 
Pint = 0.109; Phet = 0.655), although the direction of meta-analyzed interaction effect was largely 
consistent across pediatric studies with that observed in adults. We did not observe the interaction 
at AREG (rs12511037: Pint = 0.795, Phet = 0.062). 
Gene expression in human tissues 
Using Ocular Tissue Database34, we examined the expression of the associated genes in 20 
normal human donor eyes. The majority of genes identified were expressed in human retina, sclera 
or retinal pigment epithelium (RPE) (Supplementary Table 8). Among these genes, GABRR1 had 
the highest expression in the retina. The PLIER normalized mRNA expression level of GABRR1 in 
the retina was 121.7 with an expression value of 21.5 in the sclera, suggesting GABRR1 mRNA 
is more abundant within the retina. FAM150B mRNA was found highly present in the choroid/RPE 
(expression value of 333.3), while expressed at a much lower level in the retina (29.9). MAP2K1 
was widely expressed in the retina, sclera and choroid with expression values greater than 85.7.  
Gene expression of GABRR1 and protein location in mouse ocular tissues
GABA is one of the major inhibitory neurotransmitters in the retina and GABRR1 encodes the 
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GABA A receptor40. Given that receptors are attractive targets for therapeutic drugs and that GABA 
has been shown previously to modulate synaptic plasticity in the mammalian nervous system41, 
we examined GABRR1 gene expression in ocular tissues from myopic (spherical equivalent < 
-5.00 D) mouse eyes compared with age-matched control eyes (Figure 3A). At the mRNA level, 
GABRR1 was significantly up-regulated in myopic retina (1.82 fold; P = 0.012) when compared to 
naive controls. By Western blot analysis, retinal GABRR1 protein levels were also up-regulated in 
myopic versus naive control eyes (P = 0.025; Figure 3B). 
Figure 3. Differential gene expression, protein levels and immunofluorescent labeling of GABRR1 
in mice ocular tissues. A. Gene expression levels of GABRR1 in the retina in lens-induced myopic 
and naïve control eyes. B. Protein levels of GABRR1 in the retina in lens-induced myopic and naïve 
control eyes. Beta-tubulin was used as a loading control. Western blot analysis of GABRR1 protein eyes 
showed a pattern of protein expression similar to that of immunohistochemistry analysis. Data represent 
the mean ± SD; Significance level P≤0.05. C. Immunofluorescent labeling of GABRR1 in lens-induced 
myopic eyes, contra-lateral controls, and naive controls in mice. The fluorescence intensity labeled of 
the green color shows the localization of proteins, and blue color indicates the nuclei that were stained 
with DAPI. The following abbreviations represent the retinal layers: NFL, nerve fiber layer; GCL, ganglion 
cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer 
nuclear layer; PRL, photo receptor layer and RPE, retinal pigment epithelium. n = 3 eyes per group and 
repeated in duplicates. Sections incubated with 4% BSA without primary antibody were utilized as a 
negative contol.
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Additionally, we performed immunofluorescent staining in the mouse myopic retina, choroid and 
sclera tissue samples to study the localization of GABRR1 protein. GABRR1 protein was present in 
both the inner and outer retina of all the myopic and contra-lateral fellow eyes and naive controls 
(Figure 3C). There was higher expression of GABRR1 in the outer retina especially in both photo-
receptor layer (PRL) and retinal pigment epithelium (RPE) layers compared to fellow eyes and 
naive controls.
DISCUSSION
This study represents the most comprehensive genome-wide scan of gene and education 
interactions to date for refractive error. Here we identified novel genetic loci associated with 
refractive error by testing the joint contribution of SNP and SNP x education effects in large multi-
ethnic populations. Three loci (AREG, GABRR1 and PDE10A) showed strong interactions with 
education in populations of Asian descent, with larger genetic effects within subjects who had 
a higher level of education compared with those with a lower education level; no interactions 
achieved statistical significance in Europeans for top JMA associations or known myopic loci. 
Apart from confirming known associations at 17 previous published loci, we identified six new 
loci (FAM150B, LINC00340, FBN1, DIS3L-MAP2K1, ARID2 and SLC14A2) significantly associated 
with spherical equivalent using the combined multiracial cohort.
Of the novel loci, GABRR1 on chromosome 6q15 (53 kb) is an interesting functional candidate 
suggestive of a role in myopia development. Modulation of synaptic plasticity via GABA-mediated 
inhibition would be well-placed to alter the “gain” of the visually-guided feedback system controlling 
refractive development42. The lead SNP rs12215566 in GABRR1, together with 7 SNPs within the 
LD block (r2 ≥ 0.8), are intronic potentially affecting regulatory motifs (such as zfp128 and gcm1) 
which may influence transcriptional regulation. As one of the major inhibitory neurotransmitters 
in the retina, GABA is active in large retinal cells and amacrine cells14. Stone and colleagues 
have reported that antagonists to GABA A, B, and C receptors inhibited form-deprivation myopia 
in chicks, with greatest effect in the equatorial dimension43. GABA receptors also interact with 
dopamine pathways in the retina44. A recent proteomics study determined that levels of GABA 
transporter-1 (GAT-1) are significantly reduced in myopic murine retina after atropine treatment, 
implying that GABA signaling is involved in anti-myopic effects of atropine45. Therefore, our 
result in humans is in line with animal experiments, supporting the notion that the GABAergic 
neurotransmitter signaling pathway in the retina could be a potential player in the progression of 
myopia.
The rs10889855 on chromosome 6 is an intronic variant within the ARID2 gene (AT Rich Interactive 
Domain 2) and about 500kb downstream of SNAT1 (Solute Carrier Family 38, Member; Aliases 
SLC38A1). SNAT1 is a transporter of glutamine, a precursor of GABA46. It is also highly expressed 
in human retina. In our previous meta-analysis in CREAM8, we identified variants in another 
glutamate receptor gene GRIA4 (encoding glutamate receptor, ionotropic); altogether current 
evidence supports the notion that retinal neurotransmitters GABA and glutamine may be involved 
in the refractive development. 
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The strongest association signal for gene and environment interactions was from rs12511037, 
located 14 kb downstream the AREG gene (amphiregulin). AREG is a ligand of the epidermal 
growth factor receptor (EGFR) promoting the growth of normal epithelial cells, which is critical 
for cell differentiation and proliferation such as regrowth of the wounded cornea47. A link has 
been found between the muscarinic acetylcholine receptors and the EGFR, as EGFR controls fluid 
secretion in muscarinic system48,49. 
Another novel association, rs16949788 on chromosome 15, derives from a region that spans DIS3L 
and MAP2K1. MAP2K1 encodes mitogen-activated protein kinase 1 which binds to muscarinic 
receptors during proliferation50 and inhibits the proliferation of human scleral fibroblasts exposed 
to all-trans retinoic acid51. All-trans retinoic acid is a modulator of ocular growth, inhibiting the 
proliferation of human scleral fibroblasts52. 
FBN1 (Fibrillin 1) encodes a large extracellular matrix glycoprotein, a member of the fibrillin 
family. Mutations in FBN1 cause Marfan’s syndrome, a disorder of connective tissue affecting 
the ocular, skeletal and cardiovascular systems53. As a candidate gene for myopia, attempts to 
study its association with myopia previously produced inconclusive results54,55, probably due, in 
part, to underpowered studies with insufficient sample sizes. Using data from a large multi-ethnic 
population, our results support the role of FBN1 in myopia development. 
The risk alleles of rs12511037 in AREG, rs1321556 in GABRR1, rs12206610 in PDE10A had no or 
weak influence on myopic shift in the lower education group compared to the higher education 
group. This suggests that the hereditary predisposition to myopia could be latent for the risk allele 
carriers, if they are less exposed to the myopiagenic environment associated with high-level 
education. A lack of strong SNP x near work associations at these loci in pediatric populations 
leaves open the possibility that environmental risk exposures other than near work might underlie 
the SNP x education interaction seen in the adult Asian samples. 
The genome-wide significant SNPs from the joint meta-analysis approach did not exhibit any 
interactions with education in Europeans, in contrast to the significant interactive effect among 
Asians. In particular, the interactions of AREG, GABRR1 and PDE10A with education were evident 
in Asian populations only, but not in Europeans. There are a number of possible reasons. First, the 
observed heterogeneity may reflect the intense education systems in Asia1. The higher education 
level was associated with myopic shift at an average of a 1.16 D in refraction in Asians, but with 
only a 0.56 D in Europeans. It is possible that the gene and education interplay may manifest more 
in such a condition with the strong education effects, as genetic effects are generally modest 
across the populations. Second, the population distribution of refractive error is more myopic in 
Asians (-0.60 D versus 0.10 D in Europeans). A high prevalence of myopia is likely to associate 
with other lifestyle exposures, such as low amount of outdoor activities, which were not accounted 
for in the current study. Third, education systems varied widely across studies. We chose to divide 
education levels into two categories but this cut-off may not reflect the same education intensity or 
true underlying risk for myopia across countries. Misclassification in environment measurements 
is likely to bias the effect towards the null. Lastly, education in adults may not be an accurate 
surrogate for cumulative near work activity. The level of education attained may be a crude marker 
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of reading intensity and computer use during the crucial years prior to the onset of myopia. These 
factors, accompanying with varying allele frequencies at the associated SNPs, might obscure the 
power to detect the interaction effects in individuals of European ancestry. Whether such G × E 
interaction is ancestry-specific warrants further evaluation.
In summary, we identified 9 novel loci associated with refractive error in a large multi-ethnic cohort 
study by GEWIS approach. Our data provide evidence that specific genetic variants interact with 
education to influence refractive development, and further support a role for GABA neurotransmitter 
signaling in myopia development. These findings provide promising candidate genes for follow-up 
work and may lead to new genetic targets for therapeutic interventions on myopia.
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2
SUPPLEMENTARY MATERIAL
Supplementary Table S1. Description of study design, phenotyping and education levels 
Study Method of Measurement Study design       Higher 
Education (%)
Europeans
ALIENOR Speedy  K Luneau, France Population-based 45.4
ALSPAC Canon R-50 autorefractor and subjective 
refraction
Family-based study 38.6
AREDS Subjective Refraction Population-based 94.4
BATS Humphrey‐598 Automatic Refractor (USA) Twins 60.3
BMES Humphrey autorefractor 530 Population-based 65.5
CROATIA-
Korcula
Nidek ARK30 hand-held 
autorefractometer (Japan)
Family-based 52.7
CROATIA-
Split
Nidek ARK30 hand-held 
autorefractometer
Family-based 83.1
DCCT Subjective Refraction Clinic trial 86.2
EGCUT Autorefraction measurement method; self-
reported based on prescription
Population-based 37.2
EPIC Humphrey Auto-refractor 500 Population-based 62.7
ERF Topcon RM-A2000 autorefractor Family-based 29.5
FES Subjective Refraction Family-based 53.0
FITSA Topcon AT (Tokyo, Japan) Population-based 16.5
GHS1 Humphrey Automated Refractor/
Keratometer (HARK) 599 (Germany)
Population-based 47.1
GHS2 Humphrey Automated Refractor/
Keratometer (HARK) 599 (Germany)
Population-based 49.4
KORA F3 Nikon Retinomax Population-based 26.5
OGP Talana Topcon RK-8100 autorefractor Family-based 16.5
ORCADES Kowa KW 2000 autorefractometer Family-based 54.0
RAINE Nidek ARK-510A Population-based 73.6
RS-I Topcon RM-A2000 autorefractor Population-based 35.3
RS-II Topcon RM-A2000 autorefractor Population-based 46.2
RS-III Topcon RM-A2000 autorefractor Population-based 53.6
TwinsUK ARM-10 autorefractor (Takagi Ltd)  Twins study 46.7
WESDR Subjective Refraction Clinic trial study 58.4
YFS Nidek AR-310AR autorefractor Population-based 85.7
Asians
BES Canon RK-5 Auto Ref-Keratometer Population-based 14.0
Nagahama NideK ARK-530A Population-based 75.9
SCES I Canon RK-5 Auto Ref-Keratometer Population-based 21.3
SCES II Canon RK-5 Auto Ref-Keratometer Population-based 
SIMES Canon RK-5 Auto Ref-Keratometer Population-based 6.7
SINDI Canon RK-5 Auto Ref-Keratometer Population-based 22.5
SP2-1M Canon RK-5 Auto Ref-Keratometer Population-based 45.0
SP2-610 Canon RK-5 Auto Ref-Keratometer Population-based 37.4
STARS Canon RK-5 Auto Ref-Keratometer Population-based 55.7
A higher education group including those who had completed at least higher secondary education, 
polytechnic, or with ≥ 12 years spent in formal education, except using >12 years of formal education 
for four cohorts of relatively young European participants (BATS, DCCT, RAINE and WESDER; see 
Methods).
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Supplementary Table S2. Description of genotyping, imputation method and genome control 
factor lambda (λGC)
Study Genotyping method Imputation 
software
Analysis 
software
λGC for JMA
Europeans
ALIENOR Illumina HumanHap610-Quad Minimac Quicktest 1.049
ALSPAC Illumina HumanHap660 W-Quad Minimac Probabel 1.009
AREDS Illumina HumanOmni2.5-4v1_B IMPUTE2 Quicktest 1.056
BATS Illumina HumanHap610W Quad Minimac MIXABLE 1.125
BMES Illumina HumanHap670 Quad IMPUTE2 Quicktest 1.026
CROATIA-
Korcula
Illumina Human370CNV-Quad IMPUTE2 MIXABEL 1.054
CROATIA-
Split
Illumina Human370CNV-Quad IMPUTE2 MIxABEL 1.103
DCCT Illumina Human1M-Omni IMPUTE2 Quicktest 1.040
EGCUT Illumina Human OMNIExpress IMPUTE2 Quicktest 1.021
EPIC Affymetrix GeneChip Human Mapping 
500K
IMPUTE2 Quicktest 1.030
ERF Illumina 6k, Illumina 318K, Illumina 370K 
and Affymetrix 250K
Minimac MIXABEL 1.053
FES Affymetrix 250K Mapping Nspl, 250K 
Mapping StyI, and HuGeneFocussed 50K
IMPUTE2 MIXABEL 1.012
FITSA Illumina HumanHap300 IMPUTE2 Quicktest 1.109
GHS1 Affymetrix 6.0 IMPUTE2 Probabel 1.017
GHS2 Affymetrix 6.0 IMPUTE2 Probabel 1.021
KORA Illumina HumanOmni2.5-4v1_B IMPUTE2 Quicktest 1.030
OGP Talana Affymetrix 500k array Chip  IMPUTE2 MIXABEL 1.115
ORCADES Illumina HumanHap300 & Human370CNV-
Quad
IMPUTE2 MIXABEL 1.043
RAINE Illumina HumanHap610/660 Quad Minimac Probabel 1.097
RS-I Illumina Infinium II & HumanHap550 Minimac Probabel 1.046
RS-II Illumina HumanHap550 Duo & 
HumanHap610-Quad
Minimac Probabel 1.022
RS-III Illumina HumanHap610-Quad Minimac Probabel 1.024
TwinsUK Illumina HumanHap300K-Duo & 
HumanHap610-Quad 
IMPUTE2 Quicktest 1.021
WESDR Illumina Human Omni 1-Quad IMPUTE2 Quicktest 1.047
YFS Illumina HumanHap 670k BeadChip IMPUTE2 Quicktest 1.038
Asians
BES Illumina HumanHap610-Quad Minimac Quicktest 1.093
Nagahama HumanHap610KQuad, HumanOmni2.5M, 
HumanExome
Minimac Quicktest 1.047
SCES I Illumina HumanHap610-Quad Minimac Quicktest 1.052
SCES II Illumina HumanHap610-Quad Minimac Quicktest 1.072
SIMES Illumina HumanHap610-Quad Minimac Quicktest 1.049
SINDI Illumina HumanHap610-Quad Minimac Quicktest 1.046
SP2-1M Illumina HumanHap610-Quad Minimac Quicktest 1.022
SP2-610 Illumina HumanHap610-Quad Minimac Quicktest 1.043
STARS Illumina HumanHap610-Quad Minimac Quicktest 1.022
JMA – Joint meta-analysis
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Supplementary Table S4. Results of meta-regression showing the associations of each study 
characteristics with the SNP × education interaction effect on spherical equivalent
Study-level  characteristics GABRR1 (rs13215566) PDE10A 
(rs12206610) 
Effect    P Effect    P
Sample size - 0.662 - 0.636
Average spherical equivalent, D - 0.205 - 0.025
Proportion of high education group, % + 0.480 - 0.064
Ethnicity, Asian vs. European - 0.006 - 0.042
Study year - 0.409 + 0.397
Study design + 0.990 - 0.836
Average age ≥ 40 vs. <40, years + 0.057 - 0.285
Education effect on spherical equivalent, 
higher vs. lower education 
- 0.158 - 0.138
The P values were obtained from the meta-regression model, including all the covariates listed above. 
Study year, the year in the middle of the study period; Study design, independent samples  form 
population-based studies/ clinic trials vs. related samples from family-based studies/twin studies. Meta-
regression analysis included all 34 studies in Table 1.
Supplementary Table S5. Associations between three GxE loci and education in Singapore 
cohorts
SNP Gene  OR 95% CI of OR P      Phet
rs12511037 AREG 0.91 0.79 1.05 0.200 0.224
rs13215566 GABRR1 0.98 0.83 1.15 0.769 0.118
rs12206610 PDE10A 0.96 0.85 1.08 0.499 0.927
Logistic regression for education on three SNPs was performed in following study (total n = 9,004): 
SCESI, SCES II, SiMES, SINDI, SP2-1M, SP2-610 and STARS, adjusted for age, gender, and population 
stratification (SiMES and SINDI). The Odds ratio (OR) was estimated from the meta-analysis of the results 
from above studies. Education level is defined as 1= higher education, 0= low education.
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Supplementary Table S7. Meta-analysis of gene and near work interaction for spherical 
equivalent in pediatric cohorts on three index SNPs
SNP Gene A1 A2 Effect s.e. Pint Direction Phet
rs12511037 AREG C T 0.045 0.173 0.795 +-+ 0.062
rs13215566 GABRR1 C G -0.088 0.066 0.309 --- 0.655
rs12206610 PDE10A C T -0.189 0.088 0.032 --- 0.658
Meta-analysis of SNP x near work was performed in Chinese children from SCORM (n = 988), Guangzhou 
twins (n = 1,055) and European children in ALSAPC3; 4 (n = 3,792). Near work is a binary variable, 
defined as
0 = low and 1= high, relative to the median number of hours per week spent reading, writing or computer 
use.  Only near work activity outside of the regular school day was included. SCORM: Singapore Cohort 
study Of the Risk factors for Myopia; ALSPAC: Avon Longitudinal Study of Parents and Children. 
Genotyping GWAS were available from three cohorts.
Supplementary Table S8. Gene expression of identified loci in human ocular tissues
Gene Retina Sclera Choroid / RPE
FAM150B 29.94 62.13 333.33
PRL 43.48 24.74 43.64
FBN1 12.88 75.26 47.08
MAP2K1 85.72 91.26 183.61
DIS3L 43.20 32.95 42.16
SLC14A2 29.96 34.87 33.69
AREG 21.31 26.04 29.64
GABRR1 121.66 21.48 31.43
PDE10A 28.19 18.87 21.46
Expression data was obtained from Ocular Tissue Database47.  The Affymetrix GeneChip Human Exon 
1.0 ST (HuEx 1.0) microarrays were used to assess gene expression. Normalization of gene expression 
was done at both the probe set and metaprobe set level using the Probe Logarithmic Intensity Error 
(PLIER) method with GC-background correction. The PLIER normalized level of gene expression was 
presented in the table.
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Supplementary Table S9. Regulatory function for the index SNP and SNPs in linkage disequilibrium 
(r2 ≥ 0.8)
Query SNP: rs12511037 and variants with r2 >= 0.8
variant
Promoter Enhancer
DNAse
Proteins Motifs GENCODE dbSNP
histone 
marks
histone 
marks bound changed genes func annot
rs12511037     CEBPG 14kb 3' of AREG  
rs2201455  HMEC, NHEK   4 altered motifs
37kb 3' of 
AREG  
rs2643009     Cdx2,Pdx1 37kb 3' of AREG  
rs1971299     NRSF 41kb 3' of AC142293.3  
rs1494885     Foxa 40kb 3' of AC142293.3  
rs1817910     Ets,Gm397 37kb 3' of AC142293.3  
rs1389962     21 altered motifs 32kb 3' of AC142293.3  
rs78293098   FibroP  8 altered motifs 24kb 3' of AC142293.3  
rs4694198  
HMEC, 
Huvec, 
NHEK
  Dlx3,Sox 5kb 3' of AC142293.3  
Query SNP: rs13215566 and variants with r2 >= 0.8
variant
Promoter Enhancer
DNAse
Proteins Motifs GENCODE dbSNP
histone 
marks
histone 
marks bound changed genes func annot
rs12374613  H1   6 altered motifs GABRR1 intronic
rs35953049   Medullo  4 altered motifs GABRR1 intronic
rs13196063     4 altered motifs GABRR1 intronic
rs13196423     13 altered motifs GABRR1 intronic
rs35124757     Mef2,TATA GABRR1 intronic
rs13215029   HRPEpiC,SK-N-MC  5 altered motifs GABRR1 intronic
rs13201083     CTCF,NERF1a,RFX5 GABRR1 intronic
rs13215566     Gcm1,Pax-6,Zfp128 GABRR1 intronic
rs35007480   Osteobl FOXA1,GATA3
Foxd3,HDAC2,
Pou3f2 GABRR1 intronic
Query SNP: rs12206610 and variants with r2 >= 0.8
variant
Promoter Enhancer
DNAse
Proteins Motifs GENCODE dbSNP
histone 
marks
histone 
marks bound changed genes func annot
rs12216245     DMRT3 PDE10A intronic
rs62426699      PDE10A intronic
rs62426700     Evi-1,Gfi1 PDE10A intronic
rs12214904     TLX1::NFIC PDE10A intronic
rs12206610     Foxd3,Sox,Zfp105 PDE10A intronic
rs12215013     Foxa PDE10A intronic
rs12192968     LUN-1 PDE10A intronic
rs12206770     ERalpha-a,Spz1,TCF12 PDE10A intronic
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rs62426701     Foxp3 PDE10A intronic
rs62426702     ATF3,Pou2f2,TCF11::MafG PDE10A intronic
rs76154906      PDE10A intronic
rs76510607     Dobox4,SIX5 PDE10A intronic
rs76914213     Mrg1::Hoxa9 PDE10A intronic
rs11751207     5 altered motifs PDE10A intronic
rs199547339     12 altered motifs PDE10A intronic
rs78291302      PDE10A intronic
rs11751728     4 altered motifs PDE10A intronic
rs12210339   HMVEC-LLy   PDE10A intronic
rs12190475   4 cell types  4 altered motifs PDE10A intronic
rs12191985   4 cell types  GR,HNF4 PDE10A intronic
rs12210393   4 cell types  4 altered motifs PDE10A intronic
rs12192105   Jurkat  EWSR1-FLI1,TATA,p300 PDE10A intronic
rs12210507   Jurkat,RPTEC  DMRT7,YY1 PDE10A intronic
rs12212289  HSMM   AP-1,Mef2 PDE10A intronic
rs12198402  HSMM HCPEpiC  Pou3f3 PDE10A intronic
rs12198517  HSMM Jurkat  4 altered motifs PDE10A intronic
rs11752590     PLZF PDE10A intronic
rs12195874     NRSF PDE10A intronic
rs12195883     Hltf,Pou1f1,Pou5f1 PDE10A intronic
rs828571     9 altered motifs PDE10A intronic
rs12213759     E2F,TATA,YY1 PDE10A intronic
rs12209263     Pax-4,SIX5,Znf143 PDE10A intronic
rs12204986     PTF1-beta PDE10A intronic
rs12196646     7 altered motifs PDE10A intronic
rs12196655     7 altered motifs PDE10A intronic
rs12206474     7 altered motifs PDE10A intronic
rs12206582   10 cell types  5 altered motifs PDE10A intronic
rs12198136   10 cell types  6 altered motifs PDE10A intronic
rs12211245   5 cell types  5 altered motifs PDE10A intronic
rs142625747      PDE10A intronic
rs12205255     HNF4,Sox PDE10A intronic
rs12200612     5 altered motifs PDE10A intronic
rs62424870      PDE10A intronic
rs60457032     6 altered motifs PDE10A intronic
rs57345708   HMVEC-dBl-Neo  NF-I PDE10A intronic
rs12212598     PLZF PDE10A intronic
rs12206551   Osteobl  Ik-1,Spz1,Zec PDE10A intronic
rs12208043      PDE10A intronic
Query SNP: rs60843830 and variants with r2 >= 0.8
variant
Promoter Enhancer
DNAse
Proteins Motifs GENCODE dbSNP
histone 
marks
histone 
marks bound changed genes func annot
rs62114494     37 altered motifs 6.4kb 3' of SH3YL1  
rs2126129     7 altered motifs 5.2kb 3' of SH3YL1  
rs62114497  NHEK   MIZF 2.9kb 3' of SH3YL1  
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rs6709534     5 altered motifs 395bp 3' of SH3YL1  
rs56350804   PanIsletD  9 altered motifs 169bp 3' of SH3YL1  
rs200781940   PanIsletD  10 altered motifs 167bp 3' of SH3YL1  
rs9213     Ets,SIX5 SH3YL1 3'-UTR
rs3828165     5 altered motifs SH3YL1 intronic
rs60484953     6 altered motifs SH3YL1 intronic
rs3791224     4 altered motifs SH3YL1 intronic
rs3791223     Pou5f1,RBP-Jkappa SH3YL1 intronic
rs2290911     BRCA1,NF-I,RFX5 SH3YL1 synonymous
rs3791221      SH3YL1 intronic
rs3791220     4 altered motifs SH3YL1 intronic
rs17713396      SH3YL1 intronic
rs57542652   Th2  Foxp3,NF-AT1 SH3YL1 intronic
rs7601944     11 altered motifs SH3YL1 intronic
rs2306060     PRDM1 SH3YL1 intronic
rs62114501   Hepatocytes  4 altered motifs SH3YL1 intronic
rs3838489     19 altered motifs SH3YL1 intronic
rs6710091     4 altered motifs SH3YL1 intronic
rs4497901     GR SH3YL1 intronic
rs17713568     6 altered motifs SH3YL1 intronic
rs62114505     Evi-1 SH3YL1 intronic
rs55753056     4 altered motifs SH3YL1 intronic
rs17713729  HepG2   DMRT3,DMRT4,DMRT5 SH3YL1 intronic
rs17713879  K562   Nkx2 SH3YL1 intronic
rs62114538     Foxp1 SH3YL1 intronic
rs55936726  HepG2  SETDB1  SH3YL1 intronic
rs36216559 NHEK HepG2, HMEC 6 cell types HEY1,POL2 GR,Nkx2 SH3YL1 intronic
rs7595075 8 cell types HepG2 19 cell types
5 bound 
proteins AP-2,BDP1 SH3YL1 5'-UTR
rs7584915 8 cell types HepG2
H1-hESC,
8988T,Th2 ZEB1,POL2
BDP1,ELF1,
HNF4 ACP1  
rs58461606 K562, GM12878
HepG2, 
NHLF, 
HMEC
  GR ACP1 intronic
rs56321614 K562 HepG2, GM12878 CMK,HL-60  Irf,TAL1 ACP1 intronic
rs55946380 K562, GM12878 HepG2 HL-60  Cdx,p300 ACP1 intronic
rs62114544 GM12878    Znf143 ACP1 intronic
rs59937473      ACP1 intronic
rs11553746   Th1,Fibrobl,HL-60  4 altered motifs ACP1 missense
rs62114548   6 cell types CTCF,RAD21,AP2GAMMA AP-2,ZEB1 ACP1 intronic
rs7605824     E2F FAM150B intronic
rs7566279   Fibrobl   FAM150B intronic
rs56167434   Fibrobl POL2 NRSF,Sin3Ak-20,p53 FAM150B intronic
rs60149603  H1, NHLF   4 altered motifs FAM150B intronic
rs17714252  H1, NHLF    FAM150B intronic
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rs60843830 H1  WI-38  ERalpha-a,Pbx-1 FAM150B intronic
rs79154857     CTCFL,TAL1 AC079779.4  
Query SNP: rs10946507 and variants with r2 >= 0.8
variant
Promoter Enhancer
DNAse
Proteins Motifs GENCODE dbSNP
histone 
marks
histone 
marks bound changed genes func annot
rs10946507   7 cell types  GCNF,NF-I,Pou1f1 LINC00340 intronic
rs5874850     Foxp1,HMG-IY,Zfp105 LINC00340 intronic
rs964461     BCL LINC00340 intronic
rs12216030  GM12878, NHLF  
4 bound 
proteins PPAR LINC00340 intronic
Query SNP: rs8023401 and variants with r2 >= 0.8
variant
Promoter Enhancer
DNAse
Proteins Motifs GENCODE dbSNP
histone 
marks
histone 
marks bound changed genes func annot
rs201102733     6 altered motifs 9.9kb 3' of FBN1  
rs8032307  HSMM, NHLF 15 cell types  CDP,HNF1
7.9kb 3' of 
FBN1  
rs8032308  HSMM, NHLF 14 cell types  CDP,HNF1
7.9kb 3' of 
FBN1  
rs12592059     CEBPG,E2F,Pou3f2
4.1kb 3' of 
FBN1  
rs2899417     GATA,Rad21 399bp 3' of FBN1  
rs13598      FBN1 3'-UTR
rs8023401      FBN1 intronic
rs13379564     5 altered motifs FBN1 intronic
rs1820488  H1    FBN1 intronic
rs8028152      FBN1 intronic
rs9920665  HMEC, NHEK   GR,Maf FBN1 intronic
rs2042746   15 cell types  Nkx2 FBN1 intronic
rs8029557  NHLF, H1   Zic FBN1 intronic
rs2278185   5 cell types  6 altered motifs FBN1 intronic
rs201882828     HNF1,Mef2 FBN1 intronic
rs2466791  Huvec   GR,Sox FBN1 intronic
rs2017765     STAT,Znf143 FBN1 intronic
rs34539187      FBN1 intronic
rs11855195     4 altered motifs FBN1 intronic
rs75227249     Mef2,ZBTB33 FBN1 intronic
rs12907167     Pou2f2,Pou3f2 FBN1 intronic
rs17361098     4 altered motifs FBN1 intronic
rs34215103     Pou2f2 FBN1 intronic
rs16960982     4 altered motifs FBN1 intronic
rs12917479     8 altered motifs FBN1 intronic
rs71467652  H1   Hoxa5 FBN1 intronic
rs34070783     5 altered motifs FBN1 intronic
rs16960997  NHLF   5 altered motifs FBN1 intronic
rs17458846     HNF1 FBN1 intronic
rs12915497     Ets,TLX1::NFIC,YY1 FBN1 intronic
rs12915240     TLX1::NFIC,YY1 FBN1 intronic
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rs12901992      FBN1 intronic
rs12907671     7 altered motifs FBN1 intronic
rs34837775  HSMM, NHLF   Nkx2 FBN1 intronic
rs12914007  GM12878   CEBPB,p300 FBN1 intronic
rs35464791     4 altered motifs FBN1 intronic
rs35716640    CTCF AIRE,Pax-4,Sin3Ak-20 FBN1 intronic
rs11854914  Huvec    FBN1 intronic
rs12909189     6 altered motifs FBN1 intronic
rs34054358     Hoxa5,Sin3Ak-20 FBN1 intronic
rs17460049      FBN1 intronic
rs17362691    CTCF GATA,ZEB1,Zfp410 FBN1 intronic
rs2279237      FBN1 intronic
rs1871483     HNF4 FBN1 intronic
Query SNP: rs16949788 and variants with r2 >= 0.8
variant
Promoter Enhancer
DNAse
Proteins Motifs GENCODE dbSNP
histone 
marks
histone 
marks bound changed genes func annot
rs16949788     18 altered motifs DIS3L intronic
rs76878359     Maf,NRSF,PLZF DIS3L intronic
rs16949793   HeLa-S3  Mrg,Nanog,Sox DIS3L intronic
rs9806600   H7-hESC   DIS3L intronic
rs142910616     Mef2,ZBTB33 DIS3L intronic
rs8035939     Pbx3 DIS3L intronic
rs28723485     EBF,Ik-1 DIS3L intronic
rs11071885     Ets,Irf DIS3L synonymous
rs62625678     17 altered motifs 487bp 3' of TIPIN  
rs62625675     Foxo,HDAC2,YY1 TIPIN 3'-UTR
rs62627323     GR,Smad TIPIN intronic
rs9806474   Hepatocytes  AP-1,GATA,Smad4 TIPIN intronic
rs12443313  HepG2   BCL,CHD2,E2F TIPIN  
rs8042604      TIPIN  
rs12323975     Nanog TIPIN  
rs16949849  6 cell types
Hepatocytes,
Osteobl  6 altered motifs MAP2K1 intronic
rs80298548     4 altered motifs MAP2K1 intronic
Query SNP: rs10880855 and variants with r2 >= 0.8
variant
Promoter Enhancer
DNAse
Proteins Motifs GENCODE dbSNP
histone 
marks
histone 
marks bound changed genes func annot
rs67133230 9 cell types  61 cell types
5 bound 
proteins 4 altered motifs ARID2 intronic
rs7138997     4 altered motifs ARID2 intronic
rs2193749     DMRT1 ARID2 intronic
rs10880855     10 altered motifs ARID2 intronic
rs1468993      ARID2 intronic
rs12320533     4 altered motifs ARID2 intronic
rs12319077      ARID2 intronic
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rs11183201     13 altered motifs ARID2 intronic
rs201967811     5 altered motifs ARID2 intronic
rs142543635     6 altered motifs ARID2 intronic
rs10748432     Cdx,STAT ARID2 intronic
rs201070908     5 altered motifs ARID2 intronic
rs79637844     4 altered motifs ARID2 intronic
rs7132422     10 altered motifs ARID2 intronic
rs7955891     5 altered motifs ARID2 intronic
rs2408435      ARID2 intronic
rs35671385     18 altered motifs ARID2 intronic
rs201994368     5 altered motifs ARID2 intronic
rs72215781      ARID2 intronic
rs10880859     34 altered motifs ARID2 intronic
rs1863127     4 altered motifs ARID2 intronic
rs6582574      ARID2 intronic
rs10880860     7 altered motifs ARID2 intronic
rs2059404      ARID2 intronic
rs141510569     5 altered motifs ARID2 intronic
rs7976870     Ik-2,Irf,TCF4 ARID2 intronic
rs247930      ARID2 intronic
rs35117   HMVEC-LBl  Irf,Pax-4,STAT ARID2 intronic
rs35115     KAP1 ARID2 intronic
Query SNP: rs10853531 and variants with r2 >= 0.8
variant
Promoter Enhancer
DNAse
Proteins Motifs GENCODE dbSNP
histone 
marks
histone 
marks bound changed genes func annot
rs11659892     DMRT5 175kb 3' of SETBP1 intronic
rs11659914     GATA,HDAC2 175kb 3' of SETBP1 intronic
rs16978310  
HSMM, 
NHLF, 
NHEK
6 cell types  YY1 175kb 3' of SETBP1 intronic
rs7235910  NHEK, HMEC BJ GATA3 Egr-1,Hbp1
176kb 3' of 
SETBP1 intronic
rs10853531     CACD,NRSF,Pax-4 176kb 3' of SETBP1 intronic
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Supplementary Figure S1. Quantile-quantile (QQ) plots for the join meta-analysis in Europeans, 
Asians and all cohorts
A. Europeans
B. Asians
C. All
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Supplementary Figure S2. Regional association plots of the loci associated with spherical 
equivalent for the join meta-analysis. A-F. regional plots for all studies. G-I. regional plots for Asian 
studies.
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Supplementary Figure S3. Scatter plot of effects of SNP x education interaction on 39 known 
GWAS loci
The Meta-regression p values were obtained from the meta-regression with the outcome is the fold-
changes of the interaction beta coefficients from Asians versus Europeans. Beta coefficient corresponds 
to the effect of 1 additional copy of the risk allele on spherical equivalent in the high vs low educational 
setting.
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ABSTRACT 
Purpose
Myopia is hypothesized to be caused by a retina-to-sclera signaling cascade. It is unknown which 
retinal cells are involved in this process. We aimed to get hints of cell types and functions involved 
by studying refractive errors in Mendelian inherited retinal dystrophies (RD).
Methods
We included patients with Mendelian RD from three ophthalmogenetic centers (n=302) in the 
Netherlands. Patients were categorized by primary affected cell type: retinal pigment epithelium-
related macular dystrophies (RPE, n=77), cone-related dystrophies (CD, n=76), rod-related 
dystrophies, such as retinitis pigmentosa (RP, n=104), and bipolar cell dysfunction related 
dystrophies (BPD, n=45). Refractive error was measured with automated refraction, and analyzed 
as spherical equivalent (SE). Frequency distributions and mean SE of each diagnosis and causal 
gene were calculated, and risks of several degrees of myopia and hyperopia versus emmetropia 
was evaluated using logistic regression analyses, adjusting for age and sex. Reference for risk 
analyses were the population-based estimates from the Rotterdam Study III and ERF Study 
(n=5,550).
Results
Participants with BPD (mean SE -6.86 D [SD 6.38]) had the highest degree of refractive error, 
followed by CD (mean SE -3.10 D [SD 4.49]), RD (mean SE -2.27 D [SD 4.65]), and RPE related 
macular dystrophies (mean SE -0.10 D[SD 3.09]). Patients with mutations in the RPGR gene 
(causing X-linked retinitis pigmentosa; mean SE -7.63 D (SD)) and CACNA1F gene (causing 
congenital stationary night blindness; mean SE -5.33 D (SD)) presented with the highest degree 
of myopia. Persons with bipolar cell dysfunctions had the highest risk of refractive error (OR high 
myopia 239.7 and OR mild hyperopia 263.2, both P<0.0001); followed by cone related dystrophies 
(OR high myopia 19.5, P<0.0001; and OR high hyperopia 10.7, P=0.033); rod related dystrophies 
(OR high myopia 10.1, P<0.0001; OR high hyperopia 9.7, P=0.001); and RPE related dystrophies 
(OR low myopia 2.7; P=0.001; and OR high hyperopia 5.8; P=0.025).
Conclusions
Refractive errors, in particular myopia, are common in inherited RD. Bipolar cells were the common 
cell type leading to high myopia; RPGR and CACNA1F were the most common genes associated 
with high myopia. We determined two critical sites for refractive error development: regulation of 
glutamate and calcium in the bipolar synapse, bipolar cell neurotransmission, the bipolar routing 
itself and transport between IS/OS in the photoreceptor. Our findings provide more insight in the 
various steps in the signaling cascade causing myopia. 
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INTRODUCTION
Refractive errors (myopia and hyperopia) are the most common ocular disorders worldwide 
and are a prominent cause of blindness.1 This highly heritable trait has been subject to 
many studies, and the search for genes - in particular for myopia - has been ongoing 
for several decades.2,3 Myopia is thought to be caused by a visually evoked retina-to-
sclera-signaling cascade. Various genes representing different pathways in myopia 
development have been discovered.4,5 These pathways include neurotransmission (in 
photoreceptors, RPE, and choroid), retinoic acid metabolism, extracellular matrix remodeling, 
and eye development. Still, only ~4% of the heritability of refractive error is uncovered.5 
It is known that refractive errors are common in patients with retinitis pigmentosa (RP, in particular 
in X-linked forms), congenital stationary night blindness, Stargardt disease and Best macular 
dystrophy.6-9 In our outpatient clinic we also became aware of a high presence of refractive errors in 
patients with other retinal dystrophies (personal communication). Inherited retinal dystrophies are 
clinically and genetically heterogeneous, causing degeneration of the retinal pigment epithelium 
(RPE), photoreceptors (cones and rods) or the inner retina.10 According to the primary location 
of retinal cell dysfunction, they can be classified into RPE related macular dystrophies, primary 
photoreceptor dystrophies (cone and rod related dystrophies) and inner retina dystrophies 
(bipolar cell dysfunctions). Stargardt disease (STGD; 1:10,000) is the most common form of 
recessively inherited macular dystrophy, caused by mutations in the ABCA4 gene.11, 12 Other more 
rare inherited RPE related macular dystrophies are Best macular dystrophy (BEST) and pattern 
dystrophy (PD). The subgroup cone related dystrophies is formed by achromatopsia (ACH), a 
stationary cone disorder, and cone-rod dystrophies (CRD), a more progressive disorder.13 Rod-
cone dystrophies (RCD) also known as retinitis pigmentosa form the largest subtype, accounting 
for ~ 50% of all inherited retinal dystrophies.14 Lastly, congenital stationary night blindness (CSNB) 
is caused by defective retinal signaling from the photoreceptors to the adjacent bipolar cells, and 
is known to coincide with myopia (OMIM #310500).15
Myopia and inherited retinal dystrophies are caused by similar pathways, such as photoreceptor 
dysfunction and retinoic acid metabolism. Therefore, genes involved in inherited retinal dystrophies 
are excellent candidate genes for myopia, but their precise roles in the development of refractive 
errors has never been studied before. Although there are former reports that refer to an increased 
incidence of myopia in patients with some inherited retinal dystrophies, not all include specific 
quantifiable data, and they have not included a large spectrum of retinal dystrophies.6,8,16 
For more understanding in the mechanisms involved in the pathogenesis of refractive error and 
myopia, we studied a large group of patients with a broad spectrum of inherited retinal dystrophies, 
classified into RPE related macular dystrophies (RPE), cone related dystrophies (CD), rod related 
dystrophies (RD), and bipolar cell dysfunction (BPD). We investigated frequency and degree of 
refractive errors stratified by these four groups of diagnoses and by the specific genes involved 
in retinal dystrophy. 
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MATERIAL AND METHODS
Subjects
Our study population consisted of 302 patients with inherited retinal diseases, divided into four 
groups; RPE related macular dystrophies (RPE, n=77), cone related dystrophies (CD, n=76), 
rod related dystrophies (RD, n=104) and bipolar cell dysfunctions (BPD, n=45). Patients were 
ascertained at Erasmus Medical Center, the Rotterdam Eye Hospital, and Bartiméus in The 
Netherlands, ophthalmogenetic centers which belong to the National RD5000 Consortium. From 
2002, patients with ophthalmogenetic diseases who visited the clinic were collected and included 
in a database. Patients with the clinical diagnosis RPE related macular dystrophy (STGD, BEST 
and PD), cone related dystrophies (ACH, CRD), rod related dystrophies (RP, RCD) and bipolar 
cell dysfunctions (CSNB) with available data on refractive error were included. Patients without 
refractive error data or refractive error data only measured after cataract extraction were excluded. 
As a reference group, we used 2,940 participants (age 45+ years) from the population-based 
Rotterdam Study III (RS-III),17 and 2,610 participants (age 18+ years) from the Erasmus Rucphen 
Family study (ERF).18,19
Clinical assessment
We retrieved all clinical data from medical charts. These data included Snellen visual acuity, 
objective refraction based on autorefraction or subjective refractive error measured by an 
optometrist, color vision (Hardy-Rand-Rittler color vision test or Ishihara), visual field tested 
by Goldmann perimetry and electrical responses of cones, rods and bipolar cells with ERG. 
For RS-III and ERF (reference group) a similar protocol was used for phenotyping; all subjects 
underwent an ophthalmologic examination which included non-dilated automated measurement 
of refractive error (Topcon RM-A2000 autorefractor), best-corrected visual acuity and objective 
refraction, fundus photography and visual field perimetry (Humprey Visual Field Analyzer, Zeiss, 
Oberkochen, Germany). 
Molecular genetic analysis
In the outpatient clinic, patients with inherited retinal dystrophies were offered DNA analysis 
for diagnostic testing. DNA was isolated from peripheral blood lymphocytes using standard 
procedures. ABCA4 gene mutations were analyzed in CD and RD patients with microarray 
screening (performed by Asper Biotech, Tartu, Estonia) to assess a safely use of vitamin A therapy. 
In genetically unsolved retinal dystrophy cases genotyping of the most common mutations in 
PROML1, CERKL, CNGA1, CNGB1, MERTK, PDE6A, PDE6B, PNR, RDH12, RGR, RLBP1, SAG, 
TULP1, CRB1, RPE65, USH2A, USH3A, LRAT was performed (autosomal recessive RP chip, 
performed by Asper Biotech, Tartu, Estonia). In patients with RP and deafness suspected for 
Usher syndrome an additional chip was tested for the most common mutations in CDH23, MYO7A, 
PCDH15, Harmonin, SANS, USH2A, VLGR1, USH3a (USH chip, performed by Asper Biotech, 
Tartu, Estonia). X-linked CRD or X-linked RCD probands were screened for mutations in the RPGR 
gene. Patients clinically diagnosed with CSNB were screened for mutations in the CACNAF1 or 
NYX gene. 
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Statistical analysis
SE was calculated according to the standard formula (SE = sphere + ½ cylinder), and the mean 
of two eyes was used for analysis. When data from only one eye was available, the SE of this eye 
was used. In case of multiple SE measurements we used the SE measured during the first visit. 
We categorized SE into low (SE from -1.5 to -3D), moderate (SE from -3 to -6D) and high (SE of -6 
or lower) myopia; emmetropia (SE from -1.5 to +1.5D); and low (SE from +1.5 to +3D), moderate 
(SE from +3 to +6D) and high (SE of +6 or higher) hyperopia, using previously defined criteria.20 
Analyses were stratified by diagnosis (RPE, CD, RD or BPD) and by causal gene. Causal genes 
that were found in less than 3 patients were pooled into one group (‘other genes’). Logistic 
regression analyses were used to assess the risk of low, moderate and high myopia and hyperopia 
versus emmetropia per disease group, using the RS-III and ERF study as the reference group, 
and adjusting for age and sex. Subgroup analysis (ANOVA tests) were performed to compare 
the mean SE between different causal genes and to compare differences within ABCA4 related 
dystrophies (STGD, CRD and RCD) and within RPE-related dystrophies (STGD, BEST, PD). Since 
age has an influence on SE (the younger the more hyperopic) we stratified analysis by age (< 25 
years; ≥ 25 years) and used the Student t test to compare the mean SE between these age groups. 
All analyses were performed using SPSS version 20 (SPSS Inc.). 
RESULTS
Clinical characteristics of the study population (n=302) divided by diagnosis are summarized in 
Table 1. Of all patients with RPE related macular dystrophies (n=77), most were diagnosed with 
STGD (n=54), 18 with BEST and only a small group with PD (n=5). In the group with CD (n=76), 
15 patients had ACH and 61 patients CRD. The largest group was formed by patients with RD, 
including 104 RCD patients. With 45 CSNB patients, BPD formed the smallest group. 
A DNA sample was available in 83% of all included patients. In 57% of our study population 
at least one mutation was found. In total, 37% of the cases was genetically solved (autosomal 
recessive, autosomal dominant or X-linked inherited) (Table 1). Figure 1 shows the frequency of 
mutations found in various genes within the subtypes of inherited retinal diseases. Most frequently 
mutations were found in the ABCA4 gene (36%) (in 33 STGD patients, 19 CRD patients, 10 RCD 
patients), and in the USH2A gene (15%), mainly in RCD patients. Genes that were causing the 
disease in less than 3 patients were pooled, gene-specific data can be found in Table 2. 
The distribution of SE in our patient group and reference group is shown in Figure 2. In CD (mean 
SE -3.10 D [SD 4.49]), RD (mean SE -2.27 D [SD 4.65]) and BPD (mean SE -6.86 D [SD 6.38]) 
the distribution was skewed towards the left (more myopic) compared to RPE related macular 
dystrophies (mean SE -0.10 D[SD 3.09]) and the reference group (mean SE 0.04 D [SD 2.32]). The 
risks of several degrees of myopia and hyperopia per disease group, compared to the reference 
group are shown in Figure 3. Persons with bipolar cell dysfunctions had the highest risk of refractive 
error (OR high myopia 239.7 and OR mild hyperopia 263.2, both P<0.0001); followed by cone 
related dystrophies (OR high myopia 19.5, P<0.0001; and OR high hyperopia 10.7, P=0.033); rod 
related dystrophies (OR high myopia 10.1, P<0.0001; OR high hyperopia 9.7, P=0.001); 
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Table 2. Distribution of spherical equivalent in ‘other genes’
“Other genes’’, genes with causal mutations found in less than 3 subjects, were pooled.
Other genes n = 17 SE 
ALMS1 1 6.81
BBS5 1 -0.06
CERKL 1 -0.13
CNGA1 1 -2.50
CNGA3 1 -8.50
EYS 2 -4.75 ; -0.88
GUCY2D 2 -23 ; -3.50
IMPG2 1 -6.38
KCNV2 1 -3.25
NYX 1 -11.00
PDE6B 1 0.25
PDE6C 1 12.00
PRPF8 1 -0.38
TRPM1 1 -8.31
n=number; SE= spherical equivalent
and RPE related dystrophies (OR low myopia 2.7; P=0.001; and OR high hyperopia 5.8; P=0.025). 
A subgroup analysis within the RPE related macular dystrophies showed a significant (P< 0.0001) 
difference in mean SE between STGD patients (n=54; mean SE -1.10 D [SD 2.68]) and BEST 
patients (n=18; mean SE 2.34 D [SD 2.91]). 
Table 3 shows the mean SE stratified by age at first visit. Mean age at first visit in our study population 
(n=302) was 35 years [SD 18], ranging from 0 to 80 years and differing between subtypes. Only 
patients with rod related dystrophies had a significantly (P=0.027) lower mean SE (-2.83 D [SD 
4.65]) in patients >25 years than patients ≤ 25 years of age (mean SE -0.49 D [SD 4.22]). 
ABCA4, 36% 
USH2A, 15% BEST1, 
6% 
CNGB3, 
6% 
CACNA1F, 5% 
RHO, 3% 
RPGR, 3% 
PDE6A, 3% 
TULP1, 2% 
CRB1, 2% 
PRPH2, 2% 
RPE65, 2% 
CAPB4, 2% 
MYO7A, 2% 
Other, 10% 
ABCA4
USH2A
BEST1
CNGB3
CACNA1F
RHO
RPGR
PDE6A
TULP1
CRB1
PRPH2
RPE65
CAPB4
MYO7A
Other
Figure 1. Frequency of causal genes in our study population (n=172). 
The group “other” consists of various genes found in less than 3 subjects
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Table 3. Spherical equivalent stratified by age
 <10 yrs 10-25 yrs >25 yrs P-trend
 n mean SE (±SD) n mean SE (±SD) n mean SE (±SD)
RPE (n=77) 5 3.9 (2.9) 15 -0.86 (1.78) 57 -0.25 (3.15) 0.292
CD (n=76) 8 -0.23 (7.92) 20 -2.86 (3.16) 48 -3.68 (4.13) 0.023
RD (n=104) 4 1.94 (2.23) 21 -0.95 (4.39) 79 -2.83 (4.66) 0.076
BPD (n=45) 11 -3.84 (4.17) 18 -6.52 (6.28) 16 -9.34 (7.05) 0.959
RPE = RPE related macular dystrophies; C(R)D = cone related dystrophies; R(C)D = rod related 
dystrophies; BPD = bipolar cell dysfunctions; SE = spherical equivalent; SD = standard deviation. 
P-value calculated with students T-test, P < 0.05 was considered statistically significant
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Figure 2. Refractive error distribution in retinal dystrophies  
Percentages of subcategories of spherical equivalent are shown for patients with RPE-related 
dystrophies (RPE), cone related dystrophies (CD), rod related dystrophies (RD) and bipolar cell 
dysfunctions (BPD), compared to our reference group (RS-III and ERF). Mean SE in diopters (D) ± 
standard deviation are shown above each subgroup.  
RPE=RPE-related dystrophies; CD=cone related dystrophies; RD=rod related dystrophies; 
BPD=bipolar cell dysfunctions; RS-III= Rotterdam Study III; ERF = Erasmus Rucphen Family study
Figure 3. Risk of myopia and hyperopia per primary affected cell type  
This plot shows odds ratios of several degrees of myopia (right) and hyperopia (left) versus 
emmetropia per disease group. The RS-III and ERF study were used as the reference group (R), and 
analyses were adjusted for age and sex. The BPD group was too small to calculate an odds ratio for 
high hyperopia (na). OR, odds ratio; RS-III, Rotterdam Study III; ERF, Erasmus Rucphen Family Study; 
RPE, retinal pigment epithelium related macular dystrophies; CD, cone related dystrophies; RD, rod 
related dystrophies; BPD, bipolar cell dysfunction; na, not applicable; ns, non significant.
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In Figure 4A, the spherical equivalent distribution is shown for various genes causing inherited 
retinal dystrophies. Most genes (9 out of 14) coincided with myopia. With a mean SE of -2.02 D 
[SD 3.71] the ABCA4 gene formed the most common disease causing gene (n=62). The ABCA4 
gene, causing the three different diagnoses Stargardt disease (SE -1.50 [SD 2.85]), cone-rod 
dystrophy (SE -2.72 [SD 4.11]) and rod-cone dystrophy (SE -2.41 [SD 5.31]), showed no significant 
differences (P = 0.493) in SE. Patients with mutations in the BEST1 gene (n=11) had a mean SE of 
1.84 D [SD 2.95], which is significantly higher than the mean SE of the ABCA4 (n=62; P = 0.051) 
or the RPGR gene (n=6; P = 0.001). Patients with mutations in the RPGR gene (n=6) were the most 
myopic (mean SE -7.63 D [SD 3.31) of all.
DISCUSSION
We studied refractive error in 302 patients with inherited RD, and found that genes involved in 
these diseases often coincide with refractive error. Our results show that in particular BPD is 
associated with both high myopia and hyperopia, and CD and RP on the whole lead to mild 
myopia. This suggests that in particular bipolar cells are crucial for the emmetropization process. 
Although systematic reports are lacking, occasional case series reported refractive errors in 
patients with RD. Mild refractive errors have been described for Stargardt and Best disease6,9; 
more severe refractive errors for CSNB and for RP caused by RPGR.8, 16, 21-23 Our comprehensive 
analysis shows that RPE related dystrophies such as Stargardt, Best and pattern dystrophy indeed 
mostly have mild refractive errors. Photoreceptor disorders have more variability in refractive 
errors, but are also mildly myopic on average; CD have a somewhat higher frequency of moderate 
myopia (SE from -3 to -6D) than RP. Our study confirms that BPD predominantly leads to severe 
refractive errors, and remarkably, the direction of the SE is dependent on the causal gene. 
Our study has a unique design in myopia research. We selected patients with a known primary 
defect in the retina, and studied the effect on refractive error. We focused on affected cell types as 
well as on causal genes within each cell type. Since myopia develops at childhood and early youth, 
we stratified for age and found differential effects even in those with a very early onset. Our study is 
the only systematic investigation on refractive error and RD to date and includes a broad spectrum 
of diagnoses. In addition, we had access to large population-based studies, which we could use 
as a reference population. Our study has some drawbacks as well. Although our total sample size 
was substantial, subgroup analyses were limited by small numbers. The reference population 
was somewhat older that he RD cases, however, comparison to the younger ERF population did 
not significantly alter the risk estimates (data not shown). Lastly, our RD patients lacked data on 
established risk factors for myopia such as familiar occurrence of myopia and educational level.
Given our findings, what can we learn from retinal dystrophies about the development of myopia? 
Figure 4B shows the localization of the gene products in the retina. Bipolar cells appear to have 
a crucial role in emmetropization. Bipolar cells play an essential role in the retinal microcircuitry 
and transmit signals from photoreceptors to ganglion cells.24 They can be divided by ON and OFF 
subtypes, which determine excitatory and inhibitory responses in reaction to light exposure. Rod 
signal transmission primarily occurs through ON bipolar cells, whereas cones connect with both 
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Figure 4. Distribution of refractive errors for gene-specific inherited retinal dystrophies
A. Boxplots of the distribution of spherical equivalent (in diopters) on Y-axis per specific causal gene on 
X-axis. Causal genes that were found in less than 3 patients were not included in this figure, but their SE 
measurements can be found in Table 2.
B. Localization of retinal dystrophy gene products in the retina. In green: cone specific genes. In red: 
rod specific genes.
A
B
257
Occurrence of refractive errors in retinal dystrophiesChapter 5
5
ON and OFF bipolar cells. If we take a closer look at genes causing BPD, our study shows that 
mutations in CACNA1F, NYX and TRPM1 lead to high myopia, whereas mutations in CAPB4 lead 
to high hyperopia. These genes all function at the photoreceptor-bipolar synapse, and determine 
the glutamate and calcium dependent neurotransmission of the bipolar cell.25,26 TRPM1 and NYX 
are both localized at the postsynaptic terminal of the ON bipolar cells, and are involved in an 
intracellular signaling cascade.26 CACNA1F is a presynaptic calcium channel; CAPB4 is also 
expressed presynaptic, but binds calcium in the synaptic space. CACNA1F is present in both 
photoreceptor types, while CAPB4 is only present in cones.26-28 Mutations in all genes cause an 
electronegative waveform response, but only mutations in CABP4 lead to photophobia rather 
than nyctalopia, and is considered a cone synaptic disorder.29 These considerations suggest that 
regulation of glutamate and calcium in the bipolar synapse, bipolar cell neurotransmission, and 
the bipolar routing itself may all be mechanisms in refractive error development.
Several photoreceptor genes show a relation with myopia, while others have virtually no effect or 
show a relation with hyperopia. Mutations in RPGR, which is located in the connecting cilium and 
is involved in micro-tubular transport, cause high myopia, whereas mutations in USH2A, which 
is located at the apical side of the inner segment and is responsible for the maintenance of the 
photoreceptor, cause mild myopia. The development of myopia seems to be dependent of the 
location of the gene product in the photoreceptors; some structures seem to be more vulnerable 
for development of refractive error. A recent study on RP mice with PDE6B mutations suggests that 
changes in refractive error could be due to alterations in dopamine metabolism.30
Previously, numerous myopia susceptibility loci were identified for refractive error in population-
based studies.4,31 Some of the novel associations were in or near genes involved in the visual cycle 
and retinoic acid metabolism, i.e. common variants in RDH5 (encoding retinol dehydrogenase 5) 
and RGR (encoding the retinal G protein coupled receptor).4,31 Mutations in RDH5 cause a rare 
form of congenital stationary night blindness  and progressive cone dystrophy32,33, and mutations in 
RGR are involved in retinitis pigmentosa.34,35 Another myopia susceptibility gene that was identified 
was CACNA1D (encoding a voltage-sensitive calcium channel regulator).31 This gene shows great 
similarity with the CACNA1F-gene. Both genes encode a protein of the alpha subunit in the L-type 
calcium channel, localized in the presynaptic ribbon terminals of photoreceptors. Lastly, one of 
the newly identified genes, GRIA4 (encoding glutamate receptor, ionotropic, AMPA 4) encodes a 
glutamate-gated ion channel that mediates fast synaptic excitatory neurotransmission, is present 
in the retina and is crucial for emmetropization.36-39 We hypothesize that mutations in these RD 
genes can cause retinal dystrophies, whereas other - less damaging – more common genetic 
variants within these genes can cause myopia only. 
In conclusion, we showed that most genes involved in retinal dystrophies coincide with myopia, 
especially those causing BPD, CD and RP. We determined two critical sites for refractive 
error development: regulation of glutamate and calcium in the bipolar synapse, bipolar cell 
neurotransmission, and the bipolar routing itself and transport between IS/OS in the photoreceptor 
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GENERAL DISCCUSION
The aim of this thesis was to expand our knowledge regarding the pathogenesis and clinical 
impact of myopia and refractive error. Our studies provide important data with respect to the 
prevalence, impact, and genetic and environmental risk factors associated with myopia. This 
general discussion will highlight our most important findings and place them in the context of 
disease etiology and disease risk. We will also discuss the next logical steps towards further 
understanding the pathogenesis of myopia. 
MAIN FINDINGS AND CLINICAL RELEVANCE
Burden of disease
In Chapter 2, we examined the burden due to myopia and refractive error. We studied (1) the 
prevalence of refractive error in Europe (Chapter 2.1); (2) the relationship between refractive error 
and visual impairment (Chapter 2.2); and (3) the relationship between axial length and visual 
impairment and (Chapter 2.3).
Chapter 2.1 discusses the prevalence of myopia in Europe. Although the prevalence of myopia 
and refractive error in developed countries has been studied extensively1,2, estimates of refractive 
error in Europe were relatively outdated and were based only on a single cohort3. Therefore, we 
measured the prevalence of refractive error in nearly 62,000 participants pooled from population-
based studies in the European Eye Epidemiology (E3) consortium (Chapter 2.1). We found that 
refractive error affects more than half of all adults in Europe. The most common refractive error is 
myopia, with prevalence rates of 30% for myopia and 3% for high myopia. The highest prevalence 
was found among young adults; nearly 50% of this population is myopic, confirming that the 
prevalence of myopia is increasing in younger generations4-7. 
In Chapter 2.2, we studied the causes of blindness and low vision in relation to refractive error. 
It is generally accepted that high myopia often leads to vision-threatening complications8-10. 
However, up-to-date prevalence rates regarding myopic macular degeneration, glaucoma, and 
retinal detachment, as well as the precise risk of visual impairment among persons with high 
myopia, were not available. We therefore examined the frequency and causes of blindness and 
impaired vision in the population-based Rotterdam Study; these data were stratified for various 
refractive error categories. We found that one-third of all individuals with high myopia develop 
severe bilateral visual impairment, and this impairment is caused primarily by myopic macular 
degeneration. The risk of impairment increases with each incremental increase in refractive error: 
thus, compared with emmetropic individuals high myopes with a spherical equivalent (SE) of -6 D 
to -10 D have a 3.4-fold increased risk of visual impairment; high myopes with an SE of -10 D or 
worse are have a 22-fold increased risk . 
In Chapter 2.3, we further explored the risk of visual impairment in relation to axial length (AL) in a 
combined dataset from the population-based Rotterdam Study, the family-based ERF study and 
the case-control study MYST. The risk of visual impairment in high myopes was highly correlated 
with AL. Strikingly, the lifetime risk of visual impairment in eyes with an AL>30 mm was >90%. Eyes 
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with AL 26-28 mm gradually developed VA from 60-70 years, whereas eyes with >28 mm began 
to develop visual impairment as early as 45 years of age. These alarming results are consistent 
with previous studies that found a higher prevalence of pathological signs such as axial length 
and/or refractive error10-13. Moreover, our data presented in Chapter 2.2 and 2.3 provide valuable 
additional information, as we examined large cohorts, thus enabling us to perform a robust 
calculation of the risk of visual impairment in a great range of refractive error and axial length 
categories. 
Overall, our data regarding the burden associated with myopia clearly illustrate how myopia is a 
growing public health concern, affecting Western countries as well as Asian populations. Globally, 
an estimated 2.5 billion people will be myopic in the next decade, and the estimated annual 
costs of lost productivity due to visual impairment from refractive error is $268 billion14. Moreover, 
in Singapore alone, the annual costs associated with treating myopia-related complications has 
been estimated to reach $2.5 million15. The current paucity of adequate treatment modalities and 
this dramatic rise in the number of new high myopes—including here in the Netherlands—will 
place a significant burden on both our public health and our economy1,14,15. Our data underscore 
the need for a proper treatment, as reducing progressive eye growth to achieve a lower final axial 
length would significantly decrease the patient’s risk of developing visual impairment later in life. 
Indeed, each incremental decrease in final AL will improve the patient’s long-term prognosis in 
terms of preserving visual acuity. 
Genetics of refractive error and myopia endophenotypes 
Research in recent decades has shown that heritable factors play a key role in ocular refraction16-21. 
However, it was not until the introduction of high-throughput genome-wide genotyping that 
dissection of the disease genes became possible. Genome-wide association studies (GWASs) 
and other genomics-based technologies have accelerated the discovery of genes and genomic 
regions that contribute to complex genetic disorders. 
The first genomic hits for common refractive errors were discovered by our group (Chapter 3.1) 
in collaboration with the Twins UK Study22. Two loci were identified on chromosome 15, and 
the closest genes in these regions are GJD2 and RASGRF1. Identifying the functions of these 
genes led to new hypotheses regarding myopia development, as both genes play a role in retinal 
neurotransmission. The GJD2 gene encodes a protein that forms gap junctions between neurons 
in the retina, enabling the intercellular exchange of small molecules and ions23-26. The RASGRF1 
gene encodes a nuclear exchange factor that is involved in the transmission of photoreceptor 
responses27,28. Identifying these loci provided the first clear evidence that neurotransmission in the 
retina plays a role in myopia development. 
In 2011, we initiated a large consortium called CREAM (the Consortium for Refractive Error 
And Myopia), which combined data regarding refractive error and genetic markers from 56 
international studies. Using this large dataset, we confirmed our hit on chromosome 15q14 
(Chapter 3.2). In 2013, we performed a large-scale GWAS meta-analysis of spherical equivalent 
within the CREAM consortium. In addition to replicating both hits on chromosome 15, we found 
genome-wide significance for an additional 24 loci in 45,758 individuals (Chapter 3.3). The risk of 
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myopia among individuals carrying the highest number of risk alleles is ten-fold higher than the 
risk among individuals with an average number of risk alleles. We also found that some of the loci 
identified from CREAM (Chapter 3.3) and 23andMe29 studies are associated with refractive error 
as a dichotomous trait (Chapter 3.4). 
At nearly the same time, the commercial direct-to-consumer genetic testing company 23andMe 
identified 22 genomic loci in 45,771 individuals using data obtained from questionnaires regarding 
the diagnosis of myopia and the age of first glasses as outcome variables29. Despite using a 
different phenotyping method, the results obtained from the 23andMe study were strikingly 
similar to the results obtained by the CREAM consortium; specifically, 12 genome-wide significant 
hits overlapped (Figure 1). In addition, the effect sizes of most of the associations were linearly 
correlated30, indicating that these genetic associations were robust and can likely be generalized 
to other populations. The striking similarity between Caucasians and Asians in terms of genetic 
associations strengthened this notion. Other GWASs of high-myopia case-control cohorts of Han 
Chinese ethnicity found evidence of an association with several candidate genes31-34. Among 
these associations, only the association with the CTNND2 gene at 5p15 (identified by Li et al.34) 
was confirmed by other Asian studies35-37. None of these loci could be confirmed in the population-
based GWASs from either CREAM (Chapter 3.3) or 23andMe29, suggesting that these loci likely 
represent Han Chinese and/or family-specific genetic factors. 
The CREAM consortium also provided the opportunity to perform GWASs of other biometric 
phenotypes of the eye. In a subset of the CREAM population, we identified nine loci for axial 
length (Chapter 3.5), one of which had been identified previously38. Interestingly, among these 
nine loci for axial length, only three—the GJD2, LAMA2, and CD55 genes—were also associated 
with spherical equivalent. On the other hand, the locus with the highest association with axial 
Figure 1. Venn diagram of genes associated with spherical equivalent and myopia from the 
CREAM and 23andMe studies
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length—the RSPO1 gene—was not associated with refractive error in this study. This discrepancy 
in associated genes could be due to false positive findings for either spherical equivalent or 
axial length. Another possible explanation may be the smaller sample size in our GWAS meta-
analysis of axial length, in which we may have lacked sufficient power to detect the overlapping 
associations with spherical equivalent. Moreover, because the primary determinants of refractive 
error are axial length and corneal curvature, each of which has its own genetic distribution18,39,40, 
the missing genetic overlap between refractive error and axial length could be explained—at least 
in part—by overlapping genetic factors for corneal curvature. A GWAS meta-analysis of corneal 
curvature in CREAM is ongoing, following previous studies of this phenotype41,42, and this analysis 
will hopefully shed new light on this issue. In addition, multiple-trait analyses may provide insight 
into the pleiotropic effects of single-nucleotide polymorphisms (SNPs) associated with spherical 
equivalent, axial length, and corneal curvature43-45. 
We also studied the genetic susceptibility of a third refractive phenotype, astigmatism, which 
is currently poorly understood. Previously published GWAS meta-analyses of large numbers of 
individuals derived primarily from population-based cohorts identified an association with a single 
locus46,47. Even in our CREAM GWAS meta-analysis of refractive astigmatism, which included 
the largest study population for this phenotype examined to date, we only identified putative 
candidate genes for refractive astigmatism (Chapter 3.6). These results could suggest that most 
of the additive genetic risk for astigmatism arises from the combined effect of many individual 
risk variants, each of which has a small effect. Alternatively, it should be noted that the axis was 
not taken into account in our analyses. Among younger individuals, astigmatism generally goes 
“with the rule”, whereas astigmatism generally while in later life it usually switches to “against the 
rule” in older individuals48,49. A loosening of eyelid tension is the most widely supported theory 
explaining this change50. Thus, if against-the-rule and with-the-rule astigmatism have different 
etiologies, future GWAS analyses should achieve maximum statistical power by analyzing these 
two types of astigmatisms separately, and they should stratify their analyses by age. A third 
possibility for the lack of more genetic hits for astigmatism could be the case-control design of the 
study; a quantitative endophenotype—rather than a binary trait—can be used in future analyses 
to increase power.
From the genes identified in Chapter 3, we can annotate several pathways associated with 
refractive error, myopia, and axial length (Table 1; Figure 2). These pathways are consistent with 
the current hypothesis regarding myopia pathogenesis: a visually evoked signaling cascade 
(neurotransmission, signaling, retinoic acid genes) originates in the retina (neuronal development, 
ganglion cell genes), traverses the retinal pigment epithelium and choroid (signaling, intracellular 
movement genes), and terminates in the sclera, where active remodeling of the extracellular 
matrix (extracellular matrix genes, retinoic acid, apoptosis genes) causes an elongation of the eye 
(Figure 3). These neuronal development‒related genes may exert their effects at multiple sites in 
this signaling cascade. 
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Table 1. Genes identified for spherical equivalent and axial length annotated to genetic pathways
Genes identified by studies incorporated in this thesis are shown in bold. Genes with a * are 
associated with both spherical equivalent and axial length.
 Genes Pathway / Function
S
ph
er
ic
al
 e
qu
iv
al
en
t, 
m
yo
pi
a,
 a
nd
 h
yp
er
op
ia
GJD2*, RASGRF1 Neurotransmission
KCNQ5, CACNA1D, KCNJ2, KCNMA1 Ion channels
RBFOX1, CHRNG, PDE10A, GPR25, PDE11A Signal transduction
PDE11A, PTPRR MAPK signaling
BICC1, SFRP1, TCF7L2 Wnt signaling
CNDP2, MIPEP, NPLOC4, PZP, B4GALNT2 Protein processing
RDH5, CYP26A1, MAP2K, RGR Retinoic acid metabolism
LAMA2*, BMP2, BMP3, BMP4, ADAMTSL1, UND Extracellular matrix remodeling
GRIA4, ARID, GABRR1 GABA / glutamate signaling
TJP2, LRFN5 Cell adhesion
SIX6, PRSS56, CHD7, CTNND2, RORB, DLX1, ZNF64 Eye development
ZIC2 Ganglion cell growth
CD55*, C1QTNF9B Complement cascade
ZMAT4 DNA binding
AREG Cell growth
MYO1D Intracellular movements
LRRRC4, DLG2 Neuronal development
BLID Apoptosis
SHISA6, TOX, LOC100506035, SLC14A2, LINC00340, 
FAM150B, BI480957, 
Unknown
CA8, EHBP1L1, PABPCP2, QKI, SETMAR, SH3GL2, 
TMEM98, ZBTB38
A
xi
al
 le
ng
th
GJD2* Neurotransmission
LAMA2* Extracellular matrix remodeling
CD55* Complement cascade
RSPO1, ZNRF3 Wnt signaling
ZC3H11B RNA binding and processing
C3orf26, ALPPL2, TIMELESS Unknown
Environmental factors and gene-environment interactions
In Chapter 4, we discuss environmental factors and gene-environment interactions with respect 
to the pathogenesis of myopia. Many studies found that lifestyle factors play a key role in the 
onset and progression of myopia51,52. Indeed, compelling evidence suggests that the rising 
prevalence of myopia can be attributed largely to environmental factors that are associated with 
increased education and urbanization53. Importantly, education has a particularly high association 
with myopia; specifically, individuals with university or high vocational education have a 5-8-fold 
higher risk of having myopia than individuals who completed only primary school53,54. In Chapter 
4.1, we investigated the rising prevalence of myopia throughout Europe, and we asked whether 
rising education levels might explain this trend. We found that higher education is an additive 
factor—rather than an explanatory factor—in this cohort effect. Similar effects have been observed 
with respect to urban areas versus rural areas, with urban regions having a significantly higher 
prevalence of myopia55. 
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The association between these environmental factors and myopia has been investigated, and two 
key observations have emerged: (1) myopic children generally spend less time outdoors than non-
myopic children, and (2) myopic children perform more near work at an earlier age compared to 
non-myopic children56-58. The putative protective effect of spending more time outdoors is believed 
to be due to light intensity59; indoor illumination is approximately 500 lux, whereas outdoor light 
levels generally exceed 20,000 lux during the day. Higher light intensity has been associated with 
higher dopamine release in the retina60, and animal studies have shown that increased dopamine 
Figure 2. Pathway analysis for myopia genes 
Adapted from Hysi et al.113 Network connections of genes associated with refractive error in CREAM 
(Chapter 3.3) and 23andMe 29. The genes directly identified in these GWAS analyses are shown in 
round nodes, and the linker elements are shown in diamond-shaped nodes. Key MAPK, TGF-beta/
SMAD pathway elements are shown in pink. Solid blue lines depict known protein–protein interactions; 
dashed blue lines depict co-regulation relationships. The network was constructed using the Reactome 
database114,115.
Figure 3. Schematic model of the myopia signaling cascade
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levels can slow elongation of the eyeball61. Dopamine is released in a light-dependent fashion, but 
its release also depends on the spatial feature of the image62. It is possible that the spatial tuning 
of the retinal neurons determines the signals for eye growth61.
The association between near work and myopia is less clear, as the type of near work is a difficult 
factor to study, and other factors—such as using handheld digital devices and reading—have led 
to inconsistent and/or poorly reproducible results63,64. One current hypothesis is that near work 
induces myopia due to long periods of defocus in the peripheral retina65, particularly in eyes that 
are prolate in shape (Figure 4)66.
Of all the risk factors for myopia identified to date, education is by far the most easily obtained, 
has robust variables, and is not likely to lead to misclassification. On the other hand, cultural 
differences in educational systems can make it difficult to compare studies performed in different 
parts of the world. In addition, many studies used years of study as a measure of education, 
without taking into account the intensity of the study53. Lastly, educational level has generally been 
considered a surrogate measurement for cumulative near work activity, and one could argue that 
better results would likely be obtained by measuring near work activity directly. 
Having reviewed the advantages and disadvantages of studying education as an environmental 
factor, given that myopia likely results from interactions between the effects of genes and the 
environment, a study of combined effects is clearly warranted. We therefore studied the role of 
education in the development of myopia, and we performed gene-by-environment interaction 
analyses. We found an interaction between education and genetic risk; specifically, patients with 
both high genetic load and a university-level education had a much higher risk of myopia than 
patients with only one of these two factors (Chapter 4.2). This interaction was specific to three 
genetic loci, SHISA6-DNAH9, GJD2, and ZMAT4-SFRP167. 
In Chapter 4.3, we used a gene-environment-wide interaction study (GEWIS) to test the joint 
Figure 4. Peripheral hyperopic defocus
Prolate-shaped eyes have a relatively high depth of hyperopic defocus in the periphery. This may trigger 
elongation of the eye.
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contribution of the main effect of the SNP and SNP-by-education effects. Using this approach, 
we identified ten novel loci associated with refractive error in our CREAM cohort. These findings 
demonstrate the value of applying the joint methods recently proposed by Manning et al.68 by 
incorporating a clearly associated environmental risk factor in order to identify novel genetic risk 
factors, thereby shedding light on the mechanisms that lead to myopia. The novel genetic loci 
associated with refractive error could not have been identified using standard GWAS approaches. 
Our studies gene-by-environment interactions suggest that environmental factors are the requisite 
trigger for gene expression, thereby causing myopia. This interaction likely accounts for the recent 
increase in prevalence in association with increased education and urbanization. 
Interestingly, our GEWIS approach revealed strong interaction effects only in the Asian cohorts. 
This could imply that interaction effects in Caucasians may be too small to be detected using these 
methods, for example due to high variability among educational systems in Western countries. 
As discussed above, education may not be an accurate surrogate for measuring cumulative 
near work activity among Caucasian adults. We also propose that the strong interaction effects 
measured in Asian cohorts may underlie the remarkably higher prevalence of myopia in Asian 
countries compared to Western countries. 
Functional mechanisms of myopia
Studies of refractive error in a variety of animals—including chickens, rats, mice, marmots, guinea 
pigs, and monkeys—have laid the foundation for our understanding of the effect of visual input 
on eye growth. Several experimental strategies have been used to induce myopia in animals, 
including form deprivation (by blurring the eye), visual deprivation (by suturing the eyelid 
closed)69-72, and placing a negative (i.e., concave) lens in front of the eye73-76. Placing a positive 
lens in front of the eye counteracts myopia by slowing eye growth77. These lens-induced effects 
appear to be independent of visual transmission to the brain, as they are also observed in animals 
with a disrupted optic nerve. Recent animal studies demonstrated that the peripheral retina is 
more responsive to blur than the macula66,78, and experiments with monkeys and chickens support 
the notion that peripheral retinal defocus is a stimulus for the onset of myopia66,79. 
One question that arises from these animal studies is the retinal cell type(s) that are responsible 
for the development of myopia. Many genes that were found to be associated with spherical 
equivalent in our GWASs  played a role in retinal neurotransmission, suggesting that photoreceptor 
cells may be important in myopia development. To address this question further, we were fortunate 
to have access to ophthalmogenetic clinics to study a large series of retinal dystrophy patients. 
These patients mostly have a Mendelian cause to their disease, affecting only one retinal cell type 
as the primary site. In Chapter 5, we studied refractive error in a group of 302 patients with a 
variety of inherited retinal dystrophies; our results confirmed previous reports that the prevalence 
of refractive error is significantly higher in these patients80-87. Patients with a cone dystrophy or 
retinitis pigmentosa generally present with mild myopia. However, patients with congenital 
stationary night blindness (CSNB)—which is caused by defective signaling from photoreceptors to 
the ON-bipolar cells in the retina—often present with either high myopia or high hyperopia. Bipolar 
cells play an essential role in the retinal microcircuitry, transmitting signals from photoreceptors 
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to ganglion cells88. Bipolar cells can be divided into the ON subtype and the OFF subtype based 
on whether the cells have an excitatory or inhibitory response to light exposure. Rod cells signal 
primarily through ON-bipolar cells, whereas cone cells signal via both ON-bipolar cells and OFF-
bipolar cells89. This finding sheds new light on myopia pathogenesis and suggests that we should 
also focus on ON-bipolar cells as a key player in the development of myopia. 
METHODOLOGICAL CONSIDERATIONS
Relevant methodological issues have been addressed in the respective discussion sections of 
each individual chapter. Here, we will highlight some of the general methods and issues that we 
encountered. 
Phenotyping issues
Interpreting the evidence available regarding the prevalence and pathogenesis of myopia and 
refractive error can have several issues. In this thesis, we mainly used spherical equivalent to 
analyze refractive error as a quantitative trait, as data regarding the sphere and cylinder are 
clinically relevant and were readily available for all cohorts. The disadvantage of using either 
refractive error or spherical equivalent is that they are composite variables determined primarily 
by axial length and corneal curvature18,39,40. Thus, analyzing axial length (AL), corneal curvature 
(CC), or the AL/CC ratio may yield more objective, precise, and reproducible results compared to 
analyzing refractive status. However, AL and CC are not commonly measured in clinical practice 
and were not measured in our study settings. Other factors that were not addressed in this thesis 
are peripheral refraction and the shape of the eyeball.
With respect to analyzing dichotomous or categorical variables, significant differences exist in the 
definitions of myopia and high myopia7,40,53. Myopia is commonly defined as an SE of –0.5 D or 
worse, whereas high myopia is defined (rather arbitrarily) using a cutoff that ranges from –5 D to 
–10 D. Fortunately, throughout this thesis and including the consortium papers arising from the E3 
and CREAM studies (Chapters 2.1, 3.2, and 3.3), we used consistent thresholds for myopia and 
high myopia (‒0.75 D and ‒6 D, respectively). 
Genome-wide association studies
In Chapter 3, we used the GWAS approach to identify genetic associations for several refractive 
phenotypes. GWAS approaches have successfully identified hundreds of genetic variants 
associated with complex human diseases and traits, and they yielded valuable insights into their 
genetic architecture90. The main advantage of a GWAS is that it offers a hypothesis-free alternative 
that is often more appropriate for the genetic dissection of complex traits that are affected by 
several genetic variants. A large GWAS can have the statistical power needed to yield highly 
reliable results, and it can provide the firm foundation needed to draw the first lessons from genetic 
analyses of a complex genetic trait. However, the use of a GWAS can have its limitations as well. 
First, if multiple genes are involved in a trait, large sample sizes and replication studies 
are needed in order to detect an association. This requires the formation of collaborative 
consortia in order to recruit sufficient numbers of participants for meta-analyses. A 
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drawback of these consortia is that they consist of many cohorts, thereby increasing 
heterogeneity among the phenotypes and genotypes being studied. Thus, we were 
able to identify only highly consistent SNP effects in all cohorts. Due to geographical 
differences between cohorts, specific variants might exist but may not have been detected. 
 
Second, the alleles identified using a GWAS are usually not the causative alleles but are in linkage 
disequilibrium with the true causative variants. Identifying the causal variant in an associated 
locus can be difficult due to this linkage disequilibrium or because most GWAS loci contain 
multiple genes (or no genes at all). Relatively few of the proposed candidate genes have been 
experimentally validated. Indeed, the only way to show causality is to determine the biological 
pathway and the precise role that the gene plays in producing the trait or disease. Because we 
identified associations with quantitative effects, it might not be necessary to identify the precise 
causal variant underlying all identified associations. At minimum, we must investigate the functional 
role of the gene in order to reliably identify the pathway(s) involved. This is particularly true for 
genetic variants that are located in gene deserts in the vicinity of specific genes. Thus, the results 
obtained from a GWAS should always be interpreted using functional data.
Lastly, the genetic variants identified by our study explain only a small fraction of the total 
heritability of these traits. Despite the high number of loci identified to date, only approximately 
12% of the phenotypic variance is explained (Verhoeven et al., ARVO 2014, unpublished data). 
Given that the expected estimate of the total heritability of refractive error is approximately 71%17, 
much of the heritability underlying refractive error and myopia is still missing. There are two 
plausible explanations for this finding: (1) we focused on common variants, and rare variants are 
still undiscovered91; or (2) gene-gene and gene-environment interactions determine some of the 
variance92,93. Below, we discuss strategies for identifying risk variants and for further identifying 
this missing heritability.
Due to the above-mentioned limitations, GWAS approaches have been met with considerable 
skepticism with respect to their clinical applicability. Nevertheless, several GWAS findings have 
been translated successfully to clinical applications, including risk prediction, disease classification, 
drug development and drug toxicity94. Moreover, our studies have revealed putative pathways 
underlying myopia and refractive error; these pathways would not have been identified using other 
approaches. These results will serve as the starting points for future research. Translating these 
findings into direct health benefits will require an interaction between many biomedical dis ciplines, 
including genomics, molecular biology, bioinformatics, clinical medicine, and pharmacology94,95, 
and will be discussed in the next paragraph.
FUTURE DIRECTIONS
The studies described in this thesis represent an important step towards identifying genetic 
associations, and they provide important hints for potential pathways. Future research should 
focus largely on issues regarding methodological considerations, including (1) studying other 
endophenotypes of myopia and refractive error, including peripheral refraction and eyeball 
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shape; (2) identifying the missing heritability by identifying rare variants, gene-gene interactions, 
and gene-environment interactions; (3) performing experimental tests and interpreting the 
pathophysiological consequences of risks at the molecular level; and (4) translating these results 
into direct health benefits.
To identify rare variants in refractive phenotypes, we should use more detailed imputations 
(e.g., 1000 Genomes) and more in-depth genotyping (e.g., exome sequencing, whole-genome 
sequencing). Given the high overlap in results, a logical first step will be to perform a meta-analysis 
of the datasets from the CREAM (Chapter 3.2) and 23andMe29 studies. This approach will allow us 
to study low-frequency alleles using the more detailed 1000 Genomes imputations, thus yielding 
more comprehensive results without the need for de novo sequencing. This larger sample size will 
likely enable us to identify more common genetic variants with relatively modest individual effects. 
This work is currently ongoing. Moreover, future research should include comprehensive analyses 
of exome sequencing and whole-genome sequencing experiments, as previous studies showed 
that approach can be used to identify rare genetic risk factors for myopia96-98. In the future, we will 
focus our analysis on patients with an extreme phenotype (i.e., spherical equivalent of ‒10 D or 
worse) and affected families. 
Determining the relationship between genes and the environment can also reveal much of the 
variance in complex traits92; therefore, studies of gene-environment interactions are needed as 
well. In this thesis, we focused primarily on education as an environmental risk factor. Future 
research should investigate gene-environment interactions using other risk factors for myopia, 
including near work and outside activity. As misclassification is an important bias appearing in 
GEWIS99, future analyses should aim to optimize study designs in order to minimize this effect 
(e.g. use standardized questionnaires to assess environmental factors). Additionally, studying 
gene-environment interactions at a molecular level is only possible in animal studies, where 
environmental factors can be controlled in laboratory settings.
The causative genes may be identified by searching for rare alleles, and they can be validated 
using functional studies. As discussed above, it might not be necessary to identify the precise 
causal variant for all identified associations. For functional follow-up studies, we suggest to 
select those associations identified from our previous GWAS that have a relatively large effect 
size, associations that were replicated in other studies (e.g., 23andMe29 and/or follow-up studies), 
associations that are in or near plausible candidate genes and candidate genes with known 
expression in the eye. 
In addition, knockout animals (for example, genetically modified zebrafish or knockout mice) 
can be a powerful tool for studying the genetics of myopia at the functional level. The zebrafish 
embryo develops externally and is transparent; moreover, the embryo’s eyes are relatively large 
and easy to measure, and the emmetropization process develops rapidly during embryogenesis. 
The genetic control of eye growth and the retinal structure are highly conserved between zebrafish 
and humans100. Several studies have already demonstrated the power of using zebrafish to 
study myopia genetics and for testing therapeutic interventions, as zebrafish larvae can absorb 
drugs that are dissolved in the water101-103. Mouse models provide another powerful approach for 
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studying myopia genetics. The mouse genome is highly homologous to the human genome and 
can be manipulated with relative ease. Genetically modified mice are currently available for a large 
number of myopia-associated genes. Moreover, previous studies have shown that myopia can be 
induced in mice104-106, making mice highly amenable to the study of genetically and environmentally 
induced myopia107,108. Other items that should be considered in future mypia studies are 
mechanisms governing expression, such as histone modifications, microRNAs, long non-coding 
RNAs, epigenetics, splice variants, and posttranslational modifications of the encoded proteins. 
 
Systems biology is an additional powerful method for investigating pathways involved in complex 
genetic diseases. Systems biology is an emerging approach that focuses on complex interactions 
within biological systems in order to define disease mechanisms based on cell signaling and 
metabolic networks. Although the cellular basis of myopia pathogenesis is currently unknown, 
our findings—combined with the findings from 1000 Genomes, exome-sequencing analyses, 
animal studies, and other published studies—can form the starting point for in silico modeling and 
functional characterization of the pathways that lead to high myopia. Systems biology will likely 
reveal pathways that are critical for myopia, the cells and/or extracellular compartments involved 
in these pathways, and putative targets for therapeutic research and prevention modalities109.
One of the major goals of genomics research is to use GWAS findings to develop clinically relevant 
gene-based tests and therapeutic strategies targeted to disease-related molecular events94. With 
respect to age-related macular degeneration, considerable progress has been made in these 
areas110-112. When most of the risk factors for a disease are known, these factors can be used to 
predict the disease, thereby helping future clinical trials select high-risk groups for intervention at a 
young age. The ultimate goal is to identify high-risk groups according to pathways, and  treat these 
patients with regimens focused on intervention of the major pathways involved. The treatment 
target is  prevention of myopic refractive error from exceeding ‒6 D. 
FINAL REMARKS
Answering the question of why eyes become myopic cannot be answered easily. Many factors 
determine the pathway from emmetropia to myopia. Although genetic factors provide much of 
the patient’s susceptibility, environmental factors are key players in triggering the conversion 
to myopia pathogenesis. Many genetic risk variants for myopia remain to be identified, and 
researchers are exploiting new methods to discover the more rare genetic risk factors, including 
exome sequencing and whole-genome sequencing. Several studies have shown that lifestyle 
factors—in particular, education level and outdoor exposure—play a key role in the onset and 
progression of myopia. Focusing future research on the network of molecules involved, and their 
response to environmental stimuli, should create new strategies for intervention and prevention, 
ultimately reducing the prevalence of myopia-related visual impairment and blindness.
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SUMMARY
Myopia (nearsightedness) is a highly common eye condition that is predominantly caused by an 
axial elongation of the eye. Myopia can usually be corrected with negative glasses, contact lenses, 
and/or laser refractive surgery. Unfortunately, however, high myopia (defined as refractive error 
greater than ‒6 diopters) can lead to structural changes in the retina and optic disc, resulting in 
severe complications such as myopic macular degeneration, glaucoma, and retinal detachment. 
Although myopia results from an interplay between genetic and environmental risk factors, how 
these factors interrelate and cause disease at the molecular level remains poorly understood.
The main objectives of this thesis were as follows: 1) assess the current prevalence and 
visual consequences of myopia and refractive error; 2) identify genetic risk factors for 
myopia and refractive error; 3) investigate gene-environment interactions; and 4) describe 
the functional mechanisms that underlie the development of myopia. Our study population 
included the large population-based Rotterdam Study, the Erasmus Rucphen Family (ERF) 
Study, the high myopia case control study MYST, many Asian and Caucasian population-
based cohort studies from the Consortium for Refractive Error and Myopia (CREAM) and the 
European Eye Epidemiology (E3) consortium, and patients from the national RD5000 database. 
 
Chapter 1 gives a general introduction to myopia and refractive error and describes the main 
aims of this thesis. Chapter 2 discusses the prevalence and impact of myopia and refractive error. 
Chapter 2.1 describes the prevalence of refractive error specifically in Europe. We found that 
more than half of all adult Europeans have refractive error. The greatest burden from refractive 
error is associated with myopia, with prevalence rates of 30% and 3% for myopia and high myopia, 
respectively. The highest prevalence of myopia occurs among young adults, reflecting the rising 
prevalence of myopia in younger generations. In Chapter 2.2, we studied the causes of blindness 
and low vision in relation to refractive error. We found that visual impairment occurs in one-third 
of individuals with high myopia, and this impairment is caused primarily by myopic macular 
degeneration. The highest risk of visual impairment is among individuals with severe refractive 
error (‒10 D or more). We further explored the risks of visual impairment in relation to axial length 
in Chapter 2.3. The risk of visual impairment in high myopes was highly correlated with axial 
length and reached extreme figures at eyes with an axial length ≥30 mm; >90% of these eyes 
was visually impaired. These data underscore the need for a proper treatment for high myopia, as 
reducing progressive eye growth to achieve a lower final axial length would significantly decrease 
the patient’s risk of developing visual impairment later in life. Indeed, each incremental decrease 
in final AL will improve the patient’s long-term prognosis in terms of preserving visual acuity. 
In Chapter 3, we report on the genetic risk factors that we identified for refractive error and 
several myopia endophenotypes using genome-wide association studies (GWAS). Chapter 
3.1 and Chapter 3.2 describe the identification and confirmation of two genetic risk factors for 
common refractive error. These loci are located on chromosome 15q14 and 15q25, and the 
closest genes are GJD2 and RASGRF1, respectively. Identifying the functions of these genes 
has led to new hypotheses regarding the development of myopia, as each gene plays a role in 
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retinal neurotransmission. In Chapter 3.3, we discuss a large-scale GWAS meta-analysis of the 
CREAM consortium, in which we identified an additional 24 loci associated with refractive error. 
The associated genes within these loci are involved in neurotransmission, ion transport, retinoic 
acid metabolism, extracellular matrix remodeling, and eye development. Thus, these pathways 
fit nicely into the current hypothesis regarding myopia pathogenesis. In Chapter 3.4, we report 
nine loci for axial length that were identified from another GWAS meta-analysis of the CREAM 
consortium. Two of these genes are involved in Wnt signaling, a pathway that plays a major role in 
regulating eyeball size. Our meta-analysis of nine myopia and hyperopia genome-wide association 
studies is presented in Chapter 3.5, which provides further evidence that some of the CREAM loci 
are also associated with these phenotypes. Chapter 3.6 summarizes the results of a third CREAM 
meta-analysis in which we identified several novel candidate genes for refractive astigmatism. 
Furthermore, this work provided evidence to support widespread genetic co-susceptibility to 
spherical and astigmatic refractive errors.
In Chapter 4, we describe the role of education (an environmental risk factor) in the development 
of myopia, and we provide compelling evidence of a gene-by-environment interaction. In Chapter 
4.1, we report that the prevalence of myopia is increasing in Europe. We conclude that although 
education levels have risen and are generally associated with myopia, higher education appears 
to be an additive—rather than explanatory—factor. In Chapter 4.2, we discuss the identification of 
a significant biological interaction between education and the genetic risk of myopia, represented 
by our reported associated genetic risk factors. Specifically, subjects with many variants in myopia 
genes and a high educational level (e.g., university education) were significantly more likely to 
develop myopia than subjects with only one of these two factors. In Chapter 4.3, we discuss the 
identification of ten novel loci associated with refractive error; these loci were identified in the 
CREAM consortium using a genome-wide gene-by-environment approach. These data provide 
convincing evidence that specific genetic variants interact with education to influence refractive 
development, and they further support a role for GABAergic neurotransmission in the development 
of myopia. 
In Chapter 5, we discuss our study of refractive errors in patients with inherited retinal dystrophies. 
We found that refractive error—and myopia in particular—are common among these patients. 
Especially patients with congenital stationary night blindness, which is caused by defective retinal 
signaling from photoreceptors to the ON-bipolar cells, often present with both high myopia and 
high hyperopia. Patients with X-linked retinitis pigmentosa mainly presented with high myopia. 
In contrast, patients with cone dystrophies and retinitis pigmentosa generally present with mild 
myopia. This finding suggests that ON-bipolar cells play a specific role in the development of 
myopia. 
Lastly, Chapter 6 provides an overview of our main findings, a general interpretation of these 
findings, and the implications of our results. In addition, we discuss strategies for future research. 
The studies described in this thesis have provided considerable insight into the complex genetic 
and environmental factors that give rise to myopia and refractive error, and they have given us new 
directions for treating and/or preventing this rising health issue.
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Myopie (bijziendheid) is een veelvoorkomende oogaandoening die ontstaat door een verlenging 
van de oogas. Myopie kan doorgaans worden gecorrigeerd met een bril, contactlenzen en/of 
laserbehandeling of refractiechirurgie. Helaas kan hoge myopie (gedefinieerd als brilsterkte van 
meer dan -6 dioptrieën) leiden tot structurele veranderingen van het netvlies en de oogzenuw, 
waardoor ernstige complicaties zoals myope maculadegeneratie, glaucoom en netvliesloslatingen 
kunnen optreden. Het was allang bekend dat myopie ontstaat door een samenspel tussen genetische 
factoren en omgevingsfactoren (bijv. veel lezen en weinig buitenspelen), maar het was onbekend 
om welke genetische factoren het precies ging en hoe de samenhang was tussen deze factoren. 
De belangrijkste vragen die we met dit proefschrift wilden beantwoorden waren: 1) Hoe vaak komen 
myopie en refractieafwijkingen voor en wat zijn de visuele gevolgen ervan? 2) Welke genetische 
factoren veroorzaken myopie en refractieafwijkingen? 3) Hoe is de samenhang tussen genetische 
factoren en omgevingsfactoren? en 4) Welke functionele mechanismen liggen ten grondslag aan 
het ontstaan van myopie?
Onze studiepopulatie bestond uit het Erasmus Rotterdam Gezondheid Onderzoek (ERGO, ook wel 
Rotterdam Studie genoemd), de Erasmus Rucphen Familie Studie (ERF), de case control MYopie 
STudie (MYST), Aziatische, Europese, Amerikaanse en Australische studies van het Consortium 
of Refractive Error and Myopia (CREAM) en het European Eye Epidemiology (E3) consortium, en 
patiënten uit de nationale RD5000 database.
Hoofdstuk 1 geeft een algemene introductie over myopie en refractieafwijkingen. Hoofdstuk 2 geeft 
weer hoe vaak myopie en refractieafwijkingen voorkomen en wat de visuele gevolgen ervan zijn. In 
Hoofdstuk 2.1 onderzochten we hoe vaak refractieafwijkingen voorkomen in Europa. We vonden 
dat meer dan de helft van alle volwassen Europeanen een refractieafwijking heeft. Myopie komt het 
vaakst voor; 30% van alle Europeanen is myoop, 3% is hoog myoop. Er is sprake van een stijgende 
frequentie van myopie bij jongere generaties. In Hoofdstuk 2.2 hebben we onderzocht hoe vaak 
mensen met een refractieafwijking blind of slechtziend worden en wat de oorzaken hiervan zijn. We 
vonden dat een derde van de mensen met een hoge myopie blind of slechtziend wordt, en dat dit 
voornamelijk veroorzaakt wordt door myope maculadegeneratie. Mensen met een zeer hoge myopie 
(-10 D of meer) hebben het grootste risico om slechtziend te worden. Daarnaast onderzochten we 
de relatie tussen oogaslengte en slechtziendheid in Hoofdstuk 2.3. Het risico op slechtziendheid 
wordt hoger naarmate de aslengte langer wordt. Bij een hogere aslengte wordt dit effect duidelijker; 
ruim 90% van de ogen met een aslengte groter dan 30 mm wordt uiteindelijk slechtziend. Deze data 
benadrukken de noodzaak van het ontwikkelen van een goede behandeling voor hoge myopie. 
Zelfs een  geringe afname in de uiteindelijke aslengte van het oog van een patiënt met hoge myopie 
kan de visuele prognose op lange termijn sterk verbeteren.
In Hoofdstuk 3 doen we verslag van de genetische risicofactoren die we geïdentificeerd hebben 
voor refractieafwijkingen en myopie met behulp van genoomwijde associatie studies (GWAS). In 
Hoofdstuk 3.1 en Hoofdstuk 3.2 identificeerden en bevestigden we twee genetische risicofactoren 
voor refractieafwijkingen. Deze genetische factoren liggen op chromosoom 15q14 en 15q25, dichtbij 
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het GJD2- en RASGRF1-gen. Beiden genen spelen een rol in het doorgeven van signalen binnen het 
netvlies en dit leverde de eerste nieuwe inzichten in het ontstaan van myopie op. In Hoofdstuk 3.3 
bespreken we een grootschalige meta-analyse van GWAS studies binnen het CREAM consortium, 
waarin we nog eens 24 extra genetische factoren voor refractieafwijkingen vonden. De dichtbij 
gelegen genen zijn betrokken bij doorgeven van signalen en transporteren van moleculen in het 
netvlies, de vitamine A cyclus, de opbouw van het bindweefsel rondom het oog en bij de ontwikkeling 
van het oog. Deze functies passen binnen de huidige hypothese over het ontstaan van myopie. In 
Hoofdstuk 3.4 vonden wij bij een andere meta-analyse binnen CREAM negen genetische factoren 
voor aslengte. Twee van deze genen zijn betrokken bij Wnt signalering, dat een belangrijke rol heeft 
bij het reguleren van de oogbolgrootte. In Hoofdstuk 3.5 vonden we bewijs dat de genetische 
factoren voor refractieafwijkingen uit de studies van CREAM ook geassocieerd zijn met de extreme 
waarden van deze continue factor, namelijk met myopie en hyperopie (verziendheid). In Hoofdstuk 
3.6 rapporteren we over een derde CREAM meta-analyse waarin we nieuwe genetische factoren 
voor astigmatisme identificeerden. 
In Hoofdstuk 4 beschrijven we de rol van opleidingsniveau (een omgevingsfactor) in de ontwikkeling 
van myopie, en leveren wij overtuigend bewijs dat er interactie bestaat tussen genetische factoren 
en omgeving. In Hoofdstuk 4.1 melden wij dat de frequentie van myopie in Europa toeneemt en 
dat dit deels verklaard kan worden door een toename in het opleidingsniveau van de bevolking. 
In Hoofdstuk 4.2 vinden we interactie tussen opleidingsniveau en genetisch risico op myopie. 
Personen met een hoog genetisch risico én een hoog opleidingsniveau (bijv. een universitaire 
studie) hadden een veel grotere kans om myoop te worden dan personen met slechts één van 
beide factoren. In Hoofdstuk 4.3 hebben we in CREAM een genoombrede methode gebruikt om 
gen-omgevingsinteractie op te sporen; op deze manier vonden we tien nieuwe genetische factoren 
voor refractieafwijkingen die ook interactie vertonen met opleidingsniveau.
In Hoofdstuk 5 bespreken we onze studie naar refractieafwijkingen bij patiënten met erfelijke retina 
dystrofieën, aandoeningen van het netvlies. We vonden dat refractieafwijkingen, en myopie in het 
bijzonder, vaak voorkomen bij deze patiëntengroep. Vooral patiënten met congenitale stationaire 
nachtblindheid, een aandoening die veroorzaakt wordt door een defect in de signaaloverdracht 
tussen fotoreceptoren en bipolaire cellen in het netvlies, waren vaak ofwel hoog myoop ofwel hoog 
hyperoop (verziend). Patiënten met geslachtsgebonden retinitis pigmentosa hadden vaak een 
hoge myopie. Patiënten met kegeldystrofie en retinitis pigmentosa daarentegen hadden over het 
algemeen een milde myopie. Deze bevinding suggereert dat bipolaire cellen een belangrijke rol 
spelen bij het ontstaan van myopie.
Tenslotte geeft Hoofdstuk 6 een overzicht van onze belangrijkste bevindingen, een algemene 
interpretatie en de betekenis van onze resultaten. Daarnaast bespreken we strategieën voor 
toekomstig myopieonderzoek.
De in dit proefschrift beschreven studies hebben veel inzicht verschaft in de complexe achtergrond 
van myopie en refractieafwijkingen, die ontstaan door een samenspel tussen genetische factoren en 
omgevingsfactoren. Deze geven ons nieuwe richtingen voor onderzoek naar mogelijkheden tot het 
behandelen en/of voorkomen van dit toenemende gezondheidsprobleem.
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PHD PORTFOLIO 
SUMMARY OF PHD TRAINING AND TEACHING
Name PhD student: Virginie Verhoeven
Erasmus MC Department: Ophthalmology/Epidemiology
Research School: NIHES
PhD period: 2009-2015 
Promotors: prof. dr. C.C.W. Klaver and prof. dr. J.R. Vingerling
1. PhD training Year Workload 
(ECTS*)
Courses 
Master of Health Sciences, Genetic Epidemiology (NIHES) 2009-2012 70
Workshop on Photoshop and Illustrator CS5 (MolMed) 2011 0.3
Workshop on InDesign CS5 (MolMed) 2011 0.2
Biomedical English Writing and Communication (David Alexander) 2011 4.0
Next-Generation Sequencing course (MGC, Boerhaave) 2011 0.9
Seminars, symposia and workshops
Myopia workshop for opticians and optometrists, Rotterdam (oral 
presentation)
2009 1.0
Myopia workshop for ophthalmologists, Rotterdam (oral presentation) 2009 1.0
LVAO course optics and refractive surgery, Utrecht 2010 0.3
International Course Genetics in Retinal Disease, Rotterdam 2010 0.3
Research Day Rotterdam Eye Hospital, Rotterdam (oral presentation) 2010 1.0
ARVO-NED, Utrecht (oral presentation) 2010 1.0
1st European Eye Epidemiology Workshop, Bordeaux, France (oral 
presentation)
2011 1.0
CREAM consortium meeting 2012, Rotterdam (oral presentation) 2012 1.0
CREAM consortium meeting 2012, Sardinia, Italy (oral presentation) 2012 2.0
3rd European Eye Epidemiology Workshop, Bordeaux, France 2013 0.3
CREAM consortium meeting 2013, Singapore (oral presentation) 2013 2.0
CREAM consortium meeting 2014, Hong Kong (oral presentation) 2014 2.0
Co-organizer of the Epi 2020 meetings, department of Epidemiology, 
Erasmus MC
2012-2013 1.0
Research seminars, department of Epidemiology, Erasmus MC 2009-2013 4.5
National conferences
NOG Annual Meeting 2010, Maastricht 2010 0.3
SEOHS 2010, Rotterdam (oral presentation) 2010 1.0
15th Molecular Medicine Day, Rotterdam (invited oral presentation) 2011 1.0
NOG Annual Meeting 2011, Maastricht (oral presentation) 2011 1.0
NOG Annual Meeting 2012, Groningen (oral presentation) 2012 1.0
NOG Annual Meeting 2013, Groningen (oral presentation) 2013 1.0
2nd Dutch Ophthalmology PhD Day, Nijmegen (oral presentation) 2013 1.0
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International conferences
ARVO Annual Meeting 2010, Fort Lauderdale, USA (oral presentation) 2010 1.0
International Myopia Conference 2010, Tübingen, Germany (invited oral 
presentation)
2010 1.0
ARVO Annual Meeting 2011, Fort Lauderdale, USA (poster presentation) 2011 1.0
ARVO Annual Meeting 2012, Fort Lauderdale, USA (oral presentation) 2012 1.0
ARVO Annual Meeting 2013, Seattle, USA (oral presentation) 2013 1.0
ARVO Annual Meeting 2014, Orlando, USA (oral presentation) 2014 1.0
APGC-ISOHK 2014, Hong Kong (invited oral presentation) 2014 1.0
ASHG Annual Meeting 2014, San Diego, USA (poster presentation) 2014 1.0
ARVO Annual Meeting 2015, Denver, USA (invited oral presentation) 2015 1.0
2. Teaching - Supervising Master’s theses
Supervising research internship, King Wong (20 weeks) 2011 1.4
Supervising research internship, Michelle Hendriks (20 weeks) 2013 1.4
Supervising research internship, Martine Snabel (20 weeks) 2013 1.4
3. Other
Organizing committee Myopia workshops for opticians, optometrists and 
ophthalmologists, Rotterdam
2011 2.0
Founder and co-organizer of the 1st Dutch Ophthalmology PhD Day, 
Nijmegen
2012 3.0
Chair of myopia session, ARVO Annual Meeting 2014, Orlando, USA 2014 0.1
Secretary of the CREAM consortium 2010-today 4.0
Reviewer for several international journals 2009-today 1.0
Organizing committee CREAM consortium meetings Rotterdam, Sardinia, 
Singapore and Hong Kong
2012-today 4.0
* 1 ECTS (European Credit Transfer System) equals a workload of 28 hours.
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Stellingen behorende bij het proefschrift
WHAT CAUSES MYOPIA? 
Complex genetics and epidemiology of a common condition
1. 1 op de 3 personen met hoge bijziendheid (meer dan -6 dpt) wordt blind of slechtziend. 
(dit proefschrift)
2. Het GJD2-gen op chromosoom 15q14 speelt een belangrijke rol bij het ontstaan van 
myopie. (dit proefschrift) 
3. Neurotransmissie, extracellulaire matrix remodellering, retinolzuurmetabolisme en 
oogontwikkeling zijn belangrijke pathways voor het ontstaan van myopie. (dit proefschrift)
4. Personen met een hoog opleidingsniveau én een hoog genetisch risico hebben een vele 
malen grotere kans op bijziendheid dan personen met slechts één van deze factoren. 
(dit proefschrift)
5. Bipolaire cellen lijken een sleutelfunctie te vervullen bij het ontstaan van hoge myopie bij 
patiënten met een retinadystrofie. (dit proefschrift)
6. Het anamnestisch verkrijgen van brilsterkte data is net zo goed als het gedetailleerd 
meten van brilsterktes voor genetische studies naar myopie. (R. Wojciechowski & P.G. 
Hysi, PLoS Genet, 2013 Apr;9(4):e1003442).
7. Frequent (daily) consumption of curry may be protective against high myopia in 
Singaporean adults of Indian ethnicity. (A. Anuar, ARVO 2013, Invest Ophthalmol Vis 
Sci 2013;54:5705)
8. Als klinisch genetici zich naast Mendeliaanse ziekten ook gaan focussen op complex 
genetische aandoeningen, zal dit een deel van de werkgelegenheids problematiek in 
ons vakgebied oplossen.
9. Dat bijziendheid geassocieerd is met een hoger opleidingsniveau betekent niet dat 
verzienden dom zijn. 
10. Liever bijziend dan kortzichtig.
11. The best journey’s in life are those that answer questions you never thought to ask. (Rich 
Ridgeway)
Virginie J. M. Verhoeven, Rotterdam, 16 juni 2015
